% ------------------------------------------------------------------------
% SAMPLE BIBLIOGRAPHY FILE
% ------------------------------------------------------------------------
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%% Conclusion %%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
@ARTICLE{Zhou2018-tp,
  title     = "A systems approach to refine disease taxonomy by integrating
               phenotypic and molecular networks",
  author    = "Zhou, Xuezhong and Lei, Lei and Liu, Jun and Halu, Arda and
               Zhang, Yingying and Li, Bing and Guo, Zhili and Liu, Guangming
               and Sun, Changkai and Loscalzo, Joseph and Sharma, Amitabh and
               Wang, Zhong",
  journal   = "EBioMedicine",
  publisher = "Elsevier BV",
  volume    =  31,
  pages     = "79--91",
  month     =  may,
  year      =  2018,
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Grotzinger2022-ak,
  title     = "Genetic architecture of 11 major psychiatric disorders at
               biobehavioral, functional genomic and molecular genetic levels
               of analysis",
  author    = "Grotzinger, Andrew D and Mallard, Travis T and Akingbuwa,
               Wonuola A and Ip, Hill F and Adams, Mark J and Lewis, Cathryn M
               and McIntosh, Andrew M and Grove, Jakob and Dalsgaard, S{\o}ren
               and Lesch, Klaus-Peter and Strom, Nora and Meier, Sandra M and
               Mattheisen, Manuel and B{\o}rglum, Anders D and Mors, Ole and
               Breen, Gerome and {iPSYCH} and {Tourette Syndrome and Obsessive
               Compulsive Disorder Working Group of the Psychiatric Genetics
               Consortium} and {Bipolar Disorder Working Group of the
               Psychiatric Genetics Consortium} and {Major Depressive Disorder
               Working Group of the Psychiatric Genetics Consortium} and
               {Schizophrenia Working Group of the Psychiatric Genetics
               Consortium} and Lee, Phil H and Kendler, Kenneth S and Smoller,
               Jordan W and Tucker-Drob, Elliot M and Nivard, Michel G",
  abstract  = "We interrogate the joint genetic architecture of 11 major
               psychiatric disorders at biobehavioral, functional genomic and
               molecular genetic levels of analysis. We identify four broad
               factors (neurodevelopmental, compulsive, psychotic and
               internalizing) that underlie genetic correlations among the
               disorders and test whether these factors adequately explain
               their genetic correlations with biobehavioral traits. We
               introduce stratified genomic structural equation modeling, which
               we use to identify gene sets that disproportionately contribute
               to genetic risk sharing. This includes protein-truncating
               variant-intolerant genes expressed in excitatory and GABAergic
               brain cells that are enriched for genetic overlap across
               disorders with psychotic features. Multivariate association
               analyses detect 152 (20 new) independent loci that act on the
               individual factors and identify nine loci that act
               heterogeneously across disorders within a factor. Despite
               moderate-to-high genetic correlations across all 11 disorders,
               we find little utility of a single dimension of genetic risk
               across psychiatric disorders either at the level of
               biobehavioral correlates or at the level of individual variants.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  54,
  number    =  5,
  pages     = "548--559",
  month     =  may,
  year      =  2022,
  language  = "en"
}

@ARTICLE{Foxx-Orenstein2014-el,
  title    = "Common anorectal disorders",
  author   = "Foxx-Orenstein, Amy E and Umar, Sarah B and Crowell, Michael D",
  abstract = "Anorectal disorders result in many visits to healthcare
              specialists. These disorders include benign conditions such as
              hemorrhoids to more serious conditions such as malignancy; thus,
              it is important for the clinician to be familiar with these
              disorders as well as know how to conduct an appropriate history
              and physical examination. This article reviews the most common
              anorectal disorders, including hemorrhoids, anal fissures, fecal
              incontinence, proctalgia fugax, excessive perineal descent, and
              pruritus ani, and provides guidelines on comprehensive evaluation
              and management.",
  journal  = "Gastroenterol. Hepatol. (N. Y.)",
  volume   =  10,
  number   =  5,
  pages    = "294--301",
  month    =  may,
  year     =  2014,
  keywords = "Hemorrhoid; anal fissure; excessive perineal descent; fecal
              incontinence; fistula; proctalgia fugax; pruritus ani; rectoanal
              abscess",
  language = "en"
}

@ARTICLE{Felt-Bersma2009-am,
  title     = "Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae
               and sexually transmitted diseases",
  author    = "Felt-Bersma, Richelle J F and Bartelsman, Joep F",
  abstract  = "Anorectal disorders like haemorrhoids, rectal prolapse, anal
               fissures, peri-anal fistulae and sexually transmitted diseases
               are bothersome benign conditions that warrant special attention.
               They, however, can all be diagnosed by inspection or proctoscopy
               (sexually transmitted proctitis). Constipation can play an
               underlying role in haemorrhoids, rectal prolapse and anal
               fissures, and it is important to treat these conditions in order
               to avoid recurrences. Haemorrhoids and anal fissures are
               generally treated conservatively and surgery is seldom required.
               Rectal prolapse and cryptoglandular peri-anal fistulae are
               treated surgically. In a recurrent peri-anal fistula, the
               fistular tract needs to be visualised with anal ultrasound or
               magnetic resonance imaging (MRI). There are different techniques
               available for this evaluation, and care must be taken not to
               damage the anal sphincter. Peri-anal fistulae in Crohn's disease
               are treated conservatively and surgery is only required in cases
               with abscesses. Sexually transmitted proctitis needs to be
               adequately recognised and treated according to the infectious
               agent.",
  journal   = "Best Pract. Res. Clin. Gastroenterol.",
  publisher = "Elsevier BV",
  volume    =  23,
  number    =  4,
  pages     = "575--592",
  year      =  2009,
  language  = "en"
}

@ARTICLE{Garcia-Olmo2019-ql,
  title     = "Prevalence of anal fistulas in Europe: Systematic literature
               reviews and population-based database analysis",
  author    = "Garc{\'\i}a-Olmo, Dami{\'a}n and Van Assche, Gert and Tagarro,
               Ignacio and Diez, Mary Carmen and Richard, Marie Paule and
               Khalid, Javaria Mona and van Dijk, Marc and Bennett, Dimitri and
               Hokkanen, Suvi R K and Pan{\'e}s, Juli{\'a}n",
  abstract  = "INTRODUCTION: Despite the fact that perianal fistulas are
               associated with significant morbidity and impaired quality of
               life, their prevalence in Europe is unknown. The aim of this
               study was to estimate the prevalence of perianal fistulas in
               Europe, overall and according to etiology. METHODS: Two
               independent literature reviews were performed using different
               search strategies to maximize the identification of potentially
               relevant studies. Data from relevant articles were used to
               estimate the prevalence of perianal fistulas in Europe. The
               robustness of the estimate was evaluated using data from a large
               population-based database from the UK. RESULTS: A total of 26
               studies provided epidemiological data on perianal fistulas, of
               which 16 provided suitable data to estimate the prevalence.
               Estimations using these data yielded a total prevalence of 1.69
               per 10,000 population. Cryptoglandular infection and Crohn's
               disease (CD) were the predominant etiologies, with prevalence
               rates at 0.86 and 0.76 per 10,000 population, respectively.
               Comparison of prevalence data from the UK population-based
               database with the European population resulted in a standardized
               prevalence estimate of all perianal fistulas of 1.83 per 10,000
               population, confirming the robustness of the literature-based
               estimate. CONCLUSION: Although in terms of incidence
               cryptoglandular fistulas were clearly predominant, the
               prevalence of fistulas in CD and cryptoglandular infection
               appeared more balanced. This is due to the longer duration and
               higher frequency of relapses of fistulas in CD. The estimated
               prevalence implies that perianal fistulas meet the criteria to
               be considered as a rare condition in Europe (prevalence less
               than 5 per 10,000 population). FUNDING: This study was funded by
               Takeda Pharmaceutical U.S.A., Inc. and TiGenix SAU.",
  journal   = "Adv. Ther.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  36,
  number    =  12,
  pages     = "3503--3518",
  month     =  dec,
  year      =  2019,
  keywords  = "Anal fistula; Epidemiology; Europe; Incidence; Prevalence",
  copyright = "https://creativecommons.org/licenses/by-nc/4.0",
  language  = "en"
}

@ARTICLE{Hokkanen2019-ov,
  title     = "Prevalence of anal fistula in the United Kingdom",
  author    = "Hokkanen, Suvi Rk and Boxall, Naomi and Khalid, Javaria Mona and
               Bennett, Dimitri and Patel, Haridarshan",
  abstract  = "BACKGROUND: Anal fistula is a pathological connection between
               the anal canal and perianal skin, which most commonly develops
               from an infected anal crypt. While the majority of anal fistulas
               are idiopathic, they are also associated with Crohn's disease
               (CD) and other inflammatory conditions. The prevalence of anal
               fistula is estimated to be 1-2 per 10000 patients, but
               population-based studies on anal fistula epidemiology are
               limited and outdated. AIM: To assess the prevalence of anal
               fistula and relevant comorbidities, with and without CD in the
               United Kingdom and Europe. METHODS: A retrospective
               population-representative observational cohort study was
               performed in The Health Improvement Network (THIN), a United
               Kingdom primary care database. Mid-year point prevalence of anal
               fistula was calculated on the first of July for each year
               between 2014 and 2017. Estimates were calculated for anal
               fistula overall and by CD status and standardized to the United
               Kingdom and European population. Prevalence of relevant
               comorbidities including lymphogranuloma venereum, hidradenitis
               suppurativa, anal presentation of sexually transmitted diseases,
               diabetes mellitus, and radiation in the pelvic area was
               reported. RESULTS: The United Kingdom-standardized overall point
               prevalence of anal fistula was 1.80 (95\%CI: 1.65-1.94) per
               10000 patients in 2017, while the Europe standardized estimate
               was 1.83 (95\%CI: 1.68-1.98) per 10000 patients. Both these
               standardized point prevalence estimates ranged from 1.89 to 2.36
               between 2014-2016. The United Kingdom-standardized point
               prevalence of anal fistula without CD was 1.35 (95\%CI:
               1.23-1.48) per 10000 patients, while the Europe-standardized
               estimate was 1.39 (95\%CI: 1.26-1.52) per 10000 patients. In
               contrast, the standardized point prevalence estimate of anal
               fistula with CD was lower for both United Kingdom and Europe
               (0.44; 95\%CI United Kingdom: 0.37-0.52, 95\%CI Europe:
               0.37-0.51) per 10000 patients in 2017. In 2017, 19\% of anal
               fistula patients without CD and 13\% of anal fistula patients
               with CD had at least one relevant comorbidity. These results
               show that anal fistulas are infrequent in the general
               population. 24.5\% of prevalent anal fistulas are associated
               with CD, but other potentially etiological comorbidities are
               rare. CONCLUSION: This real-world evidence study estimated the
               United Kingdom-standardized prevalence of anal fistula was 1.80
               per 10000 patients in 2017. Approximately 25\% of cases may be
               associated with CD, while other comorbidities are rare.",
  journal   = "World J. Clin. Cases",
  publisher = "Baishideng Publishing Group Inc.",
  volume    =  7,
  number    =  14,
  pages     = "1795--1804",
  month     =  jul,
  year      =  2019,
  keywords  = "Anal fistula; Comorbidities; Crohn's disease; Europe;
               Prevalence; United Kingdom",
  language  = "en"
}

@ARTICLE{Fry2017-ug,
  title     = "Comparison of sociodemographic and health-related
               characteristics of {UK} biobank participants with those of the
               general population",
  author    = "Fry, Anna and Littlejohns, Thomas J and Sudlow, Cathie and
               Doherty, Nicola and Adamska, Ligia and Sprosen, Tim and Collins,
               Rory and Allen, Naomi E",
  journal   = "Am. J. Epidemiol.",
  publisher = "Oxford University Press (OUP)",
  volume    =  186,
  number    =  9,
  pages     = "1026--1034",
  month     =  nov,
  year      =  2017
}

@ARTICLE{Cereda2014-ty,
  title     = "{RNAmotifs}: prediction of multivalent {RNA} motifs that control
               alternative splicing",
  author    = "Cereda, Matteo and Pozzoli, Uberto and Rot, Gregor and Juvan,
               Peter and Schweitzer, Anthony and Clark, Tyson and Ule, Jernej",
  journal   = "Genome Biol",
  publisher = "Springer Nature",
  volume    =  15,
  number    =  1,
  pages     = "R20",
  year      =  2014
}

@ARTICLE{Wagner2016-kl,
  title     = "Dose-dependent regulation of alternative splicing by {MBNL}
               proteins reveals biomarkers for myotonic dystrophy",
  author    = "Wagner, Stacey D and Struck, Adam J and Gupta, Riti and
               Farnsworth, Dylan R and Mahady, Amy E and Eichinger, Katy and
               Thornton, Charles A and Wang, Eric T and Berglund, J Andrew",
  abstract  = "Alternative splicing is a regulated process that results in
               expression of specific mRNA and protein isoforms. Alternative
               splicing factors determine the relative abundance of each
               isoform. Here we focus on MBNL1, a splicing factor misregulated
               in the disease myotonic dystrophy. By altering the concentration
               of MBNL1 in cells across a broad dynamic range, we show that
               different splicing events require different amounts of MBNL1 for
               half-maximal response, and respond more or less steeply to
               MBNL1. Motifs around MBNL1 exon 5 were studied to assess how
               cis-elements mediate the MBNL1 dose-dependent splicing response.
               A framework was developed to estimate MBNL concentration using
               splicing responses alone, validated in the cell-based model, and
               applied to myotonic dystrophy patient muscle. Using this
               framework, we evaluated the ability of individual and
               combinations of splicing events to predict functional MBNL
               concentration in human biopsies, as well as their performance as
               biomarkers to assay mild, moderate, and severe cases of DM.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  12,
  number    =  9,
  pages     = "e1006316",
  month     =  sep,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Kang2020-xl,
  title     = "The colonic macrophage transcription factor {RBP-J} orchestrates
               intestinal immunity against bacterial pathogens",
  author    = "Kang, Lan and Zhang, Xiang and Ji, Liangliang and Kou, Tiantian
               and Smith, Sinead M and Zhao, Baohong and Guo, Xiaohuan and
               Pineda-Torra, In{\'e}s and Wu, Li and Hu, Xiaoyu",
  abstract  = "Macrophages play pleiotropic roles in maintaining the balance
               between immune tolerance and inflammatory responses in the gut.
               Here, we identified transcription factor RBP-J as a crucial
               regulator of colonic macrophage-mediated immune responses
               against the enteric pathogen Citrobacter rodentium. In the
               immune response phase, RBP-J promoted pathogen clearance by
               enhancing intestinal macrophage-elicited Th17 cell immune
               responses, which was achieved by maintenance of
               C/EBP$\beta$-dependent IL-6 production by overcoming
               miRNA-17~92-mediated suppressive effects. RBP-J
               deficiency-associated phenotypes could be genetically corrected
               by further deleting miRNA-17~92 in macrophages. In the late
               phase, noneradicated pathogens in RBP-J KO mice recruited
               abundant IL-1$\beta$-expressing CD64+Ly6C+ colonic macrophages
               and thereby promoted persistence of ILC3-derived IL-22 to
               compensate for the impaired innate and adaptive immune
               responses, leading to ultimate clearance of pathogens. These
               results demonstrated that colonic macrophage-intrinsic RBP-J
               dynamically orchestrates intestinal immunity against pathogen
               infections by interfacing with key immune cells of T and innate
               lymphoid cell lineages.",
  journal   = "J. Exp. Med.",
  publisher = "Rockefeller University Press",
  volume    =  217,
  number    =  4,
  month     =  apr,
  year      =  2020,
  copyright = "http://www.rupress.org/terms/",
  language  = "en"
}

@ARTICLE{Ostareck2019-rp,
  title     = "{RNA-binding} proteins in the control of {LPS-induced}
               macrophage response",
  author    = "Ostareck, Dirk H and Ostareck-Lederer, Antje",
  abstract  = "Innate immune response is triggered by pathogen components, like
               lipopolysaccharides (LPS) of gram-negative bacteria. LPS
               initiates Toll-like receptor 4 (TLR4) signaling, which involves
               mitogen activated protein kinases (MAPK) and nuclear factor
               kappa B (NF$\kappa$B) in different pathway branches and
               ultimately induces inflammatory cytokine and chemokine
               expression, macrophage migration and phagocytosis. Timely gene
               transcription and post-transcriptional control of gene
               expression confer the adequate synthesis of signaling molecules.
               As trans-acting factors RNA binding proteins (RBPs) contribute
               significantly to the surveillance of gene expression. RBPs are
               involved in the regulation of mRNA processing, localization,
               stability and translation. Thereby they enable rapid cellular
               responses to inflammatory mediators and facilitate a coordinated
               systemic immune response. Specific RBP binding to conserved
               sequence motifs in their target mRNAs is mediated by RNA binding
               domains, like Zink-finger domains, RNA recognition motifs (RRM),
               and hnRNP K homology domains (KH), often arranged in modular
               arrays. In this review, we focus on RBPs Tristetraprolin (TTP),
               human antigen R (HUR), T-cell intracellular antigen 1 related
               protein (TIAR), and heterogeneous ribonuclear protein K (hnRNP
               K) in LPS induced macrophages as primary responding immune
               cells. We discuss recent experiments employing RNA
               immunoprecipitation and microarray analysis (RIP-Chip) and newly
               developed individual-nucleotide resolution crosslinking and
               immunoprecipitation (iCLIP), photoactivatable
               ribonucleoside-enhanced crosslinking (PAR-iCLIP) and RNA
               sequencing techniques (RNA-Seq). The global mRNA interaction
               profile analysis of TTP, HUR, TIAR, and hnRNP K exhibited
               valuable information about the post-transcriptional control of
               inflammation related gene expression with a broad impact on
               intracellular signaling and temporal cytokine expression.",
  journal   = "Front. Genet.",
  publisher = "Frontiers Media SA",
  volume    =  10,
  pages     = "31",
  month     =  feb,
  year      =  2019,
  keywords  = "RNA-binding proteins; bacterial lipopolysaccharides;
               inflammation; macrophage activation; post-transcriptional
               regulation",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Van_Nostrand2016-ky,
  title     = "Robust transcriptome-wide discovery of {RNA-binding} protein
               binding sites with enhanced {CLIP} ({eCLIP})",
  author    = "Van Nostrand, Eric L and Pratt, Gabriel A and Shishkin,
               Alexander A and Gelboin-Burkhart, Chelsea and Fang, Mark Y and
               Sundararaman, Balaji and Blue, Steven M and Nguyen, Thai B and
               Surka, Christine and Elkins, Keri and Stanton, Rebecca and Rigo,
               Frank and Guttman, Mitchell and Yeo, Gene W",
  journal   = "Nat. Methods",
  publisher = "Springer Science and Business Media LLC",
  volume    =  13,
  number    =  6,
  pages     = "508--514",
  month     =  jun,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Wang2013-fb,
  title     = "A complex network of factors with overlapping affinities
               represses splicing through intronic elements",
  author    = "Wang, Yang and Xiao, Xinshu and Zhang, Jianming and Choudhury,
               Rajarshi and Robertson, Alex and Li, Kai and Ma, Meng and Burge,
               Christopher B and Wang, Zefeng",
  abstract  = "To better understand splicing regulation, we used a cell-based
               screen to identify ten diverse motifs that inhibit splicing from
               introns. Motifs were validated in another human cell type and
               gene context, and their presence correlated with in vivo
               splicing changes. All motifs exhibited exonic splicing enhancer
               or silencer activity, and grouping these motifs according to
               their distributions yielded clusters with distinct patterns of
               context-dependent activity. Candidate regulatory factors
               associated with each motif were identified, to recover 24 known
               and new splicing regulators. Specific domains in selected
               factors were sufficient to confer intronic-splicing-silencer
               activity. Many factors bound multiple distinct motifs with
               similar affinity, and all motifs were recognized by multiple
               factors, which revealed a complex overlapping network of
               protein-RNA interactions. This arrangement enables individual
               cis elements to function differently in distinct cellular
               contexts, depending on the spectrum of regulatory factors
               present.",
  journal   = "Nat. Struct. Mol. Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  20,
  number    =  1,
  pages     = "36--45",
  month     =  jan,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Wang2012-ni,
  title     = "Intronic splicing enhancers, cognate splicing factors and
               context-dependent regulation rules",
  author    = "Wang, Yang and Ma, Meng and Xiao, Xinshu and Wang, Zefeng",
  abstract  = "Most human genes produce multiple splicing isoforms with
               distinct functions. To systematically understand splicing
               regulation, we conducted an unbiased screen and identified >100
               intronic splicing enhancers (ISEs), clustered by sequence
               similarity. All ISEs functioned in multiple cell types and in
               heterologous introns, and patterns of distribution and
               conservation across pre-mRNA regions were similar to those of
               exonic splicing silencers. Consistently, all ISEs inhibited use
               of splice sites from exons. Putative trans-factors of each ISE
               group were identified and validated. Five distinct groups were
               recognized by hnRNP H and hnRNP F, whose C-terminal domains were
               sufficient to render context-dependent activities of ISEs. The
               sixth group was controlled by factors that either activate or
               suppress splicing. We provide a comprehensive picture of general
               ISE activities and suggest new models of how single elements can
               function oppositely, depending on locations and binding factors.",
  journal   = "Nat. Struct. Mol. Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  19,
  number    =  10,
  pages     = "1044--1052",
  month     =  oct,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Castello2013-ml,
  title     = "{RNA-binding} proteins in Mendelian disease",
  author    = "Castello, Alfredo and Fischer, Bernd and Hentze, Matthias W and
               Preiss, Thomas",
  abstract  = "RNA-binding proteins (RBPs) control all aspects of RNA fate, and
               defects in their function underlie a broad spectrum of human
               pathologies. We focus here on two recent studies that uncovered
               the in vivo mRNA interactomes of human cells, jointly
               implicating over 1100 proteins in RNA binding. Surprisingly,
               over 350 of these RBPs had no prior RNA binding-related
               annotation or domain homology. The datasets also contain many
               proteins that, when mutated, cause Mendelian diseases,
               prominently neurological, sensory, and muscular disorders and
               cancers. Disease mutations in these proteins occur throughout
               their domain architectures and many are found in non-classical
               RNA-binding domains and in disordered regions. In some cases,
               mutations might cause disease through perturbing previously
               unknown RNA-related protein functions. These studies have thus
               expanded our knowledge of RBPs and their role in genetic
               diseases. We also expect that mRNA interactome capture
               approaches will aid further exploration of RNA systems biology
               in varied physiological and pathophysiological settings.",
  journal   = "Trends Genet.",
  publisher = "Elsevier BV",
  volume    =  29,
  number    =  5,
  pages     = "318--327",
  month     =  may,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Nussbacher2015-zl,
  title     = "{RNA-binding} proteins in neurodegeneration: Seq and you shall
               receive",
  author    = "Nussbacher, Julia K and Batra, Ranjan and Lagier-Tourenne,
               Clotilde and Yeo, Gene W",
  abstract  = "As critical players in gene regulation, RNA binding proteins
               (RBPs) are taking center stage in our understanding of cellular
               function and disease. In our era of bench-top sequencers and
               unprecedented computational power, biological questions can be
               addressed in a systematic, genome-wide manner. Development of
               high-throughput sequencing (Seq) methodologies provides
               unparalleled potential to discover new mechanisms of
               disease-associated perturbations of RNA homeostasis.
               Complementary to candidate single-gene studies, these innovative
               technologies may elicit the discovery of unexpected mechanisms,
               and enable us to determine the widespread influence of the
               multifunctional RBPs on their targets. Given that the disruption
               of RNA processing is increasingly implicated in neurological
               diseases, these approaches will continue to provide insights
               into the roles of RBPs in disease pathogenesis.",
  journal   = "Trends Neurosci.",
  publisher = "Elsevier BV",
  volume    =  38,
  number    =  4,
  pages     = "226--236",
  month     =  apr,
  year      =  2015,
  keywords  = "RNA binding protein; high-throughput sequencing;
               neurodegeneration; polyadenylation; splicing",
  language  = "en"
}

@misc{mas-seq-app-note,   
    title = {Application Note: MAS-Seq for single-cell isoform sequencing},   
    url = {https://www.pacb.com/wp-content/uploads/Application-note-MAS-Seq-for-single-cell-isoform-sequencing.pdf},   
    author = {Camille Moore},   
    year = {Jan 2023},   
    note = {Accessed on 14/11/2023} 
}
@ARTICLE{Jain2022-sc,
  title     = "Advances in nanopore direct {RNA} sequencing",
  author    = "Jain, Miten and Abu-Shumays, Robin and Olsen, Hugh E and Akeson,
               Mark",
  journal   = "Nat. Methods",
  publisher = "Springer Science and Business Media LLC",
  volume    =  19,
  number    =  10,
  pages     = "1160--1164",
  month     =  oct,
  year      =  2022,
  language  = "en"
}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%% Introduction %%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
@ARTICLE{De_Klein2023-ku,
  title    = "Brain expression quantitative trait locus and network analyses
              reveal downstream effects and putative drivers for brain-related
              diseases",
  author   = "de Klein, Niek and Tsai, Ellen A and Vochteloo, Martijn and
              Baird, Denis and Huang, Yunfeng and Chen, Chia-Yen and van Dam,
              Sipko and Oelen, Roy and Deelen, Patrick and Bakker, Olivier B
              and El Garwany, Omar and Ouyang, Zhengyu and Marshall, Eric E and
              Zavodszky, Maria I and van Rheenen, Wouter and Bakker, Mark K and
              Veldink, Jan and Gaunt, Tom R and Runz, Heiko and Franke, Lude
              and Westra, Harm-Jan",
  abstract = "Identification of therapeutic targets from genome-wide
              association studies (GWAS) requires insights into downstream
              functional consequences. We harmonized 8,613 RNA-sequencing
              samples from 14 brain datasets to create the MetaBrain resource
              and performed cis- and trans-expression quantitative trait locus
              (eQTL) meta-analyses in multiple brain region- and
              ancestry-specific datasets (n $\leq$ 2,759). Many of the 16,169
              cortex cis-eQTLs were tissue-dependent when compared with blood
              cis-eQTLs. We inferred brain cell types for 3,549 cis-eQTLs by
              interaction analysis. We prioritized 186 cis-eQTLs for 31
              brain-related traits using Mendelian randomization and
              co-localization including 40 cis-eQTLs with an inferred cell
              type, such as a neuron-specific cis-eQTL (CYP24A1) for multiple
              sclerosis. We further describe 737 trans-eQTLs for 526 unique
              variants and 108 unique genes. We used brain-specific
              gene-co-regulation networks to link GWAS loci and prioritize
              additional genes for five central nervous system diseases. This
              study represents a valuable resource for post-GWAS research on
              central nervous system diseases.",
  journal  = "Nat. Genet.",
  volume   =  55,
  number   =  3,
  pages    = "377--388",
  month    =  mar,
  year     =  2023,
  language = "en"
}

@ARTICLE{Dong2023-xs,
  title     = "Benchmarking long-read {RNA-sequencing} analysis tools using in
               silico mixtures",
  author    = "Dong, Xueyi and Du, Mei R M and Gouil, Quentin and Tian, Luyi
               and Jabbari, Jafar S and Bowden, Rory and Baldoni, Pedro L and
               Chen, Yunshun and Smyth, Gordon K and Amarasinghe, Shanika L and
               Law, Charity W and Ritchie, Matthew E",
  abstract  = "The lack of benchmark data sets with inbuilt ground-truth makes
               it challenging to compare the performance of existing long-read
               isoform detection and differential expression analysis
               workflows. Here, we present a benchmark experiment using two
               human lung adenocarcinoma cell lines that were each profiled in
               triplicate together with synthetic, spliced, spike-in RNAs
               (sequins). Samples were deeply sequenced on both Illumina
               short-read and Oxford Nanopore Technologies long-read platforms.
               Alongside the ground-truth available via the sequins, we created
               in silico mixture samples to allow performance assessment in the
               absence of true positives or true negatives. Our results show
               that StringTie2 and bambu outperformed other tools from the six
               isoform detection tools tested, DESeq2, edgeR and limma-voom
               were best among the five differential transcript expression
               tools tested and there was no clear front-runner for performing
               differential transcript usage analysis between the five tools
               compared, which suggests further methods development is needed
               for this application.",
  journal   = "Nat. Methods",
  publisher = "Springer Science and Business Media LLC",
  volume    =  20,
  number    =  11,
  pages     = "1810--1821",
  month     =  nov,
  year      =  2023,
  copyright = "https://www.springernature.com/gp/researchers/text-and-data-mining",
  language  = "en"
}

@ARTICLE{Speed2014-lz,
  title     = "A genome-wide association study and biological pathway analysis
               of epilepsy prognosis in a prospective cohort of newly treated
               epilepsy",
  author    = "Speed, Doug and Hoggart, Clive and Petrovski, Slave and
               Tachmazidou, Ioanna and Coffey, Alison and Jorgensen, Andrea and
               Eleftherohorinou, Hariklia and De Iorio, Maria and Todaro,
               Marian and De, Tisham and Smith, David and Smith, Philip E and
               Jackson, Margaret and Cooper, Paul and Kellett, Mark and Howell,
               Stephen and Newton, Mark and Yerra, Raju and Tan, Meng and
               French, Chris and Reuber, Markus and Sills, Graeme E and
               Chadwick, David and Pirmohamed, Munir and Bentley, David and
               Scheffer, Ingrid and Berkovic, Samuel and Balding, David and
               Palotie, Aarno and Marson, Anthony and O'Brien, Terence J and
               Johnson, Michael R",
  abstract  = "We present the analysis of a prospective multicentre study to
               investigate genetic effects on the prognosis of newly treated
               epilepsy. Patients with a new clinical diagnosis of epilepsy
               requiring medication were recruited and followed up
               prospectively. The clinical outcome was defined as freedom from
               seizures for a minimum of 12 months in accordance with the
               consensus statement from the International League Against
               Epilepsy (ILAE). Genetic effects on remission of seizures after
               starting treatment were analysed with and without adjustment for
               significant clinical prognostic factors, and the results from
               each cohort were combined using a fixed-effects meta-analysis.
               After quality control (QC), we analysed 889 newly treated
               epilepsy patients using 472 450 genotyped and 6.9 $\times$ 10(6)
               imputed single-nucleotide polymorphisms. Suggestive evidence for
               association (defined as Pmeta 4.4\% of the variation in the
               outcome of newly treated epilepsy.",
  journal   = "Hum. Mol. Genet.",
  publisher = "Oxford University Press (OUP)",
  volume    =  23,
  number    =  1,
  pages     = "247--258",
  month     =  jan,
  year      =  2014,
  language  = "en"
}

@article{ms_susceptibility, title={Locus for severity implicates CNS resilience in progression of multiple sclerosis}, volume={619}, DOI={10.1038/s41586-023-06250-x}, number={7969}, journal={Nature}, author={Harroud, Adil and Stridh, Pernilla and McCauley, Jacob L. and Saarela, Janna and van den Bosch, Aletta M. and Engelenburg, Hendrik J. and Beecham, Ashley H. and Alfredsson, Lars and Alikhani, Katayoun and Amezcua, Lilyana and et al.}, year={2023}, pages={323â€“331}} 
@ARTICLE{Lee2017-tl,
  title     = "Genome-wide association study identifies distinct genetic
               contributions to prognosis and susceptibility in Crohn's disease",
  author    = "Lee, James C and Biasci, Daniele and Roberts, Rebecca and
               Gearry, Richard B and Mansfield, John C and Ahmad, Tariq and
               Prescott, Natalie J and Satsangi, Jack and Wilson, David C and
               Jostins, Luke and Anderson, Carl A and {UK IBD Genetics
               Consortium} and Traherne, James A and Lyons, Paul A and Parkes,
               Miles and Smith, Kenneth G C",
  abstract  = "For most immune-mediated diseases, the main determinant of
               patient well-being is not the diagnosis itself but instead the
               course that the disease takes over time (prognosis). Prognosis
               may vary substantially between patients for reasons that are
               poorly understood. Familial studies support a genetic
               contribution to prognosis, but little evidence has been found
               for a proposed association between prognosis and the burden of
               susceptibility variants. To better characterize how genetic
               variation influences disease prognosis, we performed a
               within-cases genome-wide association study in two cohorts of
               patients with Crohn's disease. We identified four genome-wide
               significant loci, none of which showed any association with
               disease susceptibility. Conversely, the aggregated effect of all
               170 disease susceptibility loci was not associated with disease
               prognosis. Together, these data suggest that the genetic
               contribution to prognosis in Crohn's disease is largely
               independent of the contribution to disease susceptibility and
               point to a biology of prognosis that could provide new
               therapeutic opportunities.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  2,
  pages     = "262--268",
  month     =  feb,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Barrett2008-lg,
  title     = "Genome-wide association defines more than 30 distinct
               susceptibility loci for Crohn's disease",
  author    = "Barrett, Jeffrey C and Hansoul, Sarah and Nicolae, Dan L and
               Cho, Judy H and Duerr, Richard H and Rioux, John D and Brant,
               Steven R and Silverberg, Mark S and Taylor, Kent D and Barmada,
               M Michael and Bitton, Alain and Dassopoulos, Themistocles and
               Datta, Lisa Wu and Green, Todd and Griffiths, Anne M and
               Kistner, Emily O and Murtha, Michael T and Regueiro, Miguel D
               and Rotter, Jerome I and Schumm, L Philip and Steinhart, A
               Hillary and Targan, Stephan R and Xavier, Ramnik J and {NIDDK
               IBD Genetics Consortium} and Libioulle, C{\'e}cile and Sandor,
               Cynthia and Lathrop, Mark and Belaiche, Jacques and Dewit,
               Olivier and Gut, Ivo and Heath, Simon and Laukens, Debby and
               Mni, Myriam and Rutgeerts, Paul and Van Gossum, Andr{\'e} and
               Zelenika, Diana and Franchimont, Denis and Hugot, Jean-Pierre
               and de Vos, Martine and Vermeire, Severine and Louis, Edouard
               and {Belgian-French IBD Consortium} and {Wellcome Trust Case
               Control Consortium} and Cardon, Lon R and Anderson, Carl A and
               Drummond, Hazel and Nimmo, Elaine and Ahmad, Tariq and Prescott,
               Natalie J and Onnie, Clive M and Fisher, Sheila A and Marchini,
               Jonathan and Ghori, Jilur and Bumpstead, Suzannah and Gwilliam,
               Rhian and Tremelling, Mark and Deloukas, Panos and Mansfield,
               John and Jewell, Derek and Satsangi, Jack and Mathew,
               Christopher G and Parkes, Miles and Georges, Michel and Daly,
               Mark J",
  abstract  = "Several risk factors for Crohn's disease have been identified in
               recent genome-wide association studies. To advance gene
               discovery further, we combined data from three studies on
               Crohn's disease (a total of 3,230 cases and 4,829 controls) and
               carried out replication in 3,664 independent cases with a
               mixture of population-based and family-based controls. The
               results strongly confirm 11 previously reported loci and provide
               genome-wide significant evidence for 21 additional loci,
               including the regions containing STAT3, JAK2, ICOSLG, CDKAL1 and
               ITLN1. The expanded molecular understanding of the basis of this
               disease offers promise for informed therapeutic development.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  40,
  number    =  8,
  pages     = "955--962",
  month     =  aug,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Gamazon2018-uz,
  title     = "Using an atlas of gene regulation across 44 human tissues to
               inform complex disease- and trait-associated variation",
  author    = "Gamazon, Eric R and {GTEx Consortium} and Segr{\`e}, Ayellet V
               and van de Bunt, Martijn and Wen, Xiaoquan and Xi, Hualin S and
               Hormozdiari, Farhad and Ongen, Halit and Konkashbaev, Anuar and
               Derks, Eske M and Aguet, Fran{\c c}ois and Quan, Jie and
               Nicolae, Dan L and Eskin, Eleazar and Kellis, Manolis and Getz,
               Gad and McCarthy, Mark I and Dermitzakis, Emmanouil T and Cox,
               Nancy J and Ardlie, Kristin G",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  7,
  pages     = "956--967",
  month     =  jul,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Van_de_Geijn2020-zn,
  title     = "Annotations capturing cell type-specific {TF} binding explain a
               large fraction of disease heritability",
  author    = "van de Geijn, Bryce and Finucane, Hilary and Gazal, Steven and
               Hormozdiari, Farhad and Amariuta, Tiffany and Liu, Xuanyao and
               Gusev, Alexander and Loh, Po-Ru and Reshef, Yakir and Kichaev,
               Gleb and Raychauduri, Soumya and Price, Alkes L",
  abstract  = "Regulatory variation plays a major role in complex disease and
               that cell type-specific binding of transcription factors (TF) is
               critical to gene regulation. However, assessing the contribution
               of genetic variation in TF-binding sites to disease heritability
               is challenging, as binding is often cell type-specific and
               annotations from directly measured TF binding are not currently
               available for most cell type-TF pairs. We investigate approaches
               to annotate TF binding, including directly measured chromatin
               data and sequence-based predictions. We find that TF-binding
               annotations constructed by intersecting sequence-based
               TF-binding predictions with cell type-specific chromatin data
               explain a large fraction of heritability across a broad set of
               diseases and corresponding cell types; this strategy of
               constructing annotations addresses both the limitation that
               identical sequences may be bound or unbound depending on
               surrounding chromatin context and the limitation that
               sequence-based predictions are generally not cell type-specific.
               We partitioned the heritability of 49 diseases and complex
               traits using stratified linkage disequilibrium (LD) score
               regression with the baseline-LD model (which is not cell
               type-specific) plus the new annotations. We determined that 100
               bp windows around MotifMap sequenced-based TF-binding
               predictions intersected with a union of six cell type-specific
               chromatin marks (imputed using ChromImpute) performed best, with
               an 58\% increase in heritability enrichment compared to the
               chromatin marks alone (11.6$\times$ vs. 7.3$\times$, P = 9
               $\times$ 10-14 for difference) and a 20\% increase in cell
               type-specific signal conditional on annotations from the
               baseline-LD model (P = 8 $\times$ 10-11 for difference). Our
               results show that TF-binding annotations explain substantial
               disease heritability and can help refine genome-wide association
               signals.",
  journal   = "Hum. Mol. Genet.",
  publisher = "Oxford University Press (OUP)",
  volume    =  29,
  number    =  7,
  pages     = "1057--1067",
  month     =  may,
  year      =  2020,
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}

@ARTICLE{Umans2021-fv,
  title     = "Where are the disease-associated {eQTLs}?",
  author    = "Umans, Benjamin D and Battle, Alexis and Gilad, Yoav",
  abstract  = "Most disease-associated variants, although located in putatively
               regulatory regions, do not have detectable effects on gene
               expression. One explanation could be that we have not examined
               gene expression in the cell types or conditions that are most
               relevant for disease. Even large-scale efforts to study gene
               expression across tissues are limited to human samples obtained
               opportunistically or postmortem, mostly from adults. In this
               review we evaluate recent findings and suggest an alternative
               strategy, drawing on the dynamic and highly context-specific
               nature of gene regulation. We discuss new technologies that can
               extend the standard regulatory mapping framework to more
               diverse, disease-relevant cell types and states.",
  journal   = "Trends Genet.",
  publisher = "Elsevier BV",
  volume    =  37,
  number    =  2,
  pages     = "109--124",
  month     =  feb,
  year      =  2021,
  keywords  = "GTeX; GWAS; QTL mapping; complex traits; dynamic gene
               regulation; eQTL",
  language  = "en"
}

@ARTICLE{Lee2014-zo,
  title     = "Common genetic variants modulate pathogen-sensing responses in
               human dendritic cells",
  author    = "Lee, Mark N and Ye, Chun and Villani, Alexandra-Chlo{\'e} and
               Raj, Towfique and Li, Weibo and Eisenhaure, Thomas M and
               Imboywa, Selina H and Chipendo, Portia I and Ran, F Ann and
               Slowikowski, Kamil and Ward, Lucas D and Raddassi, Khadir and
               McCabe, Cristin and Lee, Michelle H and Frohlich, Irene Y and
               Hafler, David A and Kellis, Manolis and Raychaudhuri, Soumya and
               Zhang, Feng and Stranger, Barbara E and Benoist, Christophe O
               and De Jager, Philip L and Regev, Aviv and Hacohen, Nir",
  abstract  = "Little is known about how human genetic variation affects the
               responses to environmental stimuli in the context of complex
               diseases. Experimental and computational approaches were applied
               to determine the effects of genetic variation on the induction
               of pathogen-responsive genes in human dendritic cells. We
               identified 121 common genetic variants associated in cis with
               variation in expression responses to Escherichia coli
               lipopolysaccharide, influenza, or interferon-$\beta$
               (IFN-$\beta$). We localized and validated causal variants to
               binding sites of pathogen-activated STAT (signal transducer and
               activator of transcription) and IRF (IFN-regulatory factor)
               transcription factors. We also identified a common variant in
               IRF7 that is associated in trans with type I IFN induction in
               response to influenza infection. Our results reveal common
               alleles that explain interindividual variation in pathogen
               sensing and provide functional annotation for genetic variants
               that alter susceptibility to inflammatory diseases.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  343,
  number    =  6175,
  pages     = "1246980",
  month     =  mar,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Fairfax2012-ur,
  title     = "Genetics of gene expression in primary immune cells identifies
               cell type--specific master regulators and roles of {HLA} alleles",
  author    = "Fairfax, Benjamin P and Makino, Seiko and Radhakrishnan,
               Jayachandran and Plant, Katharine and Leslie, Stephen and
               Dilthey, Alexander and Ellis, Peter and Langford, Cordelia and
               Vannberg, Fredrik O and Knight, Julian C",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  44,
  number    =  5,
  pages     = "502--510",
  month     =  may,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Reif1997-li,
  title     = "Pre-illness dietary factors in inflammatory bowel disease",
  author    = "Reif, S and Klein, I and Lubin, F and Farbstein, M and Hallak, A
               and Gilat, T",
  abstract  = "BACKGROUND: The effect of environmental factors has been
               demonstrated in the pathogenesis of inflammatory bowel disease
               (IBD). Nutrition may be one of them. AIM: To investigate the
               pre-illness diet in patients with recent IBD in comparison with
               matched population and clinic controls. METHODS: Quantified
               dietary histories were obtained from 87 patients with recent IBD
               (54 ulcerative colitis (UC) and 33 Crohn's disease (CD)) and 144
               controls. Odds ratios (OR) for IBD were derived for intake
               levels of various foods. RESULTS: A high sucrose consumption was
               associated with an increased risk for IBD (OR 2.85 (p = 0.03)
               against population controls and 5.3 (p = 0.00) against clinic
               controls). Lactose consumption showed no effect while fructose
               intake was negatively associated with risk for IBD (NS). Similar
               trends were noted in UC and CD. A high fat intake was associated
               with an increased risk for UC; this was particularly marked for
               animal fat (OR 4.09, p = 0.02) and cholesterol (OR 4.57, p =
               0.02). A high intake of fluids (p = 0.04), magnesium (p = 0.04),
               vitamin C, and fruits (NS) was negatively associated with the
               risk for IBD, while a positive association was found for retinol
               (p = 0.01). Most of the findings were similar in UC and CD
               except for potassium and vegetable consumption which showed a
               negative association only with risk for CD. CONCLUSIONS: An
               association was found between pre-illness diet and subsequent
               development of UC and CD. The effect of dietary components may
               be primary or modulatory.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  40,
  number    =  6,
  pages     = "754--760",
  month     =  jun,
  year      =  1997,
  language  = "en"
}

@ARTICLE{Ng2013-of,
  title     = "Geographical variability and environmental risk factors in
               inflammatory bowel disease",
  author    = "Ng, Siew C and Bernstein, Charles N and Vatn, Morten H and
               Lakatos, Peter Laszlo and Loftus, Jr, Edward V and Tysk, Curt
               and O'Morain, Colm and Moum, Bjorn and Colombel,
               Jean-Fr{\'e}d{\'e}ric and {Epidemiology and Natural History Task
               Force of the International Organization of Inflammatory Bowel
               Disease (IOIBD)}",
  abstract  = "The changing epidemiology of inflammatory bowel disease (IBD)
               across time and geography suggests that environmental factors
               play a major role in modifying disease expression. Disease
               emergence in developing nations suggests that epidemiological
               evolution is related to westernisation of lifestyle and
               industrialisation. The strongest environmental associations
               identified are cigarette smoking and appendectomy, although
               neither alone explains the variation in incidence of IBD
               worldwide. Urbanisation of societies, associated with changes in
               diet, antibiotic use, hygiene status, microbial exposures and
               pollution have been implicated as potential environmental risk
               factors for IBD. Changes in socioeconomic status might occur
               differently in different geographical areas and populations and,
               consequently, it is important to consider the heterogeneity of
               risk factors applicable to the individual patient. Environmental
               risk factors of individual, familial, community-based,
               country-based and regionally based origin may all contribute to
               the pathogenesis of IBD. The geographical variation of IBD
               provides clues for researchers to investigate possible
               environmental aetiological factors. The present review aims to
               provide an update of the literature exploring geographical
               variability in IBD and to explore the environmental risk factors
               that may account for this variability.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  62,
  number    =  4,
  pages     = "630--649",
  month     =  apr,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Severe_Covid-19_GWAS_Group2020-rn,
  title     = "Genomewide association study of severe Covid-19 with respiratory
               failure",
  author    = "{Severe Covid-19 GWAS Group} and Ellinghaus, David and
               Degenhardt, Frauke and Bujanda, Luis and Buti, Maria and
               Albillos, Agust{\'\i}n and Invernizzi, Pietro and Fern{\'a}ndez,
               Javier and Prati, Daniele and Baselli, Guido and Asselta,
               Rosanna and Grimsrud, Marit M and Milani, Chiara and Aziz,
               F{\'a}tima and K{\"a}ssens, Jan and May, Sandra and Wendorff,
               Mareike and Wienbrandt, Lars and Uellendahl-Werth, Florian and
               Zheng, Tenghao and Yi, Xiaoli and de Pablo, Ra{\'u}l and
               Chercoles, Adolfo G and Palom, Adriana and Garcia-Fernandez,
               Alba-Estela and Rodriguez-Frias, Francisco and Zanella, Alberto
               and Bandera, Alessandra and Protti, Alessandro and Aghemo,
               Alessio and Lleo, Ana and Biondi, Andrea and Caballero-Garralda,
               Andrea and Gori, Andrea and Tanck, Anja and Carreras Nolla, Anna
               and Latiano, Anna and Fracanzani, Anna Ludovica and Peschuck,
               Anna and Juli{\`a}, Antonio and Pesenti, Antonio and Voza,
               Antonio and Jim{\'e}nez, David and Mateos, Beatriz and Nafria
               Jimenez, Beatriz and Quereda, Carmen and Paccapelo, Cinzia and
               Gassner, Christoph and Angelini, Claudio and Cea, Cristina and
               Solier, Aurora and Pesta{\~n}a, David and Mu{\~n}iz-Diaz,
               Eduardo and Sandoval, Elena and Paraboschi, Elvezia M and Navas,
               Enrique and Garc{\'\i}a S{\'a}nchez, F{\'e}lix and Ceriotti,
               Ferruccio and Martinelli-Boneschi, Filippo and Peyvandi, Flora
               and Blasi, Francesco and T{\'e}llez, Luis and Blanco-Grau,
               Albert and Hemmrich-Stanisak, Georg and Grasselli, Giacomo and
               Costantino, Giorgio and Cardamone, Giulia and Foti, Giuseppe and
               Aneli, Serena and Kurihara, Hayato and ElAbd, Hesham and My,
               Ilaria and Galv{\'a}n-Femenia, Iv{\'a}n and Mart{\'\i}n, Javier
               and Erdmann, Jeanette and Ferrusqu{\'\i}a-Acosta, Jose and
               Garcia-Etxebarria, Koldo and Izquierdo-Sanchez, Laura and
               Bettini, Laura R and Sumoy, Lauro and Terranova, Leonardo and
               Moreira, Leticia and Santoro, Luigi and Scudeller, Luigia and
               Mesonero, Francisco and Roade, Luisa and R{\"u}hlemann, Malte C
               and Schaefer, Marco and Carrabba, Maria and Riveiro-Barciela,
               Mar and Figuera Basso, Maria E and Valsecchi, Maria G and
               Hernandez-Tejero, Mar{\'\i}a and Acosta-Herrera, Marialbert and
               D'Angi{\`o}, Mariella and Baldini, Marina and Cazzaniga, Marina
               and Schulzky, Martin and Cecconi, Maurizio and Wittig, Michael
               and Ciccarelli, Michele and Rodr{\'\i}guez-Gand{\'\i}a, Miguel
               and Bocciolone, Monica and Miozzo, Monica and Montano, Nicola
               and Braun, Nicole and Sacchi, Nicoletta and Mart{\'\i}nez, Nilda
               and {\"O}zer, Onur and Palmieri, Orazio and Faverio, Paola and
               Preatoni, Paoletta and Bonfanti, Paolo and Omodei, Paolo and
               Tentorio, Paolo and Castro, Pedro and Rodrigues, Pedro M and
               Blandino Ortiz, Aaron and de Cid, Rafael and Ferrer, Ricard and
               Gualtierotti, Roberta and Nieto, Rosa and Goerg, Siegfried and
               Badalamenti, Salvatore and Marsal, Sara and Matullo, Giuseppe
               and Pelusi, Serena and Juzenas, Simonas and Aliberti, Stefano
               and Monzani, Valter and Moreno, Victor and Wesse, Tanja and
               Lenz, Tobias L and Pumarola, Tomas and Rimoldi, Valeria and
               Bosari, Silvano and Albrecht, Wolfgang and Peter, Wolfgang and
               Romero-G{\'o}mez, Manuel and D'Amato, Mauro and Duga, Stefano
               and Banales, Jesus M and Hov, Johannes R and Folseraas, Trine
               and Valenti, Luca and Franke, Andre and Karlsen, Tom H",
  abstract  = "BACKGROUND: There is considerable variation in disease behavior
               among patients infected with severe acute respiratory syndrome
               coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus
               disease 2019 (Covid-19). Genomewide association analysis may
               allow for the identification of potential genetic factors
               involved in the development of Covid-19. METHODS: We conducted a
               genomewide association study involving 1980 patients with
               Covid-19 and severe disease (defined as respiratory failure) at
               seven hospitals in the Italian and Spanish epicenters of the
               SARS-CoV-2 pandemic in Europe. After quality control and the
               exclusion of population outliers, 835 patients and 1255 control
               participants from Italy and 775 patients and 950 control
               participants from Spain were included in the final analysis. In
               total, we analyzed 8,582,968 single-nucleotide polymorphisms and
               conducted a meta-analysis of the two case-control panels.
               RESULTS: We detected cross-replicating associations with
               rs11385942 at locus 3p21.31 and with rs657152 at locus 9q34.2,
               which were significant at the genomewide level (P<5$\times$10-8)
               in the meta-analysis of the two case-control panels (odds ratio,
               1.77; 95\% confidence interval [CI], 1.48 to 2.11; P =
               1.15$\times$10-10; and odds ratio, 1.32; 95\% CI, 1.20 to 1.47;
               P = 4.95$\times$10-8, respectively). At locus 3p21.31, the
               association signal spanned the genes SLC6A20, LZTFL1, CCR9,
               FYCO1, CXCR6 and XCR1. The association signal at locus 9q34.2
               coincided with the ABO blood group locus; in this cohort, a
               blood-group-specific analysis showed a higher risk in blood
               group A than in other blood groups (odds ratio, 1.45; 95\% CI,
               1.20 to 1.75; P = 1.48$\times$10-4) and a protective effect in
               blood group O as compared with other blood groups (odds ratio,
               0.65; 95\% CI, 0.53 to 0.79; P = 1.06$\times$10-5). CONCLUSIONS:
               We identified a 3p21.31 gene cluster as a genetic susceptibility
               locus in patients with Covid-19 with respiratory failure and
               confirmed a potential involvement of the ABO blood-group system.
               (Funded by Stein Erik Hagen and others.).",
  journal   = "N. Engl. J. Med.",
  publisher = "Massachusetts Medical Society",
  volume    =  383,
  number    =  16,
  pages     = "1522--1534",
  month     =  oct,
  year      =  2020,
  copyright = "http://www.nejmgroup.org/legal/terms-of-use.htm",
  language  = "en"
}

@ARTICLE{Iwaki2019-mf,
  title     = "Genomewide association study of Parkinson's disease clinical
               biomarkers in 12 longitudinal patients' cohorts",
  author    = "Iwaki, Hirotaka and Blauwendraat, Cornelis and Leonard, Hampton
               L and Kim, Jonggeol J and Liu, Ganqiang and Maple-Gr{\o}dem,
               Jodi and Corvol, Jean-Christophe and Pihlstr{\o}m, Lasse and van
               Nimwegen, Marlies and Hutten, Samantha J and Nguyen, Khanh-Dung
               H and Rick, Jacqueline and Eberly, Shirley and Faghri, Faraz and
               Auinger, Peggy and Scott, Kirsten M and Wijeyekoon, Ruwani and
               Van Deerlin, Vivianna M and Hernandez, Dena G and Gibbs, J
               Raphael and {International Parkinson's Disease Genomics
               Consortium} and Chitrala, Kumaraswamy Naidu and Day-Williams,
               Aaron G and Brice, Alexis and Alves, Guido and Noyce, Alastair J
               and Tysnes, Ole-Bj{\o}rn and Evans, Jonathan R and Breen, David
               P and Estrada, Karol and Wegel, Claire E and Danjou, Fabrice and
               Simon, David K and Andreassen, Ole and Ravina, Bernard and Toft,
               Mathias and Heutink, Peter and Bloem, Bastiaan R and Weintraub,
               Daniel and Barker, Roger A and Williams-Gray, Caroline H and van
               de Warrenburg, Bart P and Van Hilten, Jacobus J and Scherzer,
               Clemens R and Singleton, Andrew B and Nalls, Mike A",
  abstract  = "BACKGROUND: Several reports have identified different patterns
               of Parkinson's disease progression in individuals carrying
               missense variants in GBA or LRRK2 genes. The overall
               contribution of genetic factors to the severity and progression
               of Parkinson's disease, however, has not been well studied.
               OBJECTIVES: To test the association between genetic variants and
               the clinical features of Parkinson's disease on a genomewide
               scale. METHODS: We accumulated individual data from 12
               longitudinal cohorts in a total of 4093 patients with 22,307
               observations for a median of 3.81 years. Genomewide associations
               were evaluated for 25 cross-sectional and longitudinal
               phenotypes. Specific variants of interest, including 90 recently
               identified disease-risk variants, were also investigated post
               hoc for candidate associations with these phenotypes. RESULTS:
               Two variants were genomewide significant. Rs382940(T>A), within
               the intron of SLC44A1, was associated with reaching Hoehn and
               Yahr stage 3 or higher faster (hazard ratio 2.04 [1.58-2.62]; P
               value = 3.46E-8). Rs61863020(G>A), an intergenic variant and
               expression quantitative trait loci for $\alpha$-2A adrenergic
               receptor, was associated with a lower prevalence of insomnia at
               baseline (odds ratio 0.63 [0.52-0.75]; P value = 4.74E-8). In
               the targeted analysis, we found 9 associations between known
               Parkinson's risk variants and more severe motor/cognitive
               symptoms. Also, we replicated previous reports of GBA coding
               variants (rs2230288: p.E365K; rs75548401: p.T408M) being
               associated with greater motor and cognitive decline over time,
               and an APOE E4 tagging variant (rs429358) being associated with
               greater cognitive deficits in patients. CONCLUSIONS: We
               identified novel genetic factors associated with heterogeneity
               of Parkinson's disease. The results can be used for validation
               or hypothesis tests regarding Parkinson's disease. \copyright{}
               2019 International Parkinson and Movement Disorder Society.",
  journal   = "Mov. Disord.",
  publisher = "Wiley",
  volume    =  34,
  number    =  12,
  pages     = "1839--1850",
  month     =  dec,
  year      =  2019,
  keywords  = "Apolipoprotein E; GBA; Parkinson's disease; genomewide
               association study",
  copyright = "http://onlinelibrary.wiley.com/termsAndConditions\#vor",
  language  = "en"
}

@ARTICLE{Lewis2010-gx,
  title    = "Efficacy and complications of surgery for Crohn's disease",
  author   = "Lewis, Robert T and Maron, David J",
  abstract = "Patients with Crohn's disease commonly undergo surgery during
              their lifetime. Indications for surgical intervention include
              obstruction, intra-abdominal or perianal abscess, enterocutaneous
              fistulas, and complex perianal disease. As medical therapies
              continue to improve, it is important that surgical therapies are
              chosen carefully. This is particularly important in the treatment
              of perianal fistulas; combined surgical and medical therapy offer
              the best chance for success. In the treatment of small-bowel
              disease, bowel preservation is key. For the repair of short
              strictures, endoscopic dilatation is the preferred method when
              accessible; strictureplasty has been shown to be safe and
              effective for increasingly longer segments of disease.
              Intra-abdominal abscesses should be drained percutaneously, if
              possible. In the presence of colonic disease, segmental resection
              is recommended. Unfortunately, refractory disease still
              frequently requires complete proctectomy and permanent diversion.",
  journal  = "Gastroenterol. Hepatol. (N. Y.)",
  volume   =  6,
  number   =  9,
  pages    = "587--596",
  month    =  sep,
  year     =  2010,
  keywords = "Crohn's disease; fistula; stricture; surgery",
  language = "en"
}

@ARTICLE{Khor2011-td,
  title     = "Genetics and pathogenesis of inflammatory bowel disease",
  author    = "Khor, Bernard and Gardet, Agn{\`e}s and Xavier, Ramnik J",
  abstract  = "Recent advances have provided substantial insight into the
               maintenance of mucosal immunity and the pathogenesis of
               inflammatory bowel disease. Cellular programs responsible for
               intestinal homeostasis use diverse intracellular and
               intercellular networks to promote immune tolerance, inflammation
               or epithelial restitution. Complex interfaces integrate local
               host and microbial signals to activate appropriate effector
               programs selectively and even drive plasticity between these
               programs. In addition, genetic studies and mouse models have
               emphasized the role of genetic predispositions and how they
               affect interactions with microbial and environmental factors,
               leading to pro-colitogenic perturbations of the host-commensal
               relationship.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  474,
  number    =  7351,
  pages     = "307--317",
  month     =  jun,
  year      =  2011,
  language  = "en"
}

@ARTICLE{Luo2017-kx,
  title     = "Exploring the genetic architecture of inflammatory bowel disease
               by whole-genome sequencing identifies association at {ADCY7}",
  author    = "Luo, Yang and de Lange, Katrina M and Jostins, Luke and
               Moutsianas, Loukas and Randall, Joshua and Kennedy, Nicholas A
               and Lamb, Christopher A and McCarthy, Shane and Ahmad, Tariq and
               Edwards, Cathryn and Serra, Eva Goncalves and Hart, Ailsa and
               Hawkey, Chris and Mansfield, John C and Mowat, Craig and Newman,
               William G and Nichols, Sam and Pollard, Martin and Satsangi,
               Jack and Simmons, Alison and Tremelling, Mark and Uhlig, Holm
               and Wilson, David C and Lee, James C and Prescott, Natalie J and
               Lees, Charlie W and Mathew, Christopher G and Parkes, Miles and
               Barrett, Jeffrey C and Anderson, Carl A",
  abstract  = "To further resolve the genetic architecture of the inflammatory
               bowel diseases ulcerative colitis and Crohn's disease, we
               sequenced the whole genomes of 4,280 patients at low coverage
               and compared them to 3,652 previously sequenced population
               controls across 73.5 million variants. We then imputed from
               these sequences into new and existing genome-wide association
               study cohorts and tested for association at ~12 million variants
               in a total of 16,432 cases and 18,843 controls. We discovered a
               0.6\% frequency missense variant in ADCY7 that doubles the risk
               of ulcerative colitis. Despite good statistical power, we did
               not identify any other new low-frequency risk variants and found
               that such variants explained little heritability. We detected a
               burden of very rare, damaging missense variants in known Crohn's
               disease risk genes, suggesting that more comprehensive
               sequencing studies will continue to improve understanding of the
               biology of complex diseases.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  2,
  pages     = "186--192",
  month     =  feb,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Liu2015-bx,
  title     = "Association analyses identify 38 susceptibility loci for
               inflammatory bowel disease and highlight shared genetic risk
               across populations",
  author    = "Liu, Jimmy Z and van Sommeren, Suzanne and Huang, Hailiang and
               Ng, Siew C and Alberts, Rudi and Takahashi, Atsushi and Ripke,
               Stephan and Lee, James C and Jostins, Luke and Shah, Tejas and
               Abedian, Shifteh and Cheon, Jae Hee and Cho, Judy and Daryani,
               Naser E and Franke, Lude and Fuyuno, Yuta and Hart, Ailsa and
               Juyal, Ramesh C and Juyal, Garima and Kim, Won Ho and Morris,
               Andrew P and Poustchi, Hossein and Newman, William G and Midha,
               Vandana and Orchard, Timothy R and Vahedi, Homayon and Sood,
               Ajit and Sung, Joseph J Y and Malekzadeh, Reza and Westra,
               Harm-Jan and Yamazaki, Keiko and Yang, Suk-Kyun and Barrett,
               Jeffrey C and Franke, Andre and Alizadeh, Behrooz Z and Parkes,
               Miles and {Thelma} and Daly, Mark J and Kubo, Michiaki and
               Anderson, Carl A and Weersma, Rinse K and {International
               Multiple Sclerosis Genetics Consortium} and {International IBD
               Genetics Consortium}",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  47,
  number    =  9,
  pages     = "979--986",
  month     =  sep,
  year      =  2015,
  language  = "en"
}

@ARTICLE{De_Lange2017-re,
  title     = "Genome-wide association study implicates immune activation of
               multiple integrin genes in inflammatory bowel disease",
  author    = "de Lange, Katrina M and Moutsianas, Loukas and Lee, James C and
               Lamb, Christopher A and Luo, Yang and Kennedy, Nicholas A and
               Jostins, Luke and Rice, Daniel L and Gutierrez-Achury, Javier
               and Ji, Sun-Gou and Heap, Graham and Nimmo, Elaine R and
               Edwards, Cathryn and Henderson, Paul and Mowat, Craig and
               Sanderson, Jeremy and Satsangi, Jack and Simmons, Alison and
               Wilson, David C and Tremelling, Mark and Hart, Ailsa and Mathew,
               Christopher G and Newman, William G and Parkes, Miles and Lees,
               Charlie W and Uhlig, Holm and Hawkey, Chris and Prescott,
               Natalie J and Ahmad, Tariq and Mansfield, John C and Anderson,
               Carl A and Barrett, Jeffrey C",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  2,
  pages     = "256--261",
  month     =  feb,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Jostins2012-ig,
  title     = "Host--microbe interactions have shaped the genetic architecture
               of inflammatory bowel disease",
  author    = "Jostins, Luke and {The International IBD Genetics Consortium
               (IIBDGC)} and Ripke, Stephan and Weersma, Rinse K and Duerr,
               Richard H and McGovern, Dermot P and Hui, Ken Y and Lee, James C
               and Philip Schumm, L and Sharma, Yashoda and Anderson, Carl A
               and Essers, Jonah and Mitrovic, Mitja and Ning, Kaida and
               Cleynen, Isabelle and Theatre, Emilie and Spain, Sarah L and
               Raychaudhuri, Soumya and Goyette, Philippe and Wei, Zhi and
               Abraham, Clara and Achkar, Jean-Paul and Ahmad, Tariq and
               Amininejad, Leila and Ananthakrishnan, Ashwin N and Andersen,
               Vibeke and Andrews, Jane M and Baidoo, Leonard and Balschun,
               Tobias and Bampton, Peter A and Bitton, Alain and Boucher,
               Gabrielle and Brand, Stephan and B{\"u}ning, Carsten and Cohain,
               Ariella and Cichon, Sven and D'Amato, Mauro and De Jong, Dirk
               and Devaney, Kathy L and Dubinsky, Marla and Edwards, Cathryn
               and Ellinghaus, David and Ferguson, Lynnette R and Franchimont,
               Denis and Fransen, Karin and Gearry, Richard and Georges, Michel
               and Gieger, Christian and Glas, J{\"u}rgen and Haritunians,
               Talin and Hart, Ailsa and Hawkey, Chris and Hedl, Matija and Hu,
               Xinli and Karlsen, Tom H and Kupcinskas, Limas and Kugathasan,
               Subra and Latiano, Anna and Laukens, Debby and Lawrance, Ian C
               and Lees, Charlie W and Louis, Edouard and Mahy, Gillian and
               Mansfield, John and Morgan, Angharad R and Mowat, Craig and
               Newman, William and Palmieri, Orazio and Ponsioen, Cyriel Y and
               Potocnik, Uros and Prescott, Natalie J and Regueiro, Miguel and
               Rotter, Jerome I and Russell, Richard K and Sanderson, Jeremy D
               and Sans, Miquel and Satsangi, Jack and Schreiber, Stefan and
               Simms, Lisa A and Sventoraityte, Jurgita and Targan, Stephan R
               and Taylor, Kent D and Tremelling, Mark and Verspaget, Hein W
               and De Vos, Martine and Wijmenga, Cisca and Wilson, David C and
               Winkelmann, Juliane and Xavier, Ramnik J and Zeissig, Sebastian
               and Zhang, Bin and Zhang, Clarence K and Zhao, Hongyu and
               Silverberg, Mark S and Annese, Vito and Hakonarson, Hakon and
               Brant, Steven R and Radford-Smith, Graham and Mathew,
               Christopher G and Rioux, John D and Schadt, Eric E and Daly,
               Mark J and Franke, Andre and Parkes, Miles and Vermeire,
               Severine and Barrett, Jeffrey C and Cho, Judy H",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  491,
  number    =  7422,
  pages     = "119--124",
  month     =  nov,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Ng2012-mf,
  title     = "Role of genetic and environmental factors in British twins with
               inflammatory bowel disease",
  author    = "Ng, Siew C and Woodrow, Susannah and Patel, Nisha and Subhani,
               Javaid and Harbord, Marcus",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  18,
  number    =  4,
  pages     = "725--736",
  month     =  apr,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Yang2019-gt,
  title     = "Beverage intake and risk of Crohn disease: A meta-analysis of 16
               epidemiological studies",
  author    = "Yang, Yanhua and Xiang, Lili and He, Jianhua",
  abstract  = "Epidemiological studies were controversial in the association
               between beverage intake and risk of Crohn disease (CD). This
               study aimed to investigate the role of beverage intake in the
               development of CD. A systematic search was conducted in public
               databases to identify all relevant studies, and study-specific
               relative risks (RRs) and 95\% confidence intervals (CIs) were
               pooled using a random-effects model. Sixteen studies were
               identified with a total of 130,431 participants and 1933 CD
               cases. No significant association was detected between alcohol
               intake and CD risk (RR for the highest vs the lowest consumption
               level: 0.85, 95\% CI 0.68-1.08), and coffee intake and the risk
               (RR 0.82, 95\% CI 0.46-1.46). High intake of soft drinks was
               associated with CD risk (RR 1.42, 95\% CI 1.01-1.98), and tea
               intake was inversely associated with CD risk (RR 0.70, 95\% CI
               0.53-0.93). In conclusion, high intake of soft drinks might
               increase the risk of CD, whereas tea intake might decrease the
               risk.",
  journal   = "Medicine (Baltimore)",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  98,
  number    =  21,
  pages     = "e15795",
  month     =  may,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Jain2019-oy,
  title     = "Impact of obesity on disease activity and {Patient-Reported}
               Outcomes Measurement Information System ({PROMIS}) in
               inflammatory bowel diseases",
  author    = "Jain, Animesh and Nguyen, Nghia H and Proudfoot, James A and
               Martin, Christopher F and Sandborn, William J and Kappelman,
               Michael D and Long, Millie D and Singh, Siddharth",
  abstract  = "INTRODUCTION: We conducted a cohort study on the impact of
               obesity on disease activity and Patient-Reported Outcomes
               Measurement Information System (PROMIS) measures in the
               inflammatory bowel disease (IBD) Partners cohort. METHODS: We
               performed a cross-sectional and longitudinal study within IBD
               Partners, an internet-based cohort of >15,000 patients living
               with Crohn's disease (CD) and ulcerative colitis (UC). We
               included adult patients with IBD, with recorded body mass index
               (BMI), with at least 6 months of follow-up, excluding patients
               with BMI < 18.5 kg/m. We evaluated the independent effect of
               World Health Organization classes of obesity on risk of clinical
               relapse or persistent disease activity (using validated disease
               activity indexes) and PROMIS measures, using multivariate
               logistic regression and linear regression, respectively.
               RESULTS: We included 7,296 patients with IBD (4,748 patients
               with CD, 19.5\% obese; 2,548 patients with UC with intact colon,
               20.3\% obese). Obesity was independently, and in a
               dose-dependent fashion, associated with an increased risk of
               persistent disease activity or relapse in both patients with CD
               (class II or III obesity vs normal BMI: adjusted odds ratio,
               1.86; 95\% confidence interval, 1.30-2.68) and UC (adjusted odds
               ratio, 2.97; 95\% confidence interval, 1.75-5.17). Obesity was
               also independently associated with higher anxiety, depression,
               fatigue, pain, and inferior social function scores in patients
               with CD and UC at baseline and with worsening depression,
               fatigue, pain, and social function in patients with CD on
               longitudinal assessment. DISCUSSION: Obesity at baseline is
               independently associated with worsening disease activity and
               PROMIS measures in patients with IBD.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  114,
  number    =  4,
  pages     = "630--639",
  month     =  apr,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Rozich2020-ui,
  title     = "Effect of lifestyle factors on outcomes in patients with
               inflammatory bowel diseases",
  author    = "Rozich, Jacob J and Holmer, Ariela and Singh, Siddharth",
  abstract  = "Various lifestyle factors including physical activity and
               obesity, stress, sleep, and smoking may modify the risk of
               developing inflammatory bowel diseases (IBDs). In patients with
               established IBD, these lifestyle factors may significantly
               impact the natural history and clinical outcomes. Recreational
               exercise decreases the risk of flare and fatigue in patients
               with IBD. In contrast, obesity increases the risk of relapse and
               is associated with higher anxiety, depression, fatigue, and pain
               and higher health care utilization. Obesity also modifies
               pharmacokinetics of biologic agents unfavorably and is
               associated with a higher risk of treatment failure. Sleep
               disturbance is highly prevalent in patients with IBD,
               independent of disease activity, and increases the risk of
               relapse and chronic fatigue. Similarly, stress, particularly
               perceived stress rather than major life events, may trigger
               symptomatic flare in patients with IBD, although its impact on
               inflammation is unclear. Cigarette smoking is associated with
               unfavorable outcomes including the risk of corticosteroid
               dependence, surgery, and disease progression in patients with
               Crohn's disease; in contrast, smoking does not significantly
               impact outcomes in patients with ulcerative colitis, although
               some studies suggest that it may be associated with a lower risk
               of flare. The effect of alcohol and cannabis use in patients
               with IBD is inconsistent, with some studies suggesting that
               cannabis may decrease chronic pain in patients with IBD, without
               a significant effect of biological remission. Although these
               lifestyle factors are potentially modifiable, only a few
               interventional studies have been conducted. Trials of structured
               exercise and psychological therapy including mindfulness-based
               therapies such as meditation and yoga and gut-directed
               hypnotherapy have not consistently demonstrated benefit in
               clinical and/or endoscopic disease activity in IBD, although may
               improve overall quality of life.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  115,
  number    =  6,
  pages     = "832--840",
  month     =  jun,
  year      =  2020,
  language  = "en"
}

@ARTICLE{Koutroubakis2000-qt,
  title     = "Appendectomy and the development of ulcerative colitis: results
               of a metaanalysis of published case-control studies",
  author    = "Koutroubakis, I E and Vlachonikolis, I G",
  abstract  = "OBJECTIVE: Numerous epidemiological studies have been performed
               to determine risk factors that might contribute to the
               development of ulcerative colitis (UC). Recent studies have
               focused on the role of appendectomy in the disease's
               pathogenesis. This report aims to review and analyze the degree
               of evidence from recent published studies. METHODS: Medline and
               Embase databases were scrutinized for studies published between
               1987 and January 1999. Reference lists from published articles,
               reviews, and abstracts from major gastrointestinal (GI) meetings
               were also reviewed. All studies specifically designed to
               evaluate the association between appendectomy and UC were
               selected. Thirteen studies that satisfied our selection criteria
               were evaluated by metaanalysis. RESULTS: The 13 case-control
               studies collectively gathered evidence from 2770 patients with
               UC and 3352 controls. Combining the results of the individual
               studies gave an overall odds ratio of 0.307 (95\% confidence
               interval [CI] = 0.249-0.377) in favor of appendectomy (p0.10).
               The influence of potential confounding factors (mainly smoking)
               on these results could be excluded. CONCLUSIONS: The review of
               the literature and the metaanalysis of the selected studies
               suggest that the inverse association between appendectomy and UC
               is strong and consistent. Further studies are needed to
               establish whether a causal relationship exists.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  95,
  number    =  1,
  pages     = "171--176",
  month     =  jan,
  year      =  2000,
  language  = "en"
}

@ARTICLE{Cornish2008-rn,
  title     = "The risk of oral contraceptives in the etiology of inflammatory
               bowel disease: a meta-analysis",
  author    = "Cornish, Julie A and Tan, Emile and Simillis, Constantinos and
               Clark, Susan K and Teare, Julian and Tekkis, Paris P",
  abstract  = "OBJECTIVES: Several environmental and genetic factors have been
               implicated to date in the development of Crohn's disease (CD)
               and ulcerative colitis (UC). The aim of this study was to
               provide a quantification of the risk of oral contraceptive pill
               (OCP) use in the etiology of inflammatory bowel disease.
               METHODS: A literature search was performed to identify
               comparative studies reporting on the association of oral
               contraceptive use in the etiology of UC and CD between 1983 and
               2007. A random-effect meta-analysis was used to compare the
               incidence of UC or CD between the patients exposed to the OCP
               and nonexposed patients. The results were adjusted for smoking.
               RESULTS: A total of 75,815 patients were reported on by 14
               studies, with 36,797 exposed to OCP and 39,018 nonexposed women.
               The pooled relative risk (RR) for CD for women currently taking
               the OCP was 1.51 (95\% confidence interval [CI] 1.17-1.96, P=
               0.002), and 1.46 (95\% CI 1.26-1.70, P < 0.001), adjusted for
               smoking. The RR for UC in women currently taking the OCP was
               1.53 (95\% CI 1.21-1.94, P= 0.001), and 1.28 (95\% CI 1.06-1.54,
               P= 0.011), adjusted for smoking. The RR for CD increased with
               the length of exposure to OCP. Moreover, although the RR did not
               reduce once the OCP was stopped, it was no longer significant
               once the OCP was stopped (CI contains 1), both for CD and for
               UC. CONCLUSIONS: This study provides evidence of an association
               between the use of oral contraceptive agents and development of
               IBD, in particular CD. The study also suggests that the risk for
               patients who stop using the OCP reverts to that of the
               nonexposed population.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  103,
  number    =  9,
  pages     = "2394--2400",
  month     =  sep,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Richardson2003-pd,
  title     = "Effect of smoking and transdermal nicotine on colonic nicotinic
               acetylcholine receptors in ulcerative colitis",
  author    = "Richardson, C E and Morgan, J M and Jasani, B and Green, J T and
               Rhodes, J and Williams, G T and Lindstrom, J and Wonnacott, S
               and Peel, S and Thomas, G A O",
  abstract  = "BACKGROUND: Ulcerative colitis (UC) is a disease largely of
               non-smokers, in which nicotine is of therapeutic value. The mode
               of action is unknown, but may involve nicotinic acetylcholine
               receptors (nAChRs) in the bowel wall. AIM: To investigate the
               presence of nAChRs in rectal mucosa, and the effect of smoking
               and nicotine on their expression. DESIGN: Prospective
               case-control study. METHODS: In situ hybridization (ISH) and
               immunocytochemistry (ICC) were used to show alpha3 nAChRs in
               colonic mucosa. Rectal mucosa was examined from controls (n=55)
               and patients with inactive UC (n=62), both smokers and
               non-smokers, by ICC, using two antibodies to show the density
               and distribution of receptors in the mucosa. Non-smokers with UC
               (n=43) were given transdermal nicotine or placebo patches for 6
               months, and rectal biopsies, taken before and after treatment,
               were examined by ICC to show nAChRs. RESULTS: In normal colon,
               ISH and ICC showed alpha3 subunit in a wide variety of cells,
               including mucosal epithelium. In rectal biopsies, neither
               smoking nor nicotine influenced the expression of alpha3
               immunoreactivity in epithelium, either in controls or UC.
               However, controls had a significantly greater density of
               immunodetectable mucosal epithelium alpha3 subunit, compared
               with UC patients. DISCUSSION: The presence of nAChRs in colonic
               epithelium may be pertinent to the beneficial effect of nicotine
               in UC, but since neither smoking nor nicotine treatment is
               associated with any change in the expression of epithelial
               alpha3 nAChRs, the effect may be due to functional changes in
               the receptor. The decreased number of alpha3 nAChRs in UC
               compared with controls may be related to an increased cell
               turnover in UC.",
  journal   = "QJM",
  publisher = "Oxford University Press (OUP)",
  volume    =  96,
  number    =  1,
  pages     = "57--65",
  month     =  jan,
  year      =  2003,
  language  = "en"
}

@ARTICLE{Bernstein2008-ln,
  title     = "Disorders of a modern lifestyle: reconciling the epidemiology of
               inflammatory bowel diseases",
  author    = "Bernstein, Charles N and Shanahan, Fergus",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  57,
  number    =  9,
  pages     = "1185--1191",
  month     =  sep,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Thurgate2019-xj,
  title     = "An overview of inflammatory bowel disease unclassified in
               children",
  author    = "Thurgate, Lauren E and Lemberg, Daniel A and Day, Andrew S and
               Leach, Steven T",
  abstract  = "BACKGROUND: The inflammatory bowel diseases cover a diverse
               range of conditions generally grouped into Crohn's disease (CD)
               or ulcerative colitis (UC) based on clinical, laboratory,
               radiological, endoscopic, and histological criteria. However,
               inflammatory bowel disease unclassified (IBDU) is used when
               there are clinical and endoscopic signs of chronic colitis
               without specific features of UC or CD but features of both.
               Conjecture exists regarding IBDU, especially in children, as to
               whether it represents a unique childhood phenotype or whether it
               reflects the difficulties in assigning an IBD subtype at an
               early age. SUMMARY: This review examines the current
               understanding of pediatric IBDU and assesses the evidence
               supporting IBDU as a distinctive disease entity on the spectrum
               of inflammatory bowel disease. KEY MESSAGES: Pediatric-onset
               IBDU is more common than adult-onset IBDU. Therefore, an
               understanding of IBDU in this age group assumes more importance.
               However, there remains a paucity of information and a lack of
               exclusive longitudinal studies on pediatric IBDU. Subsequently
               there is significant disparity in the reported prevalence,
               clinical course, reclassification trends, and treatment
               responses around pediatric IBDU. Therefore, it remains
               challenging to chart the natural history of pediatric IBDU and
               consequently form an accurate understanding of where pediatric
               IBDU sits on the spectrum of disease.",
  journal   = "Inflamm. Intest. Dis.",
  publisher = "S. Karger AG",
  volume    =  4,
  number    =  3,
  pages     = "97--103",
  month     =  aug,
  year      =  2019,
  keywords  = "Crohn's disease; Disease classification; Inflammatory bowel
               disease; Inflammatory bowel disease unclassified; Ulcerative
               colitis",
  copyright = "https://www.karger.com/Services/SiteLicenses",
  language  = "en"
}

@ARTICLE{Hendrickson2002-ky,
  title     = "Clinical aspects and pathophysiology of inflammatory bowel
               disease",
  author    = "Hendrickson, Barbara A and Gokhale, Ranjana and Cho, Judy H",
  abstract  = "The chronic inflammatory bowel diseases (IBD), Crohn's disease
               and ulcerative colitis, are recognized as important causes of
               gastrointestinal disease in children and adults. In this review
               we delineate the clinical manifestations and diagnostic features
               of IBD. In addition, we summarize important recent advances in
               our understanding of the immune mediators of intestinal
               inflammation. This information has led to new therapeutic
               approaches in IBD. Further, we discuss the considerable data
               that point to the significance of genetic factors in the
               development of IBD and the genetic loci which have been
               implicated through genome-wide searches. The commensal bacterial
               flora also appears to be a critical element, particularly in
               regards to Crohn's disease, although the precise role of the
               bacteria in the disease manifestations remains unclear. Current
               investigations promise to yield fresh insights in these areas.",
  journal   = "Clin. Microbiol. Rev.",
  publisher = "American Society for Microbiology",
  volume    =  15,
  number    =  1,
  pages     = "79--94",
  month     =  jan,
  year      =  2002,
  language  = "en"
}

@ARTICLE{Aragam2022-ep,
  title     = "Discovery and systematic characterization of risk variants and
               genes for coronary artery disease in over a million participants",
  author    = "Aragam, Krishna G and Jiang, Tao and Goel, Anuj and Kanoni,
               Stavroula and Wolford, Brooke N and Atri, Deepak S and Weeks,
               Elle M and Wang, Minxian and Hindy, George and Zhou, Wei and
               Grace, Christopher and Roselli, Carolina and Marston, Nicholas A
               and Kamanu, Frederick K and Surakka, Ida and Venegas, Loreto
               Mu{\~n}oz and Sherliker, Paul and Koyama, Satoshi and Ishigaki,
               Kazuyoshi and {\AA}svold, Bj{\o}rn O and Brown, Michael R and
               Brumpton, Ben and de Vries, Paul S and Giannakopoulou, Olga and
               Giardoglou, Panagiota and Gudbjartsson, Daniel F and
               G{\"u}ldener, Ulrich and Haider, Syed M Ijlal and Helgadottir,
               Anna and Ibrahim, Maysson and Kastrati, Adnan and Kessler,
               Thorsten and Kyriakou, Theodosios and Konopka, Tomasz and Li,
               Ling and Ma, Lijiang and Meitinger, Thomas and Mucha, S{\"o}ren
               and Munz, Matthias and Murgia, Federico and Nielsen, Jonas B and
               N{\"o}then, Markus M and Pang, Shichao and Reinberger, Tobias
               and Schnitzler, Gavin and Smedley, Damian and Thorleifsson,
               Gudmar and von Scheidt, Moritz and Ulirsch, Jacob C and {Biobank
               Japan} and {EPIC-CVD} and Arnar, David O and Burtt, No{\"e}l P
               and Costanzo, Maria C and Flannick, Jason and Ito, Kaoru and
               Jang, Dong-Keun and Kamatani, Yoichiro and Khera, Amit V and
               Komuro, Issei and Kullo, Iftikhar J and Lotta, Luca A and
               Nelson, Christopher P and Roberts, Robert and Thorgeirsson,
               Gudmundur and Thorsteinsdottir, Unnur and Webb, Thomas R and
               Baras, Aris and Bj{\"o}rkegren, Johan L M and Boerwinkle, Eric
               and Dedoussis, George and Holm, Hilma and Hveem, Kristian and
               Melander, Olle and Morrison, Alanna C and Orho-Melander, Marju
               and Rallidis, Loukianos S and Ruusalepp, Arno and Sabatine, Marc
               S and Stefansson, Kari and Zalloua, Pierre and Ellinor, Patrick
               T and Farrall, Martin and Danesh, John and Ruff, Christian T and
               Finucane, Hilary K and Hopewell, Jemma C and Clarke, Robert and
               Gupta, Rajat M and Erdmann, Jeanette and Samani, Nilesh J and
               Schunkert, Heribert and Watkins, Hugh and Willer, Cristen J and
               Deloukas, Panos and Kathiresan, Sekar and Butterworth, Adam S
               and {CARDIoGRAMplusC4D Consortium}",
  abstract  = "The discovery of genetic loci associated with complex diseases
               has outpaced the elucidation of mechanisms of disease
               pathogenesis. Here we conducted a genome-wide association study
               (GWAS) for coronary artery disease (CAD) comprising 181,522
               cases among 1,165,690 participants of predominantly European
               ancestry. We detected 241 associations, including 30 new loci.
               Cross-ancestry meta-analysis with a Japanese GWAS yielded 38
               additional new loci. We prioritized likely causal variants using
               functionally informed fine-mapping, yielding 42 associations
               with less than five variants in the 95\% credible set.
               Similarity-based clustering suggested roles for early
               developmental processes, cell cycle signaling and vascular cell
               migration and proliferation in the pathogenesis of CAD. We
               prioritized 220 candidate causal genes, combining eight
               complementary approaches, including 123 supported by three or
               more approaches. Using CRISPR-Cas9, we experimentally validated
               the effect of an enhancer in MYO9B, which appears to mediate CAD
               risk by regulating vascular cell motility. Our analysis
               identifies and systematically characterizes >250 risk loci for
               CAD to inform experimental interrogation of putative causal
               mechanisms for CAD.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  54,
  number    =  12,
  pages     = "1803--1815",
  month     =  dec,
  year      =  2022,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Xue2018-ni,
  title     = "Genome-wide association analyses identify 143 risk variants and
               putative regulatory mechanisms for type 2 diabetes",
  author    = "Xue, Angli and Wu, Yang and Zhu, Zhihong and Zhang, Futao and
               Kemper, Kathryn E and Zheng, Zhili and Yengo, Loic and
               Lloyd-Jones, Luke R and Sidorenko, Julia and Wu, Yeda and
               Agbessi, Mawuss{\'e} and Ahsan, Habibul and Alves, Isabel and
               Andiappan, Anand and Awadalla, Philip and Battle, Alexis and
               Beutner, Frank and Bonder, Marc Jan and Boomsma, Dorret and
               Christiansen, Mark and Claringbould, Annique and Deelen, Patrick
               and Esko, T{\~o}nu and Fav{\'e}, Marie-Julie and Franke, Lude
               and Frayling, Timothy and Gharib, Sina and Gibson, Gregory and
               Hemani, Gibran and Jansen, Rick and K{\"a}h{\"o}nen, Mika and
               Kalnapenkis, Anette and Kasela, Silva and Kettunen, Johannes and
               Kim, Yungil and Kirsten, Holger and Kovacs, Peter and Krohn,
               Knut and Kronberg-Guzman, Jaanika and Kukushkina, Viktorija and
               Kutalik, Zoltan and Lee, Bernett and Lehtim{\"a}ki, Terho and
               Loeffler, Markus and Marigorta, Urko M and Metspalu, Andres and
               Milani, Lili and M{\"u}ller-Nurasyid, Martina and Nauck,
               Matthias and Nivard, Michel and Penninx, Brenda and Perola,
               Markus and Pervjakova, Natalia and Pierce, Brandon and Powell,
               Joseph and Prokisch, Holger and Psaty, Bruce and Raitakari, Olli
               and Ring, Susan and Ripatti, Samuli and Rotzschke, Olaf and
               Ru{\"e}ger, Sina and Saha, Ashis and Scholz, Markus and Schramm,
               Katharina and Sepp{\"a}l{\"a}, Ilkka and Stumvoll, Michael and
               Sullivan, Patrick and Teumer, Alexander and Thiery, Joachim and
               Tong, Lin and T{\"o}njes, Anke and van Dongen, Jenny and van
               Meurs, Joyce and Verlouw, Joost and V{\"o}lker, Uwe and
               V{\~o}sa, Urmo and Yaghootkar, Hanieh and Zeng, Biao and McRae,
               Allan F and Visscher, Peter M and Zeng, Jian and Yang, Jian and
               {eQTLGen Consortium}",
  abstract  = "AbstractType 2 diabetes (T2D) is a very common disease in
               humans. Here we conduct a meta-analysis of genome-wide
               association studies (GWAS) with ~16 million genetic variants in
               62,892 T2D cases and 596,424 controls of European ancestry. We
               identify 139 common and 4 rare variants associated with T2D, 42
               of which (39 common and 3 rare variants) are independent of the
               known variants. Integration of the gene expression data from
               blood (n = 14,115 and 2765) with the GWAS results identifies 33
               putative functional genes for T2D, 3 of which were targeted by
               approved drugs. A further integration of DNA methylation (n =
               1980) and epigenomic annotation data highlight 3 genes (CAMK1D,
               TP53INP1, and ATP5G1) with plausible regulatory mechanisms,
               whereby a genetic variant exerts an effect on T2D through
               epigenetic regulation of gene expression. Our study uncovers
               additional loci, proposes putative genetic regulatory mechanisms
               for T2D, and provides evidence of purifying selection for
               T2D-associated variants.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  9,
  number    =  1,
  month     =  jul,
  year      =  2018,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Wallace2021-rv,
  title     = "A more accurate method for colocalisation analysis allowing for
               multiple causal variants",
  author    = "Wallace, Chris",
  abstract  = "In genome-wide association studies (GWAS) it is now common to
               search for, and find, multiple causal variants located in close
               proximity. It has also become standard to ask whether different
               traits share the same causal variants, but one of the popular
               methods to answer this question, coloc, makes the simplifying
               assumption that only a single causal variant exists for any
               given trait in any genomic region. Here, we examine the
               potential of the recently proposed Sum of Single Effects (SuSiE)
               regression framework, which can be used for fine-mapping genetic
               signals, for use with coloc. SuSiE is a novel approach that
               allows evidence for association at multiple causal variants to
               be evaluated simultaneously, whilst separating the statistical
               support for each variant conditional on the causal signal being
               considered. We show this results in more accurate coloc
               inference than other proposals to adapt coloc for multiple
               causal variants based on conditioning. We therefore recommend
               that coloc be used in combination with SuSiE to optimise
               accuracy of colocalisation analyses when multiple causal
               variants exist.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  17,
  number    =  9,
  pages     = "e1009440",
  month     =  sep,
  year      =  2021,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}


@ARTICLE{Sul2013-xm,
  title     = "Effectively identifying {eQTLs} from multiple tissues by
               combining mixed model and meta-analytic approaches",
  author    = "Sul, Jae Hoon and Han, Buhm and Ye, Chun and Choi, Ted and
               Eskin, Eleazar",
  abstract  = "Gene expression data, in conjunction with information on genetic
               variants, have enabled studies to identify expression
               quantitative trait loci (eQTLs) or polymorphic locations in the
               genome that are associated with expression levels. Moreover,
               recent technological developments and cost decreases have
               further enabled studies to collect expression data in multiple
               tissues. One advantage of multiple tissue datasets is that
               studies can combine results from different tissues to identify
               eQTLs more accurately than examining each tissue separately. The
               idea of aggregating results of multiple tissues is closely
               related to the idea of meta-analysis which aggregates results of
               multiple genome-wide association studies to improve the power to
               detect associations. In principle, meta-analysis methods can be
               used to combine results from multiple tissues. However, eQTLs
               may have effects in only a single tissue, in all tissues, or in
               a subset of tissues with possibly different effect sizes. This
               heterogeneity in terms of effects across multiple tissues
               presents a key challenge to detect eQTLs. In this paper, we
               develop a framework that leverages two popular meta-analysis
               methods that address effect size heterogeneity to detect eQTLs
               across multiple tissues. We show by using simulations and
               multiple tissue data from mouse that our approach detects many
               eQTLs undetected by traditional eQTL methods. Additionally, our
               method provides an interpretation framework that accurately
               predicts whether an eQTL has an effect in a particular tissue.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  9,
  number    =  6,
  pages     = "e1003491",
  month     =  jun,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Li2018-kr,
  title     = "An empirical Bayes approach for multiple tissue {eQTL} analysis",
  author    = "Li, Gen and Shabalin, Andrey A and Rusyn, Ivan and Wright, Fred
               A and Nobel, Andrew B",
  journal   = "Biostatistics",
  publisher = "Oxford University Press (OUP)",
  volume    =  19,
  number    =  3,
  pages     = "391--406",
  month     =  jul,
  year      =  2018,
  copyright = "https://academic.oup.com/journals/pages/about\_us/legal/notices",
  language  = "en"
}

@ARTICLE{Flutre2013-sp,
  title     = "A statistical framework for joint {eQTL} analysis in multiple
               tissues",
  author    = "Flutre, Timoth{\'e}e and Wen, Xiaoquan and Pritchard, Jonathan
               and Stephens, Matthew",
  abstract  = "Mapping expression Quantitative Trait Loci (eQTLs) represents a
               powerful and widely adopted approach to identifying putative
               regulatory variants and linking them to specific genes. Up to
               now eQTL studies have been conducted in a relatively narrow
               range of tissues or cell types. However, understanding the
               biology of organismal phenotypes will involve understanding
               regulation in multiple tissues, and ongoing studies are
               collecting eQTL data in dozens of cell types. Here we present a
               statistical framework for powerfully detecting eQTLs in multiple
               tissues or cell types (or, more generally, multiple subgroups).
               The framework explicitly models the potential for each eQTL to
               be active in some tissues and inactive in others. By modeling
               the sharing of active eQTLs among tissues, this framework
               increases power to detect eQTLs that are present in more than
               one tissue compared with ``tissue-by-tissue'' analyses that
               examine each tissue separately. Conversely, by modeling the
               inactivity of eQTLs in some tissues, the framework allows the
               proportion of eQTLs shared across different tissues to be
               formally estimated as parameters of a model, addressing the
               difficulties of accounting for incomplete power when comparing
               overlaps of eQTLs identified by tissue-by-tissue analyses.
               Applying our framework to re-analyze data from transformed B
               cells, T cells, and fibroblasts, we find that it substantially
               increases power compared with tissue-by-tissue analysis,
               identifying 63\% more genes with eQTLs (at FDR = 0.05). Further,
               the results suggest that, in contrast to previous analyses of
               the same data, the majority of eQTLs detectable in these data
               are shared among all three tissues.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  9,
  number    =  5,
  pages     = "e1003486",
  month     =  may,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Raj2014-xw,
  title     = "Polarization of the effects of autoimmune and neurodegenerative
               risk alleles in leukocytes",
  author    = "Raj, Towfique and Rothamel, Katie and Mostafavi, Sara and Ye,
               Chun and Lee, Mark N and Replogle, Joseph M and Feng, Ting and
               Lee, Michelle and Asinovski, Natasha and Frohlich, Irene and
               Imboywa, Selina and Von Korff, Alina and Okada, Yukinori and
               Patsopoulos, Nikolaos A and Davis, Scott and McCabe, Cristin and
               Paik, Hyun-Il and Srivastava, Gyan P and Raychaudhuri, Soumya
               and Hafler, David A and Koller, Daphne and Regev, Aviv and
               Hacohen, Nir and Mathis, Diane and Benoist, Christophe and
               Stranger, Barbara E and De Jager, Philip L",
  abstract  = "To extend our understanding of the genetic basis of human immune
               function and dysfunction, we performed an expression
               quantitative trait locus (eQTL) study of purified CD4(+) T cells
               and monocytes, representing adaptive and innate immunity, in a
               multi-ethnic cohort of 461 healthy individuals. Context-specific
               cis- and trans-eQTLs were identified, and cross-population
               mapping allowed, in some cases, putative functional assignment
               of candidate causal regulatory variants for disease-associated
               loci. We note an over-representation of T cell-specific eQTLs
               among susceptibility alleles for autoimmune diseases and of
               monocyte-specific eQTLs among Alzheimer's and Parkinson's
               disease variants. This polarization implicates specific immune
               cell types in these diseases and points to the need to identify
               the cell-autonomous effects of disease susceptibility variants.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  344,
  number    =  6183,
  pages     = "519--523",
  month     =  may,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Peters2016-zk,
  title     = "Insight into genotype-phenotype associations through {eQTL}
               mapping in multiple cell types in health and immune-mediated
               disease",
  author    = "Peters, James E and Lyons, Paul A and Lee, James C and Richard,
               Arianne C and Fortune, Mary D and Newcombe, Paul J and
               Richardson, Sylvia and Smith, Kenneth G C",
  abstract  = "Genome-wide association studies (GWAS) have transformed our
               understanding of the genetics of complex traits such as
               autoimmune diseases, but how risk variants contribute to
               pathogenesis remains largely unknown. Identifying genetic
               variants that affect gene expression (expression quantitative
               trait loci, or eQTLs) is crucial to addressing this. eQTLs vary
               between tissues and following in vitro cellular activation, but
               have not been examined in the context of human inflammatory
               diseases. We performed eQTL mapping in five primary immune cell
               types from patients with active inflammatory bowel disease (n =
               91), anti-neutrophil cytoplasmic antibody-associated vasculitis
               (n = 46) and healthy controls (n = 43), revealing eQTLs present
               only in the context of active inflammatory disease. Moreover, we
               show that following treatment a proportion of these eQTLs
               disappear. Through joint analysis of expression data from
               multiple cell types, we reveal that previous estimates of eQTL
               immune cell-type specificity are likely to have been
               exaggerated. Finally, by analysing gene expression data from
               multiple cell types, we find eQTLs not previously identified by
               database mining at 34 inflammatory bowel disease-associated
               loci. In summary, this parallel eQTL analysis in multiple
               leucocyte subsets from patients with active disease provides new
               insights into the genetic basis of immune-mediated diseases.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  12,
  number    =  3,
  pages     = "e1005908",
  month     =  mar,
  year      =  2016,
  copyright = "https://creativecommons.org/publicdomain/zero/1.0/",
  language  = "en"
}

@ARTICLE{Monani1999-vf,
  title     = "A single nucleotide difference that alters splicing patterns
               distinguishes the {SMA} gene {SMN1} from the copy gene {SMN2}",
  author    = "Monani, U R and Lorson, C L and Parsons, D W and Prior, T W and
               Androphy, E J and Burghes, A H and McPherson, J D",
  abstract  = "Spinal muscular atrophy (SMA) is a recessive disorder
               characterized by loss of motor neurons in the spinal cord. It is
               caused by mutations in the telomeric survival motor neuron 1 (
               SMN1 ) gene. Alterations within an almost identical copy gene,
               the centromeric survival motor neuron 2 ( SMN2 ) gene produce no
               known phenotypic effect. The exons of the two genes differ by
               just two nucleotides, neither of which alters the encoded amino
               acids. At the genomic level, only five nucleotides that
               differentiate the two genes from one another have been reported.
               The entire genomic sequence of the two genes has not been
               determined. Thus, differences which might explain why SMN1 is
               the SMA gene are not readily apparent. In this study, we have
               completely sequenced and compared genomic clones containing the
               SMN genes. The two genes show striking similarity, with the
               homology being unprecedented between two different yet
               functional genes. The only critical difference in an
               approximately 32 kb region between the two SMN genes is the C->T
               base change 6 bp inside exon 7. This alteration but not other
               variations in the SMN genes affects the splicing pattern of the
               genes. The majority of the transcript from the SMN1 locus is
               full length, whereas the majority of the transcript produced by
               the SMN2 locus lacks exon 7. We suggest that the exon 7
               nucleotide change affects the activity of an exon splice
               enhancer. In SMA patients, the loss of SMN1 but the presence of
               SMN2 results in low levels of full-length SMN transcript and
               therefore low SMN protein levels which causes SMA.",
  journal   = "Hum. Mol. Genet.",
  publisher = "Oxford University Press (OUP)",
  volume    =  8,
  number    =  7,
  pages     = "1177--1183",
  month     =  jul,
  year      =  1999,
  language  = "en"
}

@ARTICLE{Geuens2016-yz,
  title     = "The {hnRNP} family: insights into their role in health and
               disease",
  author    = "Geuens, Thomas and Bouhy, Delphine and Timmerman, Vincent",
  journal   = "Hum. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  135,
  number    =  8,
  pages     = "851--867",
  month     =  aug,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Shepard2009-os,
  title     = "The {SR} protein family",
  author    = "Shepard, Peter J and Hertel, Klemens J",
  abstract  = "SUMMARY: The processing of pre-mRNAs is a fundamental step
               required for the expression of most metazoan genes. Members of
               the family of serine/arginine (SR)-rich proteins are critical
               components of the machineries carrying out these essential
               processing events, highlighting their importance in maintaining
               efficient gene expression. SR proteins are characterized by
               their ability to interact simultaneously with RNA and other
               protein components via an RNA recognition motif (RRM) and
               through a domain rich in arginine and serine residues, the RS
               domain. Their functional roles in gene expression are
               surprisingly diverse, ranging from their classical involvement
               in constitutive and alternative pre-mRNA splicing to various
               post-splicing activities, including mRNA nuclear export,
               nonsense-mediated decay, and mRNA translation. These activities
               point up the importance of SR proteins during the regulation of
               mRNA metabolism.",
  journal   = "Genome Biol.",
  publisher = "Springer Nature",
  volume    =  10,
  number    =  10,
  pages     = "242",
  month     =  oct,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Jaganathan2019-ah,
  title     = "Predicting splicing from primary sequence with deep learning",
  author    = "Jaganathan, Kishore and Kyriazopoulou Panagiotopoulou, Sofia and
               McRae, Jeremy F and Darbandi, Siavash Fazel and Knowles, David
               and Li, Yang I and Kosmicki, Jack A and Arbelaez, Juan and Cui,
               Wenwu and Schwartz, Grace B and Chow, Eric D and Kanterakis,
               Efstathios and Gao, Hong and Kia, Amirali and Batzoglou, Serafim
               and Sanders, Stephan J and Farh, Kyle Kai-How",
  abstract  = "The splicing of pre-mRNAs into mature transcripts is remarkable
               for its precision, but the mechanisms by which the cellular
               machinery achieves such specificity are incompletely understood.
               Here, we describe a deep neural network that accurately predicts
               splice junctions from an arbitrary pre-mRNA transcript sequence,
               enabling precise prediction of noncoding genetic variants that
               cause cryptic splicing. Synonymous and intronic mutations with
               predicted splice-altering consequence validate at a high rate on
               RNA-seq and are strongly deleterious in the human population. De
               novo mutations with predicted splice-altering consequence are
               significantly enriched in patients with autism and intellectual
               disability compared to healthy controls and validate against
               RNA-seq in 21 out of 28 of these patients. We estimate that
               9\%-11\% of pathogenic mutations in patients with rare genetic
               disorders are caused by this previously underappreciated class
               of disease variation.",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  176,
  number    =  3,
  pages     = "535--548.e24",
  month     =  jan,
  year      =  2019,
  keywords  = "artificial intelligence; deep learning; genetics; splicing",
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Vaquero-Garcia2016-dv,
  title     = "A new view of transcriptome complexity and regulation through
               the lens of local splicing variations",
  author    = "Vaquero-Garcia, Jorge and Barrera, Alejandro and Gazzara,
               Matthew R and Gonzalez-Vallinas, Juan and Lahens, Nicholas F
               and Hogenesch, John B and Lynch, Kristen W and Barash, Yoseph",
  abstract  = "Alternative splicing (AS) can critically affect gene function
               and disease, yet mapping splicing variations remains a
               challenge. Here, we propose a new approach to define and
               quantify mRNA splicing in units of local splicing variations
               (LSVs). LSVs capture previously defined types of alternative
               splicing as well as more complex transcript variations. Building
               the first genome wide map of LSVs from twelve mouse tissues, we
               find complex LSVs constitute over 30\% of tissue dependent
               transcript variations and affect specific protein families. We
               show the prevalence of complex LSVs is conserved in humans and
               identify hundreds of LSVs that are specific to brain subregions
               or altered in Alzheimer's patients. Amongst those are novel
               isoforms in the Camk2 family and a novel poison exon in Ptbp1, a
               key splice factor in neurogenesis. We anticipate the approach
               presented here will advance the ability to relate
               tissue-specific splice variation to genetic variation,
               phenotype, and disease.",
  journal   = "Elife",
  publisher = "eLife Sciences Publications, Ltd",
  volume    =  5,
  month     =  feb,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}



@INCOLLECTION{Lacroix2008-wq,
  title     = "Exact transcriptome reconstruction from short sequence reads",
  booktitle = "Lecture Notes in Computer Science",
  author    = "Lacroix, Vincent and Sammeth, Michael and Guigo, Roderic and
               Bergeron, Anne",
  abstract  = "In this paper we address the problem of characterizing the RNA
               complement of a given cell type, that is, the set of RNA species
               and their relative copy number, from a large set of short
               sequence reads which have been randomly sampled from the cell's
               RNA sequences through a sequencing experiment. We refer to this
               problem as the transcriptome reconstruction problem, and we
               specifically investigate, both theoretically and practically,
               the conditions under which the problem can be solved. We
               demonstrate that, even under the assumption of exact
               information, neither single read nor paired-end read sequences
               guarantee theoretically that the reconstruction problem has a
               unique solution. However, by investigating the behavior of the
               best annotated human gene set, we also show that, in practice,
               paired-end reads --- but not single reads --- may be sufficient
               to solve the vast majority of the transcript variants species
               and abundances. We finally show that, when we assume that the
               RNA species existing in the cell are known, single read
               sequences can effectively be used to infer transcript variant
               abundances.",
  publisher = "Springer Berlin Heidelberg",
  pages     = "50--63",
  series    = "Lecture notes in computer science",
  year      =  2008,
  address   = "Berlin, Heidelberg"
}

@ARTICLE{Katz2010-kl,
  title     = "Analysis and design of {RNA} sequencing experiments for
               identifying isoform regulation",
  author    = "Katz, Yarden and Wang, Eric T and Airoldi, Edoardo M and Burge,
               Christopher B",
  journal   = "Nat. Methods",
  publisher = "Springer Science and Business Media LLC",
  volume    =  7,
  number    =  12,
  pages     = "1009--1015",
  month     =  dec,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Shen2014-bq,
  title     = "{rMATS}: robust and flexible detection of differential
               alternative splicing from replicate {RNA-Seq} data",
  author    = "Shen, Shihao and Park, Juw Won and Lu, Zhi-Xiang and Lin, Lan
               and Henry, Michael D and Wu, Ying Nian and Zhou, Qing and Xing,
               Yi",
  abstract  = "Ultra-deep RNA sequencing (RNA-Seq) has become a powerful
               approach for genome-wide analysis of pre-mRNA alternative
               splicing. We previously developed multivariate analysis of
               transcript splicing (MATS), a statistical method for detecting
               differential alternative splicing between two RNA-Seq samples.
               Here we describe a new statistical model and computer program,
               replicate MATS (rMATS), designed for detection of differential
               alternative splicing from replicate RNA-Seq data. rMATS uses a
               hierarchical model to simultaneously account for sampling
               uncertainty in individual replicates and variability among
               replicates. In addition to the analysis of unpaired replicates,
               rMATS also includes a model specifically designed for paired
               replicates between sample groups. The hypothesis-testing
               framework of rMATS is flexible and can assess the statistical
               significance over any user-defined magnitude of splicing change.
               The performance of rMATS is evaluated by the analysis of
               simulated and real RNA-Seq data. rMATS outperformed two existing
               methods for replicate RNA-Seq data in all simulation settings,
               and RT-PCR yielded a high validation rate (94\%) in an RNA-Seq
               dataset of prostate cancer cell lines. Our data also provide
               guiding principles for designing RNA-Seq studies of alternative
               splicing. We demonstrate that it is essential to incorporate
               biological replicates in the study design. Of note, pooling RNAs
               or merging RNA-Seq data from multiple replicates is not an
               effective approach to account for variability, and the result is
               particularly sensitive to outliers. The rMATS source code is
               freely available at rnaseq-mats.sourceforge.net/. As the
               popularity of RNA-Seq continues to grow, we expect rMATS will be
               useful for studies of alternative splicing in diverse RNA-Seq
               projects.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "Proceedings of the National Academy of Sciences",
  volume    =  111,
  number    =  51,
  pages     = "E5593--601",
  month     =  dec,
  year      =  2014,
  keywords  = "RNA sequencing; alternative splicing; exon; isoform;
               transcriptome",
  copyright = "http://www.pnas.org/site/misc/userlicense.xhtml",
  language  = "en"
}

@ARTICLE{Trapnell2012-zh,
  title     = "Differential gene and transcript expression analysis of
               {RNA-seq} experiments with {TopHat} and Cufflinks",
  author    = "Trapnell, Cole and Roberts, Adam and Goff, Loyal and Pertea, Geo
               and Kim, Daehwan and Kelley, David R and Pimentel, Harold and
               Salzberg, Steven L and Rinn, John L and Pachter, Lior",
  abstract  = "Recent advances in high-throughput cDNA sequencing (RNA-seq) can
               reveal new genes and splice variants and quantify expression
               genome-wide in a single assay. The volume and complexity of data
               from RNA-seq experiments necessitate scalable, fast and
               mathematically principled analysis software. TopHat and
               Cufflinks are free, open-source software tools for gene
               discovery and comprehensive expression analysis of
               high-throughput mRNA sequencing (RNA-seq) data. Together, they
               allow biologists to identify new genes and new splice variants
               of known ones, as well as compare gene and transcript expression
               under two or more conditions. This protocol describes in detail
               how to use TopHat and Cufflinks to perform such analyses. It
               also covers several accessory tools and utilities that aid in
               managing data, including CummeRbund, a tool for visualizing
               RNA-seq analysis results. Although the procedure assumes basic
               informatics skills, these tools assume little to no background
               with RNA-seq analysis and are meant for novices and experts
               alike. The protocol begins with raw sequencing reads and
               produces a transcriptome assembly, lists of differentially
               expressed and regulated genes and transcripts, and
               publication-quality visualizations of analysis results. The
               protocol's execution time depends on the volume of transcriptome
               sequencing data and available computing resources but takes less
               than 1 d of computer time for typical experiments and ~1 h of
               hands-on time.",
  journal   = "Nat. Protoc.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  7,
  number    =  3,
  pages     = "562--578",
  month     =  mar,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Hagemann-Jensen2020-ob,
  title     = "Single-cell {RNA} counting at allele and isoform resolution
               using Smart-seq3",
  author    = "Hagemann-Jensen, Michael and Ziegenhain, Christoph and Chen,
               Ping and Ramsk{\"o}ld, Daniel and Hendriks, Gert-Jan and
               Larsson, Anton J M and Faridani, Omid R and Sandberg, Rickard",
  abstract  = "Large-scale sequencing of RNA from individual cells can reveal
               patterns of gene, isoform and allelic expression across cell
               types and states1. However, current short-read single-cell
               RNA-sequencing methods have limited ability to count RNAs at
               allele and isoform resolution, and long-read sequencing
               techniques lack the depth required for large-scale applications
               across cells2,3. Here we introduce Smart-seq3, which combines
               full-length transcriptome coverage with a 5' unique molecular
               identifier RNA counting strategy that enables in silico
               reconstruction of thousands of RNA molecules per cell. Of the
               counted and reconstructed molecules, 60\% could be directly
               assigned to allelic origin and 30-50\% to specific isoforms, and
               we identified substantial differences in isoform usage in
               different mouse strains and human cell types. Smart-seq3 greatly
               increased sensitivity compared to Smart-seq2, typically
               detecting thousands more transcripts per cell. We expect that
               Smart-seq3 will enable large-scale characterization of cell
               types and states across tissues and organisms.",
  journal   = "Nat. Biotechnol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  38,
  number    =  6,
  pages     = "708--714",
  month     =  jun,
  year      =  2020,
  language  = "en"
}

@misc{hca_resources,   
    title = {Human Cell Atlas Resources},   
    url = {https://www.humancellatlas.org/resources/},   
    author = {HCA},   
    year = {2023},   
    note = {Accessed on 02/11/2023} 
}
@ARTICLE{Gonzalez-Porta2013-il,
  title     = "Transcriptome analysis of human tissues and cell lines reveals
               one dominant transcript per gene",
  author    = "Gonz{\`a}lez-Porta, Mar and Frankish, Adam and Rung, Johan and
               Harrow, Jennifer and Brazma, Alvis",
  abstract  = "BACKGROUND: RNA sequencing has opened new avenues for the study
               of transcriptome composition. Significant evidence has
               accumulated showing that the human transcriptome contains in
               excess of a hundred thousand different transcripts. However, it
               is still not clear to what extent this diversity prevails when
               considering the relative abundances of different transcripts
               from the same gene. RESULTS: Here we show that, in a given
               condition, most protein coding genes have one major transcript
               expressed at significantly higher level than others, that in
               human tissues the major transcripts contribute almost 85 percent
               to the total mRNA from protein coding loci, and that often the
               same major transcript is expressed in many tissues. We detect a
               high degree of overlap between the set of major transcripts and
               a recently published set of alternatively spliced transcripts
               that are predicted to be translated utilizing proteomic data.
               Thus, we hypothesize that although some minor transcripts may
               play a functional role, the major ones are likely to be the main
               contributors to the proteome. However, we still detect a
               non-negligible fraction of protein coding genes for which the
               major transcript does not code a protein. CONCLUSIONS: Overall,
               our findings suggest that the transcriptome from protein coding
               loci is dominated by one transcript per gene and that not all
               the transcripts that contribute to transcriptome diversity are
               equally likely to contribute to protein diversity. This
               observation can help to prioritize candidate targets in
               proteomics research and to predict the functional impact of the
               detected changes in variation studies.",
  journal   = "Genome Biol.",
  publisher = "Springer Nature",
  volume    =  14,
  number    =  7,
  pages     = "R70",
  month     =  jul,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Ezkurdia2015-iv,
  title     = "Most highly expressed protein-coding genes have a single
               dominant isoform",
  author    = "Ezkurdia, Iakes and Rodriguez, Jose Manuel and Carrillo-de Santa
               Pau, Enrique and V{\'a}zquez, Jes{\'u}s and Valencia, Alfonso
               and Tress, Michael L",
  abstract  = "Although eukaryotic cells express a wide range of alternatively
               spliced transcripts, it is not clear whether genes tend to
               express a range of transcripts simultaneously across cells, or
               produce dominant isoforms in a manner that is either
               tissue-specific or regardless of tissue. To date, large-scale
               investigations into the pattern of transcript expression across
               distinct tissues have produced contradictory results. Here, we
               attempt to determine whether genes express a dominant splice
               variant at the protein level. We interrogate peptides from eight
               large-scale human proteomics experiments and databases and find
               that there is a single dominant protein isoform, irrespective of
               tissue or cell type, for the vast majority of the protein-coding
               genes in these experiments, in partial agreement with the
               conclusions from the most recent large-scale RNAseq study.
               Remarkably, the dominant isoforms from the experimental
               proteomics analyses coincided overwhelmingly with the reference
               isoforms selected by two completely orthogonal sources, the
               consensus coding sequence variants, which are agreed upon by
               separate manual genome curation teams, and the principal
               isoforms from the APPRIS database, predicted automatically from
               the conservation of protein sequence, structure, and function.",
  journal   = "J. Proteome Res.",
  publisher = "American Chemical Society (ACS)",
  volume    =  14,
  number    =  4,
  pages     = "1880--1887",
  month     =  apr,
  year      =  2015,
  keywords  = "Alternative splicing; Dominant isoforms; Large-scale proteomics;
               Protein function; Protein structure; RNAseq",
  language  = "en"
}

@ARTICLE{Wang2008-yg,
  title     = "Alternative isoform regulation in human tissue transcriptomes",
  author    = "Wang, Eric T and Sandberg, Rickard and Luo, Shujun and
               Khrebtukova, Irina and Zhang, Lu and Mayr, Christine and
               Kingsmore, Stephen F and Schroth, Gary P and Burge, Christopher
               B",
  abstract  = "Through alternative processing of pre-messenger RNAs, individual
               mammalian genes often produce multiple mRNA and protein isoforms
               that may have related, distinct or even opposing functions. Here
               we report an in-depth analysis of 15 diverse human tissue and
               cell line transcriptomes on the basis of deep sequencing of
               complementary DNA fragments, yielding a digital inventory of
               gene and mRNA isoform expression. Analyses in which sequence
               reads are mapped to exon-exon junctions indicated that 92-94\%
               of human genes undergo alternative splicing, 86\% with a minor
               isoform frequency of 15\% or more. Differences in
               isoform-specific read densities indicated that most alternative
               splicing and alternative cleavage and polyadenylation events
               vary between tissues, whereas variation between individuals was
               approximately twofold to threefold less common. Extreme or
               'switch-like' regulation of splicing between tissues was
               associated with increased sequence conservation in regulatory
               regions and with generation of full-length open reading frames.
               Patterns of alternative splicing and alternative cleavage and
               polyadenylation were strongly correlated across tissues,
               suggesting coordinated regulation of these processes, and
               sequence conservation of a subset of known regulatory motifs in
               both alternative introns and 3' untranslated regions suggested
               common involvement of specific factors in tissue-level
               regulation of both splicing and polyadenylation.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  456,
  number    =  7221,
  pages     = "470--476",
  month     =  nov,
  year      =  2008,
  language  = "en"
}

@misc{refseq_ftp,   
    title = {RefSeq FTP Site},   
    url = {ftp://ftp.ncbi.nlm.nih.gov/refseq/release/release-statistics/},   
    author = {RefSeq},   
    year = {2023},   
    note = {Accessed on 02/11/2023} 
}
@ARTICLE{OLeary2016-ci,
  title     = "Reference sequence ({RefSeq}) database at {NCBI}: current
               status, taxonomic expansion, and functional annotation",
  author    = "O'Leary, Nuala A and Wright, Mathew W and Brister, J Rodney and
               Ciufo, Stacy and Haddad, Diana and McVeigh, Rich and Rajput,
               Bhanu and Robbertse, Barbara and Smith-White, Brian and
               Ako-Adjei, Danso and Astashyn, Alexander and Badretdin, Azat and
               Bao, Yiming and Blinkova, Olga and Brover, Vyacheslav and
               Chetvernin, Vyacheslav and Choi, Jinna and Cox, Eric and
               Ermolaeva, Olga and Farrell, Catherine M and Goldfarb, Tamara
               and Gupta, Tripti and Haft, Daniel and Hatcher, Eneida and
               Hlavina, Wratko and Joardar, Vinita S and Kodali, Vamsi K and
               Li, Wenjun and Maglott, Donna and Masterson, Patrick and
               McGarvey, Kelly M and Murphy, Michael R and O'Neill, Kathleen
               and Pujar, Shashikant and Rangwala, Sanjida H and Rausch, Daniel
               and Riddick, Lillian D and Schoch, Conrad and Shkeda, Andrei and
               Storz, Susan S and Sun, Hanzhen and Thibaud-Nissen, Francoise
               and Tolstoy, Igor and Tully, Raymond E and Vatsan, Anjana R and
               Wallin, Craig and Webb, David and Wu, Wendy and Landrum, Melissa
               J and Kimchi, Avi and Tatusova, Tatiana and DiCuccio, Michael
               and Kitts, Paul and Murphy, Terence D and Pruitt, Kim D",
  abstract  = "The RefSeq project at the National Center for Biotechnology
               Information (NCBI) maintains and curates a publicly available
               database of annotated genomic, transcript, and protein sequence
               records (http://www.ncbi.nlm.nih.gov/refseq/). The RefSeq
               project leverages the data submitted to the International
               Nucleotide Sequence Database Collaboration (INSDC) against a
               combination of computation, manual curation, and collaboration
               to produce a standard set of stable, non-redundant reference
               sequences. The RefSeq project augments these reference sequences
               with current knowledge including publications, functional
               features and informative nomenclature. The database currently
               represents sequences from more than 55,000 organisms (>4800
               viruses, >40,000 prokaryotes and >10,000 eukaryotes; RefSeq
               release 71), ranging from a single record to complete genomes.
               This paper summarizes the current status of the viral,
               prokaryotic, and eukaryotic branches of the RefSeq project,
               reports on improvements to data access and details efforts to
               further expand the taxonomic representation of the collection.
               We also highlight diverse functional curation initiatives that
               support multiple uses of RefSeq data including taxonomic
               validation, genome annotation, comparative genomics, and
               clinical testing. We summarize our approach to utilizing
               available RNA-Seq and other data types in our manual curation
               process for vertebrate, plant, and other species, and describe a
               new direction for prokaryotic genomes and protein name
               management.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  44,
  number    = "D1",
  pages     = "D733--45",
  month     =  jan,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Penalva2003-bu,
  title     = "{RNA} binding protein sex-lethal (Sxl) and control of Drosophila
               sex determination and dosage compensation",
  author    = "Penalva, Luiz O F and S{\'a}nchez, Lucas",
  abstract  = "In the past two decades, scientists have elucidated the
               molecular mechanisms behind Drosophila sex determination and
               dosage compensation. These two processes are controlled
               essentially by two different sets of genes, which have in common
               a master regulatory gene, Sex-lethal (Sxl). Sxl encodes one of
               the best-characterized members of the family of RNA binding
               proteins. The analysis of different mechanisms involved in the
               regulation of the three identified Sxl target genes (Sex-lethal
               itself, transformer, and male specific lethal-2) has contributed
               to a better understanding of translation repression, as well as
               constitutive and alternative splicing. Studies using the
               Drosophila system have identified the features of the protein
               that contribute to its target specificity and regulatory
               functions. In this article, we review the existing data
               concerning Sxl protein, its biological functions, and the
               regulation of its target genes.",
  journal   = "Microbiol. Mol. Biol. Rev.",
  publisher = "American Society for Microbiology",
  volume    =  67,
  number    =  3,
  pages     = "343--59, table of contents",
  month     =  sep,
  year      =  2003,
  language  = "en"
}

@ARTICLE{Wojtowicz2004-df,
  title     = "Alternative splicing of Drosophila Dscam generates axon guidance
               receptors that exhibit isoform-specific homophilic binding",
  author    = "Wojtowicz, Woj M and Flanagan, John J and Millard, S Sean and
               Zipursky, S Lawrence and Clemens, James C",
  abstract  = "Dscam is an immunoglobulin (Ig) superfamily protein required for
               the formation of neuronal connections in Drosophila. Through
               alternative splicing, Dscam potentially gives rise to 19,008
               different extracellular domains linked to one of two alternative
               transmembrane segments, resulting in 38,016 isoforms. All
               isoforms share the same domain structure but contain variable
               amino acid sequences within three Ig domains in the
               extracellular region. We demonstrate that different isoforms
               exhibit different binding specificity. Each isoform binds to
               itself but does not bind or binds poorly to other isoforms. The
               amino acid sequences of all three variable Ig domains determine
               binding specificity. Even closely related isoforms sharing
               nearly identical amino acid sequences exhibit isoform-specific
               binding. We propose that this preferential homophilic binding
               specificity regulates interactions between cells and contributes
               to the formation of complex patterns of neuronal connections.",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  118,
  number    =  5,
  pages     = "619--633",
  month     =  sep,
  year      =  2004,
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Hattori2008-jd,
  title     = "Dscam-mediated cell recognition regulates neural circuit
               formation",
  author    = "Hattori, Daisuke and Millard, S Sean and Wojtowicz, Woj M and
               Zipursky, S Lawrence",
  abstract  = "The Dscam family of immunoglobulin cell surface proteins
               mediates recognition events between neurons that play an
               essential role in the establishment of neural circuits. The
               Drosophila Dscam1 locus encodes tens of thousands of cell
               surface proteins via alternative splicing. These isoforms
               exhibit exquisite isoform-specific binding in vitro that
               mediates homophilic repulsion in vivo. These properties provide
               the molecular basis for self-avoidance, an essential
               developmental mechanism that allows axonal and dendritic
               processes to uniformly cover their synaptic fields. In a
               mechanistically similar fashion, homophilic repulsion mediated
               by Drosophila Dscam2 prevents processes from the same class of
               cells from occupying overlapping synaptic fields through a
               process called tiling. Genetic studies in the mouse visual
               system support the view that vertebrate DSCAM also promotes both
               self-avoidance and tiling. By contrast, DSCAM and DSCAM-L
               promote layer-specific targeting in the chick visual system,
               presumably through promoting homophilic adhesion. The fly and
               mouse studies underscore the importance of homophilic repulsion
               in regulating neural circuit assembly, whereas the chick studies
               suggest that DSCAM proteins may mediate a variety of different
               recognition events during wiring in a context-dependent fashion.",
  journal   = "Annu. Rev. Cell Dev. Biol.",
  publisher = "Annual Reviews",
  volume    =  24,
  number    =  1,
  pages     = "597--620",
  year      =  2008,
  language  = "en"
}

@ARTICLE{Marasco2023-kt,
  title     = "The physiology of alternative splicing",
  author    = "Marasco, Luciano E and Kornblihtt, Alberto R",
  abstract  = "Alternative splicing is a substantial contributor to the high
               complexity of transcriptomes of multicellular eukaryotes. In
               this Review, we discuss the accumulated evidence that most of
               this complexity is reflected at the protein level and
               fundamentally shapes the physiology and pathology of organisms.
               This notion is supported not only by genome-wide analyses but,
               mainly, by detailed studies showing that global and
               gene-specific modulations of alternative splicing regulate
               highly diverse processes such as tissue-specific and
               species-specific cell differentiation, thermal regulation,
               neuron self-avoidance, infrared sensing, the Warburg effect,
               maintenance of telomere length, cancer and autism spectrum
               disorders (ASD). We also discuss how mastering the control of
               alternative splicing paved the way to clinically approved
               therapies for hereditary diseases.",
  journal   = "Nat. Rev. Mol. Cell Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  24,
  number    =  4,
  pages     = "242--254",
  month     =  apr,
  year      =  2023,
  language  = "en"
}

@ARTICLE{Messing2001-wb,
  title     = "Do plants have more genes than humans?",
  author    = "Messing, J",
  journal   = "Trends Plant Sci.",
  publisher = "Elsevier BV",
  volume    =  6,
  number    =  5,
  pages     = "195--196",
  month     =  may,
  year      =  2001,
  language  = "en"
}

@ARTICLE{Bush2017-nz,
  title     = "Alternative splicing and the evolution of phenotypic novelty",
  author    = "Bush, Stephen J and Chen, Lu and Tovar-Corona, Jaime M and
               Urrutia, Araxi O",
  abstract  = "Alternative splicing, a mechanism of post-transcriptional RNA
               processing whereby a single gene can encode multiple distinct
               transcripts, has been proposed to underlie morphological
               innovations in multicellular organisms. Genes with developmental
               functions are enriched for alternative splicing events,
               suggestive of a contribution of alternative splicing to
               developmental programmes. The role of alternative splicing as a
               source of transcript diversification has previously been
               compared to that of gene duplication, with the relationship
               between the two extensively explored. Alternative splicing is
               reduced following gene duplication with the retention of
               duplicate copies higher for genes which were alternatively
               spliced prior to duplication. Furthermore, and unlike the case
               for overall gene number, the proportion of alternatively spliced
               genes has also increased in line with the evolutionary
               diversification of cell types, suggesting alternative splicing
               may contribute to the complexity of developmental programmes.
               Together these observations suggest a prominent role for
               alternative splicing as a source of functional innovation.
               However, it is unknown whether the proliferation of alternative
               splicing events indeed reflects a functional expansion of the
               transcriptome or instead results from weaker selection acting on
               larger species, which tend to have a higher number of cell types
               and lower population sizes.This article is part of the themed
               issue `Evo-devo in the genomics era, and the origins of
               morphological diversity'.",
  journal   = "Philos. Trans. R. Soc. Lond. B Biol. Sci.",
  publisher = "The Royal Society",
  volume    =  372,
  number    =  1713,
  pages     = "20150474",
  month     =  feb,
  year      =  2017,
  copyright = "https://royalsociety.org/-/media/journals/author/Licence-to-Publish-20062019-final.pdf",
  language  = "en"
}

@ARTICLE{Koonin2006-eh,
  title     = "The origin of introns and their role in eukaryogenesis: a
               compromise solution to the introns-early versus introns-late
               debate?",
  author    = "Koonin, Eugene V",
  abstract  = "BACKGROUND: Ever since the discovery of 'genes in pieces' and
               mRNA splicing in eukaryotes, origin and evolution of
               spliceosomal introns have been considered within the conceptual
               framework of the 'introns early' versus 'introns late' debate.
               The 'introns early' hypothesis, which is closely linked to the
               so-called exon theory of gene evolution, posits that
               protein-coding genes were interrupted by numerous introns even
               at the earliest stages of life's evolution and that introns
               played a major role in the origin of proteins by facilitating
               recombination of sequences coding for small protein/peptide
               modules. Under this scenario, the absence of spliceosomal
               introns in prokaryotes is considered to be a result of ``genome
               streamlining''. The 'introns late' hypothesis counters that
               spliceosomal introns emerged only in eukaryotes, and moreover,
               have been inserted into protein-coding genes continuously
               throughout the evolution of eukaryotes. Beyond the formal
               dilemma, the more substantial side of this debate has to do with
               possible roles of introns in the evolution of eukaryotes.
               RESULTS: I argue that several lines of evidence now suggest a
               coherent solution to the introns-early versus introns-late
               debate, and the emerging picture of intron evolution integrates
               aspects of both views although, formally, there seems to be no
               support for the original version of introns-early. Firstly,
               there is growing evidence that spliceosomal introns evolved from
               group II self-splicing introns which are present, usually, in
               small numbers, in many bacteria, and probably, moved into the
               evolving eukaryotic genome from the alpha-proteobacterial
               progenitor of the mitochondria. Secondly, the concept of a
               primordial pool of 'virus-like' genetic elements implies that
               self-splicing introns are among the most ancient genetic
               entities. Thirdly, reconstructions of the ancestral state of
               eukaryotic genes suggest that the last common ancestor of extant
               eukaryotes had an intron-rich genome. Thus, it appears that
               ancestors of spliceosomal introns, indeed, have existed since
               the earliest stages of life's evolution, in a formal agreement
               with the introns-early scenario. However, there is no evidence
               that these ancient introns ever became widespread before the
               emergence of eukaryotes, hence, the central tenet of
               introns-early, the role of introns in early evolution of
               proteins, has no support. However, the demonstration that
               numerous introns invaded eukaryotic genes at the outset of
               eukaryotic evolution and that subsequent intron gain has been
               limited in many eukaryotic lineages implicates introns as an
               ancestral feature of eukaryotic genomes and refutes radical
               versions of introns-late. Perhaps, most importantly, I argue
               that the intron invasion triggered other pivotal events of
               eukaryogenesis, including the emergence of the spliceosome, the
               nucleus, the linear chromosomes, the telomerase, and the
               ubiquitin signaling system. This concept of eukaryogenesis, in a
               sense, revives some tenets of the exon hypothesis, by assigning
               to introns crucial roles in eukaryotic evolutionary innovation.
               CONCLUSION: The scenario of the origin and evolution of introns
               that is best compatible with the results of comparative genomics
               and theoretical considerations goes as follows: self-splicing
               introns since the earliest stages of life's evolution--numerous
               spliceosomal introns invading genes of the emerging eukaryote
               during eukaryogenesis--subsequent lineage-specific loss and gain
               of introns. The intron invasion, probably, spawned by the
               mitochondrial endosymbiont, might have critically contributed to
               the emergence of the principal features of the eukaryotic cell.
               This scenario combines aspects of the introns-early and
               introns-late views. REVIEWERS: this article was reviewed by W.
               Ford Doolittle, James Darnell (nominated by W. Ford Doolittle),
               William Martin, and Anthony Poole.",
  journal   = "Biol. Direct",
  publisher = "Springer Nature",
  volume    =  1,
  number    =  1,
  pages     = "22",
  month     =  aug,
  year      =  2006,
  language  = "en"
}

@ARTICLE{Knowles2006-zy,
  title     = "High rate of recent intron gain and loss in simultaneously
               duplicated Arabidopsis genes",
  author    = "Knowles, David G and McLysaght, Aoife",
  abstract  = "We examined the gene structure of a set of 2563 Arabidopsis
               thaliana paralogous pairs that were duplicated simultaneously
               20-60 MYA by tetraploidy. Out of a total of 23,164 introns in
               these genes, we found that 10,004 pairs have been conserved and
               578 introns have been inserted or deleted in the time since the
               duplication event. This intron insertion/deletion rate of 2.7 x
               10(-3) to 9.1 x 10(-4) per site per million years is high in
               comparison to previous studies. At least 56 introns were gained
               and 39 lost based on parsimony analysis of the phylogenetic
               distribution of these introns. We found weak evidence that genes
               undergoing intron gain and loss are biased with respect to gene
               ontology terms. Gene pairs that experienced at least 2 intron
               insertions or deletions show evidence of enrichment for membrane
               location and transport and transporter activity function. We do
               not find any relationship of intron flux to expression level or
               G + C content of the gene. Detection of a bias in the location
               of intron gains and losses within a gene depends on the method
               of measurement: an intragene method indicates that events
               (specifically intron losses) are biased toward the 3' end of the
               gene. Despite the relatively recent acquisition of these
               introns, we found only one case where we could identify the
               mechanism of intron origin--the TOUCH3 gene has experienced 2
               tandem, partial, internal gene duplications that duplicated a
               preexisting intron and also created a novel, alternatively
               spliced intron that makes use of a duplicated pair of cryptic
               splice sites.",
  journal   = "Mol. Biol. Evol.",
  publisher = "Oxford University Press (OUP)",
  volume    =  23,
  number    =  8,
  pages     = "1548--1557",
  month     =  aug,
  year      =  2006,
  language  = "en"
}

@ARTICLE{Gozashti2022-bz,
  title     = "Transposable elements drive intron gain in diverse eukaryotes",
  author    = "Gozashti, Landen and Roy, Scott W and Thornlow, Bryan and
               Kramer, Alexander and Ares, Jr, Manuel and Corbett-Detig,
               Russell",
  abstract  = "There is massive variation in intron numbers across eukaryotic
               genomes, yet the major drivers of intron content during
               evolution remain elusive. Rapid intron loss and gain in some
               lineages contrast with long-term evolutionary stasis in others.
               Episodic intron gain could be explained by recently discovered
               specialized transposons called Introners, but so far Introners
               are only known from a handful of species. Here, we performed a
               systematic search across 3,325 eukaryotic genomes and identified
               27,563 Introner-derived introns in 175 genomes (5.2\%). Species
               with Introners span remarkable phylogenetic diversity, from
               animals to basal protists, representing lineages whose last
               common ancestor dates to over 1.7 billion years ago. Aquatic
               organisms were 6.5 times more likely to contain Introners than
               terrestrial organisms. Introners exhibit mechanistic diversity
               but most are consistent with DNA transposition, indicating that
               Introners have evolved convergently hundreds of times from
               nonautonomous transposable elements. Transposable elements and
               aquatic taxa are associated with high rates of horizontal gene
               transfer, suggesting that this combination of factors may
               explain the punctuated and biased diversity of species
               containing Introners. More generally, our data suggest that
               Introners may explain the episodic nature of intron gain across
               the eukaryotic tree of life. These results illuminate the major
               source of ongoing intron creation in eukaryotic genomes.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "Proceedings of the National Academy of Sciences",
  volume    =  119,
  number    =  48,
  pages     = "e2209766119",
  month     =  nov,
  year      =  2022,
  keywords  = "comparative genomics; evolution; genome structure; intron;
               splicing",
  copyright = "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Kramer1996-qj,
  title     = "The structure and function of proteins involved in mammalian
               {pre-mRNA} splicing",
  author    = "Kr{\"a}mer, A",
  abstract  = "Intervening sequences are removed from nuclear pre-mRNAs in a
               well-defined multi-step pathway. Small nuclear ribonucleoprotein
               particles (snRNPs) and numerous protein factors are essential
               for the formation of the active spliceosome in which intron
               excision proceeds in two successive transesterification
               reactions. Important elements for catalysis are the RNA moieties
               of the snRNPs that align the pre-mRNA splice sites in the active
               center of the spliceosome. Although pre-mRNA splicing is almost
               certainly RNA-mediated, both snRNA-associated proteins and
               non-snRNP splicing factors participate in each step of the
               splicing reaction. Splicing proteins exert auxiliary functions
               in the recognition, selection, and juxtaposition of the splice
               sites and drive conformational changes during spliceosome
               assembly and catalysis. Many splicing factors have been isolated
               in recent years and corresponding cDNAs have been cloned. This
               review summarizes the structure and function of mammalian
               proteins which are essential components of the constitutive
               splicing machinery.",
  journal   = "Annu. Rev. Biochem.",
  publisher = "Annual Reviews",
  volume    =  65,
  number    =  1,
  pages     = "367--409",
  year      =  1996,
  language  = "en"
}

@ARTICLE{Mironov1999-qo,
  title     = "Frequent alternative splicing of human genes",
  author    = "Mironov, A A and Fickett, J W and Gelfand, M S",
  abstract  = "Alternative splicing can produce variant proteins and expression
               patterns as different as the products of different genes, yet
               the prevalence of alternative splicing has not been quantified.
               Here the spliced alignment algorithm was used to make a first
               inventory of exon-intron structures of known human genes using
               EST contigs from the TIGR Human Gene Index. The results on any
               one gene may be incomplete and will require verification, yet
               the overall trends are significant. Evidence of alternative
               splicing was shown in 35\% of genes and the majority of splicing
               events occurred in 5' untranslated regions, suggesting wide
               occurrence of alternative regulation. Most of the alternative
               splices of coding regions generated additional protein domains
               rather than alternating domains.",
  journal   = "Genome Res.",
  publisher = "Cold Spring Harbor Laboratory",
  volume    =  9,
  number    =  12,
  pages     = "1288--1293",
  month     =  dec,
  year      =  1999,
  language  = "en"
}

@ARTICLE{Sharp1994-nz,
  title     = "Split genes and {RNA} splicing",
  author    = "Sharp, P A",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  77,
  number    =  6,
  pages     = "805--815",
  month     =  jun,
  year      =  1994,
  language  = "en"
}

@ARTICLE{Pan2008-qe,
  title     = "Deep surveying of alternative splicing complexity in the human
               transcriptome by high-throughput sequencing",
  author    = "Pan, Qun and Shai, Ofer and Lee, Leo J and Frey, Brendan J and
               Blencowe, Benjamin J",
  abstract  = "We carried out the first analysis of alternative splicing
               complexity in human tissues using mRNA-Seq data. New splice
               junctions were detected in approximately 20\% of multiexon
               genes, many of which are tissue specific. By combining mRNA-Seq
               and EST-cDNA sequence data, we estimate that transcripts from
               approximately 95\% of multiexon genes undergo alternative
               splicing and that there are approximately 100,000 intermediate-
               to high-abundance alternative splicing events in major human
               tissues. From a comparison with quantitative alternative
               splicing microarray profiling data, we also show that mRNA-Seq
               data provide reliable measurements for exon inclusion levels.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  40,
  number    =  12,
  pages     = "1413--1415",
  month     =  dec,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Vinuela2020-ce,
  title     = "Genetic variant effects on gene expression in human pancreatic
               islets and their implications for {T2D}",
  author    = "Vi{\~n}uela, Ana and Varshney, Arushi and van de Bunt, Martijn
               and Prasad, Rashmi B and Asplund, Olof and Bennett, Amanda and
               Boehnke, Michael and Brown, Andrew A and Erdos, Michael R and
               Fadista, Jo{\~a}o and Hansson, Ola and Hatem, Gad and Howald,
               C{\'e}dric and Iyengar, Apoorva K and Johnson, Paul and Krus,
               Ulrika and MacDonald, Patrick E and Mahajan, Anubha and Manning
               Fox, Jocelyn E and Narisu, Narisu and Nylander, Vibe and
               Orchard, Peter and Oskolkov, Nikolay and Panousis, Nikolaos I
               and Payne, Anthony and Stitzel, Michael L and Vadlamudi,
               Swarooparani and Welch, Ryan and Collins, Francis S and Mohlke,
               Karen L and Gloyn, Anna L and Scott, Laura J and Dermitzakis,
               Emmanouil T and Groop, Leif and Parker, Stephen C J and
               McCarthy, Mark I",
  abstract  = "Most signals detected by genome-wide association studies map to
               non-coding sequence and their tissue-specific effects influence
               transcriptional regulation. However, key tissues and cell-types
               required for functional inference are absent from large-scale
               resources. Here we explore the relationship between genetic
               variants influencing predisposition to type 2 diabetes (T2D) and
               related glycemic traits, and human pancreatic islet
               transcription using data from 420 donors. We find: (a) 7741
               cis-eQTLs in islets with a replication rate across 44 GTEx
               tissues between 40\% and 73\%; (b) marked overlap between islet
               cis-eQTL signals and active regulatory sequences in islets, with
               reduced eQTL effect size observed in the stretch enhancers most
               strongly implicated in GWAS signal location; (c) enrichment of
               islet cis-eQTL signals with T2D risk variants identified in
               genome-wide association studies; and (d) colocalization between
               47 islet cis-eQTLs and variants influencing T2D or glycemic
               traits, including DGKB and TCF7L2. Our findings illustrate the
               advantages of performing functional and regulatory studies in
               disease relevant tissues.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  11,
  number    =  1,
  pages     = "4912",
  month     =  sep,
  year      =  2020,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Ongen2017-cd,
  title     = "Estimating the causal tissues for complex traits and diseases",
  author    = "Ongen, Halit and {GTEx Consortium} and Brown, Andrew A and
               Delaneau, Olivier and Panousis, Nikolaos I and Nica, Alexandra C
               and Dermitzakis, Emmanouil T",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  12,
  pages     = "1676--1683",
  month     =  dec,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Hindorff2009-te,
  title     = "Potential etiologic and functional implications of genome-wide
               association loci for human diseases and traits",
  author    = "Hindorff, Lucia A and Sethupathy, Praveen and Junkins, Heather A
               and Ramos, Erin M and Mehta, Jayashri P and Collins, Francis S
               and Manolio, Teri A",
  abstract  = "We have developed an online catalog of SNP-trait associations
               from published genome-wide association studies for use in
               investigating genomic characteristics of
               trait/disease-associated SNPs (TASs). Reported TASs were common
               [median risk allele frequency 36\%, interquartile range (IQR)
               21\%-53\%] and were associated with modest effect sizes [median
               odds ratio (OR) 1.33, IQR 1.20-1.61]. Among 20 genomic
               annotation sets, reported TASs were significantly
               overrepresented only in nonsynonymous sites [OR = 3.9 (2.2-7.0),
               p = 3.5 x 10(-7)] and 5kb-promoter regions [OR = 2.3 (1.5-3.6),
               p = 3 x 10(-4)] compared to SNPs randomly selected from
               genotyping arrays. Although 88\% of TASs were intronic (45\%) or
               intergenic (43\%), TASs were not overrepresented in introns and
               were significantly depleted in intergenic regions [OR = 0.44
               (0.34-0.58), p = 2.0 x 10(-9)]. Only slightly more TASs than
               expected by chance were predicted to be in regions under
               positive selection [OR = 1.3 (0.8-2.1), p = 0.2]. This new
               online resource, together with bioinformatic predictions of the
               underlying functionality at trait/disease-associated loci, is
               well-suited to guide future investigations of the role of common
               variants in complex disease etiology.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "Proceedings of the National Academy of Sciences",
  volume    =  106,
  number    =  23,
  pages     = "9362--9367",
  month     =  jun,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Zhernakova2017-uo,
  title     = "Identification of context-dependent expression quantitative
               trait loci in whole blood",
  author    = "Zhernakova, Daria V and Deelen, Patrick and Vermaat, Martijn and
               van Iterson, Maarten and van Galen, Michiel and Arindrarto,
               Wibowo and van 't Hof, Peter and Mei, Hailiang and van Dijk,
               Freerk and Westra, Harm-Jan and Bonder, Marc Jan and van Rooij,
               Jeroen and Verkerk, Marijn and Jhamai, P Mila and Moed, Matthijs
               and Kielbasa, Szymon M and Bot, Jan and Nooren, Irene and Pool,
               Ren{\'e} and van Dongen, Jenny and Hottenga, Jouke J and
               Stehouwer, Coen D A and van der Kallen, Carla J H and
               Schalkwijk, Casper G and Zhernakova, Alexandra and Li, Yang and
               Tigchelaar, Ettje F and de Klein, Niek and Beekman, Marian and
               Deelen, Joris and van Heemst, Diana and van den Berg, Leonard H
               and Hofman, Albert and Uitterlinden, Andr{\'e} G and van
               Greevenbroek, Marleen M J and Veldink, Jan H and Boomsma, Dorret
               I and van Duijn, Cornelia M and Wijmenga, Cisca and Slagboom, P
               Eline and Swertz, Morris A and Isaacs, Aaron and van Meurs,
               Joyce B J and Jansen, Rick and Heijmans, Bastiaan T and 't Hoen,
               Peter A C and Franke, Lude",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  1,
  pages     = "139--145",
  month     =  jan,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Sun2018-uy,
  title     = "Genomic atlas of the human plasma proteome",
  author    = "Sun, Benjamin B and Maranville, Joseph C and Peters, James E and
               Stacey, David and Staley, James R and Blackshaw, James and
               Burgess, Stephen and Jiang, Tao and Paige, Ellie and Surendran,
               Praveen and Oliver-Williams, Clare and Kamat, Mihir A and Prins,
               Bram P and Wilcox, Sheri K and Zimmerman, Erik S and Chi, An and
               Bansal, Narinder and Spain, Sarah L and Wood, Angela M and
               Morrell, Nicholas W and Bradley, John R and Janjic, Nebojsa and
               Roberts, David J and Ouwehand, Willem H and Todd, John A and
               Soranzo, Nicole and Suhre, Karsten and Paul, Dirk S and Fox,
               Caroline S and Plenge, Robert M and Danesh, John and Runz, Heiko
               and Butterworth, Adam S",
  abstract  = "Although plasma proteins have important roles in biological
               processes and are the direct targets of many drugs, the genetic
               factors that control inter-individual variation in plasma
               protein levels are not well understood. Here we characterize the
               genetic architecture of the human plasma proteome in healthy
               blood donors from the INTERVAL study. We identify 1,927 genetic
               associations with 1,478 proteins, a fourfold increase on
               existing knowledge, including trans associations for 1,104
               proteins. To understand the consequences of perturbations in
               plasma protein levels, we apply an integrated approach that
               links genetic variation with biological pathway, disease, and
               drug databases. We show that protein quantitative trait loci
               overlap with gene expression quantitative trait loci, as well as
               with disease-associated loci, and find evidence that protein
               biomarkers have causal roles in disease using Mendelian
               randomization analysis. By linking genetic factors to diseases
               via specific proteins, our analyses highlight potential
               therapeutic targets, opportunities for matching existing drugs
               with new disease indications, and potential safety concerns for
               drugs under development.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  558,
  number    =  7708,
  pages     = "73--79",
  month     =  jun,
  year      =  2018,
  language  = "en"
}


@ARTICLE{Yao2018-oy,
  title     = "Genome-wide mapping of plasma protein {QTLs} identifies
               putatively causal genes and pathways for cardiovascular disease",
  author    = "Yao, Chen and Chen, George and Song, Ci and Keefe, Joshua and
               Mendelson, Michael and Huan, Tianxiao and Sun, Benjamin B and
               Laser, Annika and Maranville, Joseph C and Wu, Hongsheng and Ho,
               Jennifer E and Courchesne, Paul and Lyass, Asya and Larson,
               Martin G and Gieger, Christian and Graumann, Johannes and
               Johnson, Andrew D and Danesh, John and Runz, Heiko and Hwang,
               Shih-Jen and Liu, Chunyu and Butterworth, Adam S and Suhre,
               Karsten and Levy, Daniel",
  abstract  = "Identifying genetic variants associated with circulating protein
               concentrations (protein quantitative trait loci; pQTLs) and
               integrating them with variants from genome-wide association
               studies (GWAS) may illuminate the proteome's causal role in
               disease and bridge a knowledge gap regarding SNP-disease
               associations. We provide the results of GWAS of 71 high-value
               cardiovascular disease proteins in 6861 Framingham Heart Study
               participants and independent external replication. We report the
               mapping of over 16,000 pQTL variants and their functional
               relevance. We provide an integrated plasma protein-QTL database.
               Thirteen proteins harbor pQTL variants that match coronary
               disease-risk variants from GWAS or test causal for coronary
               disease by Mendelian randomization. Eight of these proteins
               predict new-onset cardiovascular disease events in Framingham
               participants. We demonstrate that identifying pQTLs, integrating
               them with GWAS results, employing Mendelian randomization, and
               prospectively testing protein-trait associations holds potential
               for elucidating causal genes, proteins, and pathways for
               cardiovascular disease and may identify targets for its
               prevention and treatment.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  9,
  number    =  1,
  pages     = "3268",
  month     =  aug,
  year      =  2018,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Qi2022-iz,
  title     = "Genetic control of {RNA} splicing and its distinct role in
               complex trait variation",
  author    = "Qi, Ting and Wu, Yang and Fang, Hailing and Zhang, Futao and
               Liu, Shouye and Zeng, Jian and Yang, Jian",
  abstract  = "Most genetic variants identified from genome-wide association
               studies (GWAS) in humans are noncoding, indicating their role in
               gene regulation. Previous studies have shown considerable links
               of GWAS signals to expression quantitative trait loci (eQTLs)
               but the links to other genetic regulatory mechanisms, such as
               splicing QTLs (sQTLs), are underexplored. Here, we introduce an
               sQTL mapping method, testing for heterogeneity between
               isoform-eQTL effects (THISTLE), with improved power over
               competing methods. Applying THISTLE together with a
               complementary sQTL mapping strategy to brain transcriptomic (n =
               2,865) and genotype data, we identified 12,794 genes with
               cis-sQTLs at P < 5 $\times$ 10-8, approximately 61\% of which
               were distinct from eQTLs. Integrating the sQTL data into GWAS
               for 12 brain-related complex traits (including diseases), we
               identified 244 genes associated with the traits through
               cis-sQTLs, approximately 61\% of which could not be discovered
               using the corresponding eQTL data. Our study demonstrates the
               distinct role of most sQTLs in the genetic regulation of
               transcription and complex trait variation.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  54,
  number    =  9,
  pages     = "1355--1363",
  month     =  sep,
  year      =  2022,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Currin2021-kp,
  title     = "Genetic effects on liver chromatin accessibility identify
               disease regulatory variants",
  author    = "Currin, Kevin W and Erdos, Michael R and Narisu, Narisu and Rai,
               Vivek and Vadlamudi, Swarooparani and Perrin, Hannah J and Idol,
               Jacqueline R and Yan, Tingfen and Albanus, Ricardo D'oliveira
               and Broadaway, K Alaine and Etheridge, Amy S and Bonnycastle,
               Lori L and Orchard, Peter and Didion, John P and Chaudhry,
               Amarjit S and {NISC Comparative Sequencing Program} and
               Innocenti, Federico and Schuetz, Erin G and Scott, Laura J and
               Parker, Stephen C J and Collins, Francis S and Mohlke, Karen L",
  abstract  = "Identifying the molecular mechanisms by which genome-wide
               association study (GWAS) loci influence traits remains
               challenging. Chromatin accessibility quantitative trait loci
               (caQTLs) help identify GWAS loci that may alter GWAS traits by
               modulating chromatin structure, but caQTLs have been identified
               in a limited set of human tissues. Here we mapped caQTLs in
               human liver tissue in 20 liver samples and identified 3,123
               caQTLs. The caQTL variants are enriched in liver tissue promoter
               and enhancer states and frequently disrupt binding motifs of
               transcription factors expressed in liver. We predicted target
               genes for 861 caQTL peaks using proximity, chromatin
               interactions, correlation with promoter accessibility or gene
               expression, and colocalization with expression QTLs. Using GWAS
               signals for 19 liver function and/or cardiometabolic traits, we
               identified 110 colocalized caQTLs and GWAS signals, 56 of which
               contained a predicted caPeak target gene. At the LITAF
               LDL-cholesterol GWAS locus, we validated that a caQTL variant
               showed allelic differences in protein binding and
               transcriptional activity. These caQTLs contribute to the
               epigenomic characterization of human liver and help identify
               molecular mechanisms and genes at GWAS loci.",
  journal   = "Am. J. Hum. Genet.",
  publisher = "Elsevier BV",
  volume    =  108,
  number    =  7,
  pages     = "1169--1189",
  month     =  jul,
  year      =  2021,
  keywords  = "ATAC-seq; GWAS; caQTL; cardiometabolic traits; chromatin
               accessibility; eQTL; transcription factor motif",
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Andrews2017-os,
  title     = "Cross-tissue integration of genetic and epigenetic data offers
               insight into autism spectrum disorder",
  author    = "Andrews, Shan V and Ellis, Shannon E and Bakulski, Kelly M and
               Sheppard, Brooke and Croen, Lisa A and Hertz-Picciotto, Irva and
               Newschaffer, Craig J and Feinberg, Andrew P and Arking, Dan E
               and Ladd-Acosta, Christine and Fallin, M Daniele",
  abstract  = "AbstractIntegration of emerging epigenetic information with
               autism spectrum disorder (ASD) genetic results may elucidate
               functional insights not possible via either type of information
               in isolation. Here we use the genotype and DNA methylation
               (DNAm) data from cord blood and peripheral blood to identify
               SNPs associated with DNA methylation (meQTL lists).
               Additionally, we use publicly available fetal brain and lung
               meQTL lists to assess enrichment of ASD GWAS results for
               tissue-specific meQTLs. ASD-associated SNPs are enriched for
               fetal brain (OR = 3.55; P P",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  8,
  number    =  1,
  month     =  oct,
  year      =  2017,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Huan2019-ke,
  title     = "Genome-wide identification of {DNA} methylation {QTLs} in whole
               blood highlights pathways for cardiovascular disease",
  author    = "Huan, Tianxiao and Joehanes, Roby and Song, Ci and Peng, Fen and
               Guo, Yichen and Mendelson, Michael and Yao, Chen and Liu, Chunyu
               and Ma, Jiantao and Richard, Melissa and Agha, Golareh and Guan,
               Weihua and Almli, Lynn M and Conneely, Karen N and Keefe, Joshua
               and Hwang, Shih-Jen and Johnson, Andrew D and Fornage, Myriam
               and Liang, Liming and Levy, Daniel",
  abstract  = "Identifying methylation quantitative trait loci (meQTLs) and
               integrating them with disease-associated variants from
               genome-wide association studies (GWAS) may illuminate functional
               mechanisms underlying genetic variant-disease associations.
               Here, we perform GWAS of >415 thousand CpG methylation sites in
               whole blood from 4170 individuals and map 4.7 million cis- and
               630 thousand trans-meQTL variants targeting >120 thousand CpGs.
               Independent replication is performed in 1347 participants from
               two studies. By linking cis-meQTL variants with GWAS results for
               cardiovascular disease (CVD) traits, we identify 92 putatively
               causal CpGs for CVD traits by Mendelian randomization analysis.
               Further integrating gene expression data reveals evidence of cis
               CpG-transcript pairs causally linked to CVD. In addition, we
               identify 22 trans-meQTL hotspots each targeting more than 30
               CpGs and find that trans-meQTL hotspots appear to act in cis on
               expression of nearby transcriptional regulatory genes. Our
               findings provide a powerful meQTL resource and shed light on DNA
               methylation involvement in human diseases.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  1,
  pages     = "4267",
  month     =  sep,
  year      =  2019,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Taylor2019-tm,
  title     = "Integrative analysis of gene expression, {DNA} methylation,
               physiological traits, and genetic variation in human skeletal
               muscle",
  author    = "Taylor, D Leland and Jackson, Anne U and Narisu, Narisu and
               Hemani, Gibran and Erdos, Michael R and Chines, Peter S and
               Swift, Amy and Idol, Jackie and Didion, John P and Welch, Ryan P
               and Kinnunen, Leena and Saramies, Jouko and Lakka, Timo A and
               Laakso, Markku and Tuomilehto, Jaakko and Parker, Stephen C J
               and Koistinen, Heikki A and Davey Smith, George and Boehnke,
               Michael and Scott, Laura J and Birney, Ewan and Collins, Francis
               S",
  abstract  = "We integrate comeasured gene expression and DNA methylation
               (DNAme) in 265 human skeletal muscle biopsies from the FUSION
               study with >7 million genetic variants and eight physiological
               traits: height, waist, weight, waist-hip ratio, body mass index,
               fasting serum insulin, fasting plasma glucose, and type 2
               diabetes. We find hundreds of genes and DNAme sites associated
               with fasting insulin, waist, and body mass index, as well as
               thousands of DNAme sites associated with gene expression (eQTM).
               We find that controlling for heterogeneity in tissue/muscle
               fiber type reduces the number of physiological trait
               associations, and that long-range eQTMs (>1 Mb) are reduced when
               controlling for tissue/muscle fiber type or latent factors. We
               map genetic regulators (quantitative trait loci; QTLs) of
               expression (eQTLs) and DNAme (mQTLs). Using Mendelian
               randomization (MR) and mediation techniques, we leverage these
               genetic maps to predict 213 causal relationships between
               expression and DNAme, approximately two-thirds of which predict
               methylation to causally influence expression. We use MR to
               integrate FUSION mQTLs, FUSION eQTLs, and GTEx eQTLs for 48
               tissues with genetic associations for 534 diseases and
               quantitative traits. We identify hundreds of genes and thousands
               of DNAme sites that may drive the reported disease/quantitative
               trait genetic associations. We identify 300 gene expression MR
               associations that are present in both FUSION and GTEx skeletal
               muscle and that show stronger evidence of MR association in
               skeletal muscle than other tissues, which may partially reflect
               differences in power across tissues. As one example, we find
               that increased RXRA muscle expression may decrease lean tissue
               mass.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "Proceedings of the National Academy of Sciences",
  volume    =  116,
  number    =  22,
  pages     = "10883--10888",
  month     =  may,
  year      =  2019,
  keywords  = "DNA methylation; eQTL; gene expression; mQTL; skeletal muscle",
  copyright = "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Morrow2018-fv,
  title     = "Human lung {DNA} methylation quantitative trait loci colocalize
               with chronic obstructive pulmonary disease genome-wide
               association loci",
  author    = "Morrow, Jarrett D and Glass, Kimberly and Cho, Michael H and
               Hersh, Craig P and Pinto-Plata, Victor and Celli, Bartolome and
               Marchetti, Nathaniel and Criner, Gerard and Bueno, Raphael and
               Washko, George and Choi, Augustine M K and Quackenbush, John and
               Silverman, Edwin K and DeMeo, Dawn L",
  abstract  = "RATIONALE: As the third leading cause of death in the United
               States, the impact of chronic obstructive pulmonary disease
               (COPD) makes identification of its molecular mechanisms of great
               importance. Genome-wide association studies (GWASs) have
               identified multiple genomic regions associated with COPD.
               However, genetic variation only explains a small fraction of the
               susceptibility to COPD, and sub-genome-wide significant loci may
               play a role in pathogenesis. OBJECTIVES: Regulatory annotation
               with epigenetic evidence may give priority for further
               investigation, particularly for GWAS associations in noncoding
               regions. We performed integrative genomics analyses using DNA
               methylation profiling and genome-wide SNP genotyping from lung
               tissue samples from 90 subjects with COPD and 36 control
               subjects. METHODS: We performed methylation quantitative trait
               loci (mQTL) analyses, testing for SNPs associated with percent
               DNA methylation and assessed the colocalization of these results
               with previous COPD GWAS findings using Bayesian methods in the R
               package coloc to highlight potential regulatory features of the
               loci. MEASUREMENTS AND MAIN RESULTS: We identified 942,068
               unique SNPs and 33,996 unique CpG sites among the significant
               (5\% false discovery rate) cis-mQTL results. The genome-wide
               significant and subthreshold (P < 10-4) GWAS SNPs were enriched
               in the significant mQTL SNPs (hypergeometric test P < 0.00001).
               We observed enrichment for sites located in CpG shores and
               shelves, but not CpG islands. Using Bayesian colocalization, we
               identified loci in regions near KCNK3, EEFSEC, PIK3CD, DCDC2C,
               TCERG1L, FRMD4B, and IL27. CONCLUSIONS: Colocalization of mQTL
               and GWAS loci provides regulatory characterization of
               significant and subthreshold GWAS findings, supporting a role
               for genetic control of methylation in COPD pathogenesis.",
  journal   = "Am. J. Respir. Crit. Care Med.",
  publisher = "American Thoracic Society",
  volume    =  197,
  number    =  10,
  pages     = "1275--1284",
  month     =  may,
  year      =  2018,
  keywords  = "chronic obstructive pulmonary disease; epigenetics; mQTL;
               methylation QTL",
  language  = "en"
}

@ARTICLE{Hannon2016-mt,
  title     = "Methylation {QTLs} in the developing brain and their enrichment
               in schizophrenia risk loci",
  author    = "Hannon, Eilis and Spiers, Helen and Viana, Joana and Pidsley,
               Ruth and Burrage, Joe and Murphy, Therese M and Troakes, Claire
               and Turecki, Gustavo and O'Donovan, Michael C and Schalkwyk,
               Leonard C and Bray, Nicholas J and Mill, Jonathan",
  abstract  = "We characterized DNA methylation quantitative trait loci (mQTLs)
               in a large collection (n = 166) of human fetal brain samples
               spanning 56-166 d post-conception, identifying >16,000 fetal
               brain mQTLs. Fetal brain mQTLs were primarily cis-acting,
               enriched in regulatory chromatin domains and transcription
               factor binding sites, and showed substantial overlap with
               genetic variants that were also associated with gene expression
               in the brain. Using tissue from three distinct regions of the
               adult brain (prefrontal cortex, striatum and cerebellum), we
               found that most fetal brain mQTLs were developmentally stable,
               although a subset was characterized by fetal-specific effects.
               Fetal brain mQTLs were enriched amongst risk loci identified in
               a recent large-scale genome-wide association study (GWAS) of
               schizophrenia, a severe psychiatric disorder with a hypothesized
               neurodevelopmental component. Finally, we found that mQTLs can
               be used to refine GWAS loci through the identification of
               discrete sites of variable fetal brain methylation associated
               with schizophrenia risk variants.",
  journal   = "Nat. Neurosci.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  19,
  number    =  1,
  pages     = "48--54",
  month     =  jan,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Oliva2023-nt,
  title     = "{DNA} methylation {QTL} mapping across diverse human tissues
               provides molecular links between genetic variation and complex
               traits",
  author    = "Oliva, Meritxell and Demanelis, Kathryn and Lu, Yihao and
               Chernoff, Meytal and Jasmine, Farzana and Ahsan, Habibul and
               Kibriya, Muhammad G and Chen, Lin S and Pierce, Brandon L",
  abstract  = "Studies of DNA methylation (DNAm) in solid human tissues are
               relatively scarce; tissue-specific characterization of DNAm is
               needed to understand its role in gene regulation and its
               relevance to complex traits. We generated array-based DNAm
               profiles for 987 human samples from the Genotype-Tissue
               Expression (GTEx) project, representing 9 tissue types and 424
               subjects. We characterized methylome and transcriptome
               correlations (eQTMs), genetic regulation in cis (mQTLs and
               eQTLs) across tissues and e/mQTLs links to complex traits. We
               identified mQTLs for 286,152 CpG sites, many of which (>5\%)
               show tissue specificity, and mQTL colocalizations with 2,254
               distinct GWAS hits across 83 traits. For 91\% of these loci, a
               candidate gene link was identified by integration of functional
               maps, including eQTMs, and/or eQTL colocalization, but only 33\%
               of loci involved an eQTL and mQTL present in the same tissue
               type. With this DNAm-focused integrative analysis, we contribute
               to the understanding of molecular regulatory mechanisms in human
               tissues and their impact on complex traits.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  55,
  number    =  1,
  pages     = "112--122",
  month     =  jan,
  year      =  2023,
  copyright = "https://www.springernature.com/gp/researchers/text-and-data-mining",
  language  = "en"
}

@ARTICLE{Trynka2013-qs,
  title     = "Chromatin marks identify critical cell types for fine mapping
               complex trait variants",
  author    = "Trynka, Gosia and Sandor, Cynthia and Han, Buhm and Xu, Han and
               Stranger, Barbara E and Liu, X Shirley and Raychaudhuri, Soumya",
  abstract  = "If trait-associated variants alter regulatory regions, then they
               should fall within chromatin marks in relevant cell types.
               However, it is unclear which of the many marks are most useful
               in defining cell types associated with disease and fine mapping
               variants. We hypothesized that informative marks are
               phenotypically cell type specific; that is, SNPs associated with
               the same trait likely overlap marks in the same cell type. We
               examined 15 chromatin marks and found that those highlighting
               active gene regulation were phenotypically cell type specific.
               Trimethylation of histone H3 at lysine 4 (H3K4me3) was the most
               phenotypically cell type specific (P < 1 $\times$ 10(-6)),
               driven by colocalization of variants and marks rather than gene
               proximity (P < 0.001). H3K4me3 peaks overlapped with 37 SNPs for
               plasma low-density lipoprotein concentration in the liver (P < 7
               $\times$ 10(-5)), 31 SNPs for rheumatoid arthritis within CD4(+)
               regulatory T cells (P = 1 $\times$ 10(-4)), 67 SNPs for type 2
               diabetes in pancreatic islet cells (P = 0.003) and the liver (P
               = 0.003), and 14 SNPs for neuropsychiatric disease in neuronal
               tissues (P = 0.007). We show how cell type-specific H3K4me3
               peaks can inform the fine mapping of associated SNPs to identify
               causal variation.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  45,
  number    =  2,
  pages     = "124--130",
  month     =  feb,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Degner2012-dq,
  title     = "{DNase} {I} sensitivity {QTLs} are a major determinant of human
               expression variation",
  author    = "Degner, Jacob F and Pai, Athma A and Pique-Regi, Roger and
               Veyrieras, Jean-Baptiste and Gaffney, Daniel J and Pickrell,
               Joseph K and De Leon, Sherryl and Michelini, Katelyn and
               Lewellen, Noah and Crawford, Gregory E and Stephens, Matthew and
               Gilad, Yoav and Pritchard, Jonathan K",
  abstract  = "The mapping of expression quantitative trait loci (eQTLs) has
               emerged as an important tool for linking genetic variation to
               changes in gene regulation. However, it remains difficult to
               identify the causal variants underlying eQTLs, and little is
               known about the regulatory mechanisms by which they act. Here we
               show that genetic variants that modify chromatin accessibility
               and transcription factor binding are a major mechanism through
               which genetic variation leads to gene expression differences
               among humans. We used DNase I sequencing to measure chromatin
               accessibility in 70 Yoruba lymphoblastoid cell lines, for which
               genome-wide genotypes and estimates of gene expression levels
               are also available. We obtained a total of 2.7 billion uniquely
               mapped DNase I-sequencing (DNase-seq) reads, which allowed us to
               produce genome-wide maps of chromatin accessibility for each
               individual. We identified 8,902 locations at which the DNase-seq
               read depth correlated significantly with genotype at a nearby
               single nucleotide polymorphism or insertion/deletion (false
               discovery rate = 10\%). We call such variants 'DNase I
               sensitivity quantitative trait loci' (dsQTLs). We found that
               dsQTLs are strongly enriched within inferred transcription
               factor binding sites and are frequently associated with
               allele-specific changes in transcription factor binding. A
               substantial fraction (16\%) of dsQTLs are also associated with
               variation in the expression levels of nearby genes (that is,
               these loci are also classified as eQTLs). Conversely, we
               estimate that as many as 55\% of eQTL single nucleotide
               polymorphisms are also dsQTLs. Our observations indicate that
               dsQTLs are highly abundant in the human genome and are likely to
               be important contributors to phenotypic variation.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  482,
  number    =  7385,
  pages     = "390--394",
  month     =  feb,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Ahonen2009-eo,
  title     = "Gender differences relating to metabolic syndrome and
               proinflammation in Finnish subjects with elevated blood pressure",
  author    = "Ahonen, Tiina and Saltevo, Juha and Laakso, Markku and
               Kautiainen, Hannu and Kumpusalo, Esko and Vanhala, Mauno",
  abstract  = "Fasting insulin, adiponectin, high-sensitivity C-reactive
               protein (hs-CRP), and interleukin-1 receptor antagonist (IL-1Ra)
               were determined in 278 men and 273 women with blood pressure >
               or = 130 and/or > or = 85 mmHg and/or with antihypertensive
               medication. Metabolic syndrome (MetS) with the National
               Cholesterol Education Program (NCEP) criteria was observed in
               35\% of men and 34\% of women. Men with MetS had lower hs-CRP
               and IL-1Ra than women. The absolute gender difference in
               adiponectin was smaller and those in IL-1Ra and hs-CRP were
               greater in subjects with MetS compared to those without. After
               adjustment with body mass index the association between insulin
               and the odd's ratio (OR) for MetS remained significant in both
               genders, in females also the association between the OR for MetS
               and adiponectin. There are gender differences in subjects with
               elevated blood pressure and MetS with respect to inflammatory
               markers and the relationship between adiponectin levels and
               MetS.",
  journal   = "Mediators Inflamm.",
  publisher = "Hindawi Limited",
  volume    =  2009,
  pages     = "959281",
  month     =  aug,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Smith2007-py,
  title     = "Clustered environments and randomized genes: a fundamental
               distinction between conventional and genetic epidemiology",
  author    = "Smith, George Davey and Lawlor, Debbie A and Harbord, Roger and
               Timpson, Nic and Day, Ian and Ebrahim, Shah",
  abstract  = "BACKGROUND: In conventional epidemiology confounding of the
               exposure of interest with lifestyle or socioeconomic factors,
               and reverse causation whereby disease status influences exposure
               rather than vice versa, may invalidate causal interpretations of
               observed associations. Conversely, genetic variants should not
               be related to the confounding factors that distort associations
               in conventional observational epidemiological studies.
               Furthermore, disease onset will not influence genotype.
               Therefore, it has been suggested that genetic variants that are
               known to be associated with a modifiable (nongenetic) risk
               factor can be used to help determine the causal effect of this
               modifiable risk factor on disease outcomes. This approach,
               mendelian randomization, is increasingly being applied within
               epidemiological studies. However, there is debate about the
               underlying premise that associations between genotypes and
               disease outcomes are not confounded by other risk factors. We
               examined the extent to which genetic variants, on the one hand,
               and nongenetic environmental exposures or phenotypic
               characteristics on the other, tend to be associated with each
               other, to assess the degree of confounding that would exist in
               conventional epidemiological studies compared with mendelian
               randomization studies. METHODS AND FINDINGS: We estimated
               pairwise correlations between nongenetic baseline variables and
               genetic variables in a cross-sectional study comparing the
               number of correlations that were statistically significant at
               the 5\%, 1\%, and 0.01\% level (alpha = 0.05, 0.01, and 0.0001,
               respectively) with the number expected by chance if all
               variables were in fact uncorrelated, using a two-sided binomial
               exact test. We demonstrate that behavioural, socioeconomic, and
               physiological factors are strongly interrelated, with 45\% of
               all possible pairwise associations between 96 nongenetic
               characteristics (n = 4,560 correlations) being significant at
               the p < 0.01 level (the ratio of observed to expected
               significant associations was 45; p-value for difference between
               observed and expected < 0.000001). Similar findings were
               observed for other levels of significance. In contrast, genetic
               variants showed no greater association with each other, or with
               the 96 behavioural, socioeconomic, and physiological factors,
               than would be expected by chance. CONCLUSIONS: These data
               illustrate why observational studies have produced misleading
               claims regarding potentially causal factors for disease. The
               findings demonstrate the potential power of a methodology that
               utilizes genetic variants as indicators of exposure level when
               studying environmentally modifiable risk factors.",
  journal   = "PLoS Med.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  4,
  number    =  12,
  pages     = "e352",
  month     =  dec,
  year      =  2007,
  language  = "en"
}

@ARTICLE{Glass2013-up,
  title     = "Causal inference in public health",
  author    = "Glass, Thomas A and Goodman, Steven N and Hern{\'a}n, Miguel A
               and Samet, Jonathan M",
  abstract  = "Causal inference has a central role in public health; the
               determination that an association is causal indicates the
               possibility for intervention. We review and comment on the
               long-used guidelines for interpreting evidence as supporting a
               causal association and contrast them with the potential outcomes
               framework that encourages thinking in terms of causes that are
               interventions. We argue that in public health this framework is
               more suitable, providing an estimate of an action's consequences
               rather than the less precise notion of a risk factor's causal
               effect. A variety of modern statistical methods adopt this
               approach. When an intervention cannot be specified, causal
               relations can still exist, but how to intervene to change the
               outcome will be unclear. In application, the often-complex
               structure of causal processes needs to be acknowledged and
               appropriate data collected to study them. These newer approaches
               need to be brought to bear on the increasingly complex public
               health challenges of our globalized world.",
  journal   = "Annu. Rev. Public Health",
  publisher = "Annual Reviews",
  volume    =  34,
  number    =  1,
  pages     = "61--75",
  month     =  jan,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Malone2012-na,
  title     = "Tobacco control at twenty: reflecting on the past, considering
               the present and developing the new conversations for the future",
  author    = "Malone, Ruth E and Warner, Kenneth E",
  journal   = "Tob. Control",
  publisher = "BMJ",
  volume    =  21,
  number    =  2,
  pages     = "74--76",
  month     =  mar,
  year      =  2012,
  language  = "en"
}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%% pAD chapter%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
@ARTICLE{Finucane2018-mx,
  title     = "Heritability enrichment of specifically expressed genes
               identifies disease-relevant tissues and cell types",
  author    = "Finucane, Hilary K and Reshef, Yakir A and Anttila, Verneri and
               Slowikowski, Kamil and Gusev, Alexander and Byrnes, Andrea and
               Gazal, Steven and Loh, Po-Ru and Lareau, Caleb and Shoresh, Noam
               and Genovese, Giulio and Saunders, Arpiar and Macosko, Evan and
               Pollack, Samuela and Perry, John R B and Buenrostro, Jason D and
               Bernstein, Bradley E and Raychaudhuri, Soumya and McCarroll,
               Steven and Neale, Benjamin M and Price, Alkes L and {The
               Brainstorm Consortium}",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  4,
  pages     = "621--629",
  month     =  apr,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Sanderson2022-nm,
  title     = "Mendelian randomization",
  author    = "Sanderson, Eleanor and Glymour, M Maria and Holmes, Michael V
               and Kang, Hyunseung and Morrison, Jean and Munaf{\`o}, Marcus R
               and Palmer, Tom and Schooling, C Mary and Wallace, Chris and
               Zhao, Qingyuan and Smith, George Davey",
  abstract  = "Mendelian randomization (MR) is a term that applies to the use
               of genetic variation to address causal questions about how
               modifiable exposures influence different outcomes. The
               principles of MR are based on Mendel's laws of inheritance and
               instrumental variable estimation methods, which enable the
               inference of causal effects in the presence of unobserved
               confounding. In this Primer, we outline the principles of MR,
               the instrumental variable conditions underlying MR estimation
               and some of the methods used for estimation. We go on to discuss
               how the assumptions underlying an MR study can be assessed and
               give methods of estimation that are robust to certain violations
               of these assumptions. We give examples of a range of studies in
               which MR has been applied, the limitations of current methods of
               analysis and the outlook for MR in the future. The difference
               between the assumptions required for MR analysis and other forms
               of non-interventional epidemiological studies means that MR can
               be used as part of a triangulation across multiple sources of
               evidence for causal inference.",
  journal   = "Nat. Rev. Methods Primers",
  publisher = "Springer Science and Business Media LLC",
  volume    =  2,
  number    =  1,
  month     =  feb,
  year      =  2022,
  language  = "en"
}

@ARTICLE{Wlodarczyk2021-xw,
  title     = "Current concepts in the pathogenesis of cryptoglandular perianal
               fistula",
  author    = "W{\l}odarczyk, Marcin and W{\l}odarczyk, Jakub and
               Sobolewska-W{\l}odarczyk, Aleksandra and Trzci{\'n}ski,
               Radzis{\l}aw and Dziki, {\L}ukasz and Fichna, Jakub",
  abstract  = "Cryptoglandular perianal fistula is a common benign anorectal
               disorder that is managed mainly with surgery. A fistula is
               typically defined as a pathological communication between two
               epithelialized surfaces. More specifically, perianal fistula
               manifests as an abnormal tract between the anorectal canal and
               the perianal skin. Perianal fistulas are often characterized by
               significantly decreased patient quality of life. The
               cryptoglandular theory of perianal fistulas suggests their
               development from the proctodeal glands, which originate from the
               intersphincteric plane and perforate the internal sphincter with
               their ducts. Involvement of proctodeal glands in the
               inflammatory process could play a primary role in the formation
               of cryptoglandular perianal fistula. The objective of this
               narrative review was to investigate the current knowledge of the
               pathogenesis of cryptoglandular perianal fistula with the
               specific aims of characterizing the potential role of
               proinflammatory factors responsible for the development of
               chronic inflammation. Further studies are crucial to improve the
               therapeutic management of cryptoglandular perianal fistulas.",
  journal   = "J. Int. Med. Res.",
  publisher = "SAGE Publications",
  volume    =  49,
  number    =  2,
  pages     = "300060520986669",
  month     =  feb,
  year      =  2021,
  keywords  = "Cryptoglandular perianal fistula; adipokines; cytokines;
               pathogenesis; proctodeal glands; proinflammatory factors",
  language  = "en"
}

@misc{metal_docs,   
    title = {METAL Documentation},   
    url = {https://genome.sph.umich.edu/wiki/METAL_Documentation},   
    author = {Center for Statistical Genetics},   
    year = {December 2017},   
    note = {Accessed on 21/10/2023} 
}
@ARTICLE{Evangelou2013-rn,
  title     = "Meta-analysis methods for genome-wide association studies and
               beyond",
  author    = "Evangelou, Evangelos and Ioannidis, John P A",
  abstract  = "Meta-analysis of genome-wide association studies (GWASs) has
               become a popular method for discovering genetic risk variants.
               Here, we overview both widely applied and newer statistical
               methods for GWAS meta-analysis, including issues of
               interpretation and assessment of sources of heterogeneity. We
               also discuss extensions of these meta-analysis methods to
               complex data. Where possible, we provide guidelines for
               researchers who are planning to use these methods. Furthermore,
               we address special issues that may arise for meta-analysis of
               sequencing data and rare variants. Finally, we discuss
               challenges and solutions surrounding the goals of making
               meta-analysis data publicly available and building powerful
               consortia.",
  journal   = "Nat. Rev. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  14,
  number    =  6,
  pages     = "379--389",
  month     =  jun,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Marzo2015-wf,
  title     = "Management of perianal fistulas in Crohn's disease: an
               up-to-date review",
  author    = "Marzo, Manuela and Felice, Carla and Pugliese, Daniela and
               Andrisani, Gianluca and Mocci, Giammarco and Armuzzi, Alessandro
               and Guidi, Luisa",
  abstract  = "Perianal disease is one of the most disabling manifestations of
               Crohn's disease. A multidisciplinary approach of
               gastroenterologist, colorectal surgeon and radiologist is
               necessary for its management. A correct diagnosis, based on
               endoscopy, magnetic resonance imaging, endoanal ultrasound and
               examination under anesthesia, is crucial for perianal fistula
               treatment. Available medical and surgical therapies are
               discussed in this review, including new local treatment
               modalities that are under investigation.",
  journal   = "World J. Gastroenterol.",
  publisher = "Baishideng Publishing Group Inc.",
  volume    =  21,
  number    =  5,
  pages     = "1394--1403",
  month     =  feb,
  year      =  2015,
  keywords  = "Crohn's disease; Drug therapy; Perianal fistula; Surgery; Tumor
               necrosis factor alpha",
  language  = "en"
}
@misc{abscess_fist,   
    title = {Abscess and fistula},   
    url = {https://fascrs.org/patients/diseases-and-conditions/a-z/abscess-and-fistula#:~:text=An%20anal%20abscess%20is%20an,previous%20or%20current%20anal%20abscess},   
    author = {American Society of Colon and Rectal Surgery},   
    year = {2023},   
    note = {Accessed on 21/10/2023} 
}
@misc{div_pad,   
    title = {Diverticular Disease Expanded Information},   
    url = {https://fascrs.org/patients/diseases-and-conditions/a-z/diverticular-disease-expanded-version#:~:text=Other%20complications%20of%20diverticulosis%20include,the%20colon%20to%20the%20bladder},   
    author = {American Society of Colon and Rectal Surgery},   
    year = {2023},   
    note = {Accessed on 21/10/2023} 
}
@ARTICLE{Li2011-td,
  title     = "A statistical framework for {SNP} calling, mutation discovery,
               association mapping and population genetical parameter
               estimation from sequencing data",
  author    = "Li, Heng",
  abstract  = "MOTIVATION: Most existing methods for DNA sequence analysis rely
               on accurate sequences or genotypes. However, in applications of
               the next-generation sequencing (NGS), accurate genotypes may not
               be easily obtained (e.g. multi-sample low-coverage sequencing or
               somatic mutation discovery). These applications press for the
               development of new methods for analyzing sequence data with
               uncertainty. RESULTS: We present a statistical framework for
               calling SNPs, discovering somatic mutations, inferring
               population genetical parameters and performing association tests
               directly based on sequencing data without explicit genotyping or
               linkage-based imputation. On real data, we demonstrate that our
               method achieves comparable accuracy to alternative methods for
               estimating site allele count, for inferring allele frequency
               spectrum and for association mapping. We also highlight the
               necessity of using symmetric datasets for finding somatic
               mutations and confirm that for discovering rare events,
               mismapping is frequently the leading source of errors.
               AVAILABILITY: http://samtools.sourceforge.net. CONTACT:
               hengli@broadinstitute.org.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  27,
  number    =  21,
  pages     = "2987--2993",
  month     =  nov,
  year      =  2011,
  language  = "en"
}

@ARTICLE{Purcell2007-mu,
  title     = "{PLINK}: a tool set for whole-genome association and
               population-based linkage analyses",
  author    = "Purcell, Shaun and Neale, Benjamin and Todd-Brown, Kathe and
               Thomas, Lori and Ferreira, Manuel A R and Bender, David and
               Maller, Julian and Sklar, Pamela and de Bakker, Paul I W and
               Daly, Mark J and Sham, Pak C",
  abstract  = "Whole-genome association studies (WGAS) bring new computational,
               as well as analytic, challenges to researchers. Many existing
               genetic-analysis tools are not designed to handle such large
               data sets in a convenient manner and do not necessarily exploit
               the new opportunities that whole-genome data bring. To address
               these issues, we developed PLINK, an open-source C/C++ WGAS tool
               set. With PLINK, large data sets comprising hundreds of
               thousands of markers genotyped for thousands of individuals can
               be rapidly manipulated and analyzed in their entirety. As well
               as providing tools to make the basic analytic steps
               computationally efficient, PLINK also supports some novel
               approaches to whole-genome data that take advantage of
               whole-genome coverage. We introduce PLINK and describe the five
               main domains of function: data management, summary statistics,
               population stratification, association analysis, and
               identity-by-descent estimation. In particular, we focus on the
               estimation and use of identity-by-state and identity-by-descent
               information in the context of population-based whole-genome
               studies. This information can be used to detect and correct for
               population stratification and to identify extended chromosomal
               segments that are shared identical by descent between very
               distantly related individuals. Analysis of the patterns of
               segmental sharing has the potential to map disease loci that
               contain multiple rare variants in a population-based linkage
               analysis.",
  journal   = "Am. J. Hum. Genet.",
  publisher = "Elsevier BV",
  volume    =  81,
  number    =  3,
  pages     = "559--575",
  month     =  sep,
  year      =  2007,
  copyright = "https://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@UNPUBLISHED{Band2018-tv,
  title       = "{BGEN}: a binary file format for imputed genotype and
                 haplotype data",
  author      = "Band, Gavin and Marchini, Jonathan",
  abstract    = "ABSTRACTThe impact of modern technology on genetic
                 epidemiology has been significant, with studies comprising
                 millions of individuals assessed at tens of millions of
                 genetic variants now becoming common. Studies on this scale
                 provide logistical and analytic challenges starting with the
                 issue of efficiently storing, transmitting, and accessing
                 underlying data. Here we present a binary file format (the
                 BGEN format) that can store both directly-typed and
                 statistically imputed genotype data, and achieves substantial
                 space savings by data compression and the use of an efficient
                 representation for probabilities. We investigate the
                 properties of this format using imputed data from the UK
                 BiLEVE study, demonstrating both storage efficiency, and fast
                 data loading performance on the order of hundreds of millions
                 of imputed genotypes per second. To make using BGEN as easy as
                 possible, we provide a detailed specification and a freely
                 available reference implementation, and we leverage this by
                 developing additional tools including an indexing tool
                 (bgenix) and an R package (rbgen) that permits loading of
                 BGEN-encoded data into the R statistical programming
                 environment. The UK Biobank is one of a number of projects
                 that have used BGEN for release of imputed data, and we expect
                 the format to continue to be widely implemented and used.",
  journal     = "bioRxiv",
  institution = "bioRxiv",
  month       =  apr,
  year        =  2018
}

@ARTICLE{Bycroft2018-fj,
  title     = "The {UK} Biobank resource with deep phenotyping and genomic data",
  author    = "Bycroft, Clare and Freeman, Colin and Petkova, Desislava and
               Band, Gavin and Elliott, Lloyd T and Sharp, Kevin and Motyer,
               Allan and Vukcevic, Damjan and Delaneau, Olivier and O'Connell,
               Jared and Cortes, Adrian and Welsh, Samantha and Young, Alan and
               Effingham, Mark and McVean, Gil and Leslie, Stephen and Allen,
               Naomi and Donnelly, Peter and Marchini, Jonathan",
  abstract  = "The UK Biobank project is a prospective cohort study with deep
               genetic and phenotypic data collected on approximately 500,000
               individuals from across the United Kingdom, aged between 40 and
               69 at recruitment. The open resource is unique in its size and
               scope. A rich variety of phenotypic and health-related
               information is available on each participant, including
               biological measurements, lifestyle indicators, biomarkers in
               blood and urine, and imaging of the body and brain. Follow-up
               information is provided by linking health and medical records.
               Genome-wide genotype data have been collected on all
               participants, providing many opportunities for the discovery of
               new genetic associations and the genetic bases of complex
               traits. Here we describe the centralized analysis of the genetic
               data, including genotype quality, properties of population
               structure and relatedness of the genetic data, and efficient
               phasing and genotype imputation that increases the number of
               testable variants to around 96 million. Classical allelic
               variation at 11 human leukocyte antigen genes was imputed,
               resulting in the recovery of signals with known associations
               between human leukocyte antigen alleles and many diseases.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  562,
  number    =  7726,
  pages     = "203--209",
  month     =  oct,
  year      =  2018,
  language  = "en"
}

@misc{ukbb_sample_processing,   
    title = {Description of sample processing workflow and preparation of DNA for genotyping},   
    url = {https://biobank.ndph.ox.ac.uk/showcase/showcase/docs/genotyping_sample_workflow.pdf},   
    author = {UK Biobank},   
    year = {April 2015},   
    note = {Accessed on 20/10/2023} 
}
@misc{ukbbbelieve_array,   
    title = {UK Biobank 500K Samples Genotyping Data Generation by the Affymetrix Research Services Laboratory},   
    url = {https://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=155582},   
    author = {Affymetrix},   
    year = {April 2015},   
    note = {Accessed on 20/10/2023} 
}
@misc{ukbbaxiom_array,   
    title = {Axiomâ„¢ Genotyping Solution Data Analysis
USER GUIDE},   
    url = {https://assets.thermofisher.com/TFS-Assets/LSG/manuals/axiom_genotyping_solution_analysis_guide.pdf},   
    author = {Thermo Fisher Scientific},   
    year = {18 April 2023},   
    note = {Accessed on 20/10/2023} 
}
@misc{plink_high_ld,   
    title = {Plink QC high LD regions},   
    url = {https://github.com/meyer-lab-cshl/plinkQC/blob/master/inst/extdata/high-LD-regions-hg38-GRCh38.txt},   
    author = {PLINK},   
    year = {2023},   
    note = {Accessed on 20/10/2023} 
}
@ARTICLE{Otomo2019-os,
  title     = "Identification of novel {LFNG} mutations in spondylocostal
               dysostosis",
  author    = "Otomo, Nao and Mizumoto, Shuji and Lu, Hsing-Fang and Takeda,
               Kazuki and Campos-Xavier, Belinda and Mittaz-Crettol,
               Laur{\'e}ane and Guo, Long and Takikawa, Kazuharu and Nakamura,
               Masaya and Yamada, Shuhei and Matsumoto, Morio and Watanabe,
               Kota and Ikegawa, Shiro",
  abstract  = "Spondylocostal dysostosis (SCDO) is a heterogeneous group of
               skeletal disorders characterized by multiple segmentation
               defects involving vertebrae and ribs. Seven disease genes have
               been reported as causal genes for SCDO: DLL3, MESP2, TBX6, HES7,
               RIPPLY2, DMRT2, and LFNG. Here we report a Japanese SCDO case
               with multiple severe vertebral anomalies from cervical to sacral
               spine. The patient was a compound heterozygote for c.372delG
               (p.K124Nfs*) and c.601G>A (p.D201N) variants of LFNG, which
               encodes a glycosyltransferase (O-fucosylpeptide
               3-beta-N-acetylglucosaminyltransferase). The missense variant
               was in the DxD motif, an active-site motif of the
               glycosyltransferase, and its loss of the enzyme function was
               confirmed by an in vitro enzyme assay. This is the second report
               of LFNG mutations in SCDO.",
  journal   = "J. Hum. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  64,
  number    =  3,
  pages     = "261--264",
  month     =  mar,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Sparrow2006-vq,
  title     = "Mutation of the {LUNATIC} {FRINGE} gene in humans causes
               spondylocostal dysostosis with a severe vertebral phenotype",
  author    = "Sparrow, D B and Chapman, G and Wouters, M A and Whittock, N V
               and Ellard, S and Fatkin, D and Turnpenny, P D and Kusumi, K and
               Sillence, D and Dunwoodie, S L",
  abstract  = "The spondylocostal dysostoses (SCDs) are a heterogeneous group
               of vertebral malsegmentation disorders that arise during
               embryonic development by a disruption of somitogenesis.
               Previously, we had identified two genes that cause a subset of
               autosomal recessive forms of this disease: DLL3 (SCD1) and MESP2
               (SCD2). These genes are important components of the Notch
               signaling pathway, which has multiple roles in development and
               disease. Here, we have used a candidate-gene approach to
               identify a mutation in a third Notch pathway gene, LUNATIC
               FRINGE (LFNG), in a family with autosomal recessive SCD. LFNG
               encodes a glycosyltransferase that modifies the Notch family of
               cell-surface receptors, a key step in the regulation of this
               signaling pathway. A missense mutation was identified in a
               highly conserved phenylalanine close to the active site of the
               enzyme. Functional analysis revealed that the mutant LFNG was
               not localized to the correct compartment of the cell, was unable
               to modulate Notch signaling in a cell-based assay, and was
               enzymatically inactive. This represents the first known mutation
               in the human LFNG gene and reinforces the hypothesis that proper
               regulation of the Notch signaling pathway is an absolute
               requirement for the correct patterning of the axial skeleton.",
  journal   = "Am. J. Hum. Genet.",
  publisher = "Elsevier BV",
  volume    =  78,
  number    =  1,
  pages     = "28--37",
  month     =  jan,
  year      =  2006,
  copyright = "https://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Serth2003-kn,
  title     = "Transcriptional oscillation of Lunatic fringe is essential for
               somitogenesis",
  author    = "Serth, Katrin and Schuster-Gossler, Karin and Cordes, Ralf and
               Gossler, Achim",
  abstract  = "A molecular oscillator that controls the expression of cyclic
               genes such as lunatic fringe (Lfng) in the presomitic mesoderm
               has been shown to be coupled with somite formation in vertebrate
               embryos. To address the functional significance of
               oscillatingLfngexpression, we have generated transgenic mice
               expressingLfngconstitutively in the presomitic mesoderm in
               addition to the intrinsic cyclicLfngactivity. These transgenic
               lines displayed defects of somite patterning and vertebral
               organization that were very similar to those ofLfngnull mutants.
               Furthermore, constitutive expression of exogenousLfngdid not
               compensate for the complete loss of cyclic
               endogenousLfngactivity. Noncyclic exogenousLfngexpression did
               not abolish cyclic expression of endogenousLfngin the posterior
               presomitic mesoderm (psm) but affected its expression pattern in
               the anterior psm. Similarly, dynamic expression ofHes7was not
               abolished but abnormal expression patterns were obtained. Our
               data are consistent with a model in which alternations
               ofLfngactivity between ON and OFF states in the presomitic
               mesoderm prior to somite segmentation are critical for proper
               somite patterning, and suggest that Notch signaling might not be
               the only determinant of cyclic gene expression in the presomitic
               mesoderm of mouse embryos.",
  journal   = "Genes Dev.",
  publisher = "Cold Spring Harbor Laboratory",
  volume    =  17,
  number    =  7,
  pages     = "912--925",
  month     =  apr,
  year      =  2003,
  language  = "en"
}

@ARTICLE{Xu2017-tf,
  title     = "Mutations in the spliceosome component {CWC27} cause retinal
               degeneration with or without additional developmental anomalies",
  author    = "Xu, Mingchu and Xie, Yajing Angela and Abouzeid, Hana and
               Gordon, Christopher T and Fiorentino, Alessia and Sun, Zixi and
               Lehman, Anna and Osman, Ihab S and Dharmat, Rachayata and
               Riveiro-Alvarez, Rosa and Bapst-Wicht, Linda and Babino, Darwin
               and Arno, Gavin and Busetto, Virginia and Zhao, Li and Li, Hui
               and Lopez-Martinez, Miguel A and Azevedo, Liliana F and Hubert,
               Laurence and Pontikos, Nikolas and Eblimit, Aiden and
               Lorda-Sanchez, Isabel and Kheir, Valeria and Plagnol, Vincent
               and Oufadem, Myriam and Soens, Zachry T and Yang, Lizhu and
               Bole-Feysot, Christine and Pfundt, Rolph and Allaman-Pillet,
               Nathalie and Nitschk{\'e}, Patrick and Cheetham, Michael E and
               Lyonnet, Stanislas and Agrawal, Smriti A and Li, Huajin and
               Pinton, Ga{\"e}tan and Michaelides, Michel and Besmond, Claude
               and Li, Yumei and Yuan, Zhisheng and von Lintig, Johannes and
               Webster, Andrew R and Le Hir, Herv{\'e} and Stoilov, Peter and
               {UK Inherited Retinal Dystrophy Consortium} and Amiel, Jeanne
               and Hardcastle, Alison J and Ayuso, Carmen and Sui, Ruifang and
               Chen, Rui and Allikmets, Rando and Schorderet, Daniel F",
  abstract  = "Pre-mRNA splicing factors play a fundamental role in regulating
               transcript diversity both temporally and spatially. Genetic
               defects in several spliceosome components have been linked to a
               set of non-overlapping spliceosomopathy phenotypes in humans,
               among which skeletal developmental defects and non-syndromic
               retinitis pigmentosa (RP) are frequent findings. Here we report
               that defects in spliceosome-associated protein CWC27 are
               associated with a spectrum of disease phenotypes ranging from
               isolated RP to severe syndromic forms. By whole-exome
               sequencing, recessive protein-truncating mutations in CWC27 were
               found in seven unrelated families that show a range of clinical
               phenotypes, including retinal degeneration, brachydactyly,
               craniofacial abnormalities, short stature, and neurological
               defects. Remarkably, variable expressivity of the human
               phenotype can be recapitulated in Cwc27 mutant mouse models,
               with significant embryonic lethality and severe phenotypes in
               the complete knockout mice while mice with a partial
               loss-of-function allele mimic the isolated retinal degeneration
               phenotype. Our study describes a retinal dystrophy-related
               phenotype spectrum as well as its genetic etiology and
               highlights the complexity of the spliceosomal gene network.",
  journal   = "Am. J. Hum. Genet.",
  publisher = "Elsevier BV",
  volume    =  100,
  number    =  4,
  pages     = "592--604",
  month     =  apr,
  year      =  2017,
  keywords  = "CRISPR-Cas9; CWC27; brachydachtyly; craniofacial defects;
               neurological defects; retinal degeneration; short stature;
               spliceosome; syndrome",
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@misc{finngen_aboutdf9,   
    title = {FinnGen Data Freeze 9},   
    url = {https://r9.finngen.fi/about},   
    author = {FinnGen},   
    year = {2023},   
    note = {Accessed on 20/10/2023} 
}
@misc{finngen_endpoints,   
    title = {DATA AVAILABLE IN FINNGEN},   
    url = {https://www.finngen.fi/en/researchers/data_available},   
    author = {FinnGen},   
    year = {2023},   
    note = {Accessed on 20/10/2023} 
}
@misc{icd10_levels,   
    title = {International Classification of Diseases, (ICD-10-CM/PCS) Transition - Background},   
    url = {https://www.cdc.gov/nchs/icd/icd10cm_pcs_background},   
    author = {Centers for disease control and prevention},   
    year = {November 2015},   
    note = {Accessed on 20/10/2023} 
}
@misc{finngen_forresearchers,   
    title = {FinnGen Project},   
    url = {https://www.finngen.fi/en/for_researchers},   
    author = {FinnGen},   
    year = {2023},   
    note = {Accessed on 20/10/2023} 
}
@misc{ukbb_ehr,   
    title = {Integrating electronic health
records into the UK Biobank
Resource version 1.0},   
    url = {https://biobank.ndph.ox.ac.uk/showcase/refer.cgi?id=149480},   
    author = {UK Biobank},   
    year = {January 2014},   
    note = {Accessed on 20/10/2023} 
}
@misc{ukbb_showcase,   
    title = {UKBB Data Showcase},   
    url = {https://www.ukbiobank.ac.uk/enable-your-research/about-our-data},   
    author = {UK Biobank},   
    year = {2023},   
    note = {Accessed on 20/10/2023} 
}
@ARTICLE{Jain2012-or,
  title     = "Comparison of a fistulectomy and a fistulotomy with
               marsupialization in the management of a simple anal fistula: a
               randomized, controlled pilot trial",
  author    = "Jain, Bhupendra Kumar and Vaibhaw, Kumar and Garg, Pankaj Kumar
               and Gupta, Sanjay and Mohanty, Debajyoti",
  abstract  = "PURPOSE: This randomized clinical trial was conducted to compare
               a fistulectomy and a fistulotomy with marsupialization in the
               management of a simple anal fistula. METHODS: Forty patients
               with simple anal fistula were randomized into two groups.
               Fistulous tracts were managed by using a fistulectomy (group A)
               while a fistulotomy with marsupialization was performed in group
               B. The primary outcome measure was wound healing time while
               secondary outcome measures were operating time, postoperative
               wound size, postoperative pain, wound infection, anal
               incontinence, recurrence and patient satisfaction. RESULTS:
               Postoperative wounds in group B healed earlier in comparison to
               group A wounds (4.85 $\pm$ 1.39 weeks vs. 6.75 $\pm$ 1.83 weeks,
               P = 0.035). No significant differences existed between the
               operating times (28.00 $\pm$ 6.35 minutes vs. 28.20 $\pm$ 6.57
               minutes, P = 0.925) and visual analogue scale scores for
               postoperative pain on the first postoperative day (4.05 $\pm$
               1.47 vs. 4.50 $\pm$ 1.32, P = 0.221) for the two groups.
               Postoperative wounds were larger in group A than in group B
               (2.07 $\pm$ 0.1.90 cm(2) vs. 1.23 $\pm$ 0.87 cm(2)), however
               this difference did not reach statistical significance (P =
               0.192). Wound discharge was observed for a significantly longer
               duration in group A than in group B (4.10 $\pm$ 1.91 weeks vs.
               2.75 $\pm$ 1.71 weeks, P = 0.035). There were no differences in
               social and sexual activities after surgery between the patients
               of the two groups. No patient developed anal incontinence or
               recurrence during the follow-up period of twelve weeks.
               CONCLUSION: In comparison to a fistulectomy, a fistulotomy with
               marsupialization results in faster healing and a shorter
               duration of wound discharge without increasing the operating
               time.",
  journal   = "J. Korean Soc. Coloproctol.",
  publisher = "Korean Society of Coloproctology",
  volume    =  28,
  number    =  2,
  pages     = "78--82",
  month     =  apr,
  year      =  2012,
  keywords  = "Anal fistula; Fistulectomy; Fistulotomy",
  language  = "en"
}

@ARTICLE{Arroyo2012-qa,
  title     = "Fistulotomy and sphincter reconstruction in the treatment of
               complex fistula-in-ano: long-term clinical and manometric
               results",
  author    = "Arroyo, Antonio and P{\'e}rez-Legaz, Juan and Moya, Pedro and
               Arma{\~n}anzas, Laura and Lacueva, Javier and P{\'e}rez-Vicente,
               Francisco and Candela, Fernando and Calpena, Rafael",
  abstract  = "OBJECTIVE: To evaluate the long-term clinical and manometric
               results of fistulotomy and sphincter reconstruction for the
               treatment of complex fistula-in-ano. BACKGROUND: Complex
               fistula-in-ano is difficult to treat due to the occurrence of
               postoperative anal incontinence and the high rate of recurrence.
               METHODS: Seventy patients who were diagnosed with complex
               fistula-in-ano and underwent fistulotomy and sphincter
               reconstruction between October 2000 and October 2006 were
               analyzed in the present study. Preoperative assessment included
               physical examination, anorectal manometry, and anal
               endosonography. Appointments were scheduled every 6 months
               during the first and second year of treatment and every 2 years
               thereafter. Recurrence and incontinence were evaluated during
               each visit. Continence was assessed according to the Wexner
               continence grading scale. Anal manometry was performed 3 and 12
               months after treatment and every 2 years thereafter. Anal
               endosonography was conducted 6 months after treatment. RESULTS:
               Fistulas were classified as medium-high trans-sphincteric in 64
               patients (91.42\%) and were recurrent in 22 patients (32\%).
               Before surgery, 22 patients (32\%) reported fecal incontinence,
               which improved after surgery in 15 cases (70\%), from 6.75 to
               1.88 (P < 0.005) on the Wexner Scale. Eight preoperative
               continent patients (16.6\%) reported postoperative incontinence
               (Wexner Score < 3), and 6 patients (8.5\%) had recurrent
               incontinence. Among these patients, 2 developed recurrent
               incontinence 6 months after treatment, 2 developed recurrent
               incontinence 1 year after treatment, 1 developed recurrent
               incontinence 2 years after treatment, and 1 developed
               incontinence 5 years after treatment. CONCLUSIONS: Fistulotomy
               with sphincter reconstruction is an effective technique for the
               treatment of complex fistula-in-ano. Continence and anal
               manometry results were improved in incontinent patients and were
               not jeopardized in continent ones. Fistulotomy with sphincter
               reconstruction is an especially suitable technique for
               incontinent patients with recurrent fistulas.",
  journal   = "Ann. Surg.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  255,
  number    =  5,
  pages     = "935--939",
  month     =  may,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Zanotti2007-mb,
  title     = "An assessment of the incidence of fistula-in-ano in four
               countries of the European Union",
  author    = "Zanotti, Carlo and Martinez-Puente, Carmen and Pascual, Isabel
               and Pascual, Mar{\'\i}a and Herreros, Dolores and
               Garc{\'\i}a-Olmo, Dami{\'a}n",
  abstract  = "BACKGROUND AND AIMS: In spite of its long history,
               fistula-in-ano is generally considered to be relatively
               uncommon. Nevertheless, no comprehensive analysis of its
               incidence in developed countries is available. Our goal was to
               determine the actual incidence of fistula-in-ano based on the
               study of incidence in four countries of the European Union (EU).
               MATERIALS AND METHODS: We performed a search of hospital
               inpatient databases in five different countries. We obtained
               valid data from four European countries, namely, England (UK;
               Hospital Episodes Statistics), Germany (German hospitals'
               databases), Italy (Scheda di Dimissione Ospedaliera), and Spain
               (Conjunto M{\'\i}nimo B{\'a}sico de Datos by Insalud-Spanish
               National Health Institute). RESULTS: The incidence of
               fistula-in-ano varied among the different populations in the EU.
               In the four countries examined, it ranged from 1.04 per
               10,000/year in Spain to 2.32 per 10,000/year in Italy. A
               statistical comparison of rates from the different countries
               studied gives a confidence interval from 1.20 up to 2.80. The
               population that we studied represents almost 51\% of the total
               population of the EU. CONCLUSION: This study attempts to
               determine the actual incidence of fistula-in-ano in the European
               Community, which was previously uncertain despite its major
               negative effects on quality of life and the high cost of
               treatment. Our findings indicate that the incidence of
               fistula-in-ano in the four countries of the EU studied is
               significantly higher than that in the only previously published
               report of the incidence of fistula-in-ano in Europe.
               Nevertheless, our findings confirm the general perception that
               fistula-in-ano is a relatively uncommon disease.",
  journal   = "Int. J. Colorectal Dis.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  12,
  pages     = "1459--1462",
  month     =  dec,
  year      =  2007,
  language  = "en"
}

@ARTICLE{Eberspacher2022-sp,
  title     = "Mesenchymal stem cells for cryptoglandular anal fistula: Current
               state of art",
  author    = "Eberspacher, Chiara and Mascagni, Domenico and Ferent, Iulia
               Catalina and Coletta, Enrico and Palma, Rossella and Panetta,
               Cristina and Esposito, Anna and Arcieri, Stefano and Pontone,
               Stefano",
  abstract  = "Anal fistula is a common disease that needs surgical treatment
               to be resolved. Despite a variety of surgical options, the major
               problem is still to cure complex fistulas without any recurrence
               in the long-term follow-up but, at the same time, to avoid an
               impairment of continence. In recent years, one solution has been
               the application of mesenchymal stem cells derived from adipose
               tissue, especially in association with other treatments, such as
               the use of fibrin glue or the previous application of a seton.
               Their initial use in fistulas associated with Crohn's disease
               has shown encouraging results. In this non-systematic review our
               aim is to analyze the use in cryptoglandular fistulas: the rate
               of healing is not so high, and the number of studies is limited.
               Therefore, further randomized controlled trials are needed to
               establish their efficacy in the case of complex cryptoglandular
               anal fistulas and their possible complications.",
  journal   = "Front. Surg.",
  publisher = "Frontiers Media SA",
  volume    =  9,
  pages     = "815504",
  month     =  feb,
  year      =  2022,
  keywords  = "complication; cryptoglandular anal fistula; fecal incontinence;
               recurrence; stem cells",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Wlodarczyk2021-kh,
  title     = "Current concepts in the pathogenesis of cryptoglandular perianal
               fistula",
  author    = "W{\l}odarczyk, Marcin and W{\l}odarczyk, Jakub and
               Sobolewska-W{\l}odarczyk, Aleksandra and Trzci{\'n}ski,
               Radzis{\l}aw and Dziki, {\L}ukasz and Fichna, Jakub",
  abstract  = "Cryptoglandular perianal fistula is a common benign anorectal
               disorder that is managed mainly with surgery. A fistula is
               typically defined as a pathological communication between two
               epithelialized surfaces. More specifically, perianal fistula
               manifests as an abnormal tract between the anorectal canal and
               the perianal skin. Perianal fistulas are often characterized by
               significantly decreased patient quality of life. The
               cryptoglandular theory of perianal fistulas suggests their
               development from the proctodeal glands, which originate from the
               intersphincteric plane and perforate the internal sphincter with
               their ducts. Involvement of proctodeal glands in the
               inflammatory process could play a primary role in the formation
               of cryptoglandular perianal fistula. The objective of this
               narrative review was to investigate the current knowledge of the
               pathogenesis of cryptoglandular perianal fistula with the
               specific aims of characterizing the potential role of
               proinflammatory factors responsible for the development of
               chronic inflammation. Further studies are crucial to improve the
               therapeutic management of cryptoglandular perianal fistulas.",
  journal   = "J. Int. Med. Res.",
  publisher = "SAGE Publications",
  volume    =  49,
  number    =  2,
  pages     = "300060520986669",
  month     =  feb,
  year      =  2021,
  keywords  = "Cryptoglandular perianal fistula; adipokines; cytokines;
               pathogenesis; proctodeal glands; proinflammatory factors",
  language  = "en"
}

@ARTICLE{Parks1961-pe,
  title     = "Pathogenesis and treatment of fistula-in-Ano",
  author    = "Parks, A G",
  journal   = "BMJ",
  publisher = "BMJ",
  volume    =  1,
  number    =  5224,
  pages     = "463--460",
  month     =  feb,
  year      =  1961,
  language  = "en"
}

@ARTICLE{Mei2019-ds,
  title     = "Risk Factors for Recurrence after anal fistula surgery: A
               meta-analysis",
  author    = "Mei, Zubing and Wang, Qingming and Zhang, Yi and Liu, Peng and
               Ge, Maojun and Du, Peixin and Yang, Wei and He, Yazhou",
  abstract  = "BACKGROUND: Despite a burgeoning literature during the last two
               decades regarding perioperative risk management of anal fistula,
               little is known about its risk factors that influence
               postoperative recurrence. We performed a meta-analysis to
               summarize and assess the credibility of evidence of potential
               risk factors for anal fistula recurrence (AFR) after surgery.
               METHODS: Pubmed and EMBASE without language restriction were
               searched from inception to April 2018 that reported risk factors
               which predisposed recurrence after anal fistula surgery. We
               excluded studies that involved patients with anal fistula
               associated with Crohn's disease. MOOSE guidelines were followed
               when this meta-analysis was performed. We used random-effects
               models to pool relative risks (RRs) with 95\% confidence
               intervals (CIs). Evidence from observational studies was graded
               into high-quality (Class I), moderate-quality (Class II/III) and
               low-quality (Class IV) based on Egger's P value, total sample
               size and between-study heterogeneity. RESULTS: Of 3514 citations
               screened, 20 unique observational studies comprising 6168
               patients were involved in data synthesis. High-quality evidence
               showed that AFR was associated with high transsphincteric
               fistula (RR, 4.77; 95\% CI, 3.83 to 5.95), internal opening
               unidentified (RR, 8.54; 95\% CI, 5.29 to 13.80), and horseshoe
               extensions (RR, 1.92; 95\% CI, 1.43 to 2.59). Moderate-quality
               evidence suggested an association with prior anal surgery (RR,
               1.52; 95\% CI, 1.04 to 2.23), seton placement surgery (RR, 2.97;
               95\% CI, 1.10 to 8.06), and multiple fistula tract (RR, 4.77;
               95\% CI, 1.46 to 15.51). High-quality evidence demonstrated no
               significant association with gender or smoking; moderate-quality
               evidence also suggested no association with age, tertiary
               referral, alcohol use, diabetes mellitus, obesity, preoperative
               seton drainage, high internal opening, postoperative drainage,
               mucosal advancement flap surgery, supralevator extensions,
               location or type of anal fistula. CONCLUSION: Several patient,
               surgery and fistula-related factors are significantly associated
               with postoperative AFR. These findings strengthen clinical
               awareness of early warning to identify patients with high-risk
               disease recurrence for AFR.",
  journal   = "Int. J. Surg.",
  publisher = "Elsevier BV",
  volume    =  69,
  pages     = "153--164",
  month     =  sep,
  year      =  2019,
  keywords  = "Anal fistula; Meta-Analysis; Recurrence; Risk factor; Surgical
               treatment",
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Sneider2013-qd,
  title     = "Anal abscess and fistula",
  author    = "Sneider, Erica B and Maykel, Justin A",
  abstract  = "Benign anorectal diseases, such as anal abscesses and fistula,
               are commonly seen by primary care physicians,
               gastroenterologists, emergency physicians, general surgeons, and
               colorectal surgeons. It is important to have a thorough
               understanding of the complexity of these 2 disease processes so
               as to provide appropriate and timely treatment. We review the
               pathophysiology, presentation, diagnosis, and treatment options
               for both anal abscesses and fistulas.",
  journal   = "Gastroenterol. Clin. North Am.",
  publisher = "Elsevier BV",
  volume    =  42,
  number    =  4,
  pages     = "773--784",
  month     =  dec,
  year      =  2013,
  keywords  = "Anal abscess; Anal fistula; Endorectal advancement flap;
               Fistulizing Crohn disease; Fistulotomy; LIFT procedure",
  language  = "en"
}

@ARTICLE{Lund1996-az,
  title     = "Aetiology and treatment of anal fissure",
  author    = "Lund, J N and Scholefield, J H",
  abstract  = "Anal fissure is a common problem that causes significant
               morbidity in a young and otherwise healthy population. Treatment
               has remained largely unchanged for over 150 years and the
               pathogenesis of this condition is not yet fully explained. Acute
               fissure should be treated conservatively with dietary
               modification. Chronic fissures do not respond to conservative
               treatment. The current recommended surgical treatment for
               chronic fissure is lateral internal sphincterotomy. However,
               there is a disturbance of continence in a sizeable proportion of
               those undergoing this procedure. As yet there is no proven
               non-surgical treatment for chronic fissure. Although local
               injection of botulinum toxin and the topical application of
               nitrates show early promise, further controlled trials are
               needed.",
  journal   = "Br. J. Surg.",
  publisher = "Oxford University Press (OUP)",
  volume    =  83,
  number    =  10,
  pages     = "1335--1344",
  month     =  oct,
  year      =  1996,
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}

@misc{nice_analfiss, title={Scenario: Management of an anal fissure}, url={https://cks.nice.org.uk/topics/anal-fissure/management/management/}, journal={NICE}, publisher={NICE Clinical Knowledge Summaries}, author={NICE, NICE}, year={2021}, month={Apr}} 
@ARTICLE{Lock1977-go,
  title     = "Fissure-in-ano: the initial management and prognosis",
  author    = "Lock, M R and Thomson, J P",
  abstract  = "The results of treatment of 188 consecutive new patients with a
               primary diagnosis of fissure-in-ano presenting to the Outpatient
               Department of St Mark's Hospital are reviewed. One-third
               underwent operation as the primary treatment and were not
               studied further. Of the remaining patients who underwent
               non-operative treatment only, one-half were initially cured.
               Follow-up at 4 years showed that this cure was maintained in
               half of these cases, suggesting that there is a place for
               treatment with a dilator in the correctly selected case. The
               presence of a sentinel skin tag or a fibrous anal polyp is shown
               to have a statistically significant association with operative
               treatment. The use of a paediatric sigmoidoscope to diagnose a
               fibrous anal polyp is recommended.",
  journal   = "Br. J. Surg.",
  publisher = "Oxford University Press (OUP)",
  volume    =  64,
  number    =  5,
  pages     = "355--358",
  month     =  may,
  year      =  1977,
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}

@ARTICLE{McDonald1983-cs,
  title     = "The anal dilator in the conservative management of acute anal
               fissures",
  author    = "McDonald, P and Driscoll, A M and Nicholls, R J",
  abstract  = "Patients presenting with acute anal fissure were randomized into
               two treatment groups in a prospective clinical trial. Both
               groups received treatment for 3 weeks with a stool softener and
               lignocaine jelly. Those entered in group 1 (35 patients) were
               asked in addition to insert an anal dilator (no. 2) twice daily
               while those in group 2 (31 patients) applied the anaesthetic
               jelly without a dilator. At 6 weeks 11 (31.4 per cent) patients
               in group 1 and 12 (38.7 per cent) patients in group 2 had been
               referred for sphincterotomy owing to failure of the treatment.
               At 6 months this figure had risen to 14 (40 per cent) in group 1
               and 15 (48.4 per cent) in group 2. This difference was not
               statistically significant, suggesting that the addition of a
               dilator to the conservative treatment regimen did not diminish
               the likelihood of surgery.",
  journal   = "Br. J. Surg.",
  publisher = "Oxford University Press (OUP)",
  volume    =  70,
  number    =  1,
  pages     = "25--26",
  month     =  jan,
  year      =  1983,
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}

@BOOK{Keighley2018-iy,
  title     = "Keighley \& Williams' surgery of the anus, rectum and colon,
               fourth edition",
  editor    = "Keighley, Michael R B and Williams, Norman S",
  publisher = "CRC Press",
  edition   =  4,
  month     =  nov,
  year      =  2018,
  address   = "London, England"
}

@ARTICLE{Mapel2014-wp,
  title     = "The epidemiology and treatment of anal fissures in a
               population-based cohort",
  author    = "Mapel, Douglas W and Schum, Michael and Von Worley, Ann",
  abstract  = "BACKGROUND: Anal fissure (AF) is regarded as a common problem,
               but there are no published epidemiologic data, nor information
               on current treatment. The purpose of this study was to examine
               the incidence, associated comorbidities, and treatment of AF in
               a population-based cohort. METHODS: We conducted a retrospective
               analysis of all persons who were enrolled in one large regional
               managed care system and treated for AF during calendar years
               2005-2011. All persons aged 6 years or older who had a clinic,
               hospitalization, or surgical procedure associated with AF were
               identified from utilization data. To identify comorbidities
               associated with AF, each case was matched by age and gender to 3
               controls. RESULTS: There were 1,243 AF cases, including 721
               (58\%) females and 522 (42\%) males; 150 (12\%) of the cases
               occurred in children aged 6-17 years. The overall annual
               incidence was 0.11\% (1.1 cases per 1000 person-years), but
               ranged widely by age [0.05\% in patients 6-17 years to 0.18\% in
               patients 25-34 years]. The incidence also varied by sex, and was
               significantly higher among females 12-24 years, and among males
               55-64 years (P < 0.001). Comorbidities associated with AF
               included chronic constipation (prevalence 14.2\% vs 3.6\%),
               hypothyroidism (14.7\% vs 10.4\%), obesity (13.0\% vs 7.7\%),
               and solid tumors without metastasis (5.2\% vs 3.7\%) (P < 0.001
               for all comparisons). A total of 448 were dispensed a topical
               prescription medication, 31 had botulinum toxin injection, and
               only 13 had lateral internal sphincterotomy. CONCLUSIONS: AF is
               a common clinical problem, and the incidence varies
               substantially by age and sex. Constipation, obesity, and
               hypothyroidism are associated comorbidities. Most patients are
               prescribed topical treatments, although it appears that many
               prescriptions are never filled. Surgical interventions for AF
               including botulinum toxin and lateral internal sphincterotomy
               are uncommon.",
  journal   = "BMC Gastroenterol.",
  publisher = "Springer Nature",
  volume    =  14,
  number    =  1,
  pages     = "129",
  month     =  jul,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Beaty2016-yj,
  title     = "Anal fissure",
  author    = "Beaty, Jennifer Sam and Shashidharan, M",
  abstract  = "Anal fissure (fissure-in-ano) is a very common anorectal
               condition. The exact etiology of this condition is debated;
               however, there is a clear association with elevated internal
               anal sphincter pressures. Though hard bowel movements are
               implicated in fissure etiology, they are not universally present
               in patients with anal fissures. Half of all patients with
               fissures heal with nonoperative management such as high fiber
               diet, sitz baths, and pharmacological agents. When nonoperative
               management fails, surgical treatment with lateral internal
               sphincterotomy has a high success rate. In this chapter, we will
               review the symptoms, pathophysiology, and management of anal
               fissures.",
  journal   = "Clin. Colon Rectal Surg.",
  publisher = "Georg Thieme Verlag KG",
  volume    =  29,
  number    =  1,
  pages     = "30--37",
  month     =  mar,
  year      =  2016,
  keywords  = "anal fissure; anal pain; sphincterotomy",
  language  = "en"
}

@ARTICLE{Simpson2012-gi,
  title     = "Management of anal fistula",
  author    = "Simpson, Jonathan Alastair and Banerjea, Ayan and Scholefield,
               John Howard",
  journal   = "BMJ",
  publisher = "BMJ",
  volume    =  345,
  number    = "oct15 4",
  pages     = "e6705",
  month     =  oct,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Assi2014-at,
  title     = "Sexually transmitted infections of the anus and rectum",
  author    = "Assi, Roland and Hashim, Peter W and Reddy, Vikram B and
               Einarsdottir, Hulda and Longo, Walter E",
  abstract  = "Sexually transmitted infections (STIs) represent a significant
               public health concern. Several STIs, once thought to be on the
               verge of extinction, have recently reemerged. This change is
               thought to be partially related to an increase in STIs of the
               anus and rectum. Importantly, the global human immunodeficiency
               virus and acquired immunodeficiency syndrome (HIV/AIDS) epidemic
               has contributed to the emergence of particular anorectal lesions
               that require specialized approaches. In this report, we review
               common anorectal STIs that are frequently referred to colorectal
               surgeons in the United States. Epidemiology, clinical
               presentation, and management are summarized, including the
               latest treatment recommendations. The particularity of anorectal
               diseases in HIV/AIDS is addressed, along with recent trends in
               anal cytology and human papillomavirus vaccination.",
  journal   = "World J. Gastroenterol.",
  publisher = "Baishideng Publishing Group Inc.",
  volume    =  20,
  number    =  41,
  pages     = "15262--15268",
  month     =  nov,
  year      =  2014,
  keywords  = "Anal cytology; Highly active antiretroviral therapy; Human
               immunodeficiency virus; Human papilloma virus vaccines; Human
               papillomavirus; Perianal disease; Rectal disease; Sexual
               behavior; Sexually transmitted disease",
  language  = "en"
}

@ARTICLE{Johnston2003-jr,
  title     = "Management of late complications of pelvic radiation in the
               rectum and anus",
  author    = "Johnston, M J and Robertson, G M and Frizelle, F A",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  46,
  number    =  2,
  pages     = "247--259",
  month     =  feb,
  year      =  2003,
  language  = "en"
}

@ARTICLE{Dudukgian2011-is,
  title     = "Why do we have so much trouble treating anal fistula?",
  author    = "Dudukgian, Haig and Abcarian, Herand",
  abstract  = "Anal fistula is among the most common illnesses affecting man.
               Medical literature dating back to 400 BC has discussed this
               problem. Various causative factors have been proposed throughout
               the centuries, but it appears that the majority of fistulas
               unrelated to specific causes (e.g. Tuberculosis, Crohn's
               disease) result from infection (abscess) in anal glands
               extending from the intersphincteric plane to various anorectal
               spaces. The tubular structure of an anal fistula easily yields
               itself to division or unroofing (fistulotomy) or excision
               (fistulectomy) in most cases. The problem with this single, yet
               effective, treatment plan is that depending on the thickness of
               sphincter muscle the fistula transgresses, the patient will have
               varying degrees of fecal incontinence from minor to total. In an
               attempt to preserve continence, various procedures have been
               proposed to deal with the fistulas. These include: (1) simple
               drainage (Seton); (2) closure of fistula tract using fibrin
               sealant or anal fistula plug; (3) closure of primary opening
               using endorectal or dermal flaps, and more recently; and (4)
               ligation of intersphincteric fistula tract (LIFT). In most
               complex cases (i.e. Crohn's disease), a proximal fecal diversion
               offers a measure of symptomatic relief. The fact remains that an
               ``ideal'' procedure for anal fistula remains elusive. The
               failure of each sphincter-preserving procedure (30\%-50\%
               recurrence) often results in multiple operations. In essence,
               the price of preservation of continence at all cost is multiple
               and often different operations, prolonged disability and
               disappointment for the patient and the surgeon. Nevertheless,
               the surgeon treating anal fistulas on an occasional basis should
               never hesitate in referring the patient to a specialist.
               Conversely, an expert colorectal surgeon must be familiar with
               many different operations in order to selectively tailor an
               operation to the individual patient.",
  journal   = "World J. Gastroenterol.",
  publisher = "Baishideng Publishing Group Inc.",
  volume    =  17,
  number    =  28,
  pages     = "3292--3296",
  month     =  jul,
  year      =  2011,
  keywords  = "Abscess; Anal fistula plug; Dermal advancement flap; Endorectal
               flap; Fibrin sealant; Fistula; Ligation of intersphincteric
               fistula tract procedure",
  language  = "en"
}

@ARTICLE{Hellwege2017-xf,
  title     = "Population stratification in genetic association studies",
  author    = "Hellwege, Jacklyn N and Keaton, Jacob M and Giri, Ayush and Gao,
               Xiaoyi and Velez Edwards, Digna R and Edwards, Todd L",
  abstract  = "Population stratification (PS) is a primary consideration in
               studies of genetic determinants of human traits. Failure to
               control for PS may lead to confounding, causing a study to fail
               for lack of significant results, or resources to be wasted
               following false-positive signals. Here, historical and current
               approaches for addressing PS when performing genetic association
               studies in human populations are reviewed. Methods for detecting
               the presence of PS, including global and local ancestry methods,
               are described. Also described are approaches for accounting for
               PS when calculating association statistics, such that measures
               of association are not confounded. Many traits are being
               examined for the first time in minority populations, which may
               inherently feature PS. \copyright{} 2017 by John Wiley \& Sons,
               Inc.",
  journal   = "Curr. Protoc. Hum. Genet.",
  publisher = "Wiley",
  volume    =  95,
  number    =  1,
  pages     = "1.22.1--1.22.23",
  month     =  oct,
  year      =  2017,
  keywords  = "admixture; admixture mapping; association confounding; global
               ancestry; local ancestry; population stratification",
  copyright = "http://onlinelibrary.wiley.com/termsAndConditions\#vor",
  language  = "en"
}

@ARTICLE{Thomas2022-nb,
  title     = "{PANTHER}: Making genome-scale phylogenetics accessible to all",
  author    = "Thomas, Paul D and Ebert, Dustin and Muruganujan, Anushya and
               Mushayahama, Tremayne and Albou, Laurent-Philippe and Mi, Huaiyu",
  abstract  = "Phylogenetics is a powerful tool for analyzing protein
               sequences, by inferring their evolutionary relationships to
               other proteins. However, phylogenetics analyses can be
               challenging: they are computationally expensive and must be
               performed carefully in order to avoid systematic errors and
               artifacts. Protein Analysis THrough Evolutionary Relationships
               (PANTHER; http://pantherdb.org) is a publicly available,
               user-focused knowledgebase that stores the results of an
               extensive phylogenetic reconstruction pipeline that includes
               computational and manual processes and quality control steps.
               First, fully reconciled phylogenetic trees (including ancestral
               protein sequences) are reconstructed for a set of ``reference''
               protein sequences obtained from fully sequenced genomes of
               organisms across the tree of life. Second, the resulting
               phylogenetic trees are manually reviewed and annotated with
               function evolution events: inferred gains and losses of protein
               function along branches of the phylogenetic tree. Here, we
               describe in detail the current contents of PANTHER, how those
               contents are generated, and how they can be used in a variety of
               applications. The PANTHER knowledgebase can be downloaded or
               accessed via an extensive API. In addition, PANTHER provides
               software tools to facilitate the application of the
               knowledgebase to common protein sequence analysis tasks:
               exploring an annotated genome by gene function; performing
               ``enrichment analysis'' of lists of genes; annotating a single
               sequence or large batch of sequences by homology; and assessing
               the likelihood that a genetic variant at a particular site in a
               protein will have deleterious effects.",
  journal   = "Protein Sci.",
  publisher = "Wiley",
  volume    =  31,
  number    =  1,
  pages     = "8--22",
  month     =  jan,
  year      =  2022,
  keywords  = "gene ontology; genome analysis; hidden Markov model; molecular
               evolution; omics data analysis; phylogenetic tree; protein
               function annotation; protein function evolution",
  copyright = "http://onlinelibrary.wiley.com/termsAndConditions\#vor",
  language  = "en"
}

@ARTICLE{Gillespie2022-jr,
  title     = "The reactome pathway knowledgebase 2022",
  author    = "Gillespie, Marc and Jassal, Bijay and Stephan, Ralf and Milacic,
               Marija and Rothfels, Karen and Senff-Ribeiro, Andrea and Griss,
               Johannes and Sevilla, Cristoffer and Matthews, Lisa and Gong,
               Chuqiao and Deng, Chuan and Varusai, Thawfeek and Ragueneau,
               Eliot and Haider, Yusra and May, Bruce and Shamovsky, Veronica
               and Weiser, Joel and Brunson, Timothy and Sanati, Nasim and
               Beckman, Liam and Shao, Xiang and Fabregat, Antonio and
               Sidiropoulos, Konstantinos and Murillo, Julieth and Viteri,
               Guilherme and Cook, Justin and Shorser, Solomon and Bader, Gary
               and Demir, Emek and Sander, Chris and Haw, Robin and Wu,
               Guanming and Stein, Lincoln and Hermjakob, Henning and
               D'Eustachio, Peter",
  abstract  = "The Reactome Knowledgebase (https://reactome.org), an Elixir
               core resource, provides manually curated molecular details
               across a broad range of physiological and pathological
               biological processes in humans, including both hereditary and
               acquired disease processes. The processes are annotated as an
               ordered network of molecular transformations in a single
               consistent data model. Reactome thus functions both as a digital
               archive of manually curated human biological processes and as a
               tool for discovering functional relationships in data such as
               gene expression profiles or somatic mutation catalogs from tumor
               cells. Recent curation work has expanded our annotations of
               normal and disease-associated signaling processes and of the
               drugs that target them, in particular infections caused by the
               SARS-CoV-1 and SARS-CoV-2 coronaviruses and the host response to
               infection. New tools support better simultaneous analysis of
               high-throughput data from multiple sources and the placement of
               understudied ('dark') proteins from analyzed datasets in the
               context of Reactome's manually curated pathways.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  50,
  number    = "D1",
  pages     = "D687--D692",
  month     =  jan,
  year      =  2022,
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Westra2013-mm,
  title     = "Systematic identification of trans {eQTLs} as putative drivers
               of known disease associations",
  author    = "Westra, Harm-Jan and Peters, Marjolein J and Esko, T{\~o}nu and
               Yaghootkar, Hanieh and Schurmann, Claudia and Kettunen, Johannes
               and Christiansen, Mark W and Fairfax, Benjamin P and Schramm,
               Katharina and Powell, Joseph E and Zhernakova, Alexandra and
               Zhernakova, Daria V and Veldink, Jan H and Van den Berg, Leonard
               H and Karjalainen, Juha and Withoff, Sebo and Uitterlinden,
               Andr{\'e} G and Hofman, Albert and Rivadeneira, Fernando and 't
               Hoen, Peter A C and Reinmaa, Eva and Fischer, Krista and Nelis,
               Mari and Milani, Lili and Melzer, David and Ferrucci, Luigi and
               Singleton, Andrew B and Hernandez, Dena G and Nalls, Michael A
               and Homuth, Georg and Nauck, Matthias and Radke, D{\"o}rte and
               V{\"o}lker, Uwe and Perola, Markus and Salomaa, Veikko and
               Brody, Jennifer and Suchy-Dicey, Astrid and Gharib, Sina A and
               Enquobahrie, Daniel A and Lumley, Thomas and Montgomery, Grant W
               and Makino, Seiko and Prokisch, Holger and Herder, Christian and
               Roden, Michael and Grallert, Harald and Meitinger, Thomas and
               Strauch, Konstantin and Li, Yang and Jansen, Ritsert C and
               Visscher, Peter M and Knight, Julian C and Psaty, Bruce M and
               Ripatti, Samuli and Teumer, Alexander and Frayling, Timothy M
               and Metspalu, Andres and van Meurs, Joyce B J and Franke, Lude",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  45,
  number    =  10,
  pages     = "1238--1243",
  month     =  oct,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Van_Dam2017-vm,
  title     = "Gene co-expression analysis for functional classification and
               gene--disease predictions",
  author    = "van Dam, Sipko and V{\~o}sa, Urmo and van der Graaf, Adriaan and
               Franke, Lude and de Magalh{\~a}es, Jo{\~a}o Pedro",
  journal   = "Brief. Bioinform.",
  publisher = "Oxford University Press (OUP)",
  pages     = "bbw139",
  month     =  jan,
  year      =  2017
}

@ARTICLE{Tian2016-hy,
  title     = "The dissection of expression quantitative trait locus hotspots",
  author    = "Tian, Jianan and Keller, Mark P and Broman, Aimee Teo and
               Kendziorski, Christina and Yandell, Brian S and Attie, Alan D
               and Broman, Karl W",
  abstract  = "Studies of the genetic loci that contribute to variation in gene
               expression frequently identify loci with broad effects on gene
               expression: expression quantitative trait locus hotspots. We
               describe a set of exploratory graphical methods as well as a
               formal likelihood-based test for assessing whether a given
               hotspot is due to one or multiple polymorphisms. We first look
               at the pattern of effects of the locus on the expression traits
               that map to the locus: the direction of the effects and the
               degree of dominance. A second technique is to focus on the
               individuals that exhibit no recombination event in the region,
               apply dimensionality reduction (e.g., with linear discriminant
               analysis), and compare the phenotype distribution in the
               nonrecombinant individuals to that in the recombinant
               individuals: if the recombinant individuals display a different
               expression pattern than the nonrecombinant individuals, this
               indicates the presence of multiple causal polymorphisms. In the
               formal likelihood-based test, we compare a two-locus model, with
               each expression trait affected by one or the other locus, to a
               single-locus model. We apply our methods to a large mouse
               intercross with gene expression microarray data on six tissues.",
  journal   = "Genetics",
  publisher = "Oxford University Press (OUP)",
  volume    =  202,
  number    =  4,
  pages     = "1563--1574",
  month     =  apr,
  year      =  2016,
  keywords  = "data visualization; eQTL; gene expression; multivariate
               analysis; pleiotropy",
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}

@ARTICLE{Schadt2003-ei,
  title     = "Genetics of gene expression surveyed in maize, mouse and man",
  author    = "Schadt, Eric E and Monks, Stephanie A and Drake, Thomas A and
               Lusis, Aldons J and Che, Nam and Colinayo, Veronica and Ruff,
               Thomas G and Milligan, Stephen B and Lamb, John R and Cavet, Guy
               and Linsley, Peter S and Mao, Mao and Stoughton, Roland B and
               Friend, Stephen H",
  abstract  = "Treating messenger RNA transcript abundances as quantitative
               traits and mapping gene expression quantitative trait loci for
               these traits has been pursued in gene-specific ways. Transcript
               abundances often serve as a surrogate for classical quantitative
               traits in that the levels of expression are significantly
               correlated with the classical traits across members of a
               segregating population. The correlation structure between
               transcript abundances and classical traits has been used to
               identify susceptibility loci for complex diseases such as
               diabetes and allergic asthma. One study recently completed the
               first comprehensive dissection of transcriptional regulation in
               budding yeast, giving a detailed glimpse of a genome-wide survey
               of the genetics of gene expression. Unlike classical
               quantitative traits, which often represent gross clinical
               measurements that may be far removed from the biological
               processes giving rise to them, the genetic linkages associated
               with transcript abundance affords a closer look at cellular
               biochemical processes. Here we describe comprehensive genetic
               screens of mouse, plant and human transcriptomes by considering
               gene expression values as quantitative traits. We identify a
               gene expression pattern strongly associated with obesity in a
               murine cross, and observe two distinct obesity subtypes.
               Furthermore, we find that these obesity subtypes are under the
               control of different loci.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  422,
  number    =  6929,
  pages     = "297--302",
  month     =  mar,
  year      =  2003,
  language  = "en"
}

@ARTICLE{Brem2002-zj,
  title     = "Genetic dissection of transcriptional regulation in budding
               yeast",
  author    = "Brem, Rachel B and Yvert, Ga{\"e}l and Clinton, Rebecca and
               Kruglyak, Leonid",
  abstract  = "To begin to understand the genetic architecture of natural
               variation in gene expression, we carried out genetic linkage
               analysis of genomewide expression patterns in a cross between a
               laboratory strain and a wild strain of Saccharomyces cerevisiae.
               Over 1500 genes were differentially expressed between the parent
               strains. Expression levels of 570 genes were linked to one or
               more different loci, with most expression levels showing complex
               inheritance patterns. The loci detected by linkage fell largely
               into two categories: cis-acting modulators of single genes and
               trans-acting modulators of many genes. We found eight such
               trans-acting loci, each affecting the expression of a group of 7
               to 94 genes of related function.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  296,
  number    =  5568,
  pages     = "752--755",
  month     =  apr,
  year      =  2002,
  language  = "en"
}

@ARTICLE{Ribeiro2021-xj,
  title     = "The molecular basis, genetic control and pleiotropic effects of
               local gene co-expression",
  author    = "Ribeiro, Diogo M and Rubinacci, Simone and Ramisch, Anna and
               Hofmeister, Robin J and Dermitzakis, Emmanouil T and Delaneau,
               Olivier",
  abstract  = "Nearby genes are often expressed as a group. Yet, the
               prevalence, molecular mechanisms and genetic control of local
               gene co-expression are far from being understood. Here, by
               leveraging gene expression measurements across 49 human tissues
               and hundreds of individuals, we find that local gene
               co-expression occurs in 13\% to 53\% of genes per tissue. By
               integrating various molecular assays (e.g. ChIP-seq and Hi-C),
               we estimate the ability of several mechanisms, such as
               enhancer-gene interactions, in distinguishing gene pairs that
               are co-expressed from those that are not. Notably, we identify
               32,636 expression quantitative trait loci (eQTLs) which
               associate with co-expressed gene pairs and often overlap
               enhancer regions. Due to affecting several genes, these eQTLs
               are more often associated with multiple human traits than other
               eQTLs. Our study paves the way to comprehend trait pleiotropy
               and functional interpretation of QTL and GWAS findings. All
               local gene co-expression identified here is available through a
               public database ( https://glcoex.unil.ch/ ).",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  1,
  pages     = "4842",
  month     =  aug,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{hapmap,
  title     = "A second generation human haplotype map of over 3.1 million
               {SNPs}",
  author    = "{The International HapMap Consortium}",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  449,
  number    =  7164,
  pages     = "851--861",
  month     =  oct,
  year      =  2007,
  language  = "en"
}

@ARTICLE{Bulik-Sullivan2015-ts,
  title     = "An atlas of genetic correlations across human diseases and
               traits",
  author    = "Bulik-Sullivan, Brendan and Finucane, Hilary K and Anttila,
               Verneri and Gusev, Alexander and Day, Felix R and Loh, Po-Ru and
               {ReproGen Consortium} and {Psychiatric Genomics Consortium} and
               {Genetic Consortium for Anorexia Nervosa of the Wellcome Trust
               Case Control Consortium 3} and Duncan, Laramie and Perry, John R
               B and Patterson, Nick and Robinson, Elise B and Daly, Mark J and
               Price, Alkes L and Neale, Benjamin M",
  abstract  = "Identifying genetic correlations between complex traits and
               diseases can provide useful etiological insights and help
               prioritize likely causal relationships. The major challenges
               preventing estimation of genetic correlation from genome-wide
               association study (GWAS) data with current methods are the lack
               of availability of individual-level genotype data and widespread
               sample overlap among meta-analyses. We circumvent these
               difficulties by introducing a technique-cross-trait LD Score
               regression-for estimating genetic correlation that requires only
               GWAS summary statistics and is not biased by sample overlap. We
               use this method to estimate 276 genetic correlations among 24
               traits. The results include genetic correlations between
               anorexia nervosa and schizophrenia, anorexia and obesity, and
               educational attainment and several diseases. These results
               highlight the power of genome-wide analyses, as there currently
               are no significantly associated SNPs for anorexia nervosa and
               only three for educational attainment.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  47,
  number    =  11,
  pages     = "1236--1241",
  month     =  nov,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Bulik-Sullivan2015-fk,
  title     = "{LD} Score regression distinguishes confounding from
               polygenicity in genome-wide association studies",
  author    = "Bulik-Sullivan, Brendan K and {Schizophrenia Working Group of
               the Psychiatric Genomics Consortium} and Loh, Po-Ru and
               Finucane, Hilary K and Ripke, Stephan and Yang, Jian and
               Patterson, Nick and Daly, Mark J and Price, Alkes L and Neale,
               Benjamin M",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  47,
  number    =  3,
  pages     = "291--295",
  month     =  mar,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Qin2015-jb,
  title     = "Quantitating and dating recent gene flow between European and
               East Asian populations",
  author    = "Qin, Pengfei and Zhou, Ying and Lou, Haiyi and Lu, Dongsheng and
               Yang, Xiong and Wang, Yuchen and Jin, Li and Chung, Yeun-Jun and
               Xu, Shuhua",
  abstract  = "Historical records indicate that extensive cultural, commercial
               and technological interaction occurred between European and
               Asian populations. What have been the biological consequences of
               these contacts in terms of gene flow? We systematically
               estimated gene flow between Eurasian groups using genome-wide
               polymorphisms from 34 populations representing Europeans, East
               Asians, and Central/South Asians. We identified recent gene flow
               between Europeans and Asians in most populations we studied,
               including East Asians and Northwestern Europeans, which are
               normally considered to be non-admixed populations. In addition
               we quantitatively estimated the extent of this gene flow using
               two statistical approaches, and dated admixture events based on
               admixture linkage disequilibrium. Our results indicate that most
               genetic admixtures occurred between 2,400 and 310 years ago and
               show the admixture proportions to be highly correlated with
               geographic locations, with the highest admixture proportions
               observed in Central Asia and the lowest in East Asia and
               Northwestern Europe. Interestingly, we observed a North-to-South
               decline of European gene flow in East Asians, suggesting a
               northern path of European gene flow diffusing into East Asian
               populations. Our findings contribute to an improved
               understanding of the history of human migration and the
               evolutionary mechanisms that have shaped the genetic structure
               of populations in Eurasia.",
  journal   = "Sci. Rep.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  5,
  number    =  1,
  pages     = "9500",
  month     =  apr,
  year      =  2015,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Zheng2021-ss,
  title     = "Genome-wide analysis of 944 133 individuals provides insights
               into the etiology of haemorrhoidal disease",
  author    = "Zheng, Tenghao and Ellinghaus, David and Juzenas, Simonas and
               Cossais, Fran{\c c}ois and Burmeister, Greta and Mayr, Gabriele
               and J{\o}rgensen, Isabella Friis and Teder-Laving, Maris and
               Skogholt, Anne Heidi and Chen, Sisi and Strege, Peter R and Ito,
               Go and Banasik, Karina and Becker, Thomas and Bokelmann, Frank
               and Brunak, S{\o}ren and Buch, Stephan and Clausnitzer, Hartmut
               and Datz, Christian and {DBDS Consortium} and Degenhardt, Frauke
               and Doniec, Marek and Erikstrup, Christian and Esko, T{\~o}nu
               and Forster, Michael and Frey, Norbert and Fritsche, Lars G and
               Gabrielsen, Maiken Elvestad and Gr{\"a}{\ss}le, Tobias and Gsur,
               Andrea and Gross, Justus and Hampe, Jochen and Hendricks,
               Alexander and Hinz, Sebastian and Hveem, Kristian and Jongen,
               Johannes and Junker, Ralf and Karlsen, Tom Hemming and
               Hemmrich-Stanisak, Georg and Kruis, Wolfgang and Kupcinskas,
               Juozas and Laubert, Tilman and Rosenstiel, Philip C and
               R{\"o}cken, Christoph and Laudes, Matthias and Leendertz, Fabian
               H and Lieb, Wolfgang and Limperger, Verena and Margetis,
               Nikolaos and M{\"a}tz-Rensing, Kerstin and N{\'e}meth,
               Christopher Georg and Ness-Jensen, Eivind and Nowak-G{\"o}ttl,
               Ulrike and Pandit, Anita and Pedersen, Ole Birger and Peleikis,
               Hans G{\"u}nter and Peuker, Kenneth and Rodriguez, Cristina Leal
               and R{\"u}hlemann, Malte Christoph and Schniewind, Bodo and
               Schulzky, Martin and Skieceviciene, Jurgita and Tepel,
               J{\"u}rgen and Thomas, Laurent and Uellendahl-Werth, Florian and
               Ullum, Henrik and Vogel, Ilka and Volzke, Henry and von Fersen,
               Lorenzo and von Sch{\"o}nfels, Witigo and Vanderwerff, Brett and
               Wilking, Julia and Wittig, Michael and Zeissig, Sebastian and
               Zobel, Myrko and Zawistowski, Matthew and Vacic, Vladimir and
               Sazonova, Olga and Noblin, Elizabeth S and {23andMe Research
               Team} and Farrugia, Gianrico and Beyder, Arthur and Wedel, Thilo
               and Kahlke, Volker and Schafmayer, Clemens and D'Amato, Mauro
               and Franke, Andre",
  abstract  = "OBJECTIVE: Haemorrhoidal disease (HEM) affects a large and
               silently suffering fraction of the population but its aetiology,
               including suspected genetic predisposition, is poorly
               understood. We report the first genome-wide association study
               (GWAS) meta-analysis to identify genetic risk factors for HEM to
               date. DESIGN: We conducted a GWAS meta-analysis of 218 920
               patients with HEM and 725 213 controls of European ancestry.
               Using GWAS summary statistics, we performed multiple genetic
               correlation analyses between HEM and other traits as well as
               calculated HEM polygenic risk scores (PRS) and evaluated their
               translational potential in independent datasets. Using
               functional annotation of GWAS results, we identified HEM
               candidate genes, which differential expression and coexpression
               in HEM tissues were evaluated employing RNA-seq analyses. The
               localisation of expressed proteins at selected loci was
               investigated by immunohistochemistry. RESULTS: We demonstrate
               modest heritability and genetic correlation of HEM with several
               other diseases from the GI, neuroaffective and cardiovascular
               domains. HEM PRS validated in 180 435 individuals from
               independent datasets allowed the identification of those at risk
               and correlated with younger age of onset and recurrent surgery.
               We identified 102 independent HEM risk loci harbouring genes
               whose expression is enriched in blood vessels and GI tissues,
               and in pathways associated with smooth muscles, epithelial and
               endothelial development and morphogenesis. Network
               transcriptomic analyses highlighted HEM gene coexpression
               modules that are relevant to the development and integrity of
               the musculoskeletal and epidermal systems, and the organisation
               of the extracellular matrix. CONCLUSION: HEM has a genetic
               component that predisposes to smooth muscle, epithelial and
               connective tissue dysfunction.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  70,
  number    =  8,
  pages     = "1538--1549",
  month     =  apr,
  year      =  2021,
  keywords  = "anal canal histopathology; anorectal disorders; genetics",
  language  = "en"
}

@ARTICLE{Price2010-zb,
  title     = "New approaches to population stratification in genome-wide
               association studies",
  author    = "Price, Alkes L and Zaitlen, Noah A and Reich, David and
               Patterson, Nick",
  abstract  = "Genome-wide association (GWA) studies are an effective approach
               for identifying genetic variants associated with disease risk.
               GWA studies can be confounded by population
               stratification--systematic ancestry differences between cases
               and controls--which has previously been addressed by methods
               that infer genetic ancestry. Those methods perform well in data
               sets in which population structure is the only kind of structure
               present but are inadequate in data sets that also contain family
               structure or cryptic relatedness. Here, we review recent
               progress on methods that correct for stratification while
               accounting for these additional complexities.",
  journal   = "Nat. Rev. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  11,
  number    =  7,
  pages     = "459--463",
  month     =  jul,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Kraft2009-xg,
  title     = "Replication in genome-wide association studies",
  author    = "Kraft, Peter and Zeggini, Eleftheria and Ioannidis, John P A",
  abstract  = "Replication helps ensure that a genotype-phenotype association
               observed in a genome-wide association (GWA) study represents a
               credible association and is not a chance finding or an artifact
               due to uncontrolled biases. We discuss prerequisites for exact
               replication; issues of heterogeneity; advantages and
               disadvantages of different methods of data synthesis across
               multiple studies; frequentist vs. Bayesian inferences for
               replication; and challenges that arise from multi-team
               collaborations. While consistent replication can greatly improve
               the credibility of a genotype-phenotype association, it may not
               eliminate spurious associations due to biases shared by many
               studies. Conversely, lack of replication in well-powered
               follow-up studies usually invalidates the initially proposed
               association, although occasionally it may point to differences
               in linkage disequilibrium or effect modifiers across studies.",
  journal   = "Stat. Sci.",
  publisher = "Institute of Mathematical Statistics",
  volume    =  24,
  number    =  4,
  pages     = "561--573",
  month     =  nov,
  year      =  2009,
  language  = "en"
}


@ARTICLE{Hirsch2016-mw,
  title     = "{ICD-10}: History and context",
  author    = "Hirsch, J A and Nicola, G and McGinty, G and Liu, R W and Barr,
               R M and Chittle, M D and Manchikanti, L",
  abstract  = "In recent months, organized medicine has been consumed by the
               anticipated transition to the 10th iteration of the
               International Classification of Disease system. Implementation
               has come and gone without the disruptive effects predicted by
               many. Despite the fundamental role the International
               Classification of Disease system plays in health care delivery
               and payment policy, few neuroradiologists are familiar with the
               history of its implementation and implications beyond coding for
               diseases.",
  journal   = "AJNR Am. J. Neuroradiol.",
  publisher = "American Society of Neuroradiology (ASNR)",
  volume    =  37,
  number    =  4,
  pages     = "596--599",
  month     =  apr,
  year      =  2016,
  language  = "en"
}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%% Splicing chapter%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
@ARTICLE{Kalam2017-qa,
  title     = "Alternate splicing of transcripts shape macrophage response to
               Mycobacterium tuberculosis infection",
  author    = "Kalam, Haroon and Fontana, Mary F and Kumar, Dhiraj",
  journal   = "PLoS Pathog.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  13,
  number    =  3,
  pages     = "e1006236",
  month     =  mar,
  year      =  2017,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Sakane2012-km,
  title     = "Rab13 small {G} protein and junctional Rab13-binding protein
               ({JRAB}) orchestrate actin cytoskeletal organization during
               epithelial junctional development",
  author    = "Sakane, Ayuko and Abdallah, Ahmed Alamir Mahmoud and Nakano,
               Kiyoshi and Honda, Kazufumi and Ikeda, Wataru and Nishikawa,
               Yumiko and Matsumoto, Mitsuru and Matsushita, Natsuki and
               Kitamura, Toshio and Sasaki, Takuya",
  abstract  = "During epithelial junctional development, both vesicle transport
               and reorganization of the actin cytoskeleton must be
               spatiotemporally regulated. Coordination of these cellular
               functions is especially important, but the precise mechanism
               remains elusive. Previously, we identified junctional
               Rab13-binding protein (JRAB)/molecules interacting with
               CasL-like 2 (MICAL-L2) as an effector of the Rab13 small G
               protein, and we found that the Rab13-JRAB system may be involved
               in the formation of cell-cell adhesions via transport of
               adhesion molecules. Here, we showed that JRAB interacts with two
               actin-binding proteins, actinin-1 and -4, and filamentous actin
               via different domains and regulates actin cross-linking and
               stabilization through these interactions. During epithelial
               junctional development, JRAB is prominently enriched in the
               actin bundle at the free border; subsequently, JRAB undergoes a
               Rab13-dependent conformational change that is required for
               maturation of cell-cell adhesion sites. These results suggest
               that Rab13 and JRAB regulate reorganization of the actin
               cytoskeleton throughout epithelial junctional development from
               establishment to maturation of cell-cell adhesion.",
  journal   = "J. Biol. Chem.",
  publisher = "Elsevier BV",
  volume    =  287,
  number    =  51,
  pages     = "42455--42468",
  month     =  dec,
  year      =  2012,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@UNPUBLISHED{macromap-eqtl,
  title    = "Gene expression {QTL} mapping in stimulated {iPSC-derived}
              macrophages provides insights into common complex diseases",
  author   = "Panousis, Nikolaos I and Garwany, Omar El and Knights, Andrew and
              Rop, Jesse Cheruiyot and Kumasaka, Natsuhiko and Imaz, Maria and
              Vilarino, Lorena Boquete and Tsingene, Anthi and Barnett, Alice
              and Gomez, Celine and Anderson, Carl A and Gaffney, Daniel J",
  abstract = "AbstractMany disease-associated variants are thought to be
              regulatory but are not present in existing catalogues of
              expression quantitative trait loci (eQTL). We hypothesise that
              these variants may regulate expression in specific biological
              contexts, such as stimulated immune cells. Here, we used human
              iPSC-derived macrophages to map eQTLs across 24 cellular
              conditions. We found that 76\% of eQTLs detected in at least one
              stimulated condition were also found in naive cells. The
              percentage of response eQTLs (reQTLs) varied widely across
              conditions (3.7\% - 28.4\%), with reQTLs specific to a single
              condition being rare (1.11\%). Despite their relative rarity,
              reQTLs were overrepresented among disease-colocalizing eQTLs. We
              nominated an additional 21.7\% of disease effector genes at GWAS
              loci via colocalization of reQTLs, with 38.6\% of these not found
              in the Genotype--Tissue Expression (GTEx) catalogue. Our study
              highlights the diversity of genetic effects on expression and
              demonstrates how condition-specific regulatory variation can
              enhance our understanding of common disease risk alleles.",
  journal  = "bioRxiv",
  month    =  may,
  year     =  2023
}

@ARTICLE{Maurano2012-yw,
  title     = "Systematic localization of common disease-associated variation
               in regulatory {DNA}",
  author    = "Maurano, Matthew T and Humbert, Richard and Rynes, Eric and
               Thurman, Robert E and Haugen, Eric and Wang, Hao and Reynolds,
               Alex P and Sandstrom, Richard and Qu, Hongzhu and Brody,
               Jennifer and Shafer, Anthony and Neri, Fidencio and Lee, Kristen
               and Kutyavin, Tanya and Stehling-Sun, Sandra and Johnson, Audra
               K and Canfield, Theresa K and Giste, Erika and Diegel, Morgan
               and Bates, Daniel and Hansen, R Scott and Neph, Shane and Sabo,
               Peter J and Heimfeld, Shelly and Raubitschek, Antony and
               Ziegler, Steven and Cotsapas, Chris and Sotoodehnia, Nona and
               Glass, Ian and Sunyaev, Shamil R and Kaul, Rajinder and
               Stamatoyannopoulos, John A",
  abstract  = "Genome-wide association studies have identified many noncoding
               variants associated with common diseases and traits. We show
               that these variants are concentrated in regulatory DNA marked by
               deoxyribonuclease I (DNase I) hypersensitive sites (DHSs).
               Eighty-eight percent of such DHSs are active during fetal
               development and are enriched in variants associated with
               gestational exposure-related phenotypes. We identified distant
               gene targets for hundreds of variant-containing DHSs that may
               explain phenotype associations. Disease-associated variants
               systematically perturb transcription factor recognition
               sequences, frequently alter allelic chromatin states, and form
               regulatory networks. We also demonstrated tissue-selective
               enrichment of more weakly disease-associated variants within
               DHSs and the de novo identification of pathogenic cell types for
               Crohn's disease, multiple sclerosis, and an electrocardiogram
               trait, without prior knowledge of physiological mechanisms. Our
               results suggest pervasive involvement of regulatory DNA
               variation in common human disease and provide pathogenic
               insights into diverse disorders.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  337,
  number    =  6099,
  pages     = "1190--1195",
  month     =  sep,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Schaub2012-cy,
  title     = "Linking disease associations with regulatory information in the
               human genome",
  author    = "Schaub, Marc A and Boyle, Alan P and Kundaje, Anshul and
               Batzoglou, Serafim and Snyder, Michael",
  abstract  = "Genome-wide association studies have been successful in
               identifying single nucleotide polymorphisms (SNPs) associated
               with a large number of phenotypes. However, an associated SNP is
               likely part of a larger region of linkage disequilibrium. This
               makes it difficult to precisely identify the SNPs that have a
               biological link with the phenotype. We have systematically
               investigated the association of multiple types of ENCODE data
               with disease-associated SNPs and show that there is significant
               enrichment for functional SNPs among the currently identified
               associations. This enrichment is strongest when integrating
               multiple sources of functional information and when highest
               confidence disease-associated SNPs are used. We propose an
               approach that integrates multiple types of functional data
               generated by the ENCODE Consortium to help identify ``functional
               SNPs'' that may be associated with the disease phenotype. Our
               approach generates putative functional annotations for up to
               80\% of all previously reported associations. We show that for
               most associations, the functional SNP most strongly supported by
               experimental evidence is a SNP in linkage disequilibrium with
               the reported association rather than the reported SNP itself.
               Our results show that the experimental data sets generated by
               the ENCODE Consortium can be successfully used to suggest
               functional hypotheses for variants associated with diseases and
               other phenotypes.",
  journal   = "Genome Res.",
  publisher = "Cold Spring Harbor Laboratory",
  volume    =  22,
  number    =  9,
  pages     = "1748--1759",
  month     =  sep,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Vosa2021-pb,
  title     = "Large-scale cis- and {trans-eQTL} analyses identify thousands of
               genetic loci and polygenic scores that regulate blood gene
               expression",
  author    = "V{\~o}sa, Urmo and Claringbould, Annique and Westra, Harm-Jan
               and Bonder, Marc Jan and Deelen, Patrick and Zeng, Biao and
               Kirsten, Holger and Saha, Ashis and Kreuzhuber, Roman and Yazar,
               Seyhan and Brugge, Harm and Oelen, Roy and de Vries, Dylan H and
               van der Wijst, Monique G P and Kasela, Silva and Pervjakova,
               Natalia and Alves, Isabel and Fav{\'e}, Marie-Julie and Agbessi,
               Mawuss{\'e} and Christiansen, Mark W and Jansen, Rick and
               Sepp{\"a}l{\"a}, Ilkka and Tong, Lin and Teumer, Alexander and
               Schramm, Katharina and Hemani, Gibran and Verlouw, Joost and
               Yaghootkar, Hanieh and S{\"o}nmez Flitman, Reyhan and Brown,
               Andrew and Kukushkina, Viktorija and Kalnapenkis, Anette and
               R{\"u}eger, Sina and Porcu, Eleonora and Kronberg, Jaanika and
               Kettunen, Johannes and Lee, Bernett and Zhang, Futao and Qi,
               Ting and Hernandez, Jose Alquicira and Arindrarto, Wibowo and
               Beutner, Frank and {BIOS Consortium} and {i2QTL Consortium} and
               Dmitrieva, Julia and Elansary, Mahmoud and Fairfax, Benjamin P
               and Georges, Michel and Heijmans, Bastiaan T and Hewitt, Alex W
               and K{\"a}h{\"o}nen, Mika and Kim, Yungil and Knight, Julian C
               and Kovacs, Peter and Krohn, Knut and Li, Shuang and Loeffler,
               Markus and Marigorta, Urko M and Mei, Hailang and Momozawa,
               Yukihide and M{\"u}ller-Nurasyid, Martina and Nauck, Matthias
               and Nivard, Michel G and Penninx, Brenda W J H and Pritchard,
               Jonathan K and Raitakari, Olli T and Rotzschke, Olaf and
               Slagboom, Eline P and Stehouwer, Coen D A and Stumvoll, Michael
               and Sullivan, Patrick and 't Hoen, Peter A C and Thiery, Joachim
               and T{\"o}njes, Anke and van Dongen, Jenny and van Iterson,
               Maarten and Veldink, Jan H and V{\"o}lker, Uwe and Warmerdam,
               Robert and Wijmenga, Cisca and Swertz, Morris and Andiappan,
               Anand and Montgomery, Grant W and Ripatti, Samuli and Perola,
               Markus and Kutalik, Zoltan and Dermitzakis, Emmanouil and
               Bergmann, Sven and Frayling, Timothy and van Meurs, Joyce and
               Prokisch, Holger and Ahsan, Habibul and Pierce, Brandon L and
               Lehtim{\"a}ki, Terho and Boomsma, Dorret I and Psaty, Bruce M
               and Gharib, Sina A and Awadalla, Philip and Milani, Lili and
               Ouwehand, Willem H and Downes, Kate and Stegle, Oliver and
               Battle, Alexis and Visscher, Peter M and Yang, Jian and Scholz,
               Markus and Powell, Joseph and Gibson, Greg and Esko, T{\~o}nu
               and Franke, Lude",
  abstract  = "Trait-associated genetic variants affect complex phenotypes
               primarily via regulatory mechanisms on the transcriptome. To
               investigate the genetics of gene expression, we performed cis-
               and trans-expression quantitative trait locus (eQTL) analyses
               using blood-derived expression from 31,684 individuals through
               the eQTLGen Consortium. We detected cis-eQTL for 88\% of genes,
               and these were replicable in numerous tissues. Distal trans-eQTL
               (detected for 37\% of 10,317 trait-associated variants tested)
               showed lower replication rates, partially due to low replication
               power and confounding by cell type composition. However,
               replication analyses in single-cell RNA-seq data prioritized
               intracellular trans-eQTL. Trans-eQTL exerted their effects via
               several mechanisms, primarily through regulation by
               transcription factors. Expression of 13\% of the genes
               correlated with polygenic scores for 1,263 phenotypes,
               pinpointing potential drivers for those traits. In summary, this
               work represents a large eQTL resource, and its results serve as
               a starting point for in-depth interpretation of complex
               phenotypes.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  9,
  pages     = "1300--1310",
  month     =  sep,
  year      =  2021,
  language  = "en"
}

@ARTICLE{The_GTEx_Consortium2020-gg,
  title     = "The {GTEx} Consortium atlas of genetic regulatory effects across
               human tissues",
  author    = "{The GTEx Consortium} and Aguet, Fran{\c c}ois and Anand,
               Shankara and Ardlie, Kristin G and Gabriel, Stacey and Getz, Gad
               A and Graubert, Aaron and Hadley, Kane and Handsaker, Robert E
               and Huang, Katherine H and Kashin, Seva and Li, Xiao and
               MacArthur, Daniel G and Meier, Samuel R and Nedzel, Jared L and
               Nguyen, Duyen T and Segr{\`e}, Ayellet V and Todres, Ellen and
               Balliu, Brunilda and Barbeira, Alvaro N and Battle, Alexis and
               Bonazzola, Rodrigo and Brown, Andrew and Brown, Christopher D
               and Castel, Stephane E and Conrad, Donald F and Cotter, Daniel J
               and Cox, Nancy and Das, Sayantan and de Goede, Olivia M and
               Dermitzakis, Emmanouil T and Einson, Jonah and Engelhardt,
               Barbara E and Eskin, Eleazar and Eulalio, Tiffany Y and Ferraro,
               Nicole M and Flynn, Elise D and Fresard, Laure and Gamazon, Eric
               R and Garrido-Mart{\'\i}n, Diego and Gay, Nicole R and
               Gloudemans, Michael J and Guig{\'o}, Roderic and Hame, Andrew R
               and He, Yuan and Hoffman, Paul J and Hormozdiari, Farhad and
               Hou, Lei and Im, Hae Kyung and Jo, Brian and Kasela, Silva and
               Kellis, Manolis and Kim-Hellmuth, Sarah and Kwong, Alan and
               Lappalainen, Tuuli and Li, Xin and Liang, Yanyu and Mangul,
               Serghei and Mohammadi, Pejman and Montgomery, Stephen B and
               Mu{\~n}oz-Aguirre, Manuel and Nachun, Daniel C and Nobel, Andrew
               B and Oliva, Meritxell and Park, Yoson and Park, Yongjin and
               Parsana, Princy and Rao, Abhiram S and Reverter, Ferran and
               Rouhana, John M and Sabatti, Chiara and Saha, Ashis and
               Stephens, Matthew and Stranger, Barbara E and Strober, Benjamin
               J and Teran, Nicole A and Vi{\~n}uela, Ana and Wang, Gao and
               Wen, Xiaoquan and Wright, Fred and Wucher, Valentin and Zou,
               Yuxin and Ferreira, Pedro G and Li, Gen and Mel{\'e}, Marta and
               Yeger-Lotem, Esti and Barcus, Mary E and Bradbury, Debra and
               Krubit, Tanya and McLean, Jeffrey A and Qi, Liqun and Robinson,
               Karna and Roche, Nancy V and Smith, Anna M and Sobin, Leslie and
               Tabor, David E and Undale, Anita and Bridge, Jason and Brigham,
               Lori E and Foster, Barbara A and Gillard, Bryan M and Hasz,
               Richard and Hunter, Marcus and Johns, Christopher and Johnson,
               Mark and Karasik, Ellen and Kopen, Gene and Leinweber, William F
               and McDonald, Alisa and Moser, Michael T and Myer, Kevin and
               Ramsey, Kimberley D and Roe, Brian and Shad, Saboor and Thomas,
               Jeffrey A and Walters, Gary and Washington, Michael and Wheeler,
               Joseph and Jewell, Scott D and Rohrer, Daniel C and Valley, Dana
               R and Davis, David A and Mash, Deborah C and Branton, Philip A
               and Barker, Laura K and Gardiner, Heather M and Mosavel,
               Maghboeba and Siminoff, Laura A and Flicek, Paul and Haeussler,
               Maximilian and Juettemann, Thomas and Kent, W James and Lee,
               Christopher M and Powell, Conner C and Rosenbloom, Kate R and
               Ruffier, Magali and Sheppard, Dan and Taylor, Kieron and
               Trevanion, Stephen J and Zerbino, Daniel R and Abell, Nathan S
               and Akey, Joshua and Chen, Lin and Demanelis, Kathryn and
               Doherty, Jennifer A and Feinberg, Andrew P and Hansen, Kasper D
               and Hickey, Peter F and Jasmine, Farzana and Jiang, Lihua and
               Kaul, Rajinder and Kibriya, Muhammad G and Li, Jin Billy and Li,
               Qin and Lin, Shin and Linder, Sandra E and Pierce, Brandon L and
               Rizzardi, Lindsay F and Skol, Andrew D and Smith, Kevin S and
               Snyder, Michael and Stamatoyannopoulos, John and Tang, Hua and
               Wang, Meng and Carithers, Latarsha J and Guan, Ping and Koester,
               Susan E and Little, A Roger and Moore, Helen M and Nierras,
               Concepcion R and Rao, Abhi K and Vaught, Jimmie B and Volpi,
               Simona",
  abstract  = "The Genotype-Tissue Expression (GTEx) project dissects how
               genetic variation affects gene expression and splicing.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  369,
  number    =  6509,
  pages     = "1318--1330",
  month     =  sep,
  year      =  2020,
  copyright = "https://www.sciencemag.org/about/science-licenses-journal-article-reuse",
  language  = "en"
}

@ARTICLE{Kerimov2021-gh,
  title     = "A compendium of uniformly processed human gene expression and
               splicing quantitative trait loci",
  author    = "Kerimov, Nurlan and Hayhurst, James D and Peikova, Kateryna and
               Manning, Jonathan R and Walter, Peter and Kolberg, Liis and
               Samovi{\v c}a, Marija and Sakthivel, Manoj Pandian and Kuzmin,
               Ivan and Trevanion, Stephen J and Burdett, Tony and Jupp, Simon
               and Parkinson, Helen and Papatheodorou, Irene and Yates, Andrew
               D and Zerbino, Daniel R and Alasoo, Kaur",
  abstract  = "Many gene expression quantitative trait locus (eQTL) studies
               have published their summary statistics, which can be used to
               gain insight into complex human traits by downstream analyses,
               such as fine mapping and co-localization. However, technical
               differences between these datasets are a barrier to their
               widespread use. Consequently, target genes for most genome-wide
               association study (GWAS) signals have still not been identified.
               In the present study, we present the eQTL Catalogue (
               https://www.ebi.ac.uk/eqtl ), a resource of quality-controlled,
               uniformly re-computed gene expression and splicing QTLs from 21
               studies. We find that, for matching cell types and tissues, the
               eQTL effect sizes are highly reproducible between studies.
               Although most QTLs were shared between most bulk tissues, we
               identified a greater diversity of cell-type-specific QTLs from
               purified cell types, a subset of which also manifested as new
               disease co-localizations. Our summary statistics are freely
               available to enable the systematic interpretation of human GWAS
               associations across many cell types and tissues.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  9,
  pages     = "1290--1299",
  month     =  sep,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Chun2017-uz,
  title     = "Limited statistical evidence for shared genetic effects of
               {eQTLs} and autoimmune-disease-associated loci in three major
               immune-cell types",
  author    = "Chun, Sung and Casparino, Alexandra and Patsopoulos, Nikolaos A
               and Croteau-Chonka, Damien C and Raby, Benjamin A and De Jager,
               Philip L and Sunyaev, Shamil R and Cotsapas, Chris",
  abstract  = "Most autoimmune-disease-risk effects identified by genome-wide
               association studies (GWAS) localize to open chromatin with
               gene-regulatory activity. GWAS loci are also enriched in
               expression quantitative trait loci (eQTLs), thus suggesting that
               most risk variants alter gene expression. However, because
               causal variants are difficult to identify, and cis-eQTLs occur
               frequently, it remains challenging to identify specific
               instances of disease-relevant changes to gene regulation. Here,
               we used a novel joint likelihood framework with higher
               resolution than that of previous methods to identify loci where
               autoimmune-disease risk and an eQTL are driven by a single
               shared genetic effect. Using eQTLs from three major immune
               subpopulations, we found shared effects in only âˆ¼25\% of the
               loci examined. Thus, we show that a fraction of gene-regulatory
               changes suggest strong mechanistic hypotheses for disease risk,
               but we conclude that most risk mechanisms are not likely to
               involve changes in basal gene expression.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  4,
  pages     = "600--605",
  month     =  apr,
  year      =  2017,
  language  = "en"
}

@UNPUBLISHED{Mostafavi2022-tg,
  title    = "Limited overlap of {eQTLs} and {GWAS} hits due to systematic
              differences in discovery",
  author   = "Mostafavi, Hakhamanesh and Spence, Jeffrey P and Naqvi, Sahin and
              Pritchard, Jonathan K",
  abstract = "AbstractMost signals in genome-wide association studies (GWAS) of
              complex traits point to noncoding genetic variants with putative
              gene regulatory effects. However, currently identified expression
              quantitative trait loci (eQTLs) explain only a small fraction of
              GWAS signals. By analyzing GWAS hits for complex traits in the UK
              Biobank, and cis-eQTLs from the GTEx consortium, we show that
              these assays systematically discover different types of genes and
              variants: eQTLs cluster strongly near transcription start sites,
              while GWAS hits do not. Genes near GWAS hits are enriched in
              numerous functional annotations, are under strong selective
              constraint and have a complex regulatory landscape across
              different tissue/cell types, while genes near eQTLs are depleted
              of most functional annotations, show relaxed constraint, and have
              simpler regulatory landscapes. We describe a model to understand
              these observations, including how natural selection on complex
              traits hinders discovery of functionally-relevant eQTLs. Our
              results imply that GWAS and eQTL studies are systematically
              biased toward different types of variants, and support the use of
              complementary functional approaches alongside the next generation
              of eQTL studies.",
  journal  = "bioRxiv",
  month    =  may,
  year     =  2022
}

@ARTICLE{Li2016-wu,
  title     = "{RNA} splicing is a primary link between genetic variation and
               disease",
  author    = "Li, Yang I and van de Geijn, Bryce and Raj, Anil and Knowles,
               David A and Petti, Allegra A and Golan, David and Gilad, Yoav
               and Pritchard, Jonathan K",
  abstract  = "RNA splicing links genetics to disease Many genetic variants
               associated with disease have no apparent effect on any specific
               protein coding sequence. Li et al. systematically analyzed the
               effects of DNA variants on the main steps of gene regulation,
               from the chromatin state through protein function. One-third of
               expression quantitative train loci (QTLs) are mediated through
               transcriptional processes, not chromatin. Splice QTLs and
               expression QTLs are about comparable in their complex disease
               risk. Posttranscriptional mechanisms therefore play a large role
               in translating genotype to phenotype. Science , this issue p.
               600",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  352,
  number    =  6285,
  pages     = "600--604",
  month     =  apr,
  year      =  2016,
  copyright = "http://www.sciencemag.org/about/science-licenses-journal-article-reuse",
  language  = "en"
}

@ARTICLE{Kim-Hellmuth2020-gz,
  title     = "Cell type--specific genetic regulation of gene expression across
               human tissues",
  author    = "Kim-Hellmuth, Sarah and Aguet, Fran{\c c}ois and Oliva,
               Meritxell and Mu{\~n}oz-Aguirre, Manuel and Kasela, Silva and
               Wucher, Valentin and Castel, Stephane E and Hamel, Andrew R and
               Vi{\~n}uela, Ana and Roberts, Amy L and Mangul, Serghei and Wen,
               Xiaoquan and Wang, Gao and Barbeira, Alvaro N and
               Garrido-Mart{\'\i}n, Diego and Nadel, Brian B and Zou, Yuxin and
               Bonazzola, Rodrigo and Quan, Jie and Brown, Andrew and
               Martinez-Perez, Angel and Soria, Jos{\'e} Manuel and Getz, Gad
               and Dermitzakis, Emmanouil T and Small, Kerrin S and Stephens,
               Matthew and Xi, Hualin S and Im, Hae Kyung and Guig{\'o},
               Roderic and Segr{\`e}, Ayellet V and Stranger, Barbara E and
               Ardlie, Kristin G and Lappalainen, Tuuli and Aguet, Fran{\c
               c}ois and Anand, Shankara and Ardlie, Kristin G and Gabriel,
               Stacey and Getz, Gad A and Graubert, Aaron and Hadley, Kane and
               Handsaker, Robert E and Huang, Katherine H and Kashin, Seva and
               Li, Xiao and MacArthur, Daniel G and Meier, Samuel R and Nedzel,
               Jared L and Nguyen, Duyen T and Segr{\`e}, Ayellet V and Todres,
               Ellen and Balliu, Brunilda and Barbeira, Alvaro N and Battle,
               Alexis and Bonazzola, Rodrigo and Brown, Andrew and Brown,
               Christopher D and Castel, Stephane E and Conrad, Donald F and
               Cotter, Daniel J and Cox, Nancy and Das, Sayantan and de Goede,
               Olivia M and Dermitzakis, Emmanouil T and Einson, Jonah and
               Engelhardt, Barbara E and Eskin, Eleazar and Eulalio, Tiffany Y
               and Ferraro, Nicole M and Flynn, Elise D and Fresard, Laure and
               Gamazon, Eric R and Garrido-Mart{\'\i}n, Diego and Gay, Nicole R
               and Gloudemans, Michael J and Guig{\'o}, Roderic and Hame,
               Andrew R and He, Yuan and Hoffman, Paul J and Hormozdiari,
               Farhad and Hou, Lei and Im, Hae Kyung and Jo, Brian and Kasela,
               Silva and Kellis, Manolis and Kim-Hellmuth, Sarah and Kwong,
               Alan and Lappalainen, Tuuli and Li, Xin and Liang, Yanyu and
               Mangul, Serghei and Mohammadi, Pejman and Montgomery, Stephen B
               and Mu{\~n}oz-Aguirre, Manuel and Nachun, Daniel C and Nobel,
               Andrew B and Oliva, Meritxell and Park, Yoson and Park, Yongjin
               and Parsana, Princy and Rao, Abhiram S and Reverter, Ferran and
               Rouhana, John M and Sabatti, Chiara and Saha, Ashis and
               Stephens, Matthew and Stranger, Barbara E and Strober, Benjamin
               J and Teran, Nicole A and Vi{\~n}uela, Ana and Wang, Gao and
               Wen, Xiaoquan and Wright, Fred and Wucher, Valentin and Zou,
               Yuxin and Ferreira, Pedro G and Li, Gen and Mel{\'e}, Marta and
               Yeger-Lotem, Esti and Barcus, Mary E and Bradbury, Debra and
               Krubit, Tanya and McLean, Jeffrey A and Qi, Liqun and Robinson,
               Karna and Roche, Nancy V and Smith, Anna M and Sobin, Leslie and
               Tabor, David E and Undale, Anita and Bridge, Jason and Brigham,
               Lori E and Foster, Barbara A and Gillard, Bryan M and Hasz,
               Richard and Hunter, Marcus and Johns, Christopher and Johnson,
               Mark and Karasik, Ellen and Kopen, Gene and Leinweber, William F
               and McDonald, Alisa and Moser, Michael T and Myer, Kevin and
               Ramsey, Kimberley D and Roe, Brian and Shad, Saboor and Thomas,
               Jeffrey A and Walters, Gary and Washington, Michael and Wheeler,
               Joseph and Jewell, Scott D and Rohrer, Daniel C and Valley, Dana
               R and Davis, David A and Mash, Deborah C and Branton, Philip A
               and Barker, Laura K and Gardiner, Heather M and Mosavel,
               Maghboeba and Siminoff, Laura A and Flicek, Paul and Haeussler,
               Maximilian and Juettemann, Thomas and Kent, W James and Lee,
               Christopher M and Powell, Conner C and Rosenbloom, Kate R and
               Ruffier, Magali and Sheppard, Dan and Taylor, Kieron and
               Trevanion, Stephen J and Zerbino, Daniel R and Abell, Nathan S
               and Akey, Joshua and Chen, Lin and Demanelis, Kathryn and
               Doherty, Jennifer A and Feinberg, Andrew P and Hansen, Kasper D
               and Hickey, Peter F and Jasmine, Farzana and Jiang, Lihua and
               Kaul, Rajinder and Kibriya, Muhammad G and Li, Jin Billy and Li,
               Qin and Lin, Shin and Linder, Sandra E and Pierce, Brandon L and
               Rizzardi, Lindsay F and Skol, Andrew D and Smith, Kevin S and
               Snyder, Michael and Stamatoyannopoulos, John and Tang, Hua and
               Wang, Meng and Carithers, Latarsha J and Guan, Ping and Koester,
               Susan E and Little, A Roger and Moore, Helen M and Nierras,
               Concepcion R and Rao, Abhi K and Vaught, Jimmie B and Volpi,
               Simona and {GTEx Consortium}",
  abstract  = "Cell type composition, estimated from bulk tissue, maps the
               cellular specificity of genetic variants.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  369,
  number    =  6509,
  pages     = "eaaz8528",
  month     =  sep,
  year      =  2020,
  copyright = "https://www.sciencemag.org/about/science-licenses-journal-article-reuse",
  language  = "en"
}

@ARTICLE{Kilpinen2017-qm,
  title     = "Common genetic variation drives molecular heterogeneity in human
               {iPSCs}",
  author    = "Kilpinen, Helena and Goncalves, Angela and Leha, Andreas and
               Afzal, Vackar and Alasoo, Kaur and Ashford, Sofie and Bala,
               Sendu and Bensaddek, Dalila and Casale, Francesco Paolo and
               Culley, Oliver J and Danecek, Petr and Faulconbridge, Adam and
               Harrison, Peter W and Kathuria, Annie and McCarthy, Davis and
               McCarthy, Shane A and Meleckyte, Ruta and Memari, Yasin and
               Moens, Nathalie and Soares, Filipa and Mann, Alice and Streeter,
               Ian and Agu, Chukwuma A and Alderton, Alex and Nelson, Rachel
               and Harper, Sarah and Patel, Minal and White, Alistair and
               Patel, Sharad R and Clarke, Laura and Halai, Reena and Kirton,
               Christopher M and Kolb-Kokocinski, Anja and Beales, Philip and
               Birney, Ewan and Danovi, Davide and Lamond, Angus I and
               Ouwehand, Willem H and Vallier, Ludovic and Watt, Fiona M and
               Durbin, Richard and Stegle, Oliver and Gaffney, Daniel J",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  546,
  number    =  7658,
  pages     = "370--375",
  month     =  jun,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Li2018-ll,
  title     = "Annotation-free quantification of {RNA} splicing using
               {LeafCutter}",
  author    = "Li, Yang I and Knowles, David A and Humphrey, Jack and Barbeira,
               Alvaro N and Dickinson, Scott P and Im, Hae Kyung and Pritchard,
               Jonathan K",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  1,
  pages     = "151--158",
  month     =  jan,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Liu2018-fh,
  title     = "Alternative splicing analysis in human monocytes and macrophages
               reveals {MBNL1} as major regulator",
  author    = "Liu, Hongfei and Lorenzini, Paolo A and Zhang, Fan and Xu,
               Shaohai and Wong, Mei Su M and Zheng, Jie and Roca, Xavier",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  46,
  number    =  12,
  pages     = "6069--6086",
  month     =  jul,
  year      =  2018,
  copyright = "http://creativecommons.org/licenses/by-nc/4.0/",
  language  = "en"
}

@ARTICLE{Green2020-lf,
  title     = "Macrophage development and activation involve coordinated intron
               retention in key inflammatory regulators",
  author    = "Green, Immanuel D and Pinello, Natalia and Song, Renhua and Lee,
               Quintin and Halstead, James M and Kwok, Chau-To and Wong, Alex C
               H and Nair, Shalima S and Clark, Susan J and Roediger, Ben and
               Schmitz, Ulf and Larance, Mark and Hayashi, Rippei and Rasko,
               John E J and Wong, Justin J-L",
  abstract  = "Monocytes and macrophages are essential components of the innate
               immune system. Herein, we report that intron retention (IR)
               plays an important role in the development and function of these
               cells. Using Illumina mRNA sequencing, Nanopore direct cDNA
               sequencing and proteomics analysis, we identify IR events that
               affect the expression of key genes/proteins involved in
               macrophage development and function. We demonstrate that
               decreased IR in nuclear-detained mRNA is coupled with increased
               expression of genes encoding regulators of macrophage
               transcription, phagocytosis and inflammatory signalling,
               including ID2, IRF7, ENG and LAT. We further show that this
               dynamic IR program persists during the polarisation of resting
               macrophages into activated macrophages. In the presence of
               proinflammatory stimuli, intron-retaining CXCL2 and NFKBIZ
               transcripts are rapidly spliced, enabling timely expression of
               these key inflammatory regulators by macrophages. Our study
               provides novel insights into the molecular factors controlling
               vital regulators of the innate immune response.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  48,
  number    =  12,
  pages     = "6513--6529",
  month     =  jul,
  year      =  2020,
  copyright = "http://creativecommons.org/licenses/by-nc/4.0/",
  language  = "en"
}

@ARTICLE{Stenmark2009-ju,
  title     = "Rab {GTPases} as coordinators of vesicle traffic",
  author    = "Stenmark, Harald",
  abstract  = "Membrane trafficking between organelles by vesiculotubular
               carriers is fundamental to the existence of eukaryotic cells.
               Central in ensuring that cargoes are delivered to their correct
               destinations are the Rab GTPases, a large family of small
               GTPases that control membrane identity and vesicle budding,
               uncoating, motility and fusion through the recruitment of
               effector proteins, such as sorting adaptors, tethering factors,
               kinases, phosphatases and motors. Crosstalk between multiple Rab
               GTPases through shared effectors, or through effectors that
               recruit selective Rab activators, ensures the spatiotemporal
               regulation of vesicle traffic. Functional impairments of Rab
               pathways are associated with diseases, such as
               immunodeficiencies, cancer and neurological disorders.",
  journal   = "Nat. Rev. Mol. Cell Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  8,
  pages     = "513--525",
  month     =  aug,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Yoneyama2005-ba,
  title     = "Shared and unique functions of the {DExD/H-box} helicases
               {RIG-I}, {MDA5}, and {LGP2} in antiviral innate immunity",
  author    = "Yoneyama, Mitsutoshi and Kikuchi, Mika and Matsumoto, Kanae and
               Imaizumi, Tadaatsu and Miyagishi, Makoto and Taira, Kazunari and
               Foy, Eileen and Loo, Yueh-Ming and Gale, Jr, Michael and Akira,
               Shizuo and Yonehara, Shin and Kato, Atsushi and Fujita, Takashi",
  abstract  = "The cellular protein retinoic acid-inducible gene I (RIG-I)
               senses intracellular viral infection and triggers a signal for
               innate antiviral responses including the production of type I
               IFN. RIG-I contains a domain that belongs to a DExD/H-box
               helicase family and exhibits an N-terminal caspase recruitment
               domain (CARD) homology. There are three genes encoding
               RIG-I-related proteins in human and mouse genomes. Melanoma
               differentiation associated gene 5 (MDA5), which consists of CARD
               and a helicase domain, functions as a positive regulator,
               similarly to RIG-I. Both proteins sense viral RNA with a
               helicase domain and transmit a signal downstream by CARD; thus,
               these proteins share overlapping functions. Another protein,
               LGP2, lacks the CARD homology and functions as a negative
               regulator by interfering with the recognition of viral RNA by
               RIG-I and MDA5. The nonstructural protein 3/4A protein of
               hepatitis C virus blocks the signaling by RIG-I and MDA5;
               however, the V protein of the Sendai virus selectively abrogates
               the MDA5 function. These results highlight ingenious mechanisms
               for initiating antiviral innate immune responses and the action
               of virus-encoded inhibitors.",
  journal   = "J. Immunol.",
  publisher = "The American Association of Immunologists",
  volume    =  175,
  number    =  5,
  pages     = "2851--2858",
  month     =  sep,
  year      =  2005,
  language  = "en"
}

@ARTICLE{Kato2005-ie,
  title     = "Cell type-specific involvement of {RIG-I} in antiviral response",
  author    = "Kato, Hiroki and Sato, Shintaro and Yoneyama, Mitsutoshi and
               Yamamoto, Masahiro and Uematsu, Satoshi and Matsui, Kosuke and
               Tsujimura, Tohru and Takeda, Kiyoshi and Fujita, Takashi and
               Takeuchi, Osamu and Akira, Shizuo",
  abstract  = "Toll-like receptors (TLRs) play an important role in antiviral
               response by recognizing viral components. Recently, a RNA
               helicase, RIG-I, was also suggested to recognize viral
               double-stranded RNA. However, how these molecules contribute to
               viral recognition in vivo is poorly understood. We show by gene
               targeting that RIG-I is essential for induction of type I
               interferons (IFNs) after infection with RNA viruses in
               fibroblasts and conventional dendritic cells (DCs). RIG-I
               induces type I IFNs by activating IRF3 via IkappaB
               kinase-related kinases. In contrast, plasmacytoid DCs, which
               produce large amounts of IFN-alpha, use the TLR system rather
               than RIG-I for viral detection. Taken together, RIG-I and the
               TLR system exert antiviral responses in a cell type-specific
               manner.",
  journal   = "Immunity",
  publisher = "Elsevier BV",
  volume    =  23,
  number    =  1,
  pages     = "19--28",
  month     =  jul,
  year      =  2005,
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Castanier2012-io,
  title     = "{MAVS} ubiquitination by the {E3} ligase {TRIM25} and
               degradation by the proteasome is involved in type {I} interferon
               production after activation of the antiviral {RIG-I-like}
               receptors",
  author    = "Castanier, C{\'e}line and Zemirli, Naima and Portier, Alain and
               Garcin, Dominique and Bid{\`e}re, Nicolas and Vazquez, Aim{\'e}
               and Arnoult, Damien",
  abstract  = "BACKGROUND: During a viral infection, the intracellular
               RIG-I-like receptors (RLRs) sense viral RNA and signal through
               the mitochondrial antiviral signaling adaptor MAVS (also known
               as IPS-1, Cardif and VISA) whose activation triggers a rapid
               production of type I interferons (IFN) and of pro-inflammatory
               cytokines through the transcription factors IRF3/IRF7 and
               NF-$\kappa$B, respectively. While MAVS is essential for this
               signaling and known to operate through the scaffold protein NEMO
               and the protein kinase TBK1 that phosphorylates IRF3, its
               mechanism of action and regulation remain unclear. RESULTS: We
               report here that RLR activation triggers MAVS ubiquitination on
               lysine 7 and 10 by the E3 ubiquitin ligase TRIM25 and marks it
               for proteasomal degradation concomitantly with downstream
               signaling. Inhibition of this MAVS degradation with a proteasome
               inhibitor does not affect NF-$\kappa$B signaling but it hampers
               IRF3 activation, and NEMO and TBK1, two essential mediators in
               type I IFN production, are retained at the mitochondria.
               CONCLUSIONS: These results suggest that MAVS functions as a
               recruitment platform that assembles a signaling complex
               involving NEMO and TBK1, and that the proteasome-mediated MAVS
               degradation is required to release the signaling complex into
               the cytosol, allowing IRF3 phosphorylation by TBK1.",
  journal   = "BMC Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  1,
  pages     = "44",
  month     =  may,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Al_Hamrashdi2022-pr,
  title     = "Regulation of {IRF3} activation in human antiviral signaling
               pathways",
  author    = "Al Hamrashdi, Mariya and Brady, Gareth",
  abstract  = "The interferon regulatory factor (IRF) family of transcription
               factors play a vital role in the human innate antiviral immune
               responses with production of interferons (IFNs) as a hallmark
               outcome of activation. In recent years, IRF3 has been considered
               a principal early regulator of type I IFNs (TI-IFNs) directly
               downstream of intracellular virus sensing. Despite decades of
               research on IRF-activating pathways, many questions remain on
               the regulation of IRF3 activation. The kinases I$\kappa$B kinase
               epsilon (IKK$\epsilon$) and TANK-binding kinase-1 (TBK1) and the
               scaffold proteins TRAF family member-associated NF-kappa-B
               activator (TANK), NF-kappa-B-activating kinase-associated
               protein 1 (NAP1) and TANK-binding kinase 1-binding protein 1
               (TBKBP1)/similar to NAP1 TBK1 adaptor (SINTBAD) are believed to
               be core components of an IRF3-activation complex yet their
               contextual involvement and complex composition are still
               unclear. This review will give an overview of antiviral
               signaling pathways leading to the activation of IRF3 and discuss
               recent developments in our understanding of its proximal
               regulation.",
  journal   = "Biochem. Pharmacol.",
  publisher = "Elsevier BV",
  volume    =  200,
  number    =  115026,
  pages     = "115026",
  month     =  jun,
  year      =  2022,
  keywords  = "IKK$\epsilon$; IRF3; NAP1; TANK; TBK1; TBKBP1",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Saleh2017-fv,
  title     = "Kinase activities of {RIPK1} and {RIPK3} can direct
               {IFN-$\beta$} synthesis induced by lipopolysaccharide",
  author    = "Saleh, Danish and Najjar, Malek and Zelic, Matija and Shah,
               Saumil and Nogusa, Shoko and Polykratis, Apostolos and Paczosa,
               Michelle K and Gough, Peter J and Bertin, John and Whalen,
               Michael and Fitzgerald, Katherine A and Slavov, Nikolai and
               Pasparakis, Manolis and Balachandran, Siddharth and Kelliher,
               Michelle and Mecsas, Joan and Degterev, Alexei",
  abstract  = "The innate immune response is a central element of the initial
               defense against bacterial and viral pathogens. Macrophages are
               key innate immune cells that upon encountering
               pathogen-associated molecular patterns respond by producing
               cytokines, including IFN-$\beta$. In this study, we identify a
               novel role for RIPK1 and RIPK3, a pair of homologous
               serine/threonine kinases previously implicated in the regulation
               of necroptosis and pathologic tissue injury, in directing
               IFN-$\beta$ production in macrophages. Using genetic and
               pharmacologic tools, we show that catalytic activity of RIPK1
               directs IFN-$\beta$ synthesis induced by LPS in mice.
               Additionally, we report that RIPK1 kinase-dependent IFN-$\beta$
               production may be elicited in an analogous fashion using LPS in
               bone marrow-derived macrophages upon inhibition of caspases.
               Notably, this regulation requires kinase activities of both
               RIPK1 and RIPK3, but not the necroptosis effector protein, MLKL.
               Mechanistically, we provide evidence that necrosome-like RIPK1
               and RIPK3 aggregates facilitate canonical TRIF-dependent
               IFN-$\beta$ production downstream of the LPS receptor TLR4.
               Intriguingly, we also show that RIPK1 and RIPK3 kinase-dependent
               synthesis of IFN-$\beta$ is markedly induced by avirulent
               strains of Gram-negative bacteria, Yersinia and Klebsiella, and
               less so by their wild-type counterparts. Overall, these
               observations identify unexpected roles for RIPK1 and RIPK3
               kinases in the production of IFN-$\beta$ during the host
               inflammatory responses to bacterial infection and suggest that
               the axis in which these kinases operate may represent a target
               for bacterial virulence factors.",
  journal   = "J. Immunol.",
  publisher = "The American Association of Immunologists",
  volume    =  198,
  number    =  11,
  pages     = "4435--4447",
  month     =  jun,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Gack2009-nw,
  title     = "Influenza A virus {NS1} targets the ubiquitin ligase {TRIM25} to
               evade recognition by the host viral {RNA} sensor {RIG-I}",
  author    = "Gack, Michaela Ulrike and Albrecht, Randy Allen and Urano,
               Tomohiko and Inn, Kyung-Soo and Huang, I-Chueh and Carnero,
               Elena and Farzan, Michael and Inoue, Satoshi and Jung, Jae Ung
               and Garc{\'\i}a-Sastre, Adolfo",
  journal   = "Cell Host Microbe",
  publisher = "Elsevier BV",
  volume    =  5,
  number    =  5,
  pages     = "439--449",
  month     =  may,
  year      =  2009,
  copyright = "https://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Liao2021-aj,
  title     = "Role of alternative splicing in regulating host response to
               viral infection",
  author    = "Liao, Kuo-Chieh and Garcia-Blanco, Mariano A",
  abstract  = "The importance of transcriptional regulation of host genes in
               innate immunity against viral infection has been widely
               recognized. More recently, post-transcriptional regulatory
               mechanisms have gained appreciation as an additional and
               important layer of regulation to fine-tune host immune
               responses. Here, we review the functional significance of
               alternative splicing in innate immune responses to viral
               infection. We describe how several central components of the
               Type I and III interferon pathways encode spliced isoforms to
               regulate IFN activation and function. Additionally, the
               functional roles of splicing factors and modulators in antiviral
               immunity are discussed. Lastly, we discuss how cell death
               pathways are regulated by alternative splicing as well as the
               potential role of this regulation on host immunity and viral
               infection. Altogether, these studies highlight the importance of
               RNA splicing in regulating host-virus interactions and suggest a
               role in downregulating antiviral innate immunity; this may be
               critical to prevent pathological inflammation.",
  journal   = "Cells",
  publisher = "MDPI AG",
  volume    =  10,
  number    =  7,
  pages     = "1720",
  month     =  jul,
  year      =  2021,
  keywords  = "alternative splicing; antiviral response; cell death pathways;
               innate immunity",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Lad2008-jd,
  title     = "Identification of {MAVS} splicing variants that interfere with
               {RIGI/MAVS} pathway signaling",
  author    = "Lad, Sonya P and Yang, Guang and Scott, David A and Chao,
               Ta-Hsiang and Correia, Jean da Silva and de la Torre, Juan
               Carlos and Li, Erguang",
  abstract  = "The mitochondrial anti-viral signaling protein (MAVS), also
               known as CARDIF, IPS-1, KIAA1271 and VISA, is a mitochondria
               associated protein that regulates type I interferon production
               through coordinated activation of NF-kappaB and IRF3. The
               N-terminal CARD domain of MAVS interacts with RIGI helicase of
               upcapped RNA detection and the putative TRAF2 and TRAF6 binding
               motifs modulate protein interaction for NF-kappaB activation.
               MAVS is encoded by a single gene composed of 6 exons but is
               generally detected as multiple protein bands after separation by
               SDS-PAGE. In an effort to identify MAVS variants with diverse
               biological functions, we isolated three splicing variants and
               named them MAVS 1a (exon 2 deletion), 1b (exon 3 deletion) and
               1c (exon 6 deletion), respectively. MAVS 1a and 1b, due to a
               frame shift by exon deletion, encode 131 and 124 aa residues,
               respectively. Except the first 39 aa residues encoded by exon 1,
               MAVS 1a does not share sequence homology with known proteins, it
               instead contains a putative TRAF2-binding motif and interacts
               with TRAF2 and RIP1. MAVS 1b shares the first 97 residues with
               wt MAVS and 27 aa residues of unknown protein. Unlike MAVS that
               activates both NF-kappaB and IRF3 pathways, expression of MAVS
               1b selectively activates an IFNbeta but not an IL8 promoter.
               MAVS 1b interacts with RIP1 and FADD and exhibits anti-viral
               activity against VSV infection. This study uncovers MAVS
               splicing variants of diverse biological function.",
  journal   = "Mol. Immunol.",
  publisher = "Elsevier BV",
  volume    =  45,
  number    =  8,
  pages     = "2277--2287",
  month     =  apr,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Wagner2021-fl,
  title     = "Global transcriptomics uncovers distinct contributions from
               splicing regulatory proteins to the macrophage innate immune
               response",
  author    = "Wagner, Allison R and Scott, Haley M and West, Kelsi O and Vail,
               Krystal J and Fitzsimons, Timothy C and Coleman, Aja K and
               Carter, Kaitlyn E and Watson, Robert O and Patrick, Kristin L",
  abstract  = "Pathogen sensing via pattern recognition receptors triggers
               massive reprogramming of macrophage gene expression. While the
               signaling cascades and transcription factors that activate these
               responses are well-known, the role of post-transcriptional RNA
               processing in modulating innate immune gene expression remains
               understudied. Given their crucial role in regulating pre-mRNA
               splicing and other RNA processing steps, we hypothesized that
               members of the SR/hnRNP protein families regulate innate immune
               gene expression in distinct ways. We analyzed steady state gene
               expression and alternatively spliced isoform production in ten
               SR/hnRNP knockdown RAW 264.7 macrophage-like cell lines
               following infection with the bacterial pathogen Salmonella
               enterica serovar Typhimurium (Salmonella). We identified
               thousands of transcripts whose abundance is increased or
               decreased by SR/hnRNP knockdown in macrophages. Notably, we
               observed that SR and hnRNP proteins influence expression of
               different genes in uninfected versus Salmonella-infected
               macrophages, suggesting functionalization of these proteins upon
               pathogen sensing. Likewise, we found that knockdown of SR/hnRNPs
               promoted differential isoform usage (DIU) for thousands of
               macrophage transcripts and that these alternative splicing
               changes were distinct in uninfected and Salmonella-infected
               macrophages. Finally, having observed a surprising degree of
               similarity between the differentially expressed genes (DEGs) and
               DIUs in hnRNP K and U knockdown macrophages, we found that hnRNP
               K and U knockdown macrophages are both more restrictive to
               Vesicular Stomatitis Virus (VSV), while hnRNP K knockdown
               macrophages are more permissive to Salmonella Typhimurium. Based
               on these findings, we conclude that many innate immune genes
               evolved to rely on one or more SR/hnRNPs to ensure the proper
               magnitude of their induction, supporting a model wherein
               pre-mRNA splicing is critical for regulating innate immune gene
               expression and controlling infection outcomes in macrophages ex
               vivo.",
  journal   = "Front. Immunol.",
  publisher = "Frontiers Media SA",
  volume    =  12,
  pages     = "656885",
  month     =  jul,
  year      =  2021,
  keywords  = "RNA binding protein; SR protein; Salmonella Typhimurium; hnRNP;
               inflammation; pre-mRNA splicing",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Urbut2019-gf,
  title     = "Flexible statistical methods for estimating and testing effects
               in genomic studies with multiple conditions",
  author    = "Urbut, Sarah M and Wang, Gao and Carbonetto, Peter and Stephens,
               Matthew",
  abstract  = "We introduce new statistical methods for analyzing genomic data
               sets that measure many effects in many conditions (for example,
               gene expression changes under many treatments). These new
               methods improve on existing methods by allowing for arbitrary
               correlations in effect sizes among conditions. This flexible
               approach increases power, improves effect estimates and allows
               for more quantitative assessments of effect-size heterogeneity
               compared to simple shared or condition-specific assessments. We
               illustrate these features through an analysis of locally acting
               variants associated with gene expression (cis expression
               quantitative trait loci (eQTLs)) in 44 human tissues. Our
               analysis identifies more eQTLs than existing approaches,
               consistent with improved power. We show that although genetic
               effects on expression are extensively shared among tissues,
               effect sizes can still vary greatly among tissues. Some shared
               eQTLs show stronger effects in subsets of biologically related
               tissues (for example, brain-related tissues), or in only one
               tissue (for example, testis). Our methods are widely applicable,
               computationally tractable for many conditions and available
               online.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  51,
  number    =  1,
  pages     = "187--195",
  month     =  jan,
  year      =  2019,
  language  = "en"
}



%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% PCD chapter: pcd prevalence
@ARTICLE{Grotzinger2019-bt,
  title     = "Genomic structural equation modelling provides insights into the
               multivariate genetic architecture of complex traits",
  author    = "Grotzinger, Andrew D and Rhemtulla, Mijke and de Vlaming, Ronald
               and Ritchie, Stuart J and Mallard, Travis T and Hill, W David
               and Ip, Hill F and Marioni, Riccardo E and McIntosh, Andrew M
               and Deary, Ian J and Koellinger, Philipp D and Harden, K Paige
               and Nivard, Michel G and Tucker-Drob, Elliot M",
  abstract  = "Genetic correlations estimated from genome-wide association
               studies (GWASs) reveal pervasive pleiotropy across a wide
               variety of phenotypes. We introduce genomic structural equation
               modelling (genomic SEM): a multivariate method for analysing the
               joint genetic architecture of complex traits. Genomic SEM
               synthesizes genetic correlations and single-nucleotide
               polymorphism heritabilities inferred from GWAS summary
               statistics of individual traits from samples with varying and
               unknown degrees of overlap. Genomic SEM can be used to model
               multivariate genetic associations among phenotypes, identify
               variants with effects on general dimensions of cross-trait
               liability, calculate more predictive polygenic scores and
               identify loci that cause divergence between traits. We
               demonstrate several applications of genomic SEM, including a
               joint analysis of summary statistics from five psychiatric
               traits. We identify 27 independent single-nucleotide
               polymorphisms not previously identified in the contributing
               univariate GWASs. Polygenic scores from genomic SEM consistently
               outperform those from univariate GWASs. Genomic SEM is flexible
               and open ended, and allows for continuous innovation in
               multivariate genetic analysis.",
  journal   = "Nat. Hum. Behav.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  3,
  number    =  5,
  pages     = "513--525",
  month     =  may,
  year      =  2019,
  copyright = "https://www.springernature.com/gp/researchers/text-and-data-mining",
  language  = "en"
}

@ARTICLE{Klimenta2019-be,
  title     = "Association of biomarkers of inflammation and {HLA-DRB1} gene
               locus with risk of developing rheumatoid arthritis in females",
  author    = "Klimenta, Biljana and Nefic, Hilada and Prodanovic, Nenad and
               Jadric, Radivoj and Hukic, Fatima",
  abstract  = "Rheumatoid arthritis (RA) is an autoimmune disease causing
               chronic inflammation of the joints. Multiple factors, including
               HLA-DRB1 gene variants, influence the susceptibility to RA. The
               HLA-DRB1 gene is part of a family of genes called the human
               leukocyte antigen (HLA) complex. In this study, we compared the
               inflammatory biomarkers values, including erythrocyte
               sedimentation rate (ESR) and C-reactive protein (CRP), between
               patients with RA and healthy control group of females of the
               Public Institution Health Centre of Sarajevo Canton. In
               addition, we estimated the frequencies of the HLA-DRB1 gene
               variants and their association with the risk for RA development
               in females. The haematological and biochemical tests were
               completed on automated analyzers. To assess the association
               between the HLA-DRB genes and the risk of RA in females,
               low-resolution genotyping of the HLA-DRB1, DRB3, DRB4, and DRB5
               gene loci was performed by the sequence-specific polymerase
               chain reaction method (PCR-SSP). ESR and CRP were the most
               sensitive acute-phase reactants in females with RA and there was
               a correlation between ESR and CRP values in RA patients. There
               was significantly positive association between of the
               HLA-DRB1*03, *04, *08, *10, *11, and *14 variants and elevated
               values of ESR in RA patients, but negative between HLA-DRB1*03,
               *13 and *15 alleles and elevated CRP values. Furthermore, our
               results confirm genetic susceptibility to RA in a female
               population to the members of the HLA-DRB1*04 and *03 allelic
               groups, the DRB1*04/DRB1*04 and DRB1*03/DRB1*04 genotypes, and
               the DRB1*04-DRB4* or DRB1*03-DRB3* haplotypes, which, therefore,
               represent risk factors for the development of this disease.
               According to our results, the DRB1*01/DRB1*15 and
               DRB1*07/DRB1*16 genotypes and the HLA-DRB5 gene locus represent
               a protective factor for RA. The presence of specific HLA-DRB1
               gene variants increases the risk of developing RA, while other
               variants provide protection against disease. Therefore, HLA
               typing could be helpful in the prediction of RA development and
               establishing and confirming a definitive diagnosis of autoimmune
               diseases in some subjects. A strong association with the higher
               levels of ESR and CRP could be used to establish definitive
               diagnosis and introduce of early treatment of RA to prevent the
               occurrence of RA symptoms.",
  journal   = "Rheumatol. Int.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  39,
  number    =  12,
  pages     = "2147--2157",
  month     =  dec,
  year      =  2019,
  keywords  = "C-reactive protein (CRP); Erythrocyte sedimentation rate (ESR);
               HLA-DRB1 gene; Rheumatoid arthritis (RA)",
  language  = "en"
}

@ARTICLE{Cleynen2016-ha,
  title     = "Inherited determinants of Crohn's disease and ulcerative colitis
               phenotypes: a genetic association study",
  author    = "Cleynen, Isabelle and Boucher, Gabrielle and Jostins, Luke and
               Schumm, L Philip and Zeissig, Sebastian and Ahmad, Tariq and
               Andersen, Vibeke and Andrews, Jane M and Annese, Vito and Brand,
               Stephan and Brant, Steven R and Cho, Judy H and Daly, Mark J and
               Dubinsky, Marla and Duerr, Richard H and Ferguson, Lynnette R
               and Franke, Andre and Gearry, Richard B and Goyette, Philippe
               and Hakonarson, Hakon and Halfvarson, Jonas and Hov, Johannes R
               and Huang, Hailang and Kennedy, Nicholas A and Kupcinskas, Limas
               and Lawrance, Ian C and Lee, James C and Satsangi, Jack and
               Schreiber, Stephan and Th{\'e}{\^a}tre, Emilie and van der
               Meulen-de Jong, Andrea E and Weersma, Rinse K and Wilson, David
               C and Parkes, Miles and Vermeire, Severine and Rioux, John D and
               Mansfield, John and Silverberg, Mark S and Radford-Smith, Graham
               and McGovern, Dermot P B and Barrett, Jeffrey C and Lees,
               Charlie W",
  journal   = "Lancet",
  publisher = "Elsevier BV",
  volume    =  387,
  number    =  10014,
  pages     = "156--167",
  month     =  jan,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Goyette2015-xx,
  title     = "High-density mapping of the {MHC} identifies a shared role for
               {HLA-DRB1*01:03} in inflammatory bowel diseases and heterozygous
               advantage in ulcerative colitis",
  author    = "Goyette, Philippe and {International Inflammatory Bowel Disease
               Genetics Consortium} and Boucher, Gabrielle and Mallon, Dermot
               and Ellinghaus, Eva and Jostins, Luke and Huang, Hailiang and
               Ripke, Stephan and Gusareva, Elena S and Annese, Vito and
               Hauser, Stephen L and Oksenberg, Jorge R and Thomsen, Ingo and
               Leslie, Stephen and Daly, Mark J and Van Steen, Kristel and
               Duerr, Richard H and Barrett, Jeffrey C and McGovern, Dermot P B
               and Schumm, L Philip and Traherne, James A and Carrington, Mary
               N and Kosmoliaptsis, Vasilis and Karlsen, Tom H and Franke,
               Andre and Rioux, John D",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  47,
  number    =  2,
  pages     = "172--179",
  month     =  feb,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Goring2009-cs,
  title     = "Mechanisms of human complement factor {B} induction in sepsis
               and inhibition by activated protein {C}",
  author    = "Goring, Kim and Huang, Yong and Mowat, Connie and L{\'e}ger,
               Caroline and Lim, Teik-How and Zaheer, Raza and Mok, Dereck and
               Tibbles, Lee Anne and Zygun, David and Winston, Brent W",
  abstract  = "To investigate the potential role of the local expression of
               alternative complement factor B (hBf) in human sepsis, we
               examined the induction of Bf gene expression in human peripheral
               blood monocytes (PBMCs) from patients with septic shock and the
               mechanisms of hBf gene regulation by tumor necrosis factor
               (TNF)-alpha, interferon (IFN)-gamma, and lipopolysaccharide
               (LPS) in human monocytes. PBMCs from septic shock patients
               showed increased hBf mRNA expression when compared with control
               patients. Costimulation with TNF-alpha and IFN-gamma or
               stimulation with LPS demonstrated a time- and dose-dependent
               induction of hBf mRNA expression in human PBMCs. A region of the
               hBf promoter between -735 and +128 bp was found to mediate
               IFN-gamma, TNF-alpha, and LPS responsiveness as well as the
               synergistic effect of IFN-gamma/TNF-alpha on hBf promoter
               activity. Site-directed mutagenesis of a IFN-gamma-activation
               site (GAS) cis element (-90 to -82 bp) abrogated IFN-gamma
               responsiveness. Mutagenesis of a nuclear factor (NF)-kappaB cis
               element at -466 to -456 bp abrogated TNF-alpha and LPS
               responsiveness of the Bf promoter. Thus hBf gene expression is
               induced in PBMCs from septic shock patients, and the induction
               of hBf by IFN-gamma, TNF-alpha, and LPS is through GAS and
               NF-kappaB cis-binding sites on the hBf promoter. Furthermore,
               activated protein C (APC) inhibited LPS-stimulated hBf promoter
               activity and protein expression in human monocytes suggesting
               that the beneficial effect of APC therapy in sepsis may in part
               be due to inhibition of complement induction and/or activation
               via the alternative pathway.",
  journal   = "Am. J. Physiol. Cell Physiol.",
  publisher = "American Physiological Society",
  volume    =  296,
  number    =  5,
  pages     = "C1140--50",
  month     =  may,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Huang2002-of,
  title     = "Complement factor {B} gene regulation: synergistic effects of
               {TNF-alpha} and {IFN-gamma} in macrophages",
  author    = "Huang, Yong and Krein, Peter M and Muruve, Daniel A and Winston,
               Brent W",
  abstract  = "Complement factor B (Bf) plays an important role in activating
               the alternative complement pathway. The inflammatory cytokines,
               in particular TNF-alpha and IFN-gamma, are critical in the
               regulation of Bf gene expression in macrophages. In this study,
               we investigated the mechanisms of Bf gene regulation by
               TNF-alpha and IFN-gamma in murine macrophages. Northern analysis
               revealed that Bf mRNA expression was synergistically
               up-regulated by TNF-alpha and IFN-gamma in MH-S cells.
               Truncations of the 5' Bf promoter identified a region between
               -556 and -282 bp that mediated TNF-alpha responsiveness as well
               as the synergistic effect of TNF-alpha and IFN-gamma on Bf
               expression. Site-directed mutagenesis of a NF-kappaB-binding
               element in this region (-433 to -423 bp) abrogated TNF-alpha
               responsiveness and decreased the synergistic effect of TNF-alpha
               and IFN-gamma on Bf expression. EMSAs revealed nuclear protein
               binding to this NF-kappaB cis-binding element on TNF-alpha
               stimulation. Supershift analysis revealed that both p50 and p65
               proteins contribute to induction of Bf by TNF-alpha. An I-kappaB
               dominant negative mutant blocked Bf induction by TNF-alpha and
               reduced the synergistic induction by TNF-alpha and IFN-gamma. In
               addition, the proteasome inhibitor MG132, which blocks NF-kappaB
               induction, blocked TNF-alpha-induced Bf promoter activity and
               the synergistic induction of Bf promoter activity by TNF-alpha
               and IFN-gamma. LPS was found to induce Bf promoter activity
               through the same NF-kappaB cis-binding site. These findings
               suggest that a NF-kappaB cis-binding site between -433 and -423
               bp is required for TNF-alpha responsiveness and for TNF-alpha-
               and IFN-gamma-stimulated synergistic responsiveness of the Bf
               gene.",
  journal   = "J. Immunol.",
  publisher = "The American Association of Immunologists",
  volume    =  169,
  number    =  5,
  pages     = "2627--2635",
  month     =  sep,
  year      =  2002,
  language  = "en"
}

@ARTICLE{Seif2017-bk,
  title     = "The role of {JAK-STAT} signaling pathway and its regulators in
               the fate of {T} helper cells",
  author    = "Seif, Farhad and Khoshmirsafa, Majid and Aazami, Hossein and
               Mohsenzadegan, Monireh and Sedighi, Gholamreza and Bahar,
               Mohammadali",
  journal   = "Cell Commun. Signal.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  15,
  number    =  1,
  month     =  dec,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Hu2021-us,
  title     = "The {JAK/STAT} signaling pathway: from bench to clinic",
  author    = "Hu, Xiaoyi and Li, Jing and Fu, Maorong and Zhao, Xia and Wang,
               Wei",
  abstract  = "The Janus kinase/signal transducer and activator of
               transcription (JAK/STAT) signaling pathway was discovered more
               than a quarter-century ago. As a fulcrum of many vital cellular
               processes, the JAK/STAT pathway constitutes a rapid
               membrane-to-nucleus signaling module and induces the expression
               of various critical mediators of cancer and inflammation.
               Growing evidence suggests that dysregulation of the JAK/STAT
               pathway is associated with various cancers and autoimmune
               diseases. In this review, we discuss the current knowledge about
               the composition, activation, and regulation of the JAK/STAT
               pathway. Moreover, we highlight the role of the JAK/STAT pathway
               and its inhibitors in various diseases.",
  journal   = "Signal Transduct. Target. Ther.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  6,
  number    =  1,
  pages     = "402",
  month     =  nov,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Cano-Gamez2020-nm,
  title     = "From {GWAS} to function: Using functional genomics to identify
               the mechanisms underlying complex diseases",
  author    = "Cano-Gamez, Eddie and Trynka, Gosia",
  abstract  = "Genome-wide association studies (GWAS) have successfully mapped
               thousands of loci associated with complex traits. These
               associations could reveal the molecular mechanisms altered in
               common complex diseases and result in the identification of
               novel drug targets. However, GWAS have also left a number of
               outstanding questions. In particular, the majority of
               disease-associated loci lie in non-coding regions of the genome
               and, even though they are thought to play a role in gene
               expression regulation, it is unclear which genes they regulate
               and in which cell types or physiological contexts this
               regulation occurs. This has hindered the translation of GWAS
               findings into clinical interventions. In this review we
               summarize how these challenges have been addressed over the last
               decade, with a particular focus on the integration of GWAS
               results with functional genomics datasets. Firstly, we
               investigate how the tissues and cell types involved in diseases
               can be identified using methods that test for enrichment of GWAS
               variants in genomic annotations. Secondly, we explore how to
               find the genes regulated by GWAS loci using methods that test
               for colocalization of GWAS signals with molecular phenotypes
               such as quantitative trait loci (QTLs). Finally, we highlight
               potential future research avenues such as integrating GWAS
               results with single-cell sequencing read-outs, designing
               functionally informed polygenic risk scores (PRS), and
               validating disease associated genes using genetic engineering.
               These tools will be crucial to identify new drug targets for
               common complex diseases.",
  journal   = "Front. Genet.",
  publisher = "Frontiers Media SA",
  volume    =  11,
  pages     = "424",
  month     =  may,
  year      =  2020,
  keywords  = "GWAS; QTL; SNP enrichment; TWAS; colocalization analysis; eQTL;
               single-cell RNA seq",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}


@ARTICLE{Schwartz2022-zp,
  title     = "Efficacy and safety of 2 vedolizumab intravenous regimens for
               perianal fistulizing Crohn's disease: {ENTERPRISE} study",
  author    = "Schwartz, David A and Peyrin-Biroulet, Laurent and Lasch, Karen
               and Adsul, Shashi and Danese, Silvio",
  abstract  = "BACKGROUND \& AIMS: Fistulizing Crohn's disease (CD) is
               challenging to treat. We report results from ENTERPRISE, a
               randomized, double-blind, phase 4 trial evaluating 2 vedolizumab
               intravenous dosing regimens in patients with fistulizing CD.
               METHODS: Patients with moderately to severely active CD and 1-3
               active perianal fistulae (identified on magnetic resonance
               imaging [MRI]) received vedolizumab 300 mg intravenously at
               weeks 0, 2, 6, 14, and 22 (VDZ) or the same regimen plus an
               additional vedolizumab dose at week 10 (VDZ + wk10). Reduction
               from baseline in draining perianal fistulae and disease
               activity, MRI assessments, health-related quality of life
               (HRQoL), and safety were evaluated. Enrollment was stopped
               prematurely because of recruitment challenges; analyses are
               descriptive. RESULTS: Of 32 patients with $\geq$1 active
               fistulae at baseline per MRI and postbaseline fistulae healing
               assessment, 28 (14 per dosing regimen) had $\geq$1 draining
               fistulae at baseline (assessed by gentle finger compression
               during clinical exam). Rapid and sustained fistula closure was
               observed; 53.6\% (VDZ, 64.3\%; VDZ + wk10, 42.9\%) and 42.9\%
               (VDZ, 50.0\%; VDZ + wk10, 35.7\%) of patients achieved
               $\geq$50\% decrease in draining fistulae and 100\% fistulae
               closure, respectively, at week 30. Mean (standard deviation) CD
               and Perianal Disease Activity Index scores decreased by 51.1
               (78.3) and 4.1 (3.3), respectively, at week 30. HRQoL improved
               throughout the study. No new safety signals were observed.
               CONCLUSIONS: Sustained improvements in fistulizing CD were seen
               with both vedolizumab regimens. An additional dose at week 10
               does not appear to alter treatment outcomes. Safety profile was
               consistent with other vedolizumab studies. CLINICALTRIALS: gov
               no: NCT02630966; EudraCT: 2015-000852-12.",
  journal   = "Clin. Gastroenterol. Hepatol.",
  publisher = "Elsevier BV",
  volume    =  20,
  number    =  5,
  pages     = "1059--1067.e9",
  month     =  may,
  year      =  2022,
  keywords  = "Crohn's Disease; Fistula; Fistulae Closure; Vedolizumab",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Bataille2004-vf,
  title     = "Morphological characterisation of Crohn's disease fistulae",
  author    = "Bataille, F and Klebl, F and R{\"u}mmele, P and Schroeder, J and
               Farkas, S and Wild, P-J and F{\"u}rst, A and Hofst{\"a}dter, F
               and Sch{\"o}lmerich, J and Herfarth, H and Rogler, G",
  abstract  = "BACKGROUND: Fistulae are a common complication in up to 35\% of
               all patients with Crohn's disease. Their therapy is difficult
               and frequently unsatisfactory. To date, no histological
               comparison of Crohn's disease fistulae with non-inflammatory
               bowel disease fistulae has been performed. In addition, Crohn's
               disease fistulae have not been well characterised
               morphologically. METHODS: Eighty four fistulae from Crohn's
               disease patients were compared with 13 fistulae from controls.
               Haematoxylin-eosin staining, electron microscopy, and
               immunohistochemistry for panCytokeratin (epithelial cells), CD20
               (B cells), CD45R0 (T cells), and CD68 (macrophages) were
               performed according to standard techniques. In addition,
               histopathological findings were compared with clinical and
               laboratory data. RESULTS: In 31.0\% of controls and 27.4\% of
               Crohn's disease specimens, fistulae had a lining of flattened
               intestinal epithelium without goblet cells or, in the case of
               cutaneous/perianal disease, narrow squamous epithelium.
               Non-epithelialised fistulae were covered by a thin layer of
               (myo)fibroblasts, focally forming a new basement membrane, as
               demonstrated by electron microscopy. All fistulae were
               surrounded by granulation tissue. Crohn's disease fistulae
               presented with central infiltration by CD45R0+ T cells, followed
               by a small band of CD68+ macrophages and dense accumulation of
               CD20+ B cells. In contrast, in controls, there was dense
               infiltration by CD68+ macrophages with only few CD20+ B cells
               and CD45R0+ T lymphocytes. CONCLUSIONS: Fistulae in Crohn's
               disease differ markedly from non-Crohn's disease fistulae with
               regard to their cellular composition. The presence of an
               epithelial lining in a subgroup of fistulae may be important for
               the therapeutic approach and healing process.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  53,
  number    =  9,
  pages     = "1314--1321",
  month     =  sep,
  year      =  2004,
  language  = "en"
}

@ARTICLE{Kalluri2009-uu,
  title     = "The basics of epithelial-mesenchymal transition",
  author    = "Kalluri, Raghu and Weinberg, Robert A",
  abstract  = "The origins of the mesenchymal cells participating in tissue
               repair and pathological processes, notably tissue fibrosis,
               tumor invasiveness, and metastasis, are poorly understood.
               However, emerging evidence suggests that epithelial-mesenchymal
               transitions (EMTs) represent one important source of these
               cells. As we discuss here, processes similar to the EMTs
               associated with embryo implantation, embryogenesis, and organ
               development are appropriated and subverted by chronically
               inflamed tissues and neoplasias. The identification of the
               signaling pathways that lead to activation of EMT programs
               during these disease processes is providing new insights into
               the plasticity of cellular phenotypes and possible therapeutic
               interventions.",
  journal   = "J. Clin. Invest.",
  publisher = "American Society for Clinical Investigation",
  volume    =  119,
  number    =  6,
  pages     = "1420--1428",
  month     =  jun,
  year      =  2009,
  language  = "en"
}


@ARTICLE{Bataille2008-ej,
  title     = "Evidence for a role of epithelial mesenchymal transition during
               pathogenesis of fistulae in Crohn's disease",
  author    = "Bataille, Frauke and Rohrmeier, Christian and Bates, Richard and
               Weber, Achim and Rieder, Florian and Brenmoehl, Julia and
               Strauch, Ulrike and Farkas, Stefan and F{\"u}rst, Alois and
               Hofst{\"a}dter, Ferdinand and Sch{\"o}lmerich, J{\"u}rgen and
               Herfarth, Hans and Rogler, Gerhard",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  14,
  number    =  11,
  pages     = "1514--1527",
  month     =  nov,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Wang2022-hk,
  title     = "High resolution {HLA-DRB1} analysis and shared molecular amino
               acid signature of {DR$\beta$1} molecules in Occult hepatitis {B}
               infection",
  author    = "Wang, Tianju and Shen, Chunmei and Li, Hengxin and Chen, Liping
               and Liu, Sheng and Qi, Jun",
  abstract  = "AIM: To investigate the association of human leukocyte antigen
               (HLA)-DRB1 alleles and the variations of polymorphic amino acid
               changes in DR$\beta$1 chain in Shaanxi Han population with
               Occult hepatitis B infection (OBI). METHODS: High-resolution
               HLA-DRB1 genotyping was performed in 107 OBI carriers and 280
               normal controls. Sequence information was used to assign which
               amino acids were encoded at all polymorphic positions.
               Three-dimensional modeling was performed to explore the effect
               of the key residues on the HLA-DRB1 molecule. RESULTS: Strong
               susceptible association for allele DRB1*07:01 was observed in
               OBI carriers. The amino acid variation at HLA-DR$\beta$1
               molecule revealed susceptible associations for residues
               Gln4$\beta$, Val57$\beta$(P9), Ser60$\beta$(P9) and
               Val78$\beta$(P4), the amino acids Arg4$\beta$, Asp57$\beta$(P9),
               Tyr60$\beta$(P9) and Tyr78$\beta$(P4) showed protective
               associations. CONCLUSION: Alleles DRB1*07:01 showed strong
               susceptible associations in OBI carriers. The amino acid
               variations in DR$\beta$ molecules revealed significant molecular
               markers for susceptibility and protection from OBI in Shaanxi
               Han population.",
  journal   = "BMC Immunol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  23,
  number    =  1,
  pages     = "22",
  month     =  apr,
  year      =  2022,
  keywords  = "Amino acid variation; Human leukocyte antigen; Occult hepatitis
               B infection; Peptide binding pockets",
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Present1999-gj,
  title     = "Infliximab for the treatment of fistulas in patients with
               crohn's disease",
  author    = "Present, Daniel H and Rutgeerts, Paul and Targan, Stephan and
               Hanauer, Stephen B and Mayer, Lloyd and van Hogezand, R A and
               Podolsky, Daniel K and Sands, Bruce E and Braakman, Tanja and
               DeWoody, Kimberly L and Schaible, Thomas F and van Deventer,
               Sander J H",
  journal   = "N. Engl. J. Med.",
  publisher = "Massachusetts Medical Society",
  volume    =  340,
  number    =  18,
  pages     = "1398--1405",
  month     =  may,
  year      =  1999,
  language  = "en"
}

@ARTICLE{Sands2004-gr,
  title     = "Infliximab maintenance therapy for fistulizing Crohn's disease",
  author    = "Sands, Bruce E and Anderson, Frank H and Bernstein, Charles N
               and Chey, William Y and Feagan, Brian G and Fedorak, Richard N
               and Kamm, Michael A and Korzenik, Joshua R and Lashner, Bret A
               and Onken, Jane E and Rachmilewitz, Daniel and Rutgeerts, Paul
               and Wild, Gary and Wolf, Douglas C and Marsters, Paul A and
               Travers, Suzanne B and Blank, Marion A and van Deventer, Sander
               J",
  abstract  = "BACKGROUND: Infliximab, a monoclonal antibody against tumor
               necrosis factor, is an effective maintenance therapy for
               patients with Crohn's disease without fistulas. It is not known
               whether infliximab is an effective maintenance therapy for
               patients with fistulas. METHODS: We performed a multicenter,
               double-blind, randomized, placebo-controlled trial to evaluate
               the efficacy of infliximab maintenance therapy in 306 adult
               patients with Crohn's disease and one or more draining abdominal
               or perianal fistulas of at least three months' duration.
               Patients received 5 mg of infliximab per kilogram of body weight
               intravenously on weeks 0, 2, and 6. A total of 195 patients who
               had a response at weeks 10 and 14 and 87 patients who had no
               response were then randomly assigned to receive placebo or 5 mg
               of infliximab per kilogram every eight weeks and to be followed
               to week 54. The primary analysis was the time to the loss of
               response among patients who had a response at week 14 and
               underwent randomization. RESULTS: The time to loss of response
               was significantly longer for patients who received infliximab
               maintenance therapy than for those who received placebo
               maintenance (more than 40 weeks vs. 14 weeks, P<0.001). At week
               54, 19 percent of patients in the placebo maintenance group had
               a complete absence of draining fistulas, as compared with 36
               percent of patients in the infliximab maintenance group
               (P=0.009). CONCLUSIONS: Patients with fistulizing Crohn's
               disease who have a response to induction therapy with infliximab
               have an increased likelihood of a sustained response over a
               54-week period if infliximab treatment is continued every 8
               weeks.",
  journal   = "N. Engl. J. Med.",
  publisher = "New England Journal of Medicine (NEJM/MMS)",
  volume    =  350,
  number    =  9,
  pages     = "876--885",
  month     =  feb,
  year      =  2004,
  language  = "en"
}

@ARTICLE{Naito2022-qy,
  title     = "{HLA} imputation and its application to genetic and molecular
               fine-mapping of the {MHC} region in autoimmune diseases",
  author    = "Naito, Tatsuhiko and Okada, Yukinori",
  abstract  = "Variations of human leukocyte antigen (HLA) genes in the major
               histocompatibility complex region (MHC) significantly affect the
               risk of various diseases, especially autoimmune diseases.
               Fine-mapping of causal variants in this region was challenging
               due to the difficulty in sequencing and its inapplicability to
               large cohorts. Thus, HLA imputation, a method to infer HLA types
               from regional single nucleotide polymorphisms, has been
               developed and has successfully contributed to MHC fine-mapping
               of various diseases. Different HLA imputation methods have been
               developed, each with its own advantages, and recent methods have
               been improved in terms of accuracy and computational
               performance. Additionally, advances in HLA reference panels by
               next-generation sequencing technologies have enabled higher
               resolution and a more reliable imputation, allowing a
               finer-grained evaluation of the association between sequence
               variations and disease risk. Risk-associated variants in the MHC
               region would affect disease susceptibility through complicated
               mechanisms including alterations in peripheral responses and
               central thymic selection of T cells. The cooperation of reliable
               HLA imputation methods, informative fine-mapping, and
               experimental validation of the functional significance of MHC
               variations would be essential for further understanding of the
               role of the MHC in the immunopathology of autoimmune diseases.",
  journal   = "Semin. Immunopathol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  44,
  number    =  1,
  pages     = "15--28",
  month     =  jan,
  year      =  2022,
  keywords  = "Autoimmune diseases; Fine-mapping; HLA; HLA imputation; MHC",
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Naito2021-jl,
  title     = "A deep learning method for {HLA} imputation and trans-ethnic
               {MHC} fine-mapping of type 1 diabetes",
  author    = "Naito, Tatsuhiko and Suzuki, Ken and Hirata, Jun and Kamatani,
               Yoichiro and Matsuda, Koichi and Toda, Tatsushi and Okada,
               Yukinori",
  abstract  = "Conventional human leukocyte antigen (HLA) imputation methods
               drop their performance for infrequent alleles, which is one of
               the factors that reduce the reliability of trans-ethnic major
               histocompatibility complex (MHC) fine-mapping due to
               inter-ethnic heterogeneity in allele frequency spectra. We
               develop DEEP*HLA, a deep learning method for imputing HLA
               genotypes. Through validation using the Japanese and European
               HLA reference panels (n = 1,118 and 5,122), DEEP*HLA achieves
               the highest accuracies with significant superiority for
               low-frequency and rare alleles. DEEP*HLA is less dependent on
               distance-dependent linkage disequilibrium decay of the target
               alleles and might capture the complicated region-wide
               information. We apply DEEP*HLA to type 1 diabetes GWAS data from
               BioBank Japan (n = 62,387) and UK Biobank (n = 354,459), and
               successfully disentangle independently associated class I and II
               HLA variants with shared risk among diverse populations (the top
               signal at amino acid position 71 of HLA-DR$\beta$1; P = 7.5
               $\times$ 10-120). Our study illustrates the value of deep
               learning in genotype imputation and trans-ethnic MHC
               fine-mapping.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  1,
  pages     = "1639",
  month     =  mar,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Cook2021-px,
  title     = "Accurate imputation of human leukocyte antigens with {CookHLA}",
  author    = "Cook, Seungho and Choi, Wanson and Lim, Hyunjoon and Luo, Yang
               and Kim, Kunhee and Jia, Xiaoming and Raychaudhuri, Soumya and
               Han, Buhm",
  abstract  = "The recent development of imputation methods enabled the
               prediction of human leukocyte antigen (HLA) alleles from
               intergenic SNP data, allowing studies to fine-map HLA for immune
               phenotypes. Here we report an accurate HLA imputation method,
               CookHLA, which has superior imputation accuracy compared to
               previous methods. CookHLA differs from other approaches in that
               it locally embeds prediction markers into highly polymorphic
               exons to account for exonic variability, and in that it
               adaptively learns the genetic map within MHC from the data to
               facilitate imputation. Our benchmarking with real datasets shows
               that our method achieves high imputation accuracy in a wide
               range of scenarios, including situations where the reference
               panel is small or ethnically unmatched.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  1,
  pages     = "1264",
  month     =  feb,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Zheng2014-mj,
  title     = "{HIBAG--HLA} genotype imputation with attribute bagging",
  author    = "Zheng, X and Shen, J and Cox, C and Wakefield, J C and Ehm, M G
               and Nelson, M R and Weir, B S",
  abstract  = "Genotyping of classical human leukocyte antigen (HLA) alleles is
               an essential tool in the analysis of diseases and adverse drug
               reactions with associations mapping to the major
               histocompatibility complex (MHC). However, deriving
               high-resolution HLA types subsequent to whole-genome
               single-nucleotide polymorphism (SNP) typing or sequencing is
               often cost prohibitive for large samples. An alternative
               approach takes advantage of the extended haplotype structure
               within the MHC to predict HLA alleles using dense SNP genotypes,
               such as those available from genome-wide SNP panels. Current
               methods for HLA imputation are difficult to apply or may require
               the user to have access to large training data sets with SNP and
               HLA types. We propose HIBAG, HLA Imputation using attribute
               BAGging, that makes predictions by averaging HLA-type posterior
               probabilities over an ensemble of classifiers built on bootstrap
               samples. We assess the performance of HIBAG using our study data
               (n=2668 subjects of European ancestry) as a training set and HLA
               data from the British 1958 birth cohort study (n$\approx$1000
               subjects) as independent validation samples. Prediction
               accuracies for HLA-A, B, C, DRB1 and DQB1 range from 92.2\% to
               98.1\% using a set of SNP markers common to the Illumina 1M Duo,
               OmniQuad, OmniExpress, 660K and 550K platforms. HIBAG performed
               well compared with the other two leading methods, HLA*IMP and
               BEAGLE. This method is implemented in a freely available HIBAG R
               package that includes pre-fit classifiers for European, Asian,
               Hispanic and African ancestries, providing a readily available
               imputation approach without the need to have access to large
               training data sets.",
  journal   = "Pharmacogenomics J.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  14,
  number    =  2,
  pages     = "192--200",
  month     =  apr,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Jia2013-mh,
  title     = "Imputing amino acid polymorphisms in human leukocyte antigens",
  author    = "Jia, Xiaoming and Han, Buhm and Onengut-Gumuscu, Suna and Chen,
               Wei-Min and Concannon, Patrick J and Rich, Stephen S and
               Raychaudhuri, Soumya and de Bakker, Paul I W",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  8,
  number    =  6,
  pages     = "e64683",
  month     =  jun,
  year      =  2013,
  language  = "en"
}



@ARTICLE{Monsuur2008-fk,
  title     = "Effective detection of human leukocyte antigen risk alleles in
               celiac disease using tag single nucleotide polymorphisms",
  author    = "Monsuur, Alienke J and de Bakker, Paul I W and Zhernakova,
               Alexandra and Pinto, Dalila and Verduijn, Willem and Romanos,
               Jihane and Auricchio, Renata and Lopez, Ana and van Heel, David
               A and Crusius, J Bart A and Wijmenga, Cisca",
  abstract  = "BACKGROUND: The HLA genes, located in the MHC region on
               chromosome 6p21.3, play an important role in many autoimmune
               disorders, such as celiac disease (CD), type 1 diabetes (T1D),
               rheumatoid arthritis, multiple sclerosis, psoriasis and others.
               Known HLA variants that confer risk to CD, for example, include
               DQA1*05/DQB1*02 (DQ2.5) and DQA1*03/DQB1*0302 (DQ8). To diagnose
               the majority of CD patients and to study disease susceptibility
               and progression, typing these strongly associated HLA risk
               factors is of utmost importance. However, current genotyping
               methods for HLA risk factors involve many reactions, and are
               complicated and expensive. We sought a simple experimental
               approach using tagging SNPs that predict the CD-associated HLA
               risk factors. METHODOLOGY: Our tagging approach exploits linkage
               disequilibrium between single nucleotide polymorphism (SNPs) and
               the CD-associated HLA risk factors DQ2.5 and DQ8 that indicate
               direct risk, and DQA1*0201/DQB1*0202 (DQ2.2) and
               DQA1*0505/DQB1*0301 (DQ7) that attribute to the risk of DQ2.5 to
               CD. To evaluate the predictive power of this approach, we
               performed an empirical comparison of the predicted DQ types,
               based on these six tag SNPs, with those executed with current
               validated laboratory typing methods of the HLA-DQA1 and -DQB1
               genes in three large cohorts. The results were validated in
               three European celiac populations. CONCLUSION: Using this
               method, only six SNPs were needed to predict the risk types
               carried by >95\% of CD patients. We determined that for this
               tagging approach the sensitivity was >0.991, specificity >0.996
               and the predictive value >0.948. Our results show that this tag
               SNP method is very accurate and provides an excellent basis for
               population screening for CD. This method is broadly applicable
               in European populations.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  3,
  number    =  5,
  pages     = "e2270",
  month     =  may,
  year      =  2008,
  language  = "en"
}

@ARTICLE{De_Bakker2006-ho,
  title     = "A high-resolution {HLA} and {SNP} haplotype map for disease
               association studies in the extended human {MHC}",
  author    = "de Bakker, Paul I W and McVean, Gil and Sabeti, Pardis C and
               Miretti, Marcos M and Green, Todd and Marchini, Jonathan and Ke,
               Xiayi and Monsuur, Alienke J and Whittaker, Pamela and Delgado,
               Marcos and Morrison, Jonathan and Richardson, Angela and Walsh,
               Emily C and Gao, Xiaojiang and Galver, Luana and Hart, John and
               Hafler, David A and Pericak-Vance, Margaret and Todd, John A and
               Daly, Mark J and Trowsdale, John and Wijmenga, Cisca and Vyse,
               Tim J and Beck, Stephan and Murray, Sarah Shaw and Carrington,
               Mary and Gregory, Simon and Deloukas, Panos and Rioux, John D",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  38,
  number    =  10,
  pages     = "1166--1172",
  month     =  oct,
  year      =  2006,
  language  = "en"
}

@BOOK{Beksac2014-gm,
  title     = "Bone marrow and stem cell transplantation",
  editor    = "Beksac, Meral",
  publisher = "Humana Press",
  series    = "Methods in molecular biology (Clifton, N.J.)",
  edition   =  2,
  month     =  jan,
  year      =  2014,
  address   = "New York, NY",
  copyright = "https://www.springernature.com/gp/researchers/text-and-data-mining",
  language  = "en"
}

@ARTICLE{Tozer2009-mp,
  title     = "Etiology of perianal Crohn's disease: Role of genetic,
               microbiological, and immunological factors",
  author    = "Tozer, Philip J and Whelan, Kevin and Phillips, Robin K S and
               Hart, Ailsa L",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  15,
  number    =  10,
  pages     = "1591--1598",
  month     =  oct,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Latiano2009-bu,
  title     = "Polymorphism of the {IRGM} gene might predispose to fistulizing
               behavior in Crohn's disease",
  author    = "Latiano, A and Palmieri, O and Cucchiara, S and Castro, M and
               D'Inc{\`a}, R and Guariso, G and Dallapiccola, B and Valvano, M
               R and Latiano, T and Andriulli, A and Annese, V",
  abstract  = "OBJECTIVES: Recently, genome-wide association analyses have
               identified single nucleotide polymorphisms in the IRGM gene
               (rs1000113 and rs4958847) as strong candidate susceptibility
               factors for Crohn's disease (CD). The aim of our study was to
               test whether these variants are associated with inflammatory
               bowel disease (IBD) in adult- and childhood-onset Italian
               patients. METHODS: Allele and genotype frequencies of rs1000113
               and rs4958847 were determined in 823 CD (265 younger than 19
               years at diagnosis), 353 ulcerative colitis (UC) (130 younger
               than 19 years at diagnosis), and 578 controls. Genotype
               distributions were examined both within IBD clinical
               sub-phenotypes and CARD15 genotypes. RESULTS: rs1000113 and
               rs4958847 were both associated with adult-onset (P=2 x 10(-4);
               P=2.5 x 10(-3), respectively) and childhood-onset (P=4 x 10(-4);
               P=8 x 10(-3), respectively) CD cohorts. Similarly, the genotype
               frequencies remained significantly different for both variants
               (adult rs1000113, P=1 x 10(-4); rs4958847, P=1 x 10(-3);
               pediatric rs1000113, P=2.3 x 10(-4); rs4958847, P=9.6 x 10(-3)).
               At logistic regression, the rs4958847 polymorphism was
               associated with fistulizing behavior (P=0.037, OR=1.54,
               CI=1.02-2.31) and perianal fistulas (P=0.045, OR=1.55,
               CI=1.01-2.38). Conversely, no association with UC and
               sub-phenotypes was shown. CONCLUSIONS: We replicated the
               previously reported associations between CD and rs1000113 and
               rs4958847, confirming that IRGM is a susceptibility locus only
               for CD, either adult- or early-onset in the Italian population;
               furthermore, we have also shown its influence on specific
               clinical features (fistulizing disease).",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  104,
  number    =  1,
  pages     = "110--116",
  month     =  jan,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Eglinton2012-ls,
  title     = "Clinical and genetic risk factors for perianal Crohn's disease
               in a population-based cohort",
  author    = "Eglinton, T W and Roberts, R and Pearson, J and Barclay, M and
               Merriman, T R and Frizelle, F A and Gearry, R B",
  abstract  = "OBJECTIVES: Perianal Crohn's disease (CD) affects around
               one-quarter of CD patients and represents a distinct disease
               phenotype. The objective of this study was to investigate a
               large population-based cohort of inflammatory bowel disease
               (IBD) patients to identify clinical and genetic risk factors for
               perianal CD. METHODS: Data were collected in the Canterbury IBD
               database, estimated to include 91\% of all patients with IBD in
               Canterbury, New Zealand. Genotyping was performed for selected
               loci previously demonstrated to be associated with CD. Patients
               with perianal disease were then compared with both CD patients
               without perianal disease and healthy controls to assess the
               presence of potential phenotypic, environmental, and genetic
               risk factors. RESULTS: Of the 715 CD patients in the database,
               190 (26.5\%) had perianal disease. In all, 507 patients with
               genotype data available were analyzed. Perianal disease was
               associated with younger age at diagnosis (P < 0.0001),
               complicated intestinal disease (P < 0.0001), and ileal disease
               location (P = 0.002). There was no association with gender,
               ethnicity, smoking, or breast feeding. Genotype analysis
               revealed an association with the neutrophil cytosolic factor 4
               (NCF4) gene compared with both non-perianal CD patients (odds
               ratio (OR): 1.47; 95\% confidence interval (CI): 1.08-1.99) and
               healthy controls (OR: 1.47; 95\% CI: 1.10-1.95). There was no
               association identified with other genes, including IBD5 (OR:
               0.91; 95\% CI: 0.69-1.20), tumor necrosis factor $\alpha$ (OR:
               1.04; 95\% CI: 0.56-1.85), and IRGM (immunity-related guanosine
               triphosphatase protein type M) (OR: 1.21; 95\% CI: 0.80-1.82).
               CONCLUSIONS: This study suggests that younger age at diagnosis,
               complicated disease behavior, and ileal disease location are
               risk factors for perianal CD. In addition, this paper represents
               the first report of an association of the NCF4 gene with
               perianal disease.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  107,
  number    =  4,
  pages     = "589--596",
  month     =  apr,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Gasche2000-qh,
  title     = "A simple classification of crohn's disease: Report of the
               working party for the world congresses of gastroenterology,
               Vienna 1998",
  author    = "Gasche, Christoph and Scholmerich, Jurgen and Brynskov, Jorn and
               D'Haens, Geert and Hanauer, Stephen B and Irvine, Jan E and
               Jewell, Derek P and Rachmilewitz, Daniel and Sachar, David B and
               Sandborn, William J and Sutherland, Lloyd R",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  6,
  number    =  1,
  pages     = "8--15",
  month     =  feb,
  year      =  2000,
  language  = "en"
}

@ARTICLE{Brochard2022-hx,
  title     = "Natural history of perianal Crohn's disease: Long-term follow-up
               of a population-based cohort",
  author    = "Brochard, Charl{\`e}ne and Rabilloud, Marie-Laure and Hamonic,
               St{\'e}phanie and Bajeux, Emma and Pagenault, Ma{\"e}l and
               Dabadie, Alain and Gerfaud, Agathe and Viel, Jean-Fran{\c c}ois
               and Tron, Isabelle and Robaszkiewicz, Michel and Bretagne,
               Jean-Fran{\c c}ois and Siproudhis, Laurent and Bouguen,
               Guillaume and {Groupe ABERMAD}",
  abstract  = "BACKGROUND AND AIMS: The natural history of perianal Crohn's
               disease (PCD) remains poorly described and is mainly based on
               retrospective studies from referral centers. The aim of this
               study was to assess the incidence, outcomes and predictors of
               the onset of PCD. METHODS: All incident cases of patients
               diagnosed with possible CD were prospectively registered from
               1994 to 1997 in Brittany, a limited area in France. At
               diagnosis, the clinical features of perianal disease were
               recorded. All patient charts were reviewed from the diagnosis to
               the last clinic visit in 2015. RESULTS: Among the 272 out of 331
               incident CD patients followed up, 51 (18.7\%) patients had PCD
               at diagnosis. After a mean follow-up of 12.8 years, 93 (34\%)
               patients developed PCD. The cumulative probabilities of perianal
               CD occurrence were 22\%, 29\%, and 32\% after 1 year, 5 years,
               and 10 years, respectively. The cumulative probabilities of anal
               ulceration were 14\%, and 19\% after 1 year and 10 years,
               respectively. Extraintestinal manifestations were associated
               with the occurrence of anal ulceration. The cumulative
               probabilities of fistulizing PCD were 11\%, 16\%, and 19\% after
               1 year, 5 years, and 10 years, respectively. Extraintestinal
               manifestations, rectal involvement and anal ulceration were
               predictors of fistulizing PCD. The cumulative probability of
               developing anal stricture was 4\% after 10 years. CONCLUSIONS:
               PCD is frequently observed during CD, in approximately one-third
               of patients. These data underline the need for targeted
               therapeutic research on primary perianal lesions (proctitis,
               anal ulceration) to avoid the onset of fistulizing perianal
               disease.",
  journal   = "Clin. Gastroenterol. Hepatol.",
  publisher = "Elsevier BV",
  volume    =  20,
  number    =  2,
  pages     = "e102--e110",
  month     =  feb,
  year      =  2022,
  keywords  = "Natural History; Outcomes; Perianal Crohn's Disease; Population
               Based",
  language  = "en"
}

@misc{genepwr-docs,   
    title = {genpwr: Power Calculations Under Genetic Model Misspecification
},   
    url = {https://cran.r-project.org/web/packages/genpwr/index.html},   
    author = {Camille Moore},   
    year = {13/10/2022},   
    note = {Accessed on 25/10/2023} 
}
@misc{hibag-models-docs,   
    title = {HIBAG - HLA Genotype Imputation with Attribute Bagging
},   
    url = {https://hibag.s3.amazonaws.com/hlares_index.html},   
    author = {Xiuwen Zheng and Bruce S. Weir},   
    year = {01/03/2017},   
    note = {Accessed on 25/10/2023} 
}
@misc{hla-nomenclature-4digit,   
    title = {Full List of Class I Proteins},   
    url = {https://hla.alleles.org/proteins/class1.html},   
    author = {Anthony Nolan Research Institute },   
    year = {06/10/2023},   
    note = {Accessed on 24/10/2023} 
}
@misc{hla-nomenclature,   
    title = {Nomenclature for Factors of the HLA System},   
    url = {https://hla.alleles.org/nomenclature/naming_prev.html},   
    author = {Anthony Nolan Research Institute },   
    year = {20/09/2019},   
    note = {Accessed on 24/10/2023} 
}
@ARTICLE{Robinson2013-wv,
  title     = "The {IMGT/HLA} database",
  author    = "Robinson, James and Halliwell, Jason A and McWilliam, Hamish and
               Lopez, Rodrigo and Parham, Peter and Marsh, Steven G E",
  abstract  = "It is 14 years since the IMGT/HLA database was first released,
               providing the HLA community with a searchable repository of
               highly curated HLA sequences. The HLA complex is located within
               the 6p21.3 region of human chromosome 6 and contains more than
               220 genes of diverse function. Of these, 21 genes encode
               proteins of the immune system that are highly polymorphic. The
               naming of these HLA genes and alleles and their quality control
               is the responsibility of the World Health Organization
               Nomenclature Committee for Factors of the HLA System. Through
               the work of the HLA Informatics Group and in collaboration with
               the European Bioinformatics Institute, we are able to provide
               public access to these data through the website
               http://www.ebi.ac.uk/imgt/hla/. Regular updates to the website
               ensure that new and confirmatory sequences are dispersed to the
               HLA community and the wider research and clinical communities.
               This article describes the latest updates and additional tools
               added to the IMGT/HLA project.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  41,
  number    = "Database issue",
  pages     = "D1222--7",
  month     =  jan,
  year      =  2013,
  copyright = "http://creativecommons.org/licenses/by-nc/3.0",
  language  = "en"
}

@ARTICLE{Shiina2009-wt,
  title     = "The {HLA} genomic loci map: expression, interaction, diversity
               and disease",
  author    = "Shiina, Takashi and Hosomichi, Kazuyoshi and Inoko, Hidetoshi
               and Kulski, Jerzy K",
  abstract  = "The human leukocyte antigen (HLA) super-locus is a genomic
               region in the chromosomal position 6p21 that encodes the six
               classical transplantation HLA genes and at least 132 protein
               coding genes that have important roles in the regulation of the
               immune system as well as some other fundamental molecular and
               cellular processes. This small segment of the human genome has
               been associated with more than 100 different diseases, including
               common diseases, such as diabetes, rheumatoid arthritis,
               psoriasis, asthma and various other autoimmune disorders. The
               first complete and continuous HLA 3.6 Mb genomic sequence was
               reported in 1999 with the annotation of 224 gene loci, including
               coding and non-coding genes that were reviewed extensively in
               2004. In this review, we present (1) an updated list of all the
               HLA gene symbols, gene names, expression status, Online
               Mendelian Inheritance in Man (OMIM) numbers, including new
               genes, and latest changes to gene names and symbols, (2) a
               regional analysis of the extended class I, class I, class III,
               class II and extended class II subregions, (3) a summary of the
               interspersed repeats (retrotransposons and transposons), (4)
               examples of the sequence diversity between different HLA
               haplotypes, (5) intra- and extra-HLA gene interactions and (6)
               some of the HLA gene expression profiles and HLA genes
               associated with autoimmune and infectious diseases. Overall, the
               degrees and types of HLA super-locus coordinated gene expression
               profiles and gene variations have yet to be fully elucidated,
               integrated and defined for the processes involved with normal
               cellular and tissue physiology, inflammatory and immune
               responses, and autoimmune and infectious diseases.",
  journal   = "J. Hum. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  54,
  number    =  1,
  pages     = "15--39",
  month     =  jan,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Marsh2010-mq,
  title     = "Nomenclature for factors of the {HLA} system, 2010",
  author    = "Marsh, S G E and Albert, E D and Bodmer, W F and Bontrop, R E
               and Dupont, B and Erlich, H A and Fern{\'a}ndez-Vi{\~n}a, M and
               Geraghty, D E and Holdsworth, R and Hurley, C K and Lau, M and
               Lee, K W and Mach, B and Maiers, M and Mayr, W R and M{\"u}ller,
               C R and Parham, P and Petersdorf, E W and Sasazuki, T and
               Strominger, J L and Svejgaard, A and Terasaki, P I and Tiercy, J
               M and Trowsdale, J",
  journal   = "Tissue Antigens",
  publisher = "Wiley",
  volume    =  75,
  number    =  4,
  pages     = "291--455",
  month     =  apr,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Matzaraki2017-za,
  title     = "The {MHC} locus and genetic susceptibility to autoimmune and
               infectious diseases",
  author    = "Matzaraki, Vasiliki and Kumar, Vinod and Wijmenga, Cisca and
               Zhernakova, Alexandra",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  18,
  number    =  1,
  month     =  dec,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Ayers2011-bc,
  title     = "Penalized-regression-based multimarker genotype analysis of
               Genetic Analysis Workshop 17 data",
  author    = "Ayers, Kristin L and Mamasoula, Chrysovalanto and Cordell,
               Heather J",
  journal   = "BMC Proc.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  5,
  number    = "S9",
  pages     = "S92",
  month     =  dec,
  year      =  2011,
  language  = "en"
}

@ARTICLE{Tabangin2009-gs,
  title     = "The effect of minor allele frequency on the likelihood of
               obtaining false positives",
  author    = "Tabangin, Meredith E and Woo, Jessica G and Martin, Lisa J",
  abstract  = "Determining the most promising single-nucleotide polymorphisms
               (SNPs) presents a challenge in genome-wide association studies,
               when hundreds of thousands of association tests are conducted.
               The power to detect genetic effects is dependent on minor allele
               frequency (MAF), and genome-wide association studies SNP arrays
               include SNPs with a wide distribution of MAFs. Therefore, it is
               critical to understand MAF's effect on the false positive
               rate.Data from the Framingham Heart Study simulated data
               (Problem 3, with answers) was used to examine the effects of
               varying MAFs on the likelihood of false positives. Replication
               set 1 was used to generate 1 million permutations of
               case/control status in unrelated individuals. Logistic
               regression was used to test for the association between each SNP
               and myocardial infarction using an additive model. We report the
               number of ``significant'' tests by MAF at alpha = 10-4, 10-5,
               and 10-6.Common SNPs exhibited fewer false positives than
               expected. At alpha = 10-4, SNPs with MAF 25\% and 50\% resulted
               in 69.2 [95\%CI: 62.8-75.6] and 70.8 [95\%CI: 61.3-80.4] false
               positives, respectively, compared to 100 expected. Rare SNPs
               exhibited more variability but did not show more false-positive
               results than expected by chance. However, at alpha = 10-4, MAF =
               5\% exhibited significantly more false positives (105.5 [95\%CI:
               81-130.1]) than MAF = 25\% and 50\%. Similar results were seen
               at the other alpha values.These results suggest that removal of
               low MAF SNPs from analysis due to concerns about inflated
               false-positive results may not be appropriate.",
  journal   = "BMC Proc.",
  publisher = "Springer Nature",
  volume    = "3 Suppl 7",
  number    = "S7",
  pages     = "S41",
  month     =  dec,
  year      =  2009,
  language  = "en"
}
@ARTICLE{Unuvar_Purcu2022-zq,
  title     = "Effect of stimulation time on the expression of human macrophage
               polarization markers",
  author    = "Unuvar Purcu, Duygu and Korkmaz, Asli and Gunalp, Sinem and
               Helvaci, Derya Goksu and Erdal, Yonca and Dogan, Yavuz and
               Suner, Asli and Wingender, Gerhard and Sag, Duygu",
  abstract  = "Macrophages are highly plastic cells that can polarize into
               functionally distinct subsets in vivo and in vitro in response
               to environmental signals. The development of protocols to model
               macrophage polarization in vitro greatly contributes to our
               understanding of macrophage biology. Macrophages are divided
               into two main groups: Pro-inflammatory M1 macrophages
               (classically activated) and anti-inflammatory M2 macrophages
               (alternatively activated), based on several key surface markers
               and the production of inflammatory mediators. However, the
               expression of these common macrophage polarization markers is
               greatly affected by the stimulation time used. Unfortunately,
               there is no consensus yet regarding the optimal stimulation
               times for particular macrophage polarization markers in in vitro
               experiments. This situation is problematic, (i) as analysing a
               particular marker at a suboptimal time point can lead to
               false-negative results, and (ii) as it clearly impedes the
               comparison of different studies. Using human monocyte-derived
               macrophages (MDMs) in vitro, we analysed how the expression of
               the main polarization markers for M1 (CD64, CD86, CXCL9, CXCL10,
               HLA-DR, IDO1, IL1$\beta$, IL12, TNF), M2a (CD200R, CD206, CCL17,
               CCL22, IL-10, TGM2), and M2c (CD163, IL-10, TGF$\beta$)
               macrophages changes over time at mRNA and protein levels. Our
               data establish the most appropriate stimulation time for the
               analysis of the expression of human macrophage polarization
               markers in vitro. Providing such a reference guide will likely
               facilitate the investigation of macrophage polarization and its
               reproducibility.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  17,
  number    =  3,
  pages     = "e0265196",
  month     =  mar,
  year      =  2022,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Sharif2007-np,
  title     = "Transcriptional profiling of the {LPS} induced {NF-kappaB}
               response in macrophages",
  author    = "Sharif, Omar and Bolshakov, Viacheslav N and Raines, Stephanie
               and Newham, Peter and Perkins, Neil D",
  abstract  = "BACKGROUND: Exposure of macrophages to bacterial products such
               as lipopolysaccharide (LPS) results in activation of the
               NF-kappaB transcription factor, which orchestrates a gene
               expression programme that underpins the macrophage-dependent
               immune response. These changes include the induction or
               repression of a wide range of genes that regulate inflammation,
               cell proliferation, migration and cell survival. This process is
               tightly regulated and loss of control is associated with
               conditions such as septic shock, inflammatory diseases and
               cancer. To study this response, it is important to have in vitro
               model systems that reflect the behaviour of cells in vivo. In
               addition, it is necessary to understand the natural differences
               that can occur between individuals. In this report, we have
               investigated and compared the LPS response in macrophage derived
               cell lines and peripheral blood mononuclear cell (PBMC) derived
               macrophages. RESULTS: Gene expression profiles were determined
               following LPS treatment of THP-1 cells for 1 and 4 hours. LPS
               significantly induced or repressed 72 out of 465 genes selected
               as being known or putative NF-kappaB target genes, which
               exhibited 4 temporal patterns of expression. Results for 34 of
               these genes, including several genes not previously identified
               as LPS target genes, were validated using real time PCR. A high
               correlation between microarray and real time PCR data was found.
               Significantly, the LPS induced expression profile of THP-1
               cells, as determined using real time PCR, was found to be very
               similar to that of human PBMC derived macrophages.
               Interestingly, some differences were observed in the LPS
               response between the two donor PBMC macrophage populations.
               Surprisingly, we found that the LPS response in U937 cells was
               dramatically different to both THP-1 and PBMC derived
               macrophages. CONCLUSION: This study revealed a dynamic and
               diverse transcriptional response to LPS in macrophages,
               involving both the induction and repression of gene expression
               in a time dependent manner. Moreover, we demonstrated that the
               LPS induced transcriptional response in the THP-1 cell line is
               very similar to primary PBMC derived macrophages. Therefore,
               THP-1 cells represent a good model system for studying the
               mechanisms of LPS and NF-kappaB dependent gene expression.",
  journal   = "BMC Immunol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  8,
  number    =  1,
  pages     = "1",
  month     =  jan,
  year      =  2007,
  language  = "en"
}

@ARTICLE{Garrido-Martin2021-sk,
  title     = "Identification and analysis of splicing quantitative trait loci
               across multiple tissues in the human genome",
  author    = "Garrido-Mart{\'\i}n, Diego and Borsari, Beatrice and Calvo,
               Miquel and Reverter, Ferran and Guig{\'o}, Roderic",
  abstract  = "Alternative splicing (AS) is a fundamental step in eukaryotic
               mRNA biogenesis. Here, we develop an efficient and reproducible
               pipeline for the discovery of genetic variants that affect AS
               (splicing QTLs, sQTLs). We use it to analyze the GTEx dataset,
               generating a comprehensive catalog of sQTLs in the human genome.
               Downstream analysis of this catalog provides insight into the
               mechanisms underlying splicing regulation. We report that a core
               set of sQTLs is shared across multiple tissues. sQTLs often
               target the global splicing pattern of genes, rather than
               individual splicing events. Many also affect the expression of
               the same or other genes, uncovering regulatory loci that act
               through different mechanisms. sQTLs tend to be located in
               post-transcriptionally spliced introns, which would function as
               hotspots for splicing regulation. While many variants affect
               splicing patterns by altering the sequence of splice sites, many
               more modify the binding sites of RNA-binding proteins. Genetic
               variants affecting splicing can have a stronger phenotypic
               impact than those affecting gene expression.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  1,
  pages     = "727",
  month     =  feb,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Wang2008-fb,
  title     = "Alternative isoform regulation in human tissue transcriptomes",
  author    = "Wang, Eric T and Sandberg, Rickard and Luo, Shujun and
               Khrebtukova, Irina and Zhang, Lu and Mayr, Christine and
               Kingsmore, Stephen F and Schroth, Gary P and Burge, Christopher
               B",
  abstract  = "Through alternative processing of pre-messenger RNAs, individual
               mammalian genes often produce multiple mRNA and protein isoforms
               that may have related, distinct or even opposing functions. Here
               we report an in-depth analysis of 15 diverse human tissue and
               cell line transcriptomes on the basis of deep sequencing of
               complementary DNA fragments, yielding a digital inventory of
               gene and mRNA isoform expression. Analyses in which sequence
               reads are mapped to exon-exon junctions indicated that 92-94\%
               of human genes undergo alternative splicing, 86\% with a minor
               isoform frequency of 15\% or more. Differences in
               isoform-specific read densities indicated that most alternative
               splicing and alternative cleavage and polyadenylation events
               vary between tissues, whereas variation between individuals was
               approximately twofold to threefold less common. Extreme or
               'switch-like' regulation of splicing between tissues was
               associated with increased sequence conservation in regulatory
               regions and with generation of full-length open reading frames.
               Patterns of alternative splicing and alternative cleavage and
               polyadenylation were strongly correlated across tissues,
               suggesting coordinated regulation of these processes, and
               sequence conservation of a subset of known regulatory motifs in
               both alternative introns and 3' untranslated regions suggested
               common involvement of specific factors in tissue-level
               regulation of both splicing and polyadenylation.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  456,
  number    =  7221,
  pages     = "470--476",
  month     =  nov,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Lappalainen2013-mz,
  title     = "Transcriptome and genome sequencing uncovers functional
               variation in humans",
  author    = "Lappalainen, Tuuli and {The Geuvadis Consortium} and Sammeth,
               Michael and Friedl{\"a}nder, Marc R and `t Hoen, Peter A C and
               Monlong, Jean and Rivas, Manuel A and Gonz{\`a}lez-Porta, Mar
               and Kurbatova, Natalja and Griebel, Thasso and Ferreira, Pedro G
               and Barann, Matthias and Wieland, Thomas and Greger, Liliana and
               van Iterson, Maarten and Alml{\"o}f, Jonas and Ribeca, Paolo and
               Pulyakhina, Irina and Esser, Daniela and Giger, Thomas and
               Tikhonov, Andrew and Sultan, Marc and Bertier, Gabrielle and
               MacArthur, Daniel G and Lek, Monkol and Lizano, Esther and
               Buermans, Henk P J and Padioleau, Ismael and Schwarzmayr, Thomas
               and Karlberg, Olof and Ongen, Halit and Kilpinen, Helena and
               Beltran, Sergi and Gut, Marta and Kahlem, Katja and
               Amstislavskiy, Vyacheslav and Stegle, Oliver and Pirinen, Matti
               and Montgomery, Stephen B and Donnelly, Peter and McCarthy, Mark
               I and Flicek, Paul and Strom, Tim M and Lehrach, Hans and
               Schreiber, Stefan and Sudbrak, Ralf and Carracedo, {\'A}ngel and
               Antonarakis, Stylianos E and H{\"a}sler, Robert and Syv{\"a}nen,
               Ann-Christine and van Ommen, Gert-Jan and Brazma, Alvis and
               Meitinger, Thomas and Rosenstiel, Philip and Guig{\'o}, Roderic
               and Gut, Ivo G and Estivill, Xavier and Dermitzakis, Emmanouil T",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  501,
  number    =  7468,
  pages     = "506--511",
  month     =  sep,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Giambartolomei2014-yl,
  title     = "Bayesian test for colocalisation between pairs of genetic
               association studies using summary statistics",
  author    = "Giambartolomei, Claudia and Vukcevic, Damjan and Schadt, Eric E
               and Franke, Lude and Hingorani, Aroon D and Wallace, Chris and
               Plagnol, Vincent",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  10,
  number    =  5,
  pages     = "e1004383",
  month     =  may,
  year      =  2014,
  language  = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Buniello2019-wb,
  title     = "The {NHGRI-EBI} {GWAS} Catalog of published genome-wide
               association studies, targeted arrays and summary statistics 2019",
  author    = "Buniello, Annalisa and MacArthur, Jacqueline A L and Cerezo,
               Maria and Harris, Laura W and Hayhurst, James and Malangone,
               Cinzia and McMahon, Aoife and Morales, Joannella and Mountjoy,
               Edward and Sollis, Elliot and Suveges, Daniel and Vrousgou, Olga
               and Whetzel, Patricia L and Amode, Ridwan and Guillen, Jose A
               and Riat, Harpreet S and Trevanion, Stephen J and Hall, Peggy
               and Junkins, Heather and Flicek, Paul and Burdett, Tony and
               Hindorff, Lucia A and Cunningham, Fiona and Parkinson, Helen",
  abstract  = "The GWAS Catalog delivers a high-quality curated collection of
               all published genome-wide association studies enabling
               investigations to identify causal variants, understand disease
               mechanisms, and establish targets for novel therapies. The scope
               of the Catalog has also expanded to targeted and exome arrays
               with 1000 new associations added for these technologies. As of
               September 2018, the Catalog contains 5687 GWAS comprising 71673
               variant-trait associations from 3567 publications. New content
               includes 284 full P-value summary statistics datasets for
               genome-wide and new targeted array studies, representing 6
               $\times$ 109 individual variant-trait statistics. In the last 12
               months, the Catalog's user interface was accessed by âˆ¼90000
               unique users who viewed >1 million pages. We have improved data
               access with the release of a new RESTful API to support
               high-throughput programmatic access, an improved web interface
               and a new summary statistics database. Summary statistics
               provision is supported by a new format proposed as a community
               standard for summary statistics data representation. This format
               was derived from our experience in standardizing heterogeneous
               submissions, mapping formats and in harmonizing content.
               Availability: https://www.ebi.ac.uk/gwas/.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  47,
  number    = "D1",
  pages     = "D1005--D1012",
  month     =  jan,
  year      =  2019,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Mountjoy2021-fc,
  title     = "An open approach to systematically prioritize causal variants
               and genes at all published human {GWAS} trait-associated loci",
  author    = "Mountjoy, Edward and Schmidt, Ellen M and Carmona, Miguel and
               Schwartzentruber, Jeremy and Peat, Gareth and Miranda, Alfredo
               and Fumis, Luca and Hayhurst, James and Buniello, Annalisa and
               Karim, Mohd Anisul and Wright, Daniel and Hercules, Andrew and
               Papa, Eliseo and Fauman, Eric B and Barrett, Jeffrey C and Todd,
               John A and Ochoa, David and Dunham, Ian and Ghoussaini, Maya",
  abstract  = "Genome-wide association studies (GWASs) have identified many
               variants associated with complex traits, but identifying the
               causal gene(s) is a major challenge. In the present study, we
               present an open resource that provides systematic fine mapping
               and gene prioritization across 133,441 published human GWAS
               loci. We integrate genetics (GWAS Catalog and UK Biobank) with
               transcriptomic, proteomic and epigenomic data, including
               systematic disease-disease and disease-molecular trait
               colocalization results across 92 cell types and tissues. We
               identify 729 loci fine mapped to a single-coding causal variant
               and colocalized with a single gene. We trained a
               machine-learning model using the fine-mapped genetics and
               functional genomics data and 445 gold-standard curated GWAS loci
               to distinguish causal genes from neighboring genes,
               outperforming a naive distance-based model. Our prioritized
               genes were enriched for known approved drug targets (odds ratio
               = 8.1, 95\% confidence interval = 5.7, 11.5). These results are
               publicly available through a web portal (
               http://genetics.opentargets.org ), enabling users to easily
               prioritize genes at disease-associated loci and assess their
               potential as drug targets.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  11,
  pages     = "1527--1533",
  month     =  nov,
  year      =  2021,
  language  = "en"
}

@ARTICLE{Symoens2011-ew,
  title     = "A novel splice variant in the N-propeptide of {COL5A1} causes an
               {EDS} phenotype with severe kyphoscoliosis and eye involvement",
  author    = "Symoens, Sofie and Malfait, Fransiska and Vlummens, Philip and
               Hermanns-L{\^e}, Trinh and Syx, Delfien and De Paepe, Anne",
  abstract  = "BACKGROUND: The Ehlers-Danlos Syndrome (EDS) is a heritable
               connective tissue disorder characterized by hyperextensible
               skin, joint hypermobility and soft tissue fragility. The classic
               subtype of EDS is caused by mutations in one of the type V
               collagen genes (COL5A1 and COL5A2). Most mutations affect the
               type V collagen helical domain and lead to a diminished or
               structurally abnormal type V collagen protein. Remarkably, only
               two mutations were reported to affect the extended, highly
               conserved N-propeptide domain, which plays an important role in
               the regulation of the heterotypic collagen fibril diameter. We
               identified a novel COL5A1 N-propeptide mutation, resulting in an
               unusual but severe classic EDS phenotype and a remarkable
               splicing outcome. METHODOLOGY/PRINCIPAL FINDINGS: We identified
               a novel COL5A1 N-propeptide acceptor-splice site mutation
               (IVS6-2A>G, NM\_000093.3\_c.925-2A>G) in a patient with
               cutaneous features of EDS, severe progressive scoliosis and eye
               involvement. Two mutant transcripts were identified, one with an
               exon 7 skip and one in which exon 7 and the upstream exon 6 are
               deleted. Both transcripts are expressed and secreted into the
               extracellular matrix, where they can participate in and perturb
               collagen fibrillogenesis, as illustrated by the presence of
               dermal collagen cauliflowers. Determination of the order of
               intron removal and computational analysis showed that
               simultaneous skipping of exons 6 and 7 is due to the combined
               effect of delayed splicing of intron 7, altered pre-mRNA
               secondary structure, low splice site strength and possibly
               disturbed binding of splicing factors. CONCLUSIONS/SIGNIFICANCE:
               We report a novel COL5A1 N-propeptide acceptor-splice site
               mutation in intron 6, which not only affects splicing of the
               adjacent exon 7, but also causes a splicing error of the
               upstream exon 6. Our findings add further insights into the
               COL5A1 splicing order and show for the first time that a single
               COL5A1 acceptor-splice site mutation can perturb splicing of the
               upstream exon.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  6,
  number    =  5,
  pages     = "e20121",
  month     =  may,
  year      =  2011,
  language  = "en"
}
#####
@ARTICLE{Abramowicz2018-by,
  title     = "Splicing mutations in human genetic disorders: examples,
               detection, and confirmation",
  author    = "Abramowicz, Anna and Gos, Monika",
  journal   = "J. Appl. Genet.",
  publisher = "Springer Nature",
  volume    =  59,
  number    =  3,
  pages     = "253--268",
  month     =  aug,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Sanz2017-re,
  title     = "{Cas9/gRNA} targeted excision of cystic fibrosis-causing
               deep-intronic splicing mutations restores normal splicing of
               {CFTR} {mRNA}",
  author    = "Sanz, David J and Hollywood, Jennifer A and Scallan, Martina F
               and Harrison, Patrick T",
  abstract  = "Cystic Fibrosis is an autosomal recessive disorder caused by
               mutations in the CFTR gene. CRISPR mediated, template-dependent
               homology-directed gene editing has been used to correct the most
               common mutation, c.1521\_1523delCTT / p.Phe508del (F508del)
               which affects ~70\% of individuals, but the efficiency was
               relatively low. Here, we describe a high efficiency strategy for
               editing of three different rare CFTR mutations which together
               account for about 3\% of individuals with Cystic Fibrosis. The
               mutations cause aberrant splicing of CFTR mRNA due to the
               creation of cryptic splice signals that result in the formation
               of pseudoexons containing premature stop codons c.1679+1634A>G
               (1811+1.6kbA>G) and c.3718-2477C>T (3849+10kbC>T), or an
               out-of-frame 5' extension to an existing exon c.3140-26A>G
               (3272-26A>G). We designed pairs of Cas9 guide RNAs to create
               targeted double-stranded breaks in CFTR either side of each
               mutation which resulted in high efficiency excision of the
               target genomic regions via non-homologous end-joining repair.
               When evaluated in a mini-gene splicing assay, we showed that
               targeted excision restored normal splicing for all three
               mutations. This approach could be used to correct aberrant
               splicing signals or remove disruptive transcription regulatory
               motifs caused by deep-intronic mutations in a range of other
               genetic disorders.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  12,
  number    =  9,
  pages     = "e0184009",
  month     =  sep,
  year      =  2017,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Nellore2016-fj,
  title     = "Human splicing diversity and the extent of unannotated splice
               junctions across human {RNA-seq} samples on the Sequence Read
               Archive",
  author    = "Nellore, Abhinav and Jaffe, Andrew E and Fortin, Jean-Philippe
               and Alquicira-Hern{\'a}ndez, Jos{\'e} and Collado-Torres,
               Leonardo and Wang, Siruo and Phillips, III, Robert A and
               Karbhari, Nishika and Hansen, Kasper D and Langmead, Ben and
               Leek, Jeffrey T",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  17,
  number    =  1,
  month     =  dec,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Pickrell2010-lz,
  title     = "Noisy splicing drives {mRNA} isoform diversity in human cells",
  author    = "Pickrell, Joseph K and Pai, Athma A and Gilad, Yoav and
               Pritchard, Jonathan K",
  abstract  = "While the majority of multiexonic human genes show some evidence
               of alternative splicing, it is unclear what fraction of observed
               splice forms is functionally relevant. In this study, we examine
               the extent of alternative splicing in human cells using deep RNA
               sequencing and de novo identification of splice junctions. We
               demonstrate the existence of a large class of low abundance
               isoforms, encompassing approximately 150,000 previously
               unannotated splice junctions in our data. Newly-identified
               splice sites show little evidence of evolutionary conservation,
               suggesting that the majority are due to erroneous splice site
               choice. We show that sequence motifs involved in the recognition
               of exons are enriched in the vicinity of unconserved splice
               sites. We estimate that the average intron has a splicing error
               rate of approximately 0.7\% and show that introns in highly
               expressed genes are spliced more accurately, likely due to their
               shorter length. These results implicate noisy splicing as an
               important property of genome evolution.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  6,
  number    =  12,
  pages     = "e1001236",
  month     =  dec,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Parlato2020-lh,
  title     = "Loss-of-function mutation in {PTPN2} causes aberrant activation
               of {JAK} signaling via {STAT} and very early onset intestinal
               inflammation",
  author    = "Parlato, Marianna and Nian, Qing and Charbit-Henrion, Fabienne
               and Ruemmele, Frank M and Rodrigues-Lima, Fernando and
               Cerf-Bensussan, Nadine and {Immunobiota Study Group}",
  journal   = "Gastroenterology",
  publisher = "Elsevier BV",
  volume    =  159,
  number    =  5,
  pages     = "1968--1971.e4",
  month     =  nov,
  year      =  2020,
  keywords  = "Autoimmunity; Immune Regulation; PTPN2; VEO-IBD",
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Pike2018-wn,
  title     = "Protein tyrosine phosphatases: Regulators of {CD4} {T} cells in
               inflammatory bowel disease",
  author    = "Pike, Kelly A and Tremblay, Michel L",
  abstract  = "Protein tyrosine phosphatases (PTPs) play a critical role in
               co-ordinating the signaling networks that maintain lymphocyte
               homeostasis and direct lymphocyte activation. By
               dephosphorylating tyrosine residues, PTPs have been shown to
               modulate enzyme activity and both mediate and disrupt
               protein-protein interactions. Through these molecular
               mechanisms, PTPs ultimately impact lymphocyte responses to
               environmental cues such as inflammatory cytokines and
               chemokines, as well as antigenic stimulation. Mouse models of
               acute and chronic intestinal inflammation have been shown to be
               exacerbated in the absence of PTPs such as PTPN2 and PTPN22.
               This increase in disease severity is due in part to
               hyper-activation of lymphocytes in the absence of PTP activity.
               In accordance, human PTPs have been linked to intestinal
               inflammation. Genome wide association studies (GWAS) identified
               several PTPs within risk loci for inflammatory bowel disease
               (IBD). Therapeutically targeting PTP substrates and their
               associated signaling pathways, such as those implicated in CD4+
               T cell responses, has demonstrated clinical efficacy. The
               current review focuses on the role of PTPs in controlling CD4+ T
               cell activity in the intestinal mucosa and how disruption of PTP
               activity in CD4+ T cells can contribute to intestinal
               inflammation.",
  journal   = "Front. Immunol.",
  publisher = "Frontiers Media SA",
  volume    =  9,
  pages     = "2504",
  month     =  oct,
  year      =  2018,
  keywords  = "CD4 T cells; JAK-STAT; cytokine; inflammatory bowel disease;
               protein tyrosine phosphatase",
  language  = "en"
}

@ARTICLE{Spalinger2018-mb,
  title     = "{PTPN2} regulates inflammasome activation and controls onset of
               intestinal inflammation and colon cancer",
  author    = "Spalinger, Marianne R and Manzini, Roberto and Hering, Larissa
               and Riggs, Julianne B and Gottier, Claudia and Lang, Silvia and
               Atrott, Kirstin and Fettelschoss, Antonia and Olomski, Florian
               and K{\"u}ndig, Thomas M and Fried, Michael and McCole, Declan F
               and Rogler, Gerhard and Scharl, Michael",
  abstract  = "Variants in the gene locus encoding protein tyrosine phosphatase
               non-receptor type 2 (PTPN2) are associated with inflammatory
               disorders, including inflammatory bowel diseases, rheumatoid
               arthritis, and type 1 diabetes. The anti-inflammatory role of
               PTPN2 is highlighted by the fact that PTPN2-deficient mice die a
               few weeks after birth because of systemic inflammation and
               severe colitis. However, the tissues, cells, and molecular
               mechanisms that contribute to this phenotype remain unclear.
               Here, we demonstrate that myeloid cell-specific deletion of
               PTPN2 in mice (PTPN2-LysMCre) promotes intestinal inflammation
               but protects from colitis-associated tumor formation in an
               IL-1$\beta$-dependent manner. Elevated levels of mature
               IL-1$\beta$ production in PTPN2-LysMCre mice are a consequence
               of increased inflammasome assembly due to elevated
               phosphorylation of the inflammasome adaptor molecule ASC. Thus,
               we have identified a dual role for myeloid PTPN2 in directly
               regulating inflammasome activation and IL-1$\beta$ production to
               suppress pro-inflammatory responses during colitis but promote
               intestinal tumor development.",
  journal   = "Cell Rep.",
  publisher = "Elsevier BV",
  volume    =  22,
  number    =  7,
  pages     = "1835--1848",
  month     =  feb,
  year      =  2018,
  keywords  = "IBD; TC-PTP; colitis; inflammasome; inflammatory bowel disease;
               interleukin-1-alpha",
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Spalinger2022-xj,
  title     = "Loss of protein tyrosine phosphatase non-receptor type 2 reduces
               {IL-4-driven} alternative macrophage activation",
  author    = "Spalinger, Marianne R and Crawford, Meli'sa and Bobardt, Sarah D
               and Li, Jiang and Sayoc-Becerra, Anica and Santos, Alina N and
               Shawki, Ali and Chatterjee, Pritha and Nair, Meera G and McCole,
               Declan F",
  abstract  = "Macrophages are a heterogeneous population of innate immune
               cells that are often divided into two major subsets: classically
               activated, typically pro-inflammatory (M1) macrophages that
               mediate host defense, and alternatively activated,
               tolerance-inducing (M2) macrophages that exert homeostatic and
               tissue-regenerative functions. Disturbed macrophage
               function/differentiation results either in inadequate, excessive
               immune activation or in a failure to induce efficient protective
               immune responses against pathogens. Loss-of-function variants in
               protein tyrosine phosphatase non-receptor type 2 (PTPN2) are
               associated with chronic inflammatory disorders, but the effect
               of macrophage-intrinsic PTPN2 loss is still poorly understood.
               Here we report that PTPN2-deficient macrophages fail to acquire
               an alternatively activated/M2 phenotype. This was the
               consequence of reduced IL-6 receptor expression and a failure to
               induce IL-4 receptor in response to IL-6, resulting in an
               inability to respond to the key M2-inducing cytokine IL-4.
               Ultimately, failure to adequately respond to IL-6 and IL-4
               resulted in increased levels of M1 macrophage marker expression
               in vitro and exacerbated lung inflammation upon infection with
               Nippostrongylus brasiliensis in vivo. These results demonstrate
               that PTPN2 loss interferes with the ability of macrophages to
               adequately respond to inflammatory stimuli and might explain the
               increased susceptibility of PTPN2 loss-of-function carriers to
               developing inflammatory diseases.",
  journal   = "Mucosal Immunol.",
  publisher = "Elsevier BV",
  volume    =  15,
  number    =  1,
  pages     = "74--83",
  month     =  jan,
  year      =  2022,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Sigismund2021-cu,
  title     = "Endocytosis in the context-dependent regulation of individual
               and collective cell properties",
  author    = "Sigismund, Sara and Lanzetti, Letizia and Scita, Giorgio and Di
               Fiore, Pier Paolo",
  abstract  = "Endocytosis allows cells to transport particles and molecules
               across the plasma membrane. In addition, it is involved in the
               termination of signalling through receptor downmodulation and
               degradation. This traditional outlook has been substantially
               modified in recent years by discoveries that endocytosis and
               subsequent trafficking routes have a profound impact on the
               positive regulation and propagation of signals, being key for
               the spatiotemporal regulation of signal transmission in cells.
               Accordingly, endocytosis and membrane trafficking regulate
               virtually every aspect of cell physiology and are frequently
               subverted in pathological conditions. Two key aspects of
               endocytic control over signalling are coming into focus:
               context-dependency and long-range effects. First,
               endocytic-regulated outputs are not stereotyped but heavily
               dependent on the cell-specific regulation of endocytic networks.
               Second, endocytic regulation has an impact not only on
               individual cells but also on the behaviour of cellular
               collectives. Herein, we will discuss recent advancements in
               these areas, highlighting how endocytic trafficking impacts
               complex cell properties, including cell polarity and collective
               cell migration, and the relevance of these mechanisms to
               disease, in particular cancer.",
  journal   = "Nat. Rev. Mol. Cell Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  9,
  pages     = "625--643",
  month     =  sep,
  year      =  2021,
  language  = "en"
}

@ARTICLE{Steger2016-yl,
  title     = "Phosphoproteomics reveals that Parkinson's disease kinase
               {LRRK2} regulates a subset of Rab {GTPases}",
  author    = "Steger, Martin and Tonelli, Francesca and Ito, Genta and Davies,
               Paul and Trost, Matthias and Vetter, Melanie and Wachter,
               Stefanie and Lorentzen, Esben and Duddy, Graham and Wilson,
               Stephen and Baptista, Marco A S and Fiske, Brian K and Fell,
               Matthew J and Morrow, John A and Reith, Alastair D and Alessi,
               Dario R and Mann, Matthias",
  abstract  = "Mutations in Park8, encoding for the multidomain Leucine-rich
               repeat kinase 2 (LRRK2) protein, comprise the predominant
               genetic cause of Parkinson's disease (PD). G2019S, the most
               common amino acid substitution activates the kinase two- to
               threefold. This has motivated the development of LRRK2 kinase
               inhibitors; however, poor consensus on physiological LRRK2
               substrates has hampered clinical development of such
               therapeutics. We employ a combination of phosphoproteomics,
               genetics, and pharmacology to unambiguously identify a subset of
               Rab GTPases as key LRRK2 substrates. LRRK2 directly
               phosphorylates these both in vivo and in vitro on an
               evolutionary conserved residue in the switch II domain.
               Pathogenic LRRK2 variants mapping to different functional
               domains increase phosphorylation of Rabs and this strongly
               decreases their affinity to regulatory proteins including Rab
               GDP dissociation inhibitors (GDIs). Our findings uncover a key
               class of bona-fide LRRK2 substrates and a novel regulatory
               mechanism of Rabs that connects them to PD.",
  journal   = "Elife",
  publisher = "eLife Sciences Organisation, Ltd.",
  volume    =  5,
  month     =  jan,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/"
}
###
@ARTICLE{Bae2018-pu,
  title     = "{LRRK2} kinase regulates $\alpha$-synuclein propagation via
               {RAB35} phosphorylation",
  author    = "Bae, Eun-Jin and Kim, Dong-Kyu and Kim, Changyoun and Mante,
               Michael and Adame, Anthony and Rockenstein, Edward and Ulusoy,
               Ayse and Klinkenberg, Michael and Jeong, Ga Ram and Bae, Jae
               Ryul and Lee, Cheolsoon and Lee, He-Jin and Lee, Byung-Dae and
               Di Monte, Donato A and Masliah, Eliezer and Lee, Seung-Jae",
  abstract  = "Propagation of $\alpha$-synuclein aggregates has been suggested
               as a contributing factor in Parkinson's disease (PD)
               progression. However, the molecular mechanisms underlying
               $\alpha$-synuclein aggregation are not fully understood. Here,
               we demonstrate in cell culture, nematode, and rodent models of
               PD that leucine-rich repeat kinase 2 (LRRK2), a PD-linked
               kinase, modulates $\alpha$-synuclein propagation in a kinase
               activity-dependent manner. The PD-linked G2019S mutation in
               LRRK2, which increases kinase activity, enhances propagation
               efficiency. Furthermore, we show that the role of LRRK2 in
               $\alpha$-synuclein propagation is mediated by RAB35
               phosphorylation. Constitutive activation of RAB35 overrides the
               reduced $\alpha$-synuclein propagation phenotype in lrk-1 mutant
               C. elegans. Finally, in a mouse model of synucleinopathy,
               administration of an LRRK2 kinase inhibitor reduced
               $\alpha$-synuclein aggregation via enhanced interaction of
               $\alpha$-synuclein with the lysosomal degradation pathway. These
               results suggest that LRRK2-mediated RAB35 phosphorylation is a
               potential therapeutic target for modifying disease progression.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  9,
  number    =  1,
  pages     = "3465",
  month     =  aug,
  year      =  2018,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Bonet-Ponce2020-ri,
  title     = "{LRRK2} mediates tubulation and vesicle sorting from lysosomes",
  author    = "Bonet-Ponce, Luis and Beilina, Alexandra and Williamson, Chad D
               and Lindberg, Eric and Kluss, Jillian H and Saez-Atienzar, Sara
               and Landeck, Natalie and Kumaran, Ravindran and Mamais,
               Adamantios and Bleck, Christopher K E and Li, Yan and Cookson,
               Mark R",
  abstract  = "Genetic variation around the LRRK2 gene affects risk of both
               familial and sporadic Parkinson's disease (PD). However, the
               biological functions of LRRK2 remain incompletely understood.
               Here, we report that LRRK2 is recruited to lysosomes after
               exposure of cells to the lysosome membrane-rupturing agent
               LLOME. Using an unbiased proteomic screen, we identified the
               motor adaptor protein JIP4 as an LRRK2 partner at the lysosomal
               membrane. LRRK2 can recruit JIP4 to lysosomes in a
               kinase-dependent manner via the phosphorylation of RAB35 and
               RAB10. Using super-resolution live-cell imaging microscopy and
               FIB-SEM, we demonstrate that JIP4 promotes the formation of
               LAMP1-negative tubules that release membranous content from
               lysosomes. Thus, we describe a new process orchestrated by
               LRRK2, which we name LYTL (LYsosomal Tubulation/sorting driven
               by LRRK2), by which lysosomal tubulation is used to release
               vesicles from lysosomes. Given the central role of the lysosome
               in PD, LYTL is likely to be disease relevant.",
  journal   = "Sci. Adv.",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  6,
  number    =  46,
  pages     = "eabb2454",
  month     =  nov,
  year      =  2020,
  copyright = "https://creativecommons.org/licenses/by-nc/4.0/",
  language  = "en"
}



@ARTICLE{Lee2021-ff,
  title    = "Inflammatory bowel disease and Parkinson's disease: common
              pathophysiological links",
  author   = "Lee, Ho-Su and Lobbestael, Evy and Vermeire, S{\'e}verine and
              Sabino, Jo{\~a}o and Cleynen, Isabelle",
  abstract = "Inflammatory bowel disease and Parkinson's disease are chronic
              progressive disorders that mainly affect different organs: the
              gut and brain, respectively. Accumulating evidence has suggested
              a bidirectional link between gastrointestinal inflammation and
              neurodegeneration, in accordance with the concept of the
              'gut-brain axis'. Moreover, recent population-based studies have
              shown that inflammatory bowel disease might increase the risk of
              Parkinson's disease. Although the precise mechanisms underlying
              gut-brain interactions remain elusive, some of the latest
              findings have begun to explain the link. Several genetic loci are
              shared between both disorders with a similar direction of effect
              on the risk of both diseases. The most interesting example is
              LRRK2 (leucine-rich repeat kinase 2), initially identified as a
              causal gene in Parkinson's disease, and recently also implicated
              in Crohn's disease. In this review, we highlight recent findings
              on the link between these seemingly unrelated diseases with
              shared genetic susceptibility. We discuss supporting and
              conflicting data obtained from epidemiological and genetic
              studies along with remaining questions and concerns. In addition,
              we discuss possible biological links including the gut-brain
              axis, microbiota, autoimmunity, mitochondrial function and
              autophagy.",
  journal  = "Gut",
  volume   =  70,
  number   =  2,
  pages    = "408--417",
  month    =  feb,
  year     =  2021,
  keywords = "IBD - genetics; IBD basic research; Parkinson's disease;
              epidemiology; inflammatory bowel disease",
  language = "en"
}

@ARTICLE{Mrozowska2016-lm,
  title     = "Regulation of podocalyxin trafficking by Rab small {GTPases} in
               epithelial cells",
  author    = "Mrozowska, Paulina S and Fukuda, Mitsunori",
  journal   = "Small GTPases",
  publisher = "Informa UK Limited",
  volume    =  7,
  number    =  4,
  pages     = "231--238",
  month     =  oct,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Kinoshita2020-yl,
  title     = "{Rab35-GEFs}, {DENND1A} and folliculin differentially regulate
               podocalyxin trafficking in two- and three-dimensional epithelial
               cell cultures",
  author    = "Kinoshita, Riko and Homma, Yuta and Fukuda, Mitsunori",
  abstract  = "Polarized epithelial cells have functionally distinct apical and
               basolateral membranes through which they communicate with
               external and internal bodily environments, respectively. The
               establishment and maintenance of this asymmetric structure
               depend on polarized trafficking of specific cargos, but the
               precise molecular mechanism is incompletely understood. We
               previously showed that Rab35, a member of the Rab family small
               GTPases, differentially regulates the trafficking of an apical
               cargo, podocalyxin (PODXL), in two-dimensional (2D) and
               three-dimensional (3D) Madin-Darby canine kidney (MDCK) II cell
               cultures through specific interactions with two distinct
               effectors, OCRL inositol polyphosphate-5-phosphatase (OCRL) and
               ArfGAP with coiled-coil, ankyrin repeat and pleckstrin homology
               domains 2 (ACAP2), respectively. However, whether the upstream
               regulators of Rab35 also differ depending on the culture
               conditions remains completely unknown. Here, we investigated
               four known guanine nucleotide exchange factors (GEFs) of Rab35,
               namely DENN domain-containing 1A (DENND1A), DENND1B, DENND1C,
               and folliculin (FLCN), and demonstrate that DENND1A and FLCN
               exhibit distinct requirements for Rab35-dependent PODXL
               trafficking under the two culture conditions. In 3D cell
               cultures, only DENDN1A-knockout cysts exhibited the inverted
               localization of PODXL similar to that of Rab35-knockout cysts.
               Moreover, the DENN domain, harboring GEF activity toward Rab35,
               was required for proper PODXL trafficking to the apical
               membrane. By contrast, FLCN-knockdown cells specifically
               accumulated PODXL in actin-rich structures similar to the
               Rab35-knockdown cells in 2D cell cultures. Our findings indicate
               that two distinct functional cascades of Rab35, the
               FLCN-Rab35-OCRL and the DENND1A-Rab35-ACAP2 axes, regulate PODXL
               trafficking in 2D and 3D MDCK II cell cultures, respectively.",
  journal   = "J. Biol. Chem.",
  publisher = "Elsevier BV",
  volume    =  295,
  number    =  11,
  pages     = "3652--3663",
  month     =  mar,
  year      =  2020,
  keywords  = "3D cell culture; Rab; cell polarity; epithelial cell; guanine
               nucleotide exchange factor (GEF); membrane trafficking;
               podocalyxin; small GTPase; tissue development",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Mu2021-ar,
  title     = "The impact of cell type and context-dependent regulatory
               variants on human immune traits",
  author    = "Mu, Zepeng and Wei, Wei and Fair, Benjamin and Miao, Jinlin and
               Zhu, Ping and Li, Yang I",
  abstract  = "BACKGROUND: The vast majority of trait-associated variants
               identified using genome-wide association studies (GWAS) are
               noncoding, and therefore assumed to impact gene regulation.
               However, the majority of trait-associated loci are unexplained
               by regulatory quantitative trait loci (QTLs). RESULTS: We
               perform a comprehensive characterization of the putative
               mechanisms by which GWAS loci impact human immune traits. By
               harmonizing four major immune QTL studies, we identify 26,271
               expression QTLs (eQTLs) and 23,121 splicing QTLs (sQTLs)
               spanning 18 immune cell types. Our colocalization analyses
               between QTLs and trait-associated loci from 72 GWAS reveals that
               genetic effects on RNA expression and splicing in immune cells
               colocalize with 40.4\% of GWAS loci for immune-related traits,
               in many cases increasing the fraction of colocalized loci by two
               fold compared to previous studies. Notably, we find that the
               largest contributors of this increase are splicing QTLs, which
               colocalize on average with 14\% of all GWAS loci that do not
               colocalize with eQTLs. By contrast, we find that cell
               type-specific eQTLs, and eQTLs with small effect sizes
               contribute very few new colocalizations. To investigate the 60\%
               of GWAS loci that remain unexplained, we collect H3K27ac
               CUT\&Tag data from rheumatoid arthritis and healthy controls,
               and find large-scale differences between immune cells from the
               different disease contexts, including at regions overlapping
               unexplained GWAS loci. CONCLUSION: Altogether, our work supports
               RNA splicing as an important mediator of genetic effects on
               immune traits, and suggests that we must expand our study of
               regulatory processes in disease contexts to improve functional
               interpretation of as yet unexplained GWAS loci.",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  1,
  pages     = "122",
  month     =  apr,
  year      =  2021,
  keywords  = "Colocalization; GWAS; eQTL; sQTL",
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Melamud2009-my,
  title     = "Structural implication of splicing stochastics",
  author    = "Melamud, Eugene and Moult, John",
  abstract  = "Even though nearly every human gene has at least one alternative
               splice form, very little is so far known about the structure and
               function of resulting protein products. It is becoming
               increasingly clear that a significant fraction of all isoforms
               are products of noisy selection of splice sites and thus
               contribute little to actual functional diversity, and may
               potentially be deleterious. In this study, we examine the impact
               of alternative splicing on protein sequence and structure in
               three datasets: alternative splicing events conserved across
               multiple species, alternative splicing events in genes that are
               strongly linked to disease and all observed alternative splicing
               events. We find that the vast majority of all alternative
               isoforms result in unstable protein conformations. In contrast
               to that, the small subset of isoforms conserved across species
               tends to maintain protein structural integrity to a greater
               extent. Alternative splicing in disease-associated genes
               produces unstable structures just as frequently as all other
               genes, indicating that selection to reduce the effects of
               alternative splicing on this set is not especially pronounced.
               Overall, the properties of alternative spliced proteins are
               consistent with the outcome of noisy selection of splice sites
               by splicing machinery.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  37,
  number    =  14,
  pages     = "4862--4872",
  month     =  aug,
  year      =  2009,
  copyright = "http://creativecommons.org/licenses/by-nc/2.0/uk/",
  language  = "en"
}

@ARTICLE{Wright2022-gp,
  title     = "Long read sequencing reveals novel isoforms and insights into
               splicing regulation during cell state changes",
  author    = "Wright, David J and Hall, Nicola A L and Irish, Naomi and Man,
               Angela L and Glynn, Will and Mould, Arne and Angeles, Alejandro
               De Los and Angiolini, Emily and Swarbreck, David and Gharbi,
               Karim and Tunbridge, Elizabeth M and Haerty, Wilfried",
  abstract  = "BACKGROUND: Alternative splicing is a key mechanism underlying
               cellular differentiation and a driver of complexity in mammalian
               neuronal tissues. However, understanding of which isoforms are
               differentially used or expressed and how this affects cellular
               differentiation remains unclear. Long read sequencing allows
               full-length transcript recovery and quantification, enabling
               transcript-level analysis of alternative splicing processes and
               how these change with cell state. Here, we utilise Oxford
               Nanopore Technologies sequencing to produce a custom annotation
               of a well-studied human neuroblastoma cell line SH-SY5Y, and to
               characterise isoform expression and usage across
               differentiation. RESULTS: We identify many previously
               unannotated features, including a novel transcript of the
               voltage-gated calcium channel subunit gene, CACNA2D2. We show
               differential expression and usage of transcripts during
               differentiation identifying candidates for future research into
               state change regulation. CONCLUSIONS: Our work highlights the
               potential of long read sequencing to uncover previously unknown
               transcript diversity and mechanisms influencing alternative
               splicing.",
  journal   = "BMC Genomics",
  publisher = "Springer Science and Business Media LLC",
  volume    =  23,
  number    =  1,
  pages     = "42",
  month     =  jan,
  year      =  2022,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Rotival2019-ic,
  title     = "Defining the genetic and evolutionary architecture of
               alternative splicing in response to infection",
  author    = "Rotival, Maxime and Quach, H{\'e}l{\`e}ne and Quintana-Murci,
               Lluis",
  abstract  = "Host and environmental factors contribute to variation in human
               immune responses, yet the genetic and evolutionary drivers of
               alternative splicing in response to infection remain largely
               uncharacterised. Leveraging 970 RNA-sequencing profiles of
               resting and stimulated monocytes from 200 individuals of
               African- and European-descent, we show that immune activation
               elicits a marked remodelling of the isoform repertoire, while
               increasing the levels of erroneous splicing. We identify 1,464
               loci associated with variation in isoform usage (sQTLs), 9\% of
               them being stimulation-specific, which are enriched in
               disease-related loci. Furthermore, we detect a longstanding
               increased plasticity of immune gene splicing, and show that
               positive selection and Neanderthal introgression have both
               contributed to diversify the splicing landscape of human
               populations. Together, these findings suggest that differential
               isoform usage has been an important substrate of innovation in
               the long-term evolution of immune responses and a more recent
               vehicle of population local adaptation.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  1,
  pages     = "1671",
  month     =  apr,
  year      =  2019,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Mazin2021-lb,
  title     = "Alternative splicing during mammalian organ development",
  author    = "Mazin, Pavel V and Khaitovich, Philipp and Cardoso-Moreira,
               Margarida and Kaessmann, Henrik",
  abstract  = "Alternative splicing (AS) is pervasive in mammalian genomes, yet
               cross-species comparisons have been largely restricted to adult
               tissues and the functionality of most AS events remains unclear.
               We assessed AS patterns across pre- and postnatal development of
               seven organs in six mammals and a bird. Our analyses revealed
               that developmentally dynamic AS events, which are especially
               prevalent in the brain, are substantially more conserved than
               nondynamic ones. Cassette exons with increasing inclusion
               frequencies during development show the strongest signals of
               conserved and regulated AS. Newly emerged cassette exons are
               typically incorporated late in testis development, but those
               retained during evolution are predominantly brain specific. Our
               work suggests that an intricate interplay of programs
               controlling gene expression levels and AS is fundamental to
               organ development, especially for the brain and heart. In these
               regulatory networks, AS affords substantial functional
               diversification of genes through the generation of tissue- and
               time-specific isoforms from broadly expressed genes.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  6,
  pages     = "925--934",
  month     =  jun,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}
###
@ARTICLE{Deininger2011-cx,
  title     = "Alu elements: know the {SINEs}",
  author    = "Deininger, Prescott",
  abstract  = "Alu elements are primate-specific repeats and comprise 11\% of
               the human genome. They have wide-ranging influences on gene
               expression. Their contribution to genome evolution, gene
               regulation and disease is reviewed.",
  journal   = "Genome Biol.",
  publisher = "Springer Nature",
  volume    =  12,
  number    =  12,
  pages     = "236",
  month     =  dec,
  year      =  2011,
  language  = "en"
}

@ARTICLE{Attig2016-mj,
  title     = "Splicing repression allows the gradual emergence of new
               Alu-exons in primate evolution",
  author    = "Attig, Jan and Ruiz de los Mozos, Igor and Haberman, Nejc and
               Wang, Zhen and Emmett, Warren and Zarnack, Kathi and K{\"o}nig,
               Julian and Ule, Jernej",
  abstract  = "Alu elements are retrotransposons that frequently form new exons
               during primate evolution. Here, we assess the interplay of
               splicing repression by hnRNPC and nonsense-mediated mRNA decay
               (NMD) in the quality control and evolution of new Alu-exons. We
               identify 3100 new Alu-exons and show that NMD more efficiently
               recognises transcripts with Alu-exons compared to other exons
               with premature termination codons. However, some Alu-exons
               escape NMD, especially when an adjacent intron is retained,
               highlighting the importance of concerted repression by splicing
               and NMD. We show that evolutionary progression of 3' splice
               sites is coupled with longer repressive uridine tracts. Once the
               3' splice site at ancient Alu-exons reaches a stable phase,
               splicing repression by hnRNPC decreases, but the exons generally
               remain sensitive to NMD. We conclude that repressive motifs are
               strongest next to cryptic exons and that gradual weakening of
               these motifs contributes to the evolutionary emergence of new
               alternative exons.",
  journal   = "Elife",
  publisher = "eLife Sciences Publications, Ltd",
  volume    =  5,
  month     =  nov,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Singer2004-km,
  title     = "From ``junk'' to gene: curriculum vitae of a primate receptor
               isoform gene",
  author    = "Singer, Silke S and M{\"a}nnel, Daniela N and Hehlgans, Thomas
               and Brosius, J{\"u}rgen and Schmitz, J{\"u}rgen",
  abstract  = "Exonization of Alu retroposons awakens public opinion,
               particularly when causing genetic diseases. However, often
               neglected, alternative ``Alu-exons'' also carry the potential to
               greatly enhance genetic diversity by increasing the
               transcriptome of primates chiefly via alternative splicing.Here,
               we report a 5' exon generated from one of the two alternative
               transcripts in human tumor necrosis factor receptor gene type 2
               (p75TNFR) that contains an ancient Alu-SINE, which provides an
               alternative N-terminal protein-coding domain. We follow the
               primate evolution over the past 63 million years to reconstruct
               the key events that gave rise to a novel receptor isoform. The
               Alu integration and start codon formation occurred between 58
               and 40 million years ago (MYA) in the common ancestor of
               anthropoid primates. Yet a functional gene product could not be
               generated until a novel splice site and an open reading frame
               were introduced between 40 and 25 MYA on the catarrhine lineage
               (Old World monkeys including apes).",
  journal   = "J. Mol. Biol.",
  publisher = "Elsevier BV",
  volume    =  341,
  number    =  4,
  pages     = "883--886",
  month     =  aug,
  year      =  2004,
  language  = "en"
}

@ARTICLE{Mercuri2018-pi,
  title     = "Nusinersen versus sham control in later-onset spinal muscular
               atrophy",
  author    = "Mercuri, Eugenio and Darras, Basil T and Chiriboga, Claudia A
               and Day, John W and Campbell, Craig and Connolly, Anne M and
               Iannaccone, Susan T and Kirschner, Janbernd and Kuntz, Nancy L
               and Saito, Kayoko and Shieh, Perry B and Tulinius, M{\'a}r and
               Mazzone, Elena S and Montes, Jacqueline and Bishop, Kathie M and
               Yang, Qingqing and Foster, Richard and Gheuens, Sarah and
               Bennett, C Frank and Farwell, Wildon and Schneider, Eugene and
               De Vivo, Darryl C and Finkel, Richard S",
  journal   = "N. Engl. J. Med.",
  publisher = "Massachusetts Medical Society",
  volume    =  378,
  number    =  7,
  pages     = "625--635",
  month     =  feb,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Roberts2020-rx,
  title     = "Advances in oligonucleotide drug delivery",
  author    = "Roberts, Thomas C and Langer, Robert and Wood, Matthew J A",
  abstract  = "Oligonucleotides can be used to modulate gene expression via a
               range of processes including RNAi, target degradation by RNase
               H-mediated cleavage, splicing modulation, non-coding RNA
               inhibition, gene activation and programmed gene editing. As
               such, these molecules have potential therapeutic applications
               for myriad indications, with several oligonucleotide drugs
               recently gaining approval. However, despite recent technological
               advances, achieving efficient oligonucleotide delivery,
               particularly to extrahepatic tissues, remains a major
               translational limitation. Here, we provide an overview of
               oligonucleotide-based drug platforms, focusing on key approaches
               - including chemical modification, bioconjugation and the use of
               nanocarriers - which aim to address the delivery challenge.",
  journal   = "Nat. Rev. Drug Discov.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  19,
  number    =  10,
  pages     = "673--694",
  month     =  oct,
  year      =  2020,
  language  = "en"
}

@ARTICLE{Alasoo2018-pv,
  title     = "Shared genetic effects on chromatin and gene expression indicate
               a role for enhancer priming in immune response",
  author    = "Alasoo, Kaur and {HIPSCI Consortium} and Rodrigues, Julia and
               Mukhopadhyay, Subhankar and Knights, Andrew J and Mann, Alice L
               and Kundu, Kousik and Hale, Christine and Dougan, Gordon and
               Gaffney, Daniel J",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  3,
  pages     = "424--431",
  month     =  mar,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Lavin2014-fb,
  title     = "Tissue-resident macrophage enhancer landscapes are shaped by the
               local microenvironment",
  author    = "Lavin, Yonit and Winter, Deborah and Blecher-Gonen, Ronnie and
               David, Eyal and Keren-Shaul, Hadas and Merad, Miriam and Jung,
               Steffen and Amit, Ido",
  abstract  = "Macrophages are critical for innate immune defense and also
               control organ homeostasis in a tissue-specific manner. They
               provide a fitting model to study the impact of ontogeny and
               microenvironment on chromatin state and whether chromatin
               modifications contribute to macrophage identity. Here, we
               profile the dynamics of four histone modifications across seven
               tissue-resident macrophage populations. We identify 12,743
               macrophage-specific enhancers and establish that tissue-resident
               macrophages have distinct enhancer landscapes beyond what can be
               explained by developmental origin. Combining our enhancer
               catalog with gene expression profiles and open chromatin
               regions, we show that a combination of tissue- and
               lineage-specific transcription factors form the regulatory
               networks controlling chromatin specification in tissue-resident
               macrophages. The environment is capable of shaping the chromatin
               landscape of transplanted bone marrow precursors, and even
               differentiated macrophages can be reprogrammed when transferred
               into a new microenvironment. These results provide a
               comprehensive view of macrophage regulatory landscape and
               highlight the importance of the microenvironment, along with
               pioneer factors in orchestrating identity and plasticity.",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  159,
  number    =  6,
  pages     = "1312--1326",
  month     =  dec,
  year      =  2014,
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@UNPUBLISHED{AlKhafaji2021-af,
  title    = "High-throughput {RNA} isoform sequencing using programmable
              {cDNA} concatenation",
  author   = "Al'Khafaji, Aziz M and Smith, Jonathan T and Garimella, Kiran V
              and Babadi, Mehrtash and Sade-Feldman, Moshe and Gatzen, Michael
              and Sarkizova, Siranush and Schwartz, Marc A and Popic, Victoria
              and Blaum, Emily M and Day, Allyson and Costello, Maura and
              Bowers, Tera and Gabriel, Stacey and Banks, Eric and Philippakis,
              Anthony A and Boland, Genevieve M and Blainey, Paul C and
              Hacohen, Nir",
  abstract = "AbstractAlternative splicing is a core biological process that
              enables profound and essential diversification of gene function.
              Short-read RNA sequencing approaches fail to resolve RNA isoforms
              and therefore primarily enable gene expression measurements - an
              isoform unaware representation of the transcriptome. Conversely,
              full-length RNA sequencing using long-read technologies are able
              to capture complete transcript isoforms, but their utility is
              deeply constrained due to throughput limitations. Here, we
              introduce MAS-ISO-seq, a technique for programmably concatenating
              cDNAs into single molecules optimal for long-read sequencing,
              boosting the throughput >15 fold to nearly 40 million cDNA reads
              per run on the Sequel IIe sequencer. We validated unambiguous
              isoform assignment with MAS-ISO-seq using a synthetic RNA isoform
              library and applied this approach to single-cell RNA sequencing
              of tumor-infiltrating T cells. Results demonstrated a >30 fold
              boosted discovery of differentially spliced genes and robust cell
              clustering, as well as canonical PTPRC splicing patterns across T
              cell subpopulations and the concerted expression of the
              associated hnRNPLL splicing factor. Methods such as MAS-ISO-seq
              will drive discovery of novel isoforms and the transition from
              gene expression to transcript isoform expression analyses.",
  journal  = "bioRxiv",
  month    =  oct,
  year     =  2021
}

@ARTICLE{Amarasinghe2020-ci,
  title     = "Opportunities and challenges in long-read sequencing data
               analysis",
  author    = "Amarasinghe, Shanika L and Su, Shian and Dong, Xueyi and Zappia,
               Luke and Ritchie, Matthew E and Gouil, Quentin",
  abstract  = "Long-read technologies are overcoming early limitations in
               accuracy and throughput, broadening their application domains in
               genomics. Dedicated analysis tools that take into account the
               characteristics of long-read data are thus required, but the
               fast pace of development of such tools can be overwhelming. To
               assist in the design and analysis of long-read sequencing
               projects, we review the current landscape of available tools and
               present an online interactive database, long-read-tools.org, to
               facilitate their browsing. We further focus on the principles of
               error correction, base modification detection, and long-read
               transcriptomics analysis and highlight the challenges that
               remain.",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  21,
  number    =  1,
  pages     = "30",
  month     =  feb,
  year      =  2020,
  keywords  = "Data analysis; Long-read sequencing; Oxford Nanopore; PacBio",
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Hu2021-bv,
  title     = "{LIQA}: long-read isoform quantification and analysis",
  author    = "Hu, Yu and Fang, Li and Chen, Xuelian and Zhong, Jiang F and Li,
               Mingyao and Wang, Kai",
  abstract  = "Long-read RNA sequencing (RNA-seq) technologies can sequence
               full-length transcripts, facilitating the exploration of
               isoform-specific gene expression over short-read RNA-seq. We
               present LIQA to quantify isoform expression and detect
               differential alternative splicing (DAS) events using long-read
               direct mRNA sequencing or cDNA sequencing data. LIQA
               incorporates base pair quality score and isoform-specific read
               length information in a survival model to assign different
               weights across reads, and uses an expectation-maximization
               algorithm for parameter estimation. We apply LIQA to long-read
               RNA-seq data from the Universal Human Reference, acute myeloid
               leukemia, and esophageal squamous epithelial cells and
               demonstrate its high accuracy in profiling alternative splicing
               events.",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  1,
  pages     = "182",
  month     =  jun,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Zhao2014-ve,
  title     = "{CrossMap}: a versatile tool for coordinate conversion between
               genome assemblies",
  author    = "Zhao, Hao and Sun, Zhifu and Wang, Jing and Huang, Haojie and
               Kocher, Jean-Pierre and Wang, Liguo",
  abstract  = "MOTIVATION: Reference genome assemblies are subject to change
               and refinement from time to time. Generally, researchers need to
               convert the results that have been analyzed according to old
               assemblies to newer versions, or vice versa, to facilitate
               meta-analysis, direct comparison, data integration and
               visualization. Several useful conversion tools can convert
               genome interval files in browser extensible data or general
               feature format, but none have the functionality to convert files
               in sequence alignment map or BigWig format. This is a
               significant gap in computational genomics tools, as these
               formats are the ones most widely used for representing
               high-throughput sequencing data, such as RNA-seq, chromatin
               immunoprecipitation sequencing, DNA-seq, etc. RESULTS: Here we
               developed CrossMap, a versatile and efficient tool for
               converting genome coordinates between assemblies. CrossMap
               supports most of the commonly used file formats, including BAM,
               sequence alignment map, Wiggle, BigWig, browser extensible data,
               general feature format, gene transfer format and variant call
               format. AVAILABILITY AND IMPLEMENTATION: CrossMap is written in
               Python and C. Source code and a comprehensive user's manual are
               freely available at: http://crossmap.sourceforge.net/.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  30,
  number    =  7,
  pages     = "1006--1007",
  month     =  apr,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Price2006-kr,
  title     = "Principal components analysis corrects for stratification in
               genome-wide association studies",
  author    = "Price, Alkes L and Patterson, Nick J and Plenge, Robert M and
               Weinblatt, Michael E and Shadick, Nancy A and Reich, David",
  abstract  = "Population stratification--allele frequency differences between
               cases and controls due to systematic ancestry differences-can
               cause spurious associations in disease studies. We describe a
               method that enables explicit detection and correction of
               population stratification on a genome-wide scale. Our method
               uses principal components analysis to explicitly model ancestry
               differences between cases and controls. The resulting correction
               is specific to a candidate marker's variation in frequency
               across ancestral populations, minimizing spurious associations
               while maximizing power to detect true associations. Our simple,
               efficient approach can easily be applied to disease studies with
               hundreds of thousands of markers.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  38,
  number    =  8,
  pages     = "904--909",
  month     =  aug,
  year      =  2006,
  language  = "en"
}


##
@ARTICLE{Dobin2013-hs,
  title     = "{STAR}: ultrafast universal {RNA-seq} aligner",
  author    = "Dobin, Alexander and Davis, Carrie A and Schlesinger, Felix and
               Drenkow, Jorg and Zaleski, Chris and Jha, Sonali and Batut,
               Philippe and Chaisson, Mark and Gingeras, Thomas R",
  abstract  = "MOTIVATION: Accurate alignment of high-throughput RNA-seq data
               is a challenging and yet unsolved problem because of the
               non-contiguous transcript structure, relatively short read
               lengths and constantly increasing throughput of the sequencing
               technologies. Currently available RNA-seq aligners suffer from
               high mapping error rates, low mapping speed, read length
               limitation and mapping biases. RESULTS: To align our large (>80
               billon reads) ENCODE Transcriptome RNA-seq dataset, we developed
               the Spliced Transcripts Alignment to a Reference (STAR) software
               based on a previously undescribed RNA-seq alignment algorithm
               that uses sequential maximum mappable seed search in
               uncompressed suffix arrays followed by seed clustering and
               stitching procedure. STAR outperforms other aligners by a factor
               of >50 in mapping speed, aligning to the human genome 550
               million 2 $\times$ 76 bp paired-end reads per hour on a modest
               12-core server, while at the same time improving alignment
               sensitivity and precision. In addition to unbiased de novo
               detection of canonical junctions, STAR can discover
               non-canonical splices and chimeric (fusion) transcripts, and is
               also capable of mapping full-length RNA sequences. Using Roche
               454 sequencing of reverse transcription polymerase chain
               reaction amplicons, we experimentally validated 1960 novel
               intergenic splice junctions with an 80-90\% success rate,
               corroborating the high precision of the STAR mapping strategy.
               AVAILABILITY AND IMPLEMENTATION: STAR is implemented as a
               standalone C++ code. STAR is free open source software
               distributed under GPLv3 license and can be downloaded from
               http://code.google.com/p/rna-star/.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  29,
  number    =  1,
  pages     = "15--21",
  month     =  jan,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Van_de_Geijn2015-lb,
  title     = "{WASP}: allele-specific software for robust molecular
               quantitative trait locus discovery",
  author    = "van de Geijn, Bryce and McVicker, Graham and Gilad, Yoav and
               Pritchard, Jonathan K",
  abstract  = "Allele-specific sequencing reads provide a powerful signal for
               identifying molecular quantitative trait loci (QTLs), but they
               are challenging to analyze and are prone to technical artifacts.
               Here we describe WASP, a suite of tools for unbiased
               allele-specific read mapping and discovery of molecular QTLs.
               Using simulated reads, RNA-seq reads and chromatin
               immunoprecipitation sequencing (ChIP-seq) reads, we demonstrate
               that WASP has a low error rate and is far more powerful than
               existing QTL-mapping approaches.",
  journal   = "Nat. Methods",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  11,
  pages     = "1061--1063",
  month     =  nov,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Li2009-yk,
  title     = "The Sequence {Alignment/Map} format and {SAMtools}",
  author    = "Li, Heng and Handsaker, Bob and Wysoker, Alec and Fennell, Tim
               and Ruan, Jue and Homer, Nils and Marth, Gabor and Abecasis,
               Goncalo and Durbin, Richard and {1000 Genome Project Data
               Processing Subgroup}",
  abstract  = "SUMMARY: The Sequence Alignment/Map (SAM) format is a generic
               alignment format for storing read alignments against reference
               sequences, supporting short and long reads (up to 128 Mbp)
               produced by different sequencing platforms. It is flexible in
               style, compact in size, efficient in random access and is the
               format in which alignments from the 1000 Genomes Project are
               released. SAMtools implements various utilities for
               post-processing alignments in the SAM format, such as indexing,
               variant caller and alignment viewer, and thus provides universal
               tools for processing read alignments. AVAILABILITY:
               http://samtools.sourceforge.net.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  25,
  number    =  16,
  pages     = "2078--2079",
  month     =  aug,
  year      =  2009,
  copyright = "http://creativecommons.org/licenses/by-nc/2.0/uk/",
  language  = "en"
}

@ARTICLE{Cotto2023-yp,
  title    = "Integrated analysis of genomic and transcriptomic data for the
              discovery of splice-associated variants in cancer",
  author   = "Cotto, Kelsy C and Feng, Yang-Yang and Ramu, Avinash and
              Richters, Megan and Freshour, Sharon L and Skidmore, Zachary L
              and Xia, Huiming and McMichael, Joshua F and Kunisaki, Jason and
              Campbell, Katie M and Chen, Timothy Hung-Po and Rozycki, Emily B
              and Adkins, Douglas and Devarakonda, Siddhartha and Sankararaman,
              Sumithra and Lin, Yiing and Chapman, William C and Maher,
              Christopher A and Arora, Vivek and Dunn, Gavin P and Uppaluri,
              Ravindra and Govindan, Ramaswamy and Griffith, Obi L and
              Griffith, Malachi",
  abstract = "Somatic mutations within non-coding regions and even exons may
              have unidentified regulatory consequences that are often
              overlooked in analysis workflows. Here we present RegTools (
              www.regtools.org ), a computationally efficient, free, and
              open-source software package designed to integrate somatic
              variants from genomic data with splice junctions from bulk or
              single cell transcriptomic data to identify variants that may
              cause aberrant splicing. We apply RegTools to over 9000 tumor
              samples with both tumor DNA and RNA sequence data. RegTools
              discovers 235,778 events where a splice-associated variant
              significantly increases the splicing of a particular junction,
              across 158,200 unique variants and 131,212 unique junctions. To
              characterize these somatic variants and their associated splice
              isoforms, we annotate them with the Variant Effect Predictor,
              SpliceAI, and Genotype-Tissue Expression junction counts and
              compare our results to other tools that integrate genomic and
              transcriptomic data. While many events are corroborated by the
              aforementioned tools, the flexibility of RegTools also allows us
              to identify splice-associated variants in known cancer drivers,
              such as TP53, CDKN2A, and B2M, and other genes.",
  journal  = "Nat. Commun.",
  volume   =  14,
  number   =  1,
  pages    = "1589",
  month    =  mar,
  year     =  2023,
  language = "en"
}

@ARTICLE{Delaneau2017-dg,
  title     = "A complete tool set for molecular {QTL} discovery and analysis",
  author    = "Delaneau, Olivier and Ongen, Halit and Brown, Andrew A and Fort,
               Alexandre and Panousis, Nikolaos I and Dermitzakis, Emmanouil T",
  abstract  = "Population scale studies combining genetic information with
               molecular phenotypes (for example, gene expression) have become
               a standard to dissect the effects of genetic variants onto
               organismal phenotypes. These kinds of data sets require
               powerful, fast and versatile methods able to discover molecular
               Quantitative Trait Loci (molQTL). Here we propose such a
               solution, QTLtools, a modular framework that contains multiple
               new and well-established methods to prepare the data, to
               discover proximal and distal molQTLs and, finally, to integrate
               them with GWAS variants and functional annotations of the
               genome. We demonstrate its utility by performing a complete
               expression QTL study in a few easy-to-perform steps. QTLtools is
               open source and available at
               https://qtltools.github.io/qtltools/.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  8,
  number    =  1,
  pages     = "15452",
  month     =  may,
  year      =  2017,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}
@ARTICLE{Storey2003-zd,
  title     = "Statistical significance for genomewide studies",
  author    = "Storey, John D and Tibshirani, Robert",
  abstract  = "With the increase in genomewide experiments and the sequencing
               of multiple genomes, the analysis of large data sets has become
               commonplace in biology. It is often the case that thousands of
               features in a genomewide data set are tested against some null
               hypothesis, where a number of features are expected to be
               significant. Here we propose an approach to measuring
               statistical significance in these genomewide studies based on
               the concept of the false discovery rate. This approach offers a
               sensible balance between the number of true and false positives
               that is automatically calibrated and easily interpreted. In
               doing so, a measure of statistical significance called the q
               value is associated with each tested feature. The q value is
               similar to the well known p value, except it is a measure of
               significance in terms of the false discovery rate rather than
               the false positive rate. Our approach avoids a flood of false
               positive results, while offering a more liberal criterion than
               what has been used in genome scans for linkage.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "Proceedings of the National Academy of Sciences",
  volume    =  100,
  number    =  16,
  pages     = "9440--9445",
  month     =  aug,
  year      =  2003,
  language  = "en"
}



@ARTICLE{Zhou2018-jh,
  title     = "Efficiently controlling for case-control imbalance and sample
               relatedness in large-scale genetic association studies",
  author    = "Zhou, Wei and Nielsen, Jonas B and Fritsche, Lars G and Dey,
               Rounak and Gabrielsen, Maiken E and Wolford, Brooke N and
               LeFaive, Jonathon and VandeHaar, Peter and Gagliano, Sarah A and
               Gifford, Aliya and Bastarache, Lisa A and Wei, Wei-Qi and Denny,
               Joshua C and Lin, Maoxuan and Hveem, Kristian and Kang, Hyun Min
               and Abecasis, Goncalo R and Willer, Cristen J and Lee, Seunggeun",
  abstract  = "In genome-wide association studies (GWAS) for thousands of
               phenotypes in large biobanks, most binary traits have
               substantially fewer cases than controls. Both of the widely used
               approaches, the linear mixed model and the recently proposed
               logistic mixed model, perform poorly; they produce large type I
               error rates when used to analyze unbalanced case-control
               phenotypes. Here we propose a scalable and accurate generalized
               mixed model association test that uses the saddlepoint
               approximation to calibrate the distribution of score test
               statistics. This method, SAIGE (Scalable and Accurate
               Implementation of GEneralized mixed model), provides accurate P
               values even when case-control ratios are extremely unbalanced.
               SAIGE uses state-of-art optimization strategies to reduce
               computational costs; hence, it is applicable to GWAS for
               thousands of phenotypes by large biobanks. Through the analysis
               of UK Biobank data of 408,961 samples from white British
               participants with European ancestry for > 1,400 binary
               phenotypes, we show that SAIGE can efficiently analyze large
               sample data, controlling for unbalanced case-control ratios and
               sample relatedness.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  9,
  pages     = "1335--1341",
  month     =  sep,
  year      =  2018,
  language  = "en"
}
@ARTICLE{Liu2019-fv,
  title     = "Abundant associations with gene expression complicate {GWAS}
               follow-up",
  author    = "Liu, Boxiang and Gloudemans, Michael J and Rao, Abhiram S and
               Ingelsson, Erik and Montgomery, Stephen B",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  51,
  number    =  5,
  pages     = "768--769",
  month     =  may,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Gu2016-oc,
  title     = "Complex heatmaps reveal patterns and correlations in
               multidimensional genomic data",
  author    = "Gu, Zuguang and Eils, Roland and Schlesner, Matthias",
  abstract  = "Abstract Summary: Parallel heatmaps with carefully designed
               annotation graphics are powerful for efficient visualization of
               patterns and relationships among high dimensional genomic data.
               Here we present the ComplexHeatmap package that provides rich
               functionalities for customizing heatmaps, arranging multiple
               parallel heatmaps and including user-defined annotation
               graphics. We demonstrate the power of ComplexHeatmap to easily
               reveal patterns and correlations among multiple sources of
               information with four real-world datasets. Availability and
               Implementation: The ComplexHeatmap package and documentation are
               freely available from the Bioconductor project:
               http://www.bioconductor.org/packages/devel/bioc/html/ComplexHeatmap.html.
               Contact: m.schlesner@dkfz.de Supplementary information:
               Supplementary data are available at Bioinformatics online.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  32,
  number    =  18,
  pages     = "2847--2849",
  month     =  sep,
  year      =  2016,
  language  = "en"
}

%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%End Macromap%%%%
%%%%%%%%%%%%%%%%%%%%%%%%
@online{ukibdgc-info,
    title = {UK IBD Genetics Consortium Aims},  
    author = {The UK IBD Genetics Consortium},  
    year = {2023},
    url = {https://www.ibdresearch.co.uk/what-is-inflammatory-bowel-disease-ibd/aims/},   
    urldate      = {30/09/2023}
}
@online{ibdbr-further-info,
    title = {What is the IBD BioResource?},  
    author = {The IBD BioResource},  
    year = {2022},
    url = {https://www.ibdbioresource.nihr.ac.uk/index.php/patients/further-information/},   
    urldate      = {30/09/2023}
}
@online{ibdbr-questionnaire-v7,
    title = {The IBD BioResource Questionnaire Version 7},  
    author = {The IBD BioResource},  
    year = {2021},
    url = {https://www.ibdbioresource.nihr.ac.uk/wp-content/uploads/2022/02/PIS-V7.pdf},   
    urldate      = {30/09/2023}
}
@online{ibdbr-protocol-v8,
    title = {The IBD BioResource Protocol Version 8},  
    author = {The IBD BioResource},  
    year = {2021},
    url = {https://www.ibdbioresource.nihr.ac.uk/wp-content/uploads/2022/02/Protocol-V8.pdf},   
    urldate      = {30/09/2023}
}
@ARTICLE{Scharl2013-uf,
  title     = "Interleukin-13 and transforming growth factor $\beta$ synergise
               in the pathogenesis of human intestinal fistulae",
  author    = "Scharl, Michael and Frei, Sandra and Pesch, Theresa and
               Kellermeier, Silvia and Arikkat, Joba and Frei, Pascal and
               Fried, Michael and Weber, Achim and Jehle, Ekkehard and
               R{\"u}hl, Anne and Rogler, Gerhard",
  abstract  = "OBJECTIVE: Epithelial to mesenchymal transition (EMT) seems to
               play an important role in the pathogenesis of fistulae, a common
               clinical complication of Crohn's disease (CD). TGF$\beta$ and
               interleukin-13 (IL-13) have been correlated with the onset of
               EMT-associated organ fibrosis and high levels of TGF$\beta$ have
               been shown in transitional cells (TCs) lining CD fistula tracts.
               This study investigated whether IL-13 could be involved in the
               pathogenesis of CD-associated fistulae. DESIGN: Protein or mRNA
               levels in HT29 intestinal epithelial cells (IECs) or colonic
               lamina propria fibroblasts (CLPFs) were studied by western
               blotting or real-time PCR. CLPFs were isolated from
               non-inflammatory disease controls or patients with CD with or
               without fistulae and IL-13 levels were analysed in surgically
               removed fistula specimens by immunohistochemistry. RESULTS:
               TGF$\beta$ induced IL-13 secretion in CLPFs from patients with
               fistulising CD. In fistula specimens high levels of IL-13 were
               detected in TCs covering fistula tracts. In HT29 IEC monolayers,
               IL-13 induced SLUG and $\beta$6-integrin mRNA, which are
               associated with cell invasion. HT29 spheroids completely
               disintegrated when treated with TGF$\beta$ for 7 days, whereas
               IL-13-treated spheroids did not show morphological changes.
               Here, TGF$\beta$ induced mRNA expression of SNAIL1 and IL-13,
               whereas IL-13 elevated SLUG and $\beta$6-integrin mRNA. An
               anti-IL-13 antibody was able to prevent IL-13-induced SLUG
               expression in HT29 IECs. CONCLUSIONS: TGF$\beta$ induces IL-13
               expression and an EMT-like phenotype of IECs, while IL-13
               promotes the expression of genes associated with cell invasion.
               These findings suggest that TGF$\beta$ and IL-13 play a
               synergistic role in the pathogenesis of fistulae and inhibition
               of IL-13 might represent a novel therapeutic approach for
               fistula treatment.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  62,
  number    =  1,
  pages     = "63--72",
  month     =  jan,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Peyrin-Biroulet2010-mf,
  title     = "The natural history of adult Crohn's disease in population-based
               cohorts",
  author    = "Peyrin-Biroulet, Laurent and Loftus, Jr, Edward V and Colombel,
               Jean-Frederic and Sandborn, William J",
  abstract  = "OBJECTIVES: Natural history studies provide invaluable data on
               the disease course. First, they help define the end points for
               clinical trials that are designed to test drugs for the end
               point of disease modification in chronic disabling diseases.
               Natural history studies can also help to identify subsets of
               patients in whom the disease prognosis can be stratified
               according to clinical features. This comprehensive review
               summarizes our current knowledge of the natural history of
               Crohn's disease in adults as reported in population-based
               studies that include long-term follow-up results. METHODS: We
               conducted a literature search of English and non-English
               language publications listed in the electronic databases of
               MEDLINE (source PUBMED, 1935 to December 2008). RESULTS:
               One-third of the patients had ileitis, colitis, or ileocolitis
               at the time of diagnosis. Disease location remained broadly
               stable over time. Up to one-third of the patients had evidence
               of a stricturing or penetrating intestinal complication at
               diagnosis, and half of all patients had experienced an
               intestinal complication within 20 years after diagnosis. Ten
               percent of the patients had prolonged clinical remission.
               Steroid dependency occurred in one-third of the patients, and
               surgery was required in one-third after initiation of steroid
               therapy. The annual incidence of hospitalizations was 20\%. Half
               of the patients required surgery within 10 years after
               diagnosis. The risk of postoperative recurrence was 44-55\%
               after 10 years. CONCLUSIONS: Crohn's disease is a disabling
               condition over time. The impact of changing treatment paradigms
               with increased use of immunosuppressants and biological agents
               on its natural history is poorly known.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  105,
  number    =  2,
  pages     = "289--297",
  month     =  feb,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Scharl2017-sp,
  title     = "Fistulizing Crohn's disease",
  author    = "Scharl, Michael and Rogler, Gerhard and Biedermann, Luc",
  abstract  = "Fistulas still represent one of the most important complications
               in patients with Crohn's disease (CD). At least one third of CD
               patients suffer from fistulas during their disease course and
               amongst them longstanding remission of complex fistulas occurs
               only in about one third. So far, fistula pathogenesis is only
               partially understood. From a histopathological view, a fistula
               is a tube covered by flat epithelial cells. Current research
               suggests that the driving force for fistula development is
               epithelial-to-mesenchymal transition (EMT). Around the fistula,
               high levels of tumor necrosis factor (TNF), IL-13, and
               TGF$\beta$ can be detected and recent studies indicated an
               involvement of the intestinal microbiota. Fistula diagnosis
               requires clinical and surgical assessment, radiologic
               investigations, e.g., magnet resonance imaging and endoscopy.
               Routine medical treatment of fistulas includes antibiotics,
               immunosuppressives, and anti-TNF antibodies. There is no
               well-established role for calcineurin inhibitors in fistula
               treatment, corticosteroids appear to be even contra-productive.
               A promising novel approach might be the application of adipose
               tissue-derived or bone marrow-derived mesenchymal stem cells
               that have been studied recently. Due to insufficient efficacy of
               medical treatment and recurrence of fistulas, surgical
               interventions are frequently necessary. Further research is
               needed to better understand fistula pathogenesis aiming to
               develop novel treatment option for our patients.",
  journal   = "Clin. Transl. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  8,
  number    =  7,
  pages     = "e106",
  month     =  jul,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Eglinton2012-hh,
  title     = "The spectrum of perianal Crohn's disease in a population-based
               cohort",
  author    = "Eglinton, Tim W and Barclay, Murray L and Gearry, Richard B and
               Frizelle, Frank A",
  abstract  = "BACKGROUND: Perianal Crohn's disease represents a phenotype
               distinct from luminal Crohn's disease and may follow a different
               course. To date, the only detailed classifications of perianal
               Crohn's disease arise from referral center cohorts that do not
               reflect the spectrum of disease in the population as a whole.
               OBJECTIVES: The aim of this study was to document the rate,
               classification, and time course of symptomatic perianal Crohn's
               disease in a population-based cohort. DESIGN: This is a
               population-based cohort study. SETTING: : This study was
               conducted in the Canterbury region of New Zealand. PATIENTS: All
               patients with IBD in Canterbury, New Zealand, were eligible for
               recruitment over a 3-year period. MAIN OUTCOME MEASURES: The
               clinical records of all patients with Crohn's disease were
               reviewed, and all symptomatic perianal disease was classified
               according to the American Gastroenterological Society position
               statement. The rate of perianal involvement and timing of onset
               relative to Crohn's diagnosis was determined. RESULTS:
               Ninety-one percent of IBD patients in the region were recruited.
               Seven hundred fifteen patients had Crohn's disease, of which 190
               (26.6\%) patients had symptomatic perianal disease. The median
               age of patients with perianal disease was 37 years (range, 4-82
               years) and 58.4\% were female. Median follow-up was 9 years
               (range, 2 months to 45 years) from Crohn's disease diagnosis.
               Onset of perianal disease ranged from 18 years pre-Crohn's
               diagnosis to 33 years post-Crohn's diagnosis. Fistulas were the
               most common lesion (50\% of patients), followed by perianal
               abscesses (42.1\%), fissures (32.6\%), skin tags (11.1\%),
               strictures (7.4\%), and hemorrhoids (1.6\%). The cumulative
               probability at 20 years of any perianal Crohn's disease was
               42.7\% and of a perianal fistula 28.3\%. LIMITATIONS: This study
               assumed all noted perianal lesions were related to Crohn's
               disease and the retrospective classification may have been
               inaccurate in some cases. CONCLUSIONS: This study provides the
               first detailed classification of perianal Crohn's disease in a
               population-based cohort.",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  55,
  number    =  7,
  pages     = "773--777",
  month     =  jul,
  year      =  2012,
  language  = "en"
}

@article {Irvine1995-ej,
	Title = {Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group},
	Author = {Irvine, EJ},
	Number = {1},
	Volume = {20},
	Month = {January},
	Year = {1995},
	Journal = {Journal of clinical gastroenterology},
	ISSN = {0192-0790},
	Pages = {27â€”32},
	Abstract = {Troublesome perianal disease occurs in approximately 35% of patients with Crohn's disease, yet conventional disease activity indices do not reflect the severity of this feature. To assess the degree of impairment and response to therapy, we identified five simple elements and graded each on a 5-point Likert scale in 37 patients at 124 visits. At each visit a Crohn's Disease (CDAI) or Simple Activity Index (HBDAI), Perianal Disease Activity Index (PDAI), and treatment were recorded. The PDAI was validated against physician (MDGA) and patient (PGA) global assessments, and treatment was prescribed for the perianal disease. Measurement error was evaluated in 19 patients who were clinically stable at two consecutive visits. The ability of the PDAI to detect important clinical change was tested in 20 subjects exhibiting a change on PGA at consecutive visits. There were strong correlations between PDAI, MDGA, and PGA scores at all visits (R = 0.66-0.72; p &lt; 0.001), whereas the CDAI and HBDAI correlated poorly with PDAI (R &lt; 0.23). Physicians prescribed more aggressive therapy for higher PDAI scores (r = 0.53). Mean PDAI scores between visits in clinically stable subjects were not significantly different [5.58 +/- 2.79 (initial); 5.42 +/- 2.55 (follow-up); p = 0.63]. PDAI significantly improved between visits when the perianal disease had improved (PDAI score difference 3.05 +/- 2.96; P = .0002). We conclude that the PDAI is simple and clinically useful for patient management. It should now be assessed in a clinical trial.},
	URL = {http://europepmc.org/abstract/MED/7884173}
}


@ARTICLE{Hughes1992-kc,
  title     = "Clinical classification of perianal Crohn's disease",
  author    = "Hughes, Leslie E",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  35,
  number    =  10,
  pages     = "928--932",
  month     =  oct,
  year      =  1992,
  language  = "en"
}

@ARTICLE{Safar2007-dk,
  title     = "Perianal Crohn's disease",
  author    = "Safar, Bashar and Sands, Dana",
  abstract  = "Crohn's disease is commonly complicated by perianal
               manifestations. The surgeon plays a pivotal role in caring for
               these patients; a detailed history along with a thorough
               clinical exam provides the treating physician with invaluable
               information upon which to base further investigations and
               management decisions. Other than abscess drainage, medical
               management to control proximal disease often precedes any
               surgical attempt to cure the disease. Surgical interventions are
               indicated in selective patients, but are often complicated by
               poor wound healing and recurrences. A sizable percentage of
               these patients may need a proctectomy.",
  journal   = "Clin. Colon Rectal Surg.",
  publisher = "Georg Thieme Verlag KG",
  volume    =  20,
  number    =  4,
  pages     = "282--293",
  month     =  nov,
  year      =  2007,
  keywords  = "Crohn's disease; fistula; perianal",
  language  = "en"
}

@ARTICLE{Scheurlen2023-gk,
  title    = "State-of-the-art surgery for Crohn's disease: part {III-perianal}
              Crohn's disease",
  author   = "Scheurlen, Katharina M and MacLeod, Anne and Kavalukas, Sandra L
              and Galandiuk, Susan",
  abstract = "PURPOSE: Diagnosis and treatment of perianal Crohn's disease is
              challenging and requires its own domain of therapy. Different
              types of perianal disease require a spectrum of treatment
              strategies. Treatment options range from conservative therapy,
              including immunosuppressives, biologics, or stem cell therapy, to
              surgical treatment with specific indications depending on the
              underlying lesion. This is part III of the series
              ``state-of-the-art surgery for Crohn's disease,'' focusing on the
              management of perianal disease. We discuss the definition and
              diagnosis of perianal Crohn's disease, the treatment of perianal
              lesions, and specific surgical indications and techniques.
              RESULTS AND CONCLUSION: Pitfalls and complications play a
              substantial role in the treatment of perianal Crohn's disease,
              and surgical therapy may fail. Realistic treatment goals and an
              individual patient-oriented treatment approach are crucial in the
              treatment of perianal Crohn's disease.",
  journal  = "Langenbecks Arch. Surg.",
  volume   =  408,
  number   =  1,
  pages    = "132",
  month    =  mar,
  year     =  2023,
  keywords = "Anal canal; Colonic Crohn's disease; Mesenchymal stem cells;
              Rectal diseases; Rectal fistula; Recurrence",
  language = "en"
}

@ARTICLE{Pikarsky2002-gf,
  title     = "Perianal Crohn disease",
  author    = "Pikarsky, Alon J and Gervaz, Pascal and Wexner, Steven D",
  journal   = "Arch. Surg.",
  publisher = "American Medical Association (AMA)",
  volume    =  137,
  number    =  7,
  month     =  jul,
  year      =  2002,
  language  = "en"
}

@ARTICLE{Eglinton2012-vx,
  title     = "The spectrum of perianal Crohn's disease in a population-based
               cohort",
  author    = "Eglinton, Tim W and Barclay, Murray L and Gearry, Richard B and
               Frizelle, Frank A",
  abstract  = "BACKGROUND: Perianal Crohn's disease represents a phenotype
               distinct from luminal Crohn's disease and may follow a different
               course. To date, the only detailed classifications of perianal
               Crohn's disease arise from referral center cohorts that do not
               reflect the spectrum of disease in the population as a whole.
               OBJECTIVES: The aim of this study was to document the rate,
               classification, and time course of symptomatic perianal Crohn's
               disease in a population-based cohort. DESIGN: This is a
               population-based cohort study. SETTING: : This study was
               conducted in the Canterbury region of New Zealand. PATIENTS: All
               patients with IBD in Canterbury, New Zealand, were eligible for
               recruitment over a 3-year period. MAIN OUTCOME MEASURES: The
               clinical records of all patients with Crohn's disease were
               reviewed, and all symptomatic perianal disease was classified
               according to the American Gastroenterological Society position
               statement. The rate of perianal involvement and timing of onset
               relative to Crohn's diagnosis was determined. RESULTS:
               Ninety-one percent of IBD patients in the region were recruited.
               Seven hundred fifteen patients had Crohn's disease, of which 190
               (26.6\%) patients had symptomatic perianal disease. The median
               age of patients with perianal disease was 37 years (range, 4-82
               years) and 58.4\% were female. Median follow-up was 9 years
               (range, 2 months to 45 years) from Crohn's disease diagnosis.
               Onset of perianal disease ranged from 18 years pre-Crohn's
               diagnosis to 33 years post-Crohn's diagnosis. Fistulas were the
               most common lesion (50\% of patients), followed by perianal
               abscesses (42.1\%), fissures (32.6\%), skin tags (11.1\%),
               strictures (7.4\%), and hemorrhoids (1.6\%). The cumulative
               probability at 20 years of any perianal Crohn's disease was
               42.7\% and of a perianal fistula 28.3\%. LIMITATIONS: This study
               assumed all noted perianal lesions were related to Crohn's
               disease and the retrospective classification may have been
               inaccurate in some cases. CONCLUSIONS: This study provides the
               first detailed classification of perianal Crohn's disease in a
               population-based cohort.",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  55,
  number    =  7,
  pages     = "773--777",
  month     =  jul,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Adegbola2020-nd,
  title     = "Burden of disease and adaptation to life in patients with
               Crohn's perianal fistula: a qualitative exploration",
  author    = "Adegbola, Samuel O and Dibley, Lesley and Sahnan, Kapil and
               Wade, Tiffany and Verjee, Azmina and Sawyer, Rachel and Mannick,
               Sameer and McCluskey, Damian and Yassin, Nuha and Phillips,
               Robin K S and Tozer, Philip J and Norton, Christine and Hart,
               Ailsa L",
  abstract  = "BACKGROUND: Perianal fistulas are a challenging manifestation of
               Crohn's disease. Best medical and surgical therapy results in
               only about a third of patients remaining in remission at one
               year on maintenance treatment and sustained healing is often
               elusive. There is little published data on patient perspective
               of living with the condition or coping strategies in the face of
               non-curative/non-definitive treatment. We aimed to understand
               the experience of living with perianal fistula(s) and their
               impact on quality of life and routine functioning. METHODS: This
               exploratory qualitative study used purposive sampling to recruit
               participants with current / previous diagnosis of Crohn's anal
               fistulas, from national IBD / bowel disease charities. The
               ``standards for reporting qualitative research'' (SRQR)
               recommendations were followed. Unstructured individual
               face-to-face interviews were audio recorded, transcribed and
               analysed thematically. Early themes were reviewed by the study
               team including patient advocates, clinicians and qualitative
               researchers. RESULTS: Twelve interviews were conducted,
               achieving apparent data saturation. Three broad themes were
               uncovered: Burden of symptoms; Burden of treatment; and Impact
               on emotional, physical and social well-being. Each included
               several sub-themes, with considerable interplay between these.
               The impact of perianal fistula(s) on patients with CD is intense
               and wide reaching, negatively affecting intimate, close and
               social relationships. Fistulas cause losses in life and
               work-related opportunities, and treatments can be difficult to
               tolerate. CONCLUSION: Crohn's perianal fistulas exert a heavy
               negative physical and emotional impact on patients. These
               findings will inform development of a patient reported outcome
               measure to assess treatment effectiveness and quality of life
               for patients living with this challenging condition.",
  journal   = "Health Qual. Life Outcomes",
  publisher = "Springer Science and Business Media LLC",
  volume    =  18,
  number    =  1,
  pages     = "370",
  month     =  nov,
  year      =  2020,
  keywords  = "Crohn's anal fistula; Patient reported outcomes; Quality of life",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Panes2018-su,
  title     = "Burden and outcomes for complex perianal fistulas in Crohn's
               disease: Systematic review",
  author    = "Panes, Julian and Reinisch, Walter and Rupniewska, Ewa and Khan,
               Shahnaz and Forns, Joan and Khalid, Javaria Mona and Bojic,
               Daniela and Patel, Haridarshan",
  abstract  = "AIM: To systematically review the literature on epidemiology,
               disease burden, and treatment outcomes for Crohn's disease (CD)
               patients with complex perianal fistulas. METHODS: PubMed,
               Embase, and Cochrane were searched for relevant articles
               (published 2000-November 2016) and congress abstracts (published
               2011-November 2016). RESULTS: Of 535 records reviewed, 62
               relevant sources were identified (mostly small observational
               studies). The cumulative incidence of complex perianal fistulas
               in CD from two referral-centre studies was 12\%-14\% (follow-up
               time, 12 years in one study; not reported in the second study).
               Complex perianal fistulas result in greatly diminished quality
               of life; up to 59\% of patients are at risk of faecal
               incontinence. Treatments include combinations of medical and
               surgical interventions and expanded allogeneic adipose-derived
               stem cells. High proportions of patients experience lack of or
               inadequate response to treatment (failure and relapse rates,
               respectively: medical, 12\%-73\% and 0\%-41\%; surgical:
               0\%-100\% and 11\%-20\%; combined medical/surgical: 0\%-80\% and
               0\%-50\%; stem cells: 29\%-47\% and not reported). Few studies
               (1 of infliximab; 3 of surgical interventions) have been
               conducted in treatment-refractory patients, a population with
               high unmet needs. Limited data exist on the clinical value of
               anti-tumour necrosis factor-$\alpha$ dose escalation in patients
               with complex perianal fistulas in CD. CONCLUSION: Complex
               perianal fistulas in CD pose substantial clinical and humanistic
               burden. There is a need for effective treatments, especially for
               patients refractory to anti-tumour necrosis factor-$\alpha$
               agents, as evidenced by high failure and relapse rates.",
  journal   = "World J. Gastroenterol.",
  publisher = "Baishideng Publishing Group Inc.",
  volume    =  24,
  number    =  42,
  pages     = "4821--4834",
  month     =  nov,
  year      =  2018,
  keywords  = "Burden; Complex perianal fistulas; Crohn's disease;
               Epidemiology; Outcomes; Systematic literature review; Treatment",
  language  = "en"
}

@ARTICLE{Braithwaite2017-zo,
  title     = "Prognostic factors affecting outcomes in fistulating perianal
               Crohn's disease: a systematic review",
  author    = "Braithwaite, G C and Lee, M J and Hind, D and Brown, S R",
  journal   = "Tech. Coloproctol.",
  publisher = "Springer Nature",
  volume    =  21,
  number    =  7,
  pages     = "501--519",
  month     =  jul,
  year      =  2017
}

@ARTICLE{Ng2016-al,
  title     = "Changing epidemiological trends of inflammatory bowel disease in
               Asia",
  author    = "Ng, Wee Khoon and Wong, Sunny H and Ng, Siew C",
  abstract  = "Inflammatory bowel disease (IBD) has become more common in Asia
               over the past few decades. The rate of increase in prevalence of
               the disease varies greatly in Asia, with several countries in
               East Asia experiencing a more than doubled increase in IBD
               prevalence over the past decade. Historically, ulcerative
               colitis (UC) is more common than Crohn's disease (CD) in Asia.
               However, a reverse trend is beginning to appear in more
               developed countries in Asia such as Japan, Korea, and Hong Kong.
               While Asian IBD patients share many similarities with their
               Western counterparts, there are important differences with
               significant clinical implications. In Asia, there are more men
               with CD, more ileo-colonic involvement in CD, less familial
               aggregation, fewer extra-intestinal manifestations and worse
               clinical outcomes for older-onset patients with UC. These
               differences are likely related to the different genetic makeup
               and environmental exposures in different regions. Evaluation of
               the differences and rates in epidemiologic trends may help
               researchers and clinicians estimate disease burden and
               understand the reasons behind these differences, which may hold
               the key to unravel the etiology of IBD.",
  journal   = "Intest. Res.",
  publisher = "Korean Association for the Study of Intestinal Diseases",
  volume    =  14,
  number    =  2,
  pages     = "111--119",
  month     =  apr,
  year      =  2016,
  keywords  = "Asia; Colitis, ulcerative; Crohn disease; Epidemiology;
               Inflammatory bowel diseases",
  language  = "en"
}

@ARTICLE{Wils2021-ao,
  title     = "Fistulizing perianal lesions in a French population with Crohn's
               disease",
  author    = "Wils, Pauline and Leroyer, Ariane and Fumery, Mathurin and
               Fernandez-Nistal, Alonso and Gower-Rousseau, Corinne and
               Pariente, Benjamin",
  journal   = "Dig. Liver Dis.",
  publisher = "Elsevier BV",
  volume    =  53,
  number    =  5,
  pages     = "661--665",
  month     =  may,
  year      =  2021,
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Pogacnik2019-aj,
  title     = "Perianal Crohn's disease",
  author    = "Pogacnik, Javier Salgado and Salgado, Gervasio",
  abstract  = "This article provides an overview of the principles in the
               evaluation and management of perianal Crohn's disease (CD).
               Manifestation-specific treatment is addressed including abscess,
               fistula, skin tags, hemorrhoids, fissure, ulcers, strictures,
               ano-, and rectovaginal fistulas as well CD-associated
               hidradenitis suppurativa.",
  journal   = "Clin. Colon Rectal Surg.",
  publisher = "Georg Thieme Verlag KG",
  volume    =  32,
  number    =  5,
  pages     = "377--385",
  month     =  sep,
  year      =  2019,
  keywords  = "Crohn's disease; abscess; evaluation; fistula; management;
               perianal",
  language  = "en"
}

@ARTICLE{Mizushima2021-hk,
  title     = "Diagnostic features of perianal fistula in patients with Crohn's
               disease: Analysis of a Japanese claims database",
  author    = "Mizushima, Tsunekazu and Ota, Mihoko and Fujitani, Yasushi and
               Kanauchi, Yuya and Iwakiri, Ryuichi",
  abstract  = "Background: Perianal fistula (PAF) is a disabling complication
               of Crohn's disease (CD) which greatly impacts the quality of
               life. To address a scarcity of data in Asian populations, we
               determined the prevalence of CD-associated PAF in Japan, the
               order of diagnosis, and medical history of patients. Methods: A
               retrospective, longitudinal, observational cohort study was
               conducted, using an employer-based health insurance claims
               database. The study included patients diagnosed with CD and/or
               PAF from October 2013 to September 2019. Results: The age- and
               gender-adjusted prevalence rates of CD-associated PAF increased
               from 10.33 per 100 000 in 2014, to 13.68 per 100 000 in 2019.
               Among patients with CD-associated PAF, 15.7\% were diagnosed
               with PAF after diagnosis of CD, 68.6\% were diagnosed with PAF
               before diagnosis with CD, and 15.7\% were diagnosed with CD and
               PAF within the same month. Of the patients diagnosed with CD
               after PAF, approximately 30\% were diagnosed with PAF by the age
               of 20 years, whereas less than 10\% of PAF patients without CD
               were diagnosed with PAF by the age of 20 years. Conclusions: The
               study reveals the prevalence of CD-associated PAF in Japan and
               that most individuals were diagnosed with CD after the diagnosis
               of PAF. Crohn's disease may be underdiagnosed in patients with
               PAF; patients diagnosed with PAF at a young age should be
               monitored to allow timely diagnosis of CD.",
  journal   = "Crohns Colitis 360",
  publisher = "Oxford University Press (OUP)",
  volume    =  3,
  number    =  3,
  pages     = "otab055",
  month     =  jul,
  year      =  2021,
  keywords  = "Crohn's disease; Japan; perianal fistula",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Brochard2022-kz,
  title     = "Natural history of perianal Crohn's disease: Long-term follow-up
               of a population-based cohort",
  author    = "Brochard, Charl{\`e}ne and Rabilloud, Marie-Laure and Hamonic,
               St{\'e}phanie and Bajeux, Emma and Pagenault, Ma{\"e}l and
               Dabadie, Alain and Gerfaud, Agathe and Viel, Jean-Fran{\c c}ois
               and Tron, Isabelle and Robaszkiewicz, Michel and Bretagne,
               Jean-Fran{\c c}ois and Siproudhis, Laurent and Bouguen,
               Guillaume and {Groupe ABERMAD}",
  abstract  = "BACKGROUND AND AIMS: The natural history of perianal Crohn's
               disease (PCD) remains poorly described and is mainly based on
               retrospective studies from referral centers. The aim of this
               study was to assess the incidence, outcomes and predictors of
               the onset of PCD. METHODS: All incident cases of patients
               diagnosed with possible CD were prospectively registered from
               1994 to 1997 in Brittany, a limited area in France. At
               diagnosis, the clinical features of perianal disease were
               recorded. All patient charts were reviewed from the diagnosis to
               the last clinic visit in 2015. RESULTS: Among the 272 out of 331
               incident CD patients followed up, 51 (18.7\%) patients had PCD
               at diagnosis. After a mean follow-up of 12.8 years, 93 (34\%)
               patients developed PCD. The cumulative probabilities of perianal
               CD occurrence were 22\%, 29\%, and 32\% after 1 year, 5 years,
               and 10 years, respectively. The cumulative probabilities of anal
               ulceration were 14\%, and 19\% after 1 year and 10 years,
               respectively. Extraintestinal manifestations were associated
               with the occurrence of anal ulceration. The cumulative
               probabilities of fistulizing PCD were 11\%, 16\%, and 19\% after
               1 year, 5 years, and 10 years, respectively. Extraintestinal
               manifestations, rectal involvement and anal ulceration were
               predictors of fistulizing PCD. The cumulative probability of
               developing anal stricture was 4\% after 10 years. CONCLUSIONS:
               PCD is frequently observed during CD, in approximately one-third
               of patients. These data underline the need for targeted
               therapeutic research on primary perianal lesions (proctitis,
               anal ulceration) to avoid the onset of fistulizing perianal
               disease.",
  journal   = "Clin. Gastroenterol. Hepatol.",
  publisher = "Elsevier BV",
  volume    =  20,
  number    =  2,
  pages     = "e102--e110",
  month     =  feb,
  year      =  2022,
  keywords  = "Natural History; Outcomes; Perianal Crohn's Disease; Population
               Based",
  language  = "en"
}

@ARTICLE{Bruckner2018-ag,
  title     = "Incidence and risk factors for perianal disease in pediatric
               Crohn disease patients followed in {CEDATA-GPGE} registry",
  author    = "Br{\"u}ckner, Annecarin and Werkstetter, Katharina J and de
               Laffolie, Jan and Wendt, Claudia and Prell, Christine and
               Weidenhausen, Tanja and Zimmer, Klaus P and Koletzko, Sibylle",
  journal   = "J. Pediatr. Gastroenterol. Nutr.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  66,
  number    =  1,
  pages     = "73--78",
  month     =  jan,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Gottgens2017-df,
  title     = "Time trends in the epidemiology and outcome of perianal
               fistulizing Crohn's disease in a population-based cohort",
  author    = "G{\"o}ttgens, Kevin W A and Jeuring, Steven F G and Sturkenboom,
               Rosel and Romberg-Camps, Mari{\"e}lle J L and Oostenbrug,
               Liekele E and Jonkers, Daisy M A E and Stassen, Laurents P S and
               Masclee, Ad A M and Pierik, Marieke J and Breukink,
               St{\'e}phanie O",
  journal   = "Eur. J. Gastroenterol. Hepatol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  29,
  number    =  5,
  pages     = "595--601",
  month     =  may,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Tsai2022-kz,
  title     = "Epidemiology and natural history of perianal Crohn's disease: A
               systematic review and meta-analysis of population-based cohorts",
  author    = "Tsai, Lester and McCurdy, Jeffrey D and Ma, Christopher and
               Jairath, Vipul and Singh, Siddharth",
  abstract  = "BACKGROUND AND AIMS: Perianal Crohn's disease (pCD) is a
               potentially severe phenotype of CD. We conducted a systematic
               review with meta-analysis to estimate cumulative incidence, risk
               factors, and outcomes of pCD in population-based cohort studies.
               METHODS: Through a systematic literature review through March 1,
               2021, we identified population-based inception cohort studies
               reporting cumulative incidence of perianal disease (primarily
               abscess and/or fistula) in patients with CD. We estimated the
               cumulative incidence of pCD at presentation and 1-, 5-, and
               10-year follow-up, and risk factors for perianal disease and
               outcomes including risk of major (bowel resection, proctectomy,
               ostomy) and minor perianal (incision and drainage, seton
               placement, etc.) surgery. RESULTS: In 12 population-based
               studies, prevalence of pCD was 18.7\% (95\% confidence interval
               [CI], 12.5\%-27.0\%) with 1-, 5-, and 10-year risk of perianal
               disease being 14.3\% (95\% CI, 7.9\%-24.6\%), 17.6\% (95\% CI,
               11.3\%-26.5\%), and 18.9\% (95\% CI, 15.0\%-23.4\%),
               respectively. Approximately 11.5\% of patients (95\% CI,
               6.7\%-19.0\%) had perianal disease at or before CD diagnosis.
               Colonic disease location and rectal involvement were associated
               with higher risk of pCD. Overall, 63.3\% of patients (95\% CI,
               53.3-72.3) required minor perianal surgery and 6.4\% of patients
               (95\% CI, 1.8\%-20.6\%) required major abdominal surgery for
               pCD. Use of biologic therapy for pCD is common and has steadily
               increased throughout the years. CONCLUSIONS: Approximately 1 in
               5 patients with CD develops perianal disease within 10 years of
               CD diagnosis, including 11.5\% who have perianal disease at
               presentation. Approximately two-thirds of patients require
               perianal surgery, with a smaller fraction requiring major
               abdominal surgery.",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  28,
  number    =  10,
  pages     = "1477--1484",
  month     =  oct,
  year      =  2022,
  keywords  = "Montreal classification; anti-TNF; epidemiology; fistula;
               natural history",
  copyright = "https://academic.oup.com/pages/standard-publication-reuse-rights",
  language  = "en"
}
%%%
@ARTICLE{Adegbola2018-ha,
  title     = "Medical and surgical management of perianal Crohn's disease",
  author    = "Adegbola, Samuel",
  journal   = "Ann. Gastroenterol.",
  publisher = "Hellenic Society of Gastroenterology",
  year      =  2018
}
@ARTICLE{Jones1966-tt,
  title     = "Corticosteroids and corticotrophin in the treatment of Crohn's
               disease",
  author    = "Jones, J H and Lennard-Jones, J E",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  7,
  number    =  2,
  pages     = "181--187",
  month     =  apr,
  year      =  1966,
  language  = "en"
}
@ARTICLE{Haennig2015-pj,
  title     = "The results of seton drainage combined with {anti-TNF$\alpha$}
               therapy for anal fistula in Crohn's disease",
  author    = "Haennig, A and Staumont, G and Lepage, B and Faure, P and Alric,
               L and Buscail, L and Bournet, B and Moreau, J",
  abstract  = "AIM: Combined infliximab and sphincter-sparing surgery can be
               effective in perianal fistula associated with Crohn's disease
               (CD). This study aimed to assess the efficacy of local surgery
               combined with infliximab on sustained fistula closure and to
               identify predictive factors for response after this combined
               treatment. METHOD: Between 2000 and 2010, 81 patients with
               fistulising perianal CD were included in this observational
               study. Drainage with a loose seton was followed by infliximab
               therapy. The primary end-points were the rate of complete
               fistula closure and time required for this to occur. RESULTS:
               The fistula was complex in 71 (88\%) of the 81 patients. Local
               proctological surgery was carried out in 77 (95\%), including
               seton drainage in 62 (80.5\%) of these. This was continued for a
               median duration of 3.8 months and the patient then received
               infliximab therapy. The median follow-up after treatment was 64
               months (2-263). Initial complete closure of the fistula occurred
               in 71 (88\%) cases at a median interval of 12.4 months (1-147)
               from the start of treatment. Recurrence was observed in 29
               (41\%) patients at a median interval of 38.5 months (2-48) from
               the start of treatment. They were treated again with combined
               treatment with successful closure in 19 (65.5\%) patients. The
               total rate of closure of the fistula was 75.3\%. Female gender,
               anal stenosis, rectovaginal and complex fistula formation were
               factors independently associated with failure of combined
               treatment. CONCLUSION: Seton drainage for several months
               combined with infliximab therapy is effective in closing the
               fistula in 75\% of patients with complex perianal fistula
               formation associated with CD.",
  journal   = "Colorectal Dis.",
  publisher = "Wiley",
  volume    =  17,
  number    =  4,
  pages     = "311--319",
  month     =  apr,
  year      =  2015,
  keywords  = "Crohn's disease; infliximab; perianal fistula; setons",
  language  = "en"
}

@ARTICLE{Gaertner2007-wb,
  title     = "Does infliximab infusion impact results of operative treatment
               for Crohn's perianal fistulas?",
  author    = "Gaertner, Wolfgang B and Decanini, Alejandra and Mellgren,
               Anders and Lowry, Ann C and Goldberg, Stanley M and Madoff,
               Robert D and Spencer, Michael P",
  abstract  = "PURPOSE: Infliximab is an effective treatment for active
               intestinal Crohn's disease; however, the efficacy of infliximab
               in perianal Crohn's disease is controversial. This study was
               designed to compare patients with Crohn's disease who underwent
               perianal fistula surgery with or without infliximab infusion.
               METHODS: A retrospective chart review of 226 consecutive
               patients with Crohn's disease who underwent operative treatment
               with or without infliximab (3-6 infusions of 5 mg/kg) from March
               1991 through December 2005 was completed. Patients were
               classified as completely healed, minimally symptomatic (seton
               placement with minimal drainage and/or infliximab dependence),
               and failure (persistent or recurrent symptomatic fistula,
               diverting procedure, or proctectomy). RESULTS: A total of 226
               patients underwent operative treatment alone (n = 147) or in
               combination with infliximab infusion (n = 79). Age, gender, and
               preoperative history of intestinal and perianal Crohn's disease
               were similar between groups. Mean follow-up was 30 (range,
               6-216) months. Operative treatment consisted of seton drainage
               (n = 112), conventional fistulotomy (n = 92), fibrin glue
               injection (n = 14), advancement flap (n = 5), collagen plug
               insertion (n = 2), and transperineal repair (n = 1).
               Eighty-eight patients (60 percent) healed completely with
               operative treatment alone, and 47 patients (59 percent) healed
               after operative treatment in combination with infliximab (P =
               not significant). CONCLUSIONS: Operative treatment of perianal
               fistulas in patients with Crohn's disease resulted in complete
               healing in approximately 60 percent of patients. Preoperative
               infliximab infusion did not affect overall healing rates.",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  50,
  number    =  11,
  pages     = "1754--1760",
  month     =  nov,
  year      =  2007,
  language  = "en"
}
@ARTICLE{Kotze2014-fh,
  title     = "Perianal complete remission with combined therapy (seton
               placement and {anti-TNF} agents) in Crohn's disease: a Brazilian
               multicenter observational study",
  author    = "Kotze, Paulo Gustavo and Albuquerque, Idblan Carvalho de and da
               Luz Moreira, Andr{\'e} and Tonini, Wanessa Bertrami and
               Olandoski, Marcia and Coy, Claudio Saddy Rodrigues",
  abstract  = "BACKGROUND: Perianal fistulizing Crohn's disease is one of the
               most severe phenotypes of inflammatory bowel diseases. Combined
               therapy with seton placement and anti-TNF therapy is the most
               common strategy for this condition. OBJECTIVES: The aim of this
               study was to analyze the rates of complete perianal remission
               after combined therapy for perianal fistulizing Crohn's disease.
               METHODS: This was a retrospective observational study with
               perianal fistulizing Crohn's disease patients submitted to
               combined therapy from four inflammatory bowel diseases referral
               centers. We analyzed patients' demographic characteristics,
               Montreal classification, concomitant medication, classification
               of the fistulae, occurrence of perianal complete remission and
               recurrence after remission. Complete perianal remission was
               defined as absence of drainage from the fistulae associated with
               seton removal. DISCUSSION: A total of 78 patients were included,
               44 (55.8\%) females with a mean age of 33.8 ($\pm$15) years.
               Most patients were treated with Infliximab, 66.2\%, than with
               Adalimumab, 33.8\%. Complex fistulae were found in 52/78
               patients (66.7\%). After a medium follow-up of 48.2 months,
               41/78 patients (52.6\%) had complete perianal remission (95\%
               CI: 43.5\%-63.6\%). Recurrence occurred in four (9.8\%) patients
               (95\% CI: 0.7\%-18.8\%) in an average period of 74.8 months.
               CONCLUSIONS: Combined therapy lead to favorable and durable
               results in perianal fistulizing Crohn's disease.",
  journal   = "Arq. Gastroenterol.",
  publisher = "FapUNIFESP (SciELO)",
  volume    =  51,
  number    =  4,
  pages     = "284--289",
  month     =  oct,
  year      =  2014,
  language  = "en"
}
@ARTICLE{Regueiro2003-lf,
  title     = "Treatment of perianal fistulizing crohn's disease with
               infliximab alone or as an adjunct to exam under anesthesia with
               Seton placement",
  author    = "Regueiro, Miguel and Mardini, Houssam",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  9,
  number    =  2,
  pages     = "98--103",
  month     =  mar,
  year      =  2003,
  language  = "en"
}
@ARTICLE{Duricova2014-gf,
  title     = "Age-related differences in presentation and course of
               inflammatory bowel disease: an update on the population-based
               literature",
  author    = "Duricova, Dana and Burisch, Johan and Jess, Tine and
               Gower-Rousseau, Corinne and Lakatos, Peter L and {ECCO-EpiCom}",
  abstract  = "Current data indicate a change in the epidemiology of
               inflammatory bowel diseases. The disease has become more
               widespread and the rise in the incidence has been reported in
               all age groups including early childhood and according to recent
               data also the elderly population. Some earlier studies have
               suggested that the phenotype and natural history of the disease
               may be different according to age of onset. Recently the
               importance of age at onset was reported in two population-based
               studies from France and Hungary including both paediatric and
               adult onset inception cohorts. Early onset disease was
               associated with more frequent disease extension in both Crohn's
               disease and ulcerative colitis and in most but not all studies
               with higher frequency of complicated disease behaviour. This is
               also accompanied by striking differences in the medical
               management with earlier and more prevalent (2-3-fold) use of
               immunosuppressives and to some extent biologicals in patients
               with early compared to elderly-onset disease, especially in
               Crohn's disease. However, the results of population-based
               studies on impact of age on surgery rates in CrohnÂ´s disease as
               well as ulcerative colitis are conflicting. Furthermore,
               published data indicate that relative but not absolute risk of
               developing cancer and mortality is higher in patients with an
               early onset disease. Critical reviews that focus on the
               importance of age at onset in inflammatory bowel disease are
               rare. Therefore, the aim of this review is to describe the
               differences in epidemiology, clinical characteristics, and
               natural history of paediatric and elderly-onset inflammatory
               bowel disease based on studies performed in general population.",
  journal   = "J. Crohns. Colitis",
  publisher = "Oxford University Press (OUP)",
  volume    =  8,
  number    =  11,
  pages     = "1351--1361",
  month     =  nov,
  year      =  2014,
  keywords  = "Age at onset;; Disease phenotype;; Incidence;; Inflammatory
               bowel disease;; Mortality; Surgery;",
  language  = "en"
}
@ARTICLE{Kaur2016-bs,
  title     = "Perianal crohn's disease is associated with distal colonic
               disease, stricturing disease behavior, {IBD-associated}
               serologies and genetic variation in the {JAK-STAT} pathway",
  author    = "Kaur, Manreet and Panikkath, Deepa and Yan, Xiaofei and Liu,
               Zhenqiu and Berel, Dror and Li, Dalin and Vasiliauskas, Eric A
               and Ippoliti, Andrew and Dubinsky, Marla and Shih, David Q and
               Melmed, Gil Y and Haritunians, Talin and Fleshner, Phillip and
               Targan, Stephan R and McGovern, Dermot P B",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  22,
  number    =  4,
  pages     = "862--869",
  month     =  apr,
  year      =  2016
}

@ARTICLE{Van_Drongelen2017-dh,
  title     = "Human leukocyte antigen--disease associations in rheumatoid
               arthritis",
  author    = "van Drongelen, Vincent and Holoshitz, Joseph",
  journal   = "Rheum. Dis. Clin. North Am.",
  publisher = "Elsevier BV",
  volume    =  43,
  number    =  3,
  pages     = "363--376",
  month     =  aug,
  year      =  2017,
  language  = "en"
}
@ARTICLE{Raychaudhuri2012-em,
  title     = "Five amino acids in three {HLA} proteins explain most of the
               association between {MHC} and seropositive rheumatoid arthritis",
  author    = "Raychaudhuri, Soumya and Sandor, Cynthia and Stahl, Eli A and
               Freudenberg, Jan and Lee, Hye-Soon and Jia, Xiaoming and
               Alfredsson, Lars and Padyukov, Leonid and Klareskog, Lars and
               Worthington, Jane and Siminovitch, Katherine A and Bae,
               Sang-Cheol and Plenge, Robert M and Gregersen, Peter K and de
               Bakker, Paul I W",
  abstract  = "The genetic association of the major histocompatibility complex
               (MHC) to rheumatoid arthritis risk has commonly been attributed
               to alleles in HLA-DRB1. However, debate persists about the
               identity of the causal variants in HLA-DRB1 and the presence of
               independent effects elsewhere in the MHC. Using existing
               genome-wide SNP data in 5,018 individuals with seropositive
               rheumatoid arthritis (cases) and 14,974 unaffected controls, we
               imputed and tested classical alleles and amino acid
               polymorphisms in HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1,
               HLA-DQA1, HLA-DQB1 and HLA-DRB1, as well as 3,117 SNPs across
               the MHC. Conditional and haplotype analyses identified that
               three amino acid positions (11, 71 and 74) in HLA-DR$\beta$1 and
               single-amino-acid polymorphisms in HLA-B (at position 9) and
               HLA-DP$\beta$1 (at position 9), which are all located in
               peptide-binding grooves, almost completely explain the MHC
               association to rheumatoid arthritis risk. This study shows how
               imputation of functional variation from large reference panels
               can help fine map association signals in the MHC.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  44,
  number    =  3,
  pages     = "291--296",
  month     =  jan,
  year      =  2012,
  copyright = "https://www.springernature.com/gp/researchers/text-and-data-mining",
  language  = "en"
}


@ARTICLE{Akhlaghpour2023-jw,
  title    = "Genetic coding variant in complement factor {B} ({CFB}) is
              associated with increased risk for perianal Crohn's disease and
              leads to impaired {CFB} cleavage and phagocytosis",
  author   = "Akhlaghpour, Marzieh and Haritunians, Talin and More, Shyam K and
              Thomas, Lisa S and Stamps, Dalton T and Dube, Shishir and Li,
              Dalin and Yang, Shaohong and Landers, Carol J and Mengesha,
              Emebet and Hamade, Hussein and Murali, Ramachandran and Potdar,
              Alka A and Wolf, Andrea J and Botwin, Gregory J and Khrom,
              Michelle and {International IBD Genetics Consortium} and
              Ananthakrishnan, Ashwin N and Faubion, William A and Jabri, Bana
              and Lira, Sergio A and Newberry, Rodney D and Sandler, Robert S
              and Sartor, R Balfour and Xavier, Ramnik J and Brant, Steven R
              and Cho, Judy H and Duerr, Richard H and Lazarev, Mark G and
              Rioux, John D and Schumm, L Philip and Silverberg, Mark S and
              Zaghiyan, Karen and Fleshner, Phillip and Melmed, Gil Y and
              Vasiliauskas, Eric A and Ha, Christina and Rabizadeh, Shervin and
              Syal, Gaurav and Bonthala, Nirupama N and Ziring, David A and
              Targan, Stephan R and Long, Millie D and McGovern, Dermot P B and
              Michelsen, Kathrin S",
  abstract = "OBJECTIVE: Perianal Crohn's disease (pCD) occurs in up to 40\% of
              patients with CD and is associated with poor quality of life,
              limited treatment responses and poorly understood aetiology. We
              performed a genetic association study comparing CD subjects with
              and without perianal disease and subsequently performed
              functional follow-up studies for a pCD associated SNP in
              Complement Factor B (CFB). DESIGN: Immunochip-based meta-analysis
              on 4056 pCD and 11 088 patients with CD from three independent
              cohorts was performed. Serological and clinical variables were
              analysed by regression analyses. Risk allele of rs4151651 was
              introduced into human CFB plasmid by site-directed mutagenesis.
              Binding of recombinant G252 or S252 CFB to C3b and its cleavage
              was determined in cell-free assays. Macrophage phagocytosis in
              presence of recombinant CFB or serum from CFB risk, or protective
              CD or healthy subjects was assessed by flow cytometry. RESULTS:
              Perianal complications were associated with colonic involvement,
              OmpC and ASCA serology, and serology quartile sum score. We
              identified a genetic association for pCD (rs4151651), a
              non-synonymous SNP (G252S) in CFB, in all three cohorts.
              Recombinant S252 CFB had reduced binding to C3b, its cleavage was
              impaired, and complement-driven phagocytosis and cytokine
              secretion were reduced compared with G252 CFB. Serine 252
              generates a de novo glycosylation site in CFB. Serum from
              homozygous risk patients displayed significantly decreased
              macrophage phagocytosis compared with non-risk serum. CONCLUSION:
              pCD-associated rs4151651 in CFB is a loss-of-function mutation
              that impairs its cleavage, activation of alternative complement
              pathway, and pathogen phagocytosis thus implicating the
              alternative complement pathway and CFB in pCD aetiology.",
  journal  = "Gut",
  month    =  apr,
  year     =  2023,
  keywords = "IBD - GENETICS; INFLAMMATORY BOWEL DISEASE; META-ANALYSIS",
  language = "en"
}
% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kaur2016-ut,
  title     = "Perianal crohn's disease is associated with distal colonic
               disease, stricturing disease behavior, {IBD-associated}
               serologies and genetic variation in the {JAK-STAT} pathway",
  author    = "Kaur, Manreet and Panikkath, Deepa and Yan, Xiaofei and Liu,
               Zhenqiu and Berel, Dror and Li, Dalin and Vasiliauskas, Eric A
               and Ippoliti, Andrew and Dubinsky, Marla and Shih, David Q and
               Melmed, Gil Y and Haritunians, Talin and Fleshner, Phillip and
               Targan, Stephan R and McGovern, Dermot P B",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  22,
  number    =  4,
  pages     = "862--869",
  month     =  apr,
  year      =  2016
}

@ARTICLE{Park2019-kj,
  title     = "Update on the natural course of fistulizing perianal Crohn's
               disease in a population-based cohort",
  author    = "Park, Sang Hyoung and Aniwan, Satimai and Scott Harmsen, W and
               Tremaine, William J and Lightner, Amy L and Faubion, William A
               and Loftus, Edward V",
  abstract  = "BACKGROUND: This study sought to re-estimate the cumulative
               incidence of perianal or rectovaginal fistulas and the
               associated proctectomy rate in the prebiologic era vs the
               biologic era using a population-based cohort of Crohn's disease
               (CD) patients. METHODS: The medical records of 414 residents of
               Olmsted County, Minnesota, who were diagnosed with CD between
               1970 and 2010 were reviewed. The cumulative incidence of
               perianal or rectovaginal fistulas from time of CD diagnosis and
               the cumulative rate of proctectomy from date of first perianal
               or rectovaginal fistula diagnosis were estimated using the
               Kaplan-Meier method. RESULTS: Eighty-five patients (20.5\%)
               diagnosed with CD between 1970 and 2010 had at least 1 perianal
               or rectovaginal fistula episode between January 1, 1970, and
               June 30, 2016. The cumulative incidence of perianal or
               rectovaginal fistulas was 18\% after 10 years, 23\% after 20
               years, and 24\% after 30-40 years from CD diagnosis. The
               cumulative incidence of perianal or rectovaginal fistulas was
               significantly lower in patients diagnosed in 1998 or after than
               in patients diagnosed before 1998 (P = 0.03, log-rank). Among 85
               patients developing perianal or rectovaginal fistulas, 16
               patients (18.8\%) underwent proctectomy for the treatment of
               perianal or rectovaginal fistulas during follow-up. CONCLUSIONS:
               In a population-based inception cohort of CD, one-fifth of
               patients were diagnosed with at least 1 perianal or rectovaginal
               fistula. The cumulative probability of perianal or rectovaginal
               fistulizing disease has decreased over time.",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  25,
  number    =  6,
  pages     = "1054--1060",
  month     =  may,
  year      =  2019,
  keywords  = "Crohn's disease; natural history; perianal fistula; rectovaginal
               fistula",
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}
@ARTICLE{Molineros2019-mu,
  title     = "Amino acid signatures of {HLA} {Class-I} and {II} molecules are
               strongly associated with {SLE} susceptibility and autoantibody
               production in Eastern Asians",
  author    = "Molineros, Julio E and Looger, Loren L and Kim, Kwangwoo and
               Okada, Yukinori and Terao, Chikashi and Sun, Celi and Zhou,
               Xu-Jie and Raj, Prithvi and Kochi, Yuta and Suzuki, Akari and
               Akizuki, Shuji and Nakabo, Shuichiro and Bang, So-Young and Lee,
               Hye-Soon and Kang, Young Mo and Suh, Chang-Hee and Chung, Won
               Tae and Park, Yong-Beom and Choe, Jung-Yoon and Shim,
               Seung-Cheol and Lee, Shin-Seok and Zuo, Xiaoxia and Yamamoto,
               Kazuhiko and Li, Quan-Zhen and Shen, Nan and Porter, Lauren L
               and Harley, John B and Chua, Kek Heng and Zhang, Hong and
               Wakeland, Edward K and Tsao, Betty P and Bae, Sang-Cheol and
               Nath, Swapan K",
  abstract  = "Human leukocyte antigen (HLA) is a key genetic factor conferring
               risk of systemic lupus erythematosus (SLE), but precise
               independent localization of HLA effects is extremely
               challenging. As a result, the contribution of specific HLA
               alleles and amino-acid residues to the overall risk of SLE and
               to risk of specific autoantibodies are far from completely
               understood. Here, we dissected (a) overall SLE association
               signals across HLA, (b) HLA-peptide interaction, and (c)
               residue-autoantibody association. Classical alleles, SNPs, and
               amino-acid residues of eight HLA genes were imputed across 4,915
               SLE cases and 13,513 controls from Eastern Asia. We performed
               association followed by conditional analysis across HLA,
               assessing both overall SLE risk and risk of autoantibody
               production. DR15 alleles HLA-DRB1*15:01 (P = 1.4x10-27, odds
               ratio (OR) = 1.57) and HLA-DQB1*06:02 (P = 7.4x10-23, OR = 1.55)
               formed the most significant haplotype (OR = 2.33). Conditioned
               protein-residue signals were stronger than allele signals and
               mapped predominantly to HLA-DRB1 residue 13 (P = 2.2x10-75) and
               its proxy position 11 (P = 1.1x10-67), followed by HLA-DRB1-37
               (P = 4.5x10-24). After conditioning on HLA-DRB1, novel
               associations at HLA-A-70 (P = 1.4x10-8), HLA-DPB1-35 (P =
               9.0x10-16), HLA-DQB1-37 (P = 2.7x10-14), and HLA-B-9 (P =
               6.5x10-15) emerged. Together, these seven residues increased the
               proportion of explained heritability due to HLA to 2.6\%. Risk
               residues for both overall disease and hallmark autoantibodies
               (i.e., nRNP: DRB1-11, P = 2.0x10-14; DRB1-13, P = 2.9x10-13;
               DRB1-30, P = 3.9x10-14) localized to the peptide-binding groove
               of HLA-DRB1. Enrichment for specific amino-acid characteristics
               in the peptide-binding groove correlated with overall SLE risk
               and with autoantibody presence. Risk residues were in primarily
               negatively charged side-chains, in contrast with rheumatoid
               arthritis. We identified novel SLE signals in HLA Class I loci
               (HLA-A, HLA-B), and localized primary Class II signals to five
               residues in HLA-DRB1, HLA-DPB1, and HLA-DQB1. These findings
               provide insights about the mechanisms by which the risk residues
               interact with each other to produce autoantibodies and are
               involved in SLE pathophysiology.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  15,
  number    =  4,
  pages     = "e1008092",
  month     =  apr,
  year      =  2019,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}


% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{king-software,
  title     = "Robust relationship inference in genome-wide association studies",
  author    = "Manichaikul, Ani and Mychaleckyj, Josyf C and Rich, Stephen S
               and Daly, Kathy and Sale, Mich{\`e}le and Chen, Wei-Min",
  abstract  = "MOTIVATION: Genome-wide association studies (GWASs) have been
               widely used to map loci contributing to variation in complex
               traits and risk of diseases in humans. Accurate specification of
               familial relationships is crucial for family-based GWAS, as well
               as in population-based GWAS with unknown (or unrecognized)
               family structure. The family structure in a GWAS should be
               routinely investigated using the SNP data prior to the analysis
               of population structure or phenotype. Existing algorithms for
               relationship inference have a major weakness of estimating
               allele frequencies at each SNP from the entire sample, under a
               strong assumption of homogeneous population structure. This
               assumption is often untenable. RESULTS: Here, we present a rapid
               algorithm for relationship inference using high-throughput
               genotype data typical of GWAS that allows the presence of
               unknown population substructure. The relationship of any pair of
               individuals can be precisely inferred by robust estimation of
               their kinship coefficient, independent of sample composition or
               population structure (sample invariance). We present simulation
               experiments to demonstrate that the algorithm has sufficient
               power to provide reliable inference on millions of unrelated
               pairs and thousands of relative pairs (up to 3rd-degree
               relationships). Application of our robust algorithm to HapMap
               and GWAS datasets demonstrates that it performs properly even
               under extreme population stratification, while algorithms
               assuming a homogeneous population give systematically biased
               results. Our extremely efficient implementation performs
               relationship inference on millions of pairs of individuals in a
               matter of minutes, dozens of times faster than the most
               efficient existing algorithm known to us. AVAILABILITY: Our
               robust relationship inference algorithm is implemented in a
               freely available software package, KING, available for download
               at http://people.virginia.edu/âˆ¼wc9c/KING.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  26,
  number    =  22,
  pages     = "2867--2873",
  month     =  nov,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Mbatchou2021-qm,
  title     = "Computationally efficient whole-genome regression for
               quantitative and binary traits",
  author    = "Mbatchou, Joelle and Barnard, Leland and Backman, Joshua and
               Marcketta, Anthony and Kosmicki, Jack A and Ziyatdinov, Andrey
               and Benner, Christian and O'Dushlaine, Colm and Barber, Mathew
               and Boutkov, Boris and Habegger, Lukas and Ferreira, Manuel and
               Baras, Aris and Reid, Jeffrey and Abecasis, Goncalo and Maxwell,
               Evan and Marchini, Jonathan",
  abstract  = "Genome-wide association analysis of cohorts with thousands of
               phenotypes is computationally expensive, particularly when
               accounting for sample relatedness or population structure. Here
               we present a novel machine-learning method called REGENIE for
               fitting a whole-genome regression model for quantitative and
               binary phenotypes that is substantially faster than alternatives
               in multi-trait analyses while maintaining statistical
               efficiency. The method naturally accommodates parallel analysis
               of multiple phenotypes and requires only local segments of the
               genotype matrix to be loaded in memory, in contrast to existing
               alternatives, which must load genome-wide matrices into memory.
               This results in substantial savings in compute time and memory
               usage. We introduce a fast, approximate Firth logistic
               regression test for unbalanced case-control phenotypes. The
               method is ideally suited to take advantage of distributed
               computing frameworks. We demonstrate the accuracy and
               computational benefits of this approach using the UK Biobank
               dataset with up to 407,746 individuals.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  7,
  pages     = "1097--1103",
  month     =  jul,
  year      =  2021,
  language  = "en"
}


@ARTICLE{1000gphc,
  title     = "High-coverage whole-genome sequencing of the expanded 1000
               Genomes Project cohort including 602 trios",
  author    = "Byrska-Bishop, Marta and Evani, Uday S and Zhao, Xuefang and
               Basile, Anna O and Abel, Haley J and Regier, Allison A and
               Corvelo, Andr{\'e} and Clarke, Wayne E and Musunuri, Rajeeva and
               Nagulapalli, Kshithija and Fairley, Susan and Runnels, Alexi and
               Winterkorn, Lara and Lowy, Ernesto and {Human Genome Structural
               Variation Consortium} and {Paul Flicek} and Germer, Soren and
               Brand, Harrison and Hall, Ira M and Talkowski, Michael E and
               Narzisi, Giuseppe and Zody, Michael C",
  abstract  = "The 1000 Genomes Project (1kGP) is the largest fully open
               resource of whole-genome sequencing (WGS) data consented for
               public distribution without access or use restrictions. The
               final, phase 3 release of the 1kGP included 2,504 unrelated
               samples from 26 populations and was based primarily on
               low-coverage WGS. Here, we present a high-coverage 3,202-sample
               WGS 1kGP resource, which now includes 602 complete trios,
               sequenced to a depth of 30X using Illumina. We performed
               single-nucleotide variant (SNV) and short insertion and deletion
               (INDEL) discovery and generated a comprehensive set of
               structural variants (SVs) by integrating multiple analytic
               methods through a machine learning model. We show gains in
               sensitivity and precision of variant calls compared to phase 3,
               especially among rare SNVs as well as INDELs and SVs spanning
               frequency spectrum. We also generated an improved reference
               imputation panel, making variants discovered here accessible for
               association studies.",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  185,
  number    =  18,
  pages     = "3426--3440.e19",
  month     =  sep,
  year      =  2022,
  keywords  = "1000 Genomes Project; INDEL; SNV; population genetics; reference
               imputation panel; structural variation; trio sequencing;
               whole-genome sequencing",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}


% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{1000gp,
  title     = "A global reference for human genetic variation",
  author    = "The 1000 Genomes Project Consortium",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  526,
  number    =  7571,
  pages     = "68--74",
  month     =  oct,
  year      =  2015,
  copyright = "https://creativecommons.org/licenses/by-nc-sa/3.0/",
  language  = "en"
}





